UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
[X]
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2008
OR
[
] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission file number 1-8323
CIGNA Corporation
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
(State or other jurisdiction of
|
|
06-1059331
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
|
|
|
Two Liberty Place, Philadelphia, Pennsylvania
|
|
19192
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code (215) 761-1000
Securities registered pursuant to section 12(b) of the Act
:
|
|
|
|
|
Name of each exchange on
|
Title of each class
|
|
which registered
|
Common Stock, Par Value $0.25
|
|
New York Stock Exchange, Inc.
|
Securities registered pursuant to section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act.
Yes
X
No ___
Indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or Section 15(d) of the Act.
Yes ___No
X
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes
X
No ___
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, or a smaller reporting company.
See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large
accelerated filer [X ]
|
|
Accelerated filer
[ ]
|
|
Non-accelerated filer [ ]
|
|
Smaller Reporting Company [ ]
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes ___No
X
The aggregate market value of the voting stock held by non-affiliates of the registrant as of
June 30, 2008 was approximately
$13.2 billion.
As of January 30, 2009, 271,037,887 shares of the registrants Common Stock were outstanding.
Part III of this Form 10-K incorporates by reference information from the registrants proxy
statement to be dated on or about
March 19, 2009.
PART I
Item 1.
BUSINESS
A. Description of Business
CIGNA Corporation and its subsidiaries constitute one of the largest investor-owned health
service organizations in the United States. Its subsidiaries are major providers of health care
and related benefits, the majority of which are offered through the workplace, including: health
care products and services; group disability, life and accident insurance; and workers
compensation case management and related services. The Company also has certain inactive
businesses, including a run-off reinsurance operation. CIGNA Corporation had consolidated
shareholders equity of $3.6 billion and assets of $41.4 billion as of December 31, 2008, and
revenues of $19.1 billion for the year then ended. CIGNAs major insurance subsidiary, Connecticut
General Life Insurance Company (CG Life), traces its origins to 1865. CIGNA Corporation was
incorporated in the State of Delaware in 1981.
As used in this document, CIGNA and the Company may refer to CIGNA Corporation itself, one
or more of its subsidiaries, or CIGNA Corporation and its consolidated subsidiaries. CIGNA
Corporation is a holding company and is not an insurance company. Its subsidiaries conduct various
businesses, which are described in this Form 10-K.
CIGNAs revenues are derived principally from premiums, fees, mail order pharmacy, other
revenues and investment income. The financial results of CIGNAs businesses are reported in the
following segments:
|
|
Health Care;
|
|
|
|
Disability and Life;
|
|
|
|
International;
|
|
|
|
Run-off Reinsurance; and
|
|
|
|
Other Operations.
|
Available Information
Our annual, quarterly and current reports, proxy statements and other information are also
made available free of charge on our website (http://www.cigna.com, under the InvestorsSEC
Filings captions) as soon as reasonably practicable after we electronically file these materials
with, or furnish them to, the Securities and Exchange Commission (the SEC). We use our website
as a channel of distribution for material company information. Important information, including
[news releases, analyst presentations and financial information] regarding CIGNA is routinely
posted on and accessible at www.cigna.com. See Code of Ethics and Other Corporate Governance
Disclosures in Part III, Item 10 on page 140 of this Form 10-K for additional available
information.
B. Financial Information about Business Segments
The financial information included herein is in conformity with accounting principles
generally accepted in the United States of America (GAAP), unless otherwise indicated. Certain
reclassifications have been made to prior years financial information to conform to the 2008
presentation. Industry rankings and percentages set forth herein are for the year ended December
31, 2007, unless otherwise indicated. Unless otherwise noted, statements set forth in this
document concerning CIGNAs rank or position in an industry or particular line of business have
been developed internally, based on publicly available information.
Financial data for each of CIGNAs business segments is set forth in Note 21 to the
Consolidated Financial Statements beginning on page 130 of this Form 10-K.
C. Health Care
CIGNAs Health Care segment (CIGNA HealthCare) offers insured and self-funded medical,
dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs
and other products and services that may be integrated to provide individuals with comprehensive
health care benefit programs. CIGNA HealthCare also provides disability and life insurance
products
1
that were historically sold in connection with certain experience-rated medical products.
These products and services are provided and administered by subsidiaries of CIGNA Corporation.
CIGNA HealthCare is focused on helping to improve the health, well-being and security of the
individuals which it serves. CIGNA HealthCare believes the most sustainable approach to enhancing
quality and managing health care costs is to fully engage customers in their own health care.
Therefore, CIGNA HealthCare seeks to engage its members by providing actionable information about
health and advocacy programs, including information about the cost and quality of care that members
can use to make informed choices about health care for themselves and their families.
Underlying CIGNA HealthCares operations is a foundation of clinical expertise and an ability
to provide quality service. CIGNA HealthCares strengths include: (1) its ability to integrate
medical and specialty product offerings to achieve a more holistic and integrated approach to
members health that promotes consistent case management; and (2) its ability to provide predictive
modeling and other analytical tools (for example, through the Companys exclusive access to
analytical tools and algorithms developed by the University of Michigan), to assist in providing
targeted outreach and health advocacy by CIGNAs clinical professionals to CIGNA HealthCare
members.
Principal Products and Services and Funding Arrangements
With the exception of HMO and Medicare Part D products, each of CIGNA HealthCares products
(as described below) is offered with multiple funding options (also described below). CIGNA may
sell multiple products under the same funding arrangement to the same employer. Accordingly, the
revenue table included in the Health Care section of the Managements Discussion and Analysis
(MD&A) beginning on page 54 reflects both the product type and funding arrangement as well as the
impact from the acquisition in April of 2008 of Great-West Healthcare, the health care division of
Great-West Life & Annuity Insurance Company. CIGNA HealthCare companies offer products and
services in all 50 states, the District of Columbia, Puerto Rico and the US Virgin Islands.
Medical
CIGNA HealthCare provides a wide array of products and services to meet the needs of employers
and other sponsors of health benefit plans and the employees and dependents participating in these
plans, including:
|
|
Network and Open Access Plus Plans
.
CIGNA HealthCare offers a product line of
indemnity managed care benefit plans. All indemnity benefit plans in the managed care product
line use meaningful coinsurance differences for in-network versus out-of-network care,
give members the option of selecting a primary care physician, and use a national provider
network, which is somewhat smaller than the national network used with the preferred provider
(PPO) plan product line. The Network, Network Open Access, and Open Access Plus In-Network
(OAPIN) products cover only those services provided by CIGNA HealthCare participating
(in-network) providers and emergency services provided by non-participating
(out-of-network) providers. The Network POS, Network POS Open Access and Open Access Plus
plans cover health care services provided by participating (in-network), and
non-participating (out-of-network) health care providers.
|
|
|
|
Preferred Provider (PPO) Plans
.
CIGNA HealthCare also offers a PPO product line
that features a broader national network with generally less favorable provider discounts than
the managed care products described above, no requirement to select a primary care physician,
and in-network and out-of-network coverage, but with lesser benefit incentives to encourage
the use of participating providers.
|
|
|
|
Health Maintenance Organizations (HMOs)
.
HMOs are required by law to provide
coverage for all basic health services. They use various tools to facilitate the appropriate
use of health care services through employed and/or contracted health care providers. HMOs
control unit costs by negotiating rates of reimbursement with providers and by requiring that
certain treatments be authorized for coverage in advance. CIGNA HealthCare offers HMO plans
that require members to obtain all non-emergency services from participating providers as well
as point of service (POS) HMO plans that also provide a lesser level of insurance coverage
for out-of-network care from non-participating providers.
|
|
|
|
Voluntary Plans
. CIGNA HealthCares voluntary medical products are offered to
employers with 51 or more eligible employees and are designed to meet the needs of the working
uninsured (such as hourly or part-time employees) by offering more limited and more affordable
coverage than traditional major medical plans.
|
2
|
|
|
CIGNA Choice Fund
®
, Health Reimbursement Arrangements (HRAs), Health
Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs)
.
In connection with
many of the products described above, CIGNA HealthCare offers the
CIGNA Choice Fund
suite of consumer-directed products, including HRA, HSA and FSA options. An HRA allows
employers to choose from a variety of benefit plan designs and for employees to fund
un-reimbursed health care expenses with reimbursement account funds that can be rolled over
from year to year. HSA plans allow employers to choose from a variety of benefit plan designs
and funding options and combine a high deductible payment feature for a health plan with a
tax-preferred savings account offering mutual fund investment options. Funds in an HSA can be
used to pay the deductible and for other eligible tax-deductible medical expenses. In
connection with its consumer-directed products, CIGNA HealthCare offers Custom Benefit
Builder
SM
, a tool that allows members to customize plan options including
co-payments and deductible levels, to create a personalized benefit design that meets their
individual needs. In 2007, CIGNA HealthCare expanded the availability of its HRA plans to
smaller businesses with 51-200 employees and also began offering an integrated HSA product to
this segment. The HRA and HSA products for employers with 51-200 employees are now available
in 49 states.
|
|
|
|
Stop-Loss Coverage
.
CIGNA HealthCare offers stop-loss insurance coverage to both
experience-rated and self-insured plans. This stop-loss coverage reimburses the plan for
claims in excess of some predetermined amount, either for individuals (specific) or the
entire group (aggregate), or both.
|
|
|
|
Shared Administration Services
.
CIGNA HealthCare makes shared administration
products available to self-insured Taft-Hartley trusts and other groups. CIGNA HealthCare
provides these self-insured plans access to its national provider network and provides claim
re-pricing and other services (e.g. utilization management).
|
Specialty
Health Advocacy and CareAllies
®
. Through its CareAllies brand, CIGNA HealthCare
offers medical management, disease management, and health advocacy services to employers and other
plan sponsors. CareAllies services are not only offered to members covered under CIGNA HealthCare
administered plans but also to those employees who have elected coverage under a plan offered
through their employer by competing insurers/third party administrators. CareAllies offers a
consistent set of services to address the clinical and administrative inconsistencies that are
inherent in the multi-vendor approach. Through its health advocacy programs, CIGNA HealthCare
works to:
|
|
help healthy people stay healthy;
|
|
|
|
help people change behaviors that are putting their health at risk;
|
|
|
|
help people with existing health care issues access quality care and practice healthy
self-care; and
|
|
|
|
help people with a disabling illness or injury return to productive work quickly and
safely.
|
In addition, CIGNA HealthCare offers a wide array of programs and services to help individuals
improve the health of the mind and body, including:
|
|
early intervention by CIGNAs network of approximately 2,400 clinical professionals;
|
|
|
|
CIGNAs online health assessment, powered by analytics from the University of Michigan
Health Management Research Center, which helps members identify potential health risks and
learn what they can do to live a healthier life;
|
|
|
|
the CIGNA Well Aware for Better Health
®
program, which helps patients with
chronic conditions such as asthma, diabetes, depression and weight complications better manage
their conditions;
|
|
|
|
CIGNA Health Advisor
®
, one of our fastest-growing offerings, which provides
members with access to a personal health coach to help them reach their health and wellness
goals;
|
|
|
|
CIGNAs Well Informed program (first available in January 2008), which uses clinical
rules-based software to identify potential gaps and omissions in members health care through
analysis of the Companys integrated medical, behavioral, pharmacy and lab data allowing CIGNA
HealthCare to communicate the gaps to the member and the members doctor; and
|
3
|
|
CIGNAs online coaching capabilities.
|
Behavioral Health
.
CIGNA Behavioral Health arranges for the provision of behavioral
health care services to individuals through its network of participating behavioral health care
providers, offers behavioral health care management services, employee assistance programs, and
work/life programs to employer sponsored benefit plans, HMOs, governmental entities and disability
insurers. CIGNA Behavioral Health focuses on integrating its programs and services to facilitate
customized, holistic care.
As of December 31, 2008, CIGNA Behavioral Healths national network had approximately 66,800
access points to independent psychiatrists, psychologists and clinical social workers and
approximately 5,600 facilities and clinics that are reimbursed on a contracted fee-for-service
basis.
In 2008, CIGNA completed its integration of the CIGNA Behavioral Health, vielife® and
CareAllies brands and operations into a unified Health Solutions unit that supports CIGNAs health
advocacy strategy and manages the delivery of the Companys health and wellness programs,
including: condition and disease management, maternity management, case management, lifestyle
management, health coaching (including online), employee assistance, work/life balance, mental
health and substance abuse, health assessment, oncology support, transplant network/management,
24-hour health information line, wellness consulting, and the Healthy
Rewards® discount
program.
Dental
. CIGNA Dental Health offers a variety of dental care products including dental
health maintenance organization (DHMO), dental preferred provider organization (DPPO), dental
exclusive provider organization (DEPO), traditional indemnity products and a dental discount
program. Customers can purchase CIGNA Dental Health products as stand-alone products or integrated
with CIGNA HealthCares medical products. As of December 31, 2008, CIGNA Dental Health members
totaled approximately 10.6 million, representing employees at more than one-third of all Fortune
100 companies. Managed dental care products are offered in 36 states and the District of Columbia
through a network of independent providers that have contracted with CIGNA Dental Health to provide
dental services to members.
CIGNA Dental Health members access care from one of the largest dental HMO and dental PPO
networks in the U.S., with approximately 110,000 DPPO-contracted access points (approximately
56,000 unique providers) and approximately 41,500 dental HMO-contracted access points
(approximately 10,500 unique providers).
CIGNA Dental Health stresses preventive dentistry; it believes that promoting preventive care
contributes to a healthier workforce, an improved quality of life, increased productivity and fewer
treatment claims and associated costs over time. CIGNA Dental Health offers members a dental
treatment cost estimator to educate individuals on oral health and aid them in their dental health
care decision-making.
Vision.
CIGNA Vision offers flexible, cost-effective PPO coverage that includes a
range of both in and out-of-network benefits for routine vision services. CIGNAs national vision
care network, which consists of over 40,000 providers in approximately 20,000 locations, includes
private practice ophthalmologist and optometrist offices, as well as retail eye care centers.
Routine vision products are offered in conjunction with CIGNA HealthCares medical and dental
product offerings.
Pharmacy
. CIGNA Pharmacy offers prescription drug plans to its insured and
self-funded members both in conjunction with its medical products and on a stand-alone basis. With
a nationwide network of approximately 58,000 contracted pharmacies, CIGNA Pharmacy is a
comprehensive pharmacy benefits manager offering clinical integration programs, specialty pharmacy
solutions, and fast, efficient home delivery pharmacy capabilities that improve outcomes and reduce
costs for a
Return On Health®.
Programs that reflect this integration of medical, behavioral and pharmacy offerings include:
|
|
Well Informed
. CIGNAs Well Informed program focuses on the chronic conditions most likely
to benefit from disciplined prescription therapy, such as asthma, diabetes, back pain and high
cholesterol.
|
|
|
|
Cost Management Programs
. CIGNAs cost management programs motivate individuals and
physicians to take positive steps in the treatment of acute, chronic and complex conditions.
For example,
Step Therapy
is a Cost Management program that encourages individuals to use
generic drugs and low-cost alternatives for anti-ulcer, hypertension, and high cholesterol
medications through communications with the individual and the individuals physician.
|
4
|
|
Specialty Pharmacy Solutions
. As an integrated payor, CIGNA HealthCare is uniquely
positioned to manage holistic care for individuals with chronic conditions. This approach
allows individuals to access medication in the most appropriate setting based on their unique
circumstances. This results in less confusion and disruption in care, which in turn promotes
medication adherence and healthier outcomes.
|
|
|
CIGNA Tel-Drug® Home Delivery Pharmacy
. CIGNA HealthCare also offers cost-effective mail
order, telephone and on-line pharmaceutical fulfillment services through its home delivery
operation. CIGNA Tel-Drug Home Delivery Pharmacy provides an individual-focused, efficient
home delivery pharmacy with high standards of quality, accuracy and individual care relating
to maintenance and specialty medications. Orders may be submitted through the mail, via phone
or through the internet at myCIGNA.com.
|
|
|
|
CIGNA HealthCare also offers a suite of online tools to individuals, including our
award-winning
Prescription Drug Price Quote Tool
, which empowers individuals with actionable
information that helps them maximize their benefits and lower their out-of-pocket costs.
|
Medicare Part D
. CIGNAs Medicare Part D prescription drug program, CIGNA Medicare Rx
®
, provides a number of plan options as well as service and information support to
Medicare-eligible members aged 65 and over. CIGNA Medicare Rx
is available in all 50
states and the District of Columbia.
Retail Pharmacies
.
CIGNA HealthCare operates 19 retail pharmacies, including on-site
retail pharmacies for members to serve the needs of CIGNA HealthCare members.
Funding Arrangements
The segments health care products and services are offered through the following funding
arrangements:
|
|
guaranteed cost;
|
|
|
|
retrospectively experience-rated (including minimum premium funding arrangements); and
|
|
|
|
administrative service.
|
Guaranteed Cost
.
Under guaranteed cost funding arrangements, group policyholders pay
a fixed premium and CIGNA HealthCare bears the risk for claims and costs that exceed the premium.
Some insurance policies are offered on a guaranteed cost basis. The HMO product is offered only on
a guaranteed cost basis.
Retrospectively Experience-rated (including Minimum Premium)
.
Under insurance
policies using a retrospectively experience-rated funding arrangement, a premium that typically
includes a margin to partially protect against adverse claim fluctuations is determined at the
beginning of the policy period. CIGNA HealthCare generally bears the risk if claims and expenses
exceed this premium, but has the potential to recover any deficit from margins in future years if
the policy is renewed. For additional discussion, see Pricing, Reserves and Reinsurance later in
this section of the 10-K.
Under insurance policies using a minimum premium funding arrangement, instead of paying a
fixed monthly premium, the group policyholder establishes and funds a bank account and authorizes
the insurer to draw upon funds in the account to pay claims and other authorized expenses. The
policyholder pays a significantly reduced monthly residual premium while the policy is in effect
and a supplemental premium (to cover reserves for run-out claims and administrative expenses) upon
termination. Minimum premium funding arrangements combine insurance protection with an element of
self-funding. The policyholder is responsible for funding all claims up to a predetermined
aggregate, maximum amount, and CIGNA HealthCare bears the risk for claim costs incurred in excess
of that amount. CIGNA HealthCare has the potential to recover this deficit from margins in future
years if the policy is renewed. Accordingly, minimum premium funding arrangements have a risk
profile similar to retrospectively experience-rated insurance arrangements.
Administrative Service
.
Under the administrative service funding arrangement, CIGNA
HealthCare contracts with employers on an administrative services only (ASO) basis to administer
claims and perform other plan related services. CIGNA HealthCare collects administrative service
fees in exchange for providing ASO plans with access to CIGNA HealthCares applicable participating
provider network and for providing other services and programs including: quality management;
utilization management; cost
5
containment; health advocacy; 24-hour help line; case management; disease management; pharmacy
benefit management; behavioral health care management services (through its provider networks); or
any combination of the services. The employer/plan sponsor is responsible for self-funding all
claims, but may purchase stop-loss insurance from CIGNA HealthCare or other insurers for claims in
excess of a predetermined amount, for either individuals (specific), the entire group
(aggregate), or both.
In 2008, CIGNA purchased Great-West Healthcare, the healthcare division of Great-West Life &
Annuity Insurance Company (Great-West). Great-West Healthcare has historically offered similar
products and services through similar funding arrangements, although Great-West Healthcare focused
on smaller customers, and as a result, a substantially higher portion of the claims in their book
of business are covered by some type of stop-loss arrangement.
Financial information, including premiums and fees is presented in the Health Care section of
the MD&A beginning on page 54 and Note 21 to CIGNAs
Consolidated Financial Statements beginning on page 130.
Service and Quality
CIGNA HealthCare operates eleven service centers that together processed approximately 122
million medical claims in 2008. Satisfying customers and members is a primary business objective
and critical to the Companys success. To address a variety of member issues, CIGNA HealthCare
offers members access to its grievance and appeals processes. CIGNA operates six member service
centers that members can call toll-free to address requests for information and complaints and
grievances. CIGNA HealthCare customer service representatives are empowered to immediately resolve
a wide range of issues to help members obtain the most from their benefit plan. In many cases, a
customer service representative can resolve the members issue. If an issue cannot be resolved
informally, CIGNA HealthCare has a formal appeals process that can be initiated by telephone or in
writing and involves two levels of internal review. For those matters not resolved by internal
reviews, CIGNA HealthCare members are offered the option of a voluntary external review of claims.
The CIGNA HealthCare formal appeals process addresses member inquiries and appeals concerning
initial coverage determinations based on medical necessity and other benefits/coverage
determinations. CIGNA HealthCares formal appeals process meets National Committee for Quality
Assurance (NCQA), Employee Retirement Income Security Act (ERISA), Utilization Review
Accreditation Commission (URAC) and/or applicable state regulatory requirements.
CIGNA HealthCares commitment to promoting quality care and service to its members is
reflected in a variety of activities including: the credentialing of medical providers and
facilities that participate in CIGNA HealthCares Managed Care and PPO networks; the development of
the CIGNA Care
®
specialist physician designation described below, and participation in
initiatives that provide information to members to enable educated health care decision-making.
Participating Provider Network
. CIGNA HealthCare has an extensive national network of
participating health care providers, which as of December 31, 2008 consisted of approximately 5,200
hospitals and approximately 573,000 providers as well as other facilities, pharmacies and vendors
of health care services and supplies (these hospital and provider counts exclude the impact of the
Great-West Healthcare acquisition). As part of the purchase of Great-West Healthcare, CIGNA
acquired the participating provider network of Great-West Healthcare. In many cases, the providers
in the Great-West Healthcare network were already in the CIGNA HealthCare participating provider
network, however, the acquisition has expanded and strengthened CIGNA HealthCares network in some
regions of the country. CIGNA HealthCare is in the process of consolidating the network it
acquired from Great-West with its existing participating provider network. As of December 31,
2007, CIGNA HealthCares national network of participating health care providers consisted of
approximately 5,100 hospitals and approximately 542,000 providers.
In most instances, CIGNA HealthCare contracts directly with the participating provider to
provide covered services to members at agreed-upon rates of reimbursement. In some instances,
however, CIGNA HealthCare companies contract with third parties for access to their provider
networks. In addition, CIGNA HealthCare has entered into strategic alliances with several regional
managed care organizations (Tufts Health Plan, HealthPartners, Inc., Health Alliance Plan, and MVP
Health Plan) to gain access to their provider networks and discounts.
CIGNA Care
®
.
CIGNA Care
is a benefit design option available
for CIGNA HealthCare administered plans in 57 service areas across the country. CIGNA Care is a
subset of participating physicians in certain specialties who are designated as CIGNA Care
physicians based on specific clinical quality and cost-efficiency selection criteria. Members pay
reduced co-payments or co-insurance when they receive care from a specialist designated as a CIGNA
Care provider. CIGNA participating specialists are evaluated annually for the CIGNA Care
designation.
6
Provider Credentialing
.
CIGNA HealthCare credentials physicians, hospitals and other
health care providers in its participating provider networks using quality criteria which meet or
exceed the standards of external accreditation or state regulatory agencies, or both. Typically,
most providers are re-credentialed every three years.
Health Plan Credentialing
.
Each of CIGNA HealthCares 23 HMO and POS plans that have
undergone an accreditation review have earned the highest rating possible Excellent from the
NCQA and have earned Distinction for NCQAs Quality Plus Member Connections and Physician and
Hospital Quality standards. The Member Connections standards assess a plans web-based and
telephonic consumer decision support tools. The Physician and Hospital Quality standards assess
how well a plan provides members with information about physicians and hospitals in its network to
help consumers make informed health care decisions. In early 2008, CIGNA HealthCare received
Full accreditation (the highest rating possible) from NCQA for its PPO plans and for CIGNAs Open
Access Plus plans nationwide. The case management and utilization management programs provided to
CIGNA HealthCare members have been awarded full accreditation by URAC.
HEDIS
®
Measures
.
In addition, CIGNA HealthCare participates in NCQAs
Health Plan Employer Data and Information Set (HEDIS
®
) Quality Compass Report.
HEDIS
®
Effectiveness of Care measures are a standard set of metrics to evaluate the
effectiveness of managed care clinical programs. CIGNA HealthCares national results compare
favorably to industry averages.
Technology.
CIGNA HealthCare understands the critical importance of information
technology to the level of service the Company is able to provide to its members and to the
continued growth of the health care business. The health care marketplace is evolving and the level
of service that is acceptable to consumers today may not be acceptable tomorrow. Therefore, CIGNA
HealthCare continues to invest in its information technology infrastructure and capabilities
including technology essential to fundamental claim administration and customer service, as well as
tools and Internet-enabled technology that support CIGNA HealthCares focus on engaging members in
health care decisions.
For example, CIGNA HealthCare has developed a range of member decision support tools
including:
|
|
myCIGNA.com, CIGNAs consumer Internet portal. The portal is personalized with each
members CIGNA medical, dental and pharmacy plan information;
|
|
|
|
myCignaPlans.com, a website which allows prospective members to compare plan coverage and
pricing options, before enrolling, based on a variety of factors. The application gives
members information on the total health care cost to them and their employer;
|
|
|
|
a number of interactive online cost and quality information tools that compare hospital
quality and efficiency information, prescription drug choices and average price estimates and
member-specific average out-of-pocket cost estimates for certain medical procedures; and
|
|
|
|
Health Risk Assessment, an online interactive tool through which members can identify
potential health risks and monitor their health status.
|
In addition, a special website designed for seniors was launched in 2007 to offer customized
features as well as access to both the myCIGNA.com and cigna.com websites.
Pricing, Reserves and Reinsurance
Premiums and fees charged for HMO and most health insurance products and life insurance
products are generally set in advance of the policy period and are guaranteed for one year.
Premium rates for fully insured products are established either on a guaranteed cost basis or on a
retrospectively experience-rated basis.
Charges to customers established on a guaranteed cost basis at the beginning of the policy
period cannot be adjusted to reflect actual claim experience during the policy period. A
guaranteed cost pricing methodology reflects assumptions about future claims, health care inflation
(unit cost, location of delivery of care and utilization), effective medical cost management,
expenses, credit risk, enrollment mix, investment returns, and profit margins. Claim and expense
assumptions may be based in whole or in part on prior experience of the account or on a pool of
accounts, depending on the group size and the statistical credibility of the experience.
Generally, guaranteed cost groups are smaller and less statistically credible than retrospectively
experience-rated groups. In addition, pricing for health care products that use networks of
contracted providers reflects assumptions about the impact of the reimbursement rates in the
provider contracts on future claims. Premium rates may vary among accounts to reflect the
anticipated contract mix,
7
family size, industry, renewal date, and other cost-predictive factors. In some states, premium
rates must be approved by the state insurance departments, and state laws may restrict or limit the
use of rating methods.
Premiums established for retrospectively experience-rated business may be adjusted for the
actual claim and, in some cases, administrative cost experience of the account through an
experience settlement process subsequent to the policy period. To the extent that the cost
experience is favorable in relation to the prospectively determined premium rates, a portion of the
initial premiums may be credited to the policyholder as an experience refund. If claim experience
is adverse in relation to the initial premiums, CIGNA HealthCare may recover the resulting
experience deficit, according to contractual provisions, through future premiums and experience
settlements, provided the policy remains in force.
CIGNA HealthCare contracts on an ASO basis with customers who fund their own claims. CIGNA
HealthCare charges these customers administrative fees based on the expected cost of administering
their self-funded programs. In some cases, CIGNA HealthCare provides performance guarantees
associated with meeting certain service related and other performance standards. If these
standards are not met, CIGNA HealthCare may be financially at risk up to a stated percentage of the
contracted fee or a stated dollar amount. CIGNA HealthCare establishes liabilities for estimated
payouts associated with these guarantees.
In addition to paying current benefits and expenses under HMO and health insurance policies,
CIGNA HealthCare establishes reserves for amounts estimated to settle reported claims not yet paid,
as well as claims incurred, but not yet reported. Also, liabilities are established for estimated
experience refunds based on the results of retrospectively experience-rated policies and applicable
contract terms.
As of December 31, 2008, approximately $1.0 billion, or 65% of the reserves of CIGNA
HealthCares operations comprise liabilities that are likely to be paid within one year, primarily
for medical and dental claims, as well as certain group disability and life insurance claims. Of
the reserve amount expected to be paid within one year, $202 million relates to amounts recoverable
from certain ASO customers and from minimum premium policyholders, and is offset by a receivable.
The remaining reserves related primarily to contracts that are short term in nature, but have long
term payouts and include liabilities for group long-term disability insurance benefits and group
life insurance benefits for disabled and retired individuals, benefits paid in the form of both
life and non-life contingent annuities to survivors and contractholder deposit funds.
CIGNA HealthCare credits interest on experience refund balances to retrospectively
experience-rated policyholders through rates that are set by CIGNA HealthCare taking investment
performance and market rates into consideration. Generally, for interest-crediting rates set at
CIGNA HealthCares discretion, higher rates are credited to funds with longer terms reflecting the
fact that higher yields are generally available on investments with longer maturities. For 2008,
the rates of interest credited ranged from 2.75% to 4.00%, with a weighted average rate of 3.15%.
The profitability of CIGNA HealthCares fully insured health care products depends on the
adequacy of premiums charged relative to claims and expenses. For medical and dental products,
profitability reflects the accuracy of cost projections for health care (unit costs and
utilization), the adequacy of fees charged for administration and risk assumption and effective
medical cost and utilization management.
CIGNA HealthCare reduces its exposure to large catastrophic losses under group life,
disability and accidental death contracts by purchasing reinsurance from unaffiliated reinsurers.
Markets and Distribution
CIGNA HealthCare targets the following markets for its products:
|
|
national accounts, which are multi-site employers generally with more than 5,000 employees;
|
|
|
|
regional accounts, which are generally defined as multi-site employers with more than 250
but fewer than 5,000 employees, and single-site employers with more than 250 employees;
|
|
|
|
Select, which generally includes employers with 51- 250 employees;
|
|
|
|
small business, which generally includes employers with 2-50 employees;
|
8
|
|
individuals;
|
|
|
|
government, which includes employees in federal, state and local governments, primary and
secondary schools, and colleges and universities;
|
|
|
|
Taft-Hartley plans, which includes members covered by union trust funds;
|
|
|
|
seniors, which focuses on the health care needs of individuals 50 years and older;
|
|
|
|
voluntary, which focuses on employers with working uninsured employees; and
|
|
|
|
emerging markets, which includes non-CIGNA HealthCare payors to which leased network and
other services are offered.
|
To date, the national and regional account markets have comprised a significant amount of
CIGNA HealthCares business. With the acquisition of Great-West Healthcare, the healthcare
division of Great-West, the Select, small business, and emerging markets now constitute a larger
share of CIGNA HealthCares business.
CIGNA HealthCare employs group sales representatives to distribute its products and services
through insurance brokers and insurance consultants or directly to employers. CIGNA HealthCare
also employs representatives to sell utilization review services, managed behavioral health care
and employee assistance services directly to insurance companies, HMOs, third party administrators
and employer groups. As of December 31, 2008, the field sales force for the products and services
of this segment consisted of approximately 970 sales representatives in approximately 120 field
locations.
Competition
CIGNA HealthCares business is subject to intense competition, and industry consolidation has
created an even more competitive business environment. While no one competitor dominates the
health care market, CIGNA HealthCare expects a continuing trend of consolidation in the industry
given the current economic environment.
In certain geographic locations, some health care companies may have significant market share
positions. A large number of health care companies and other entities compete in offering similar
products. Competition in the health care market exists both for employers and other groups
sponsoring plans and for the employees in those instances where the employer offers its employees
the choice of products of more than one health care company. Most group policies are subject to
annual review by the policyholder, who may seek competitive quotations prior to renewal.
The principal competitive factors are: quality and cost-effectiveness of service and provider
networks; effectiveness of medical care management; product responsiveness to the needs of
customers and their employees; cost-containment services; technology; price; and effectiveness of
marketing and sales. Financial strength of the insurer, as indicated by ratings issued by
nationally recognized rating agencies, is also a competitive factor. For more information
concerning insurance ratings, see Ratings in Section J beginning on page 28. CIGNA HealthCare
believes that its national scope, integrated approach to consumer engagement, breadth of product
and funding offerings, clinical care and medical management capabilities and funding options are
strategic competitive advantages. These advantages allow CIGNA HealthCare to respond to the
diverse needs of its customer base in each market in which it operates. CIGNA HealthCare also
believes that its focus on helping to improve the health, well-being and security of its members
will allow it to distinguish itself from its competitors.
The principal competitors are:
|
|
other large insurance companies that provide group health and life insurance products;
|
|
|
|
Blue Cross and Blue Shield organizations;
|
|
|
|
stand-alone HMOs and PPOs;
|
|
|
|
third party administrators;
|
|
|
|
HMOs affiliated with major insurance companies and hospitals; and
|
9
|
|
national managed pharmacy, behavioral health and utilization review services companies.
|
Competition also arises from smaller regional or specialty companies with strength in a
particular geographic area or product line, administrative service firms and, indirectly,
self-insurers. In addition to these traditional competitors, a new group of competitors is
emerging. These new competitors are focused on delivering employee benefits and services through
Internet-enabled technology that allows consumers to take a more active role in the management of
their health. This is accomplished primarily through financial incentives, access to enhanced
medical quality data and other information sharing. The effective use of the Companys health
advocacy capabilities, decision support tools (some of which are web-based) and enabling technology
are critical to success in the health care industry, and CIGNA HealthCare believes they will be
competitive differentiators.
Industry Developments and Strategic Overview
Both state and federal lawmakers have supported a broad range of health care reform efforts
due to the recent demand for changes to the health care industry. The Company expects that these
efforts will intensify in 2009. The proposal and/or passing of any reform initiatives would affect
the health care industry in general and CIGNA, specifically. CIGNA advocates creating a value-based
healthcare system that provides access to care for the uninsured, fosters and rewards quality, and
makes care more affordable by educating consumers to the true costs and quality of care and
supporting better decision making. CIGNA envisions such a system as a partnership between private
and public sectors, taking the best of what the private and public sector programs offer and
creating a system that addresses the needs of all. CIGNA is intensely involved in developing
workable solutions for reforming Americas healthcare system.
As part of its business strategy, CIGNA continually evaluates potential acquisitions and other
transactions that could enhance the Companys competitive capabilities and provide a basis for
membership growth and/or improved medical costs. In 2008, CIGNA acquired the assets of Great-West
Healthcare, the healthcare division of Great-West.
Also, in connection with CIGNAs long-term business strategy, the Company intends to continue
to focus on the fundamentals of its health care business in order to provide consistent, reliable
service to customers at a competitive cost; differentiating the health care business from its
competitors by facilitating consumer engagement to realize improvement in the individuals health
and well-being; and segment expansion, particularly in the voluntary, individual, small business
and Select markets.
10
D. Disability and Life
Principal Products and Services
CIGNAs Disability and Life segment (CIGNA Disability and Life) provides the following
insurance products and their related services: group life insurance, long-term and short-term
disability insurance, workers compensation and disability case management, and accident and
specialty insurance. These products and services are provided by subsidiaries of CIGNA
Corporation.
Disability Insurance
CIGNA Disability and Life markets group long-term and short-term disability insurance products
and services in all 50 states and statutorily required disability insurance plans in certain
states. These products and services generally provide a fixed level of income to replace a portion
of wages lost because of disability. They also provide assistance to the employee in returning to
work and assistance to the employer in managing the cost of employee disability. Group disability
coverage is typically employer-paid or a combination of employer and employee-paid.
CIGNA Disability and Life also provides case management and related services to workers
compensation insurers and employers who self-fund workers compensation and disability benefits.
CIGNA Disability and Lifes disability insurance products may be integrated with other
disability benefit programs, behavioral programs, workers compensation, medical programs, social
security advocacy, and the Family and Medical Leave Act and leave of absence administration. CIGNA
Disability and Life believes this integration provides customers with increased efficiency and
effectiveness in disability claims management, enhances productivity and reduces overall costs to
employers. Combining CIGNA Disability and Life disability and CIGNA HealthCares medical programs
may provide enhanced opportunities to influence outcomes, reduce the cost of both medical and
disability events and improve the return to work rate. CIGNA Disability and Life has formalized an
integrated approach to health and wellness through the Disability and Healthcare Connect Program.
This program uses information from the CIGNA HealthCare and CIGNA Disability and Life databases to
help identify, treat and manage disabilities before they become chronic, longer in duration and
more costly. Proactive outreach from CIGNA Behavioral Health assists employees suffering from a
mental health condition, either as a primary condition or as a result of another condition. CIGNA
may receive fees for providing these integrated services to customers.
CIGNA Disability and Life is an industry leader in returning employees to work quickly.
Shorter disability claim durations mean higher productivity and lower cost for employers and a
better quality of life for their employees. Data from a recent industry customer satisfaction
survey showed that CIGNA Disability and Lifes short-term and long-term disability claimant
satisfaction levels meet and in certain metrics exceed those of our competitors.
Approximately 7,100 insured disability policies covering approximately 4.9 million lives were
outstanding as of December 31, 2008.
Life Insurance
Group life insurance products include group term life and group universal life. Group term
life insurance may be employer-paid basic life insurance, employee-paid supplemental life insurance
or a combination thereof.
CIGNA no longer actively markets group universal life insurance to new employers, but
continues to administer the product for and markets to existing policyholders. Group universal
life insurance is a voluntary life insurance product in which the owner may accumulate cash value.
The cash value earns interest at rates declared from time to time, subject to a minimum guaranteed
contracted rate, and may be borrowed, withdrawn, or, within certain limits, used to fund future
life insurance coverage. With group variable universal life insurance, the cash value varies
directly with the performance of the underlying investments and neither the return nor the
principal is guaranteed.
Approximately 6,500 group life insurance policies covering approximately 6.2 million lives
were outstanding as of December 31, 2008.
11
Other Products and Services
CIGNA Disability and Life offers personal accident insurance coverage, which consists
primarily of accidental death and dismemberment and travel accident insurance to employers. Group
accident insurance may be employer-paid or employee-paid.
CIGNA Disability and Life also offers specialty insurance services that consist primarily of
life, accident, student accident medical and disability insurance to professional associations,
financial institutions, schools and participant organizations.
Voluntary benefits are those paid by the employee and are offered at the employers worksite.
CIGNA Disability and Life plans provide, among other services, flexible enrollment options, list
billing, medical underwriting, and individual record keeping. CIGNA Disability and Life designed
its voluntary offerings to offer employers a complete and simple way to manage their benefits,
including personalized enrollment communication and administration of the benefits program.
Pricing, Reserves and Reinsurance
Premiums and fees charged for disability and life insurance products are generally established
in advance of the policy period and are generally guaranteed for one to three years, but policies
may be subject to early termination.
Premium rates reflect assumptions about future claims, expenses, credit risk, investment
returns and profit margins. Assumptions may be based in whole or in part on prior experience of the
account or on a pool of accounts, depending on the group size and the statistical credibility of
the experience, which varies by product.
Fees for universal life insurance products consist of mortality, administrative and surrender
charges assessed against the policyholders fund balance. Interest credited and mortality charges
for universal life, and mortality charges on variable universal life, may be adjusted prospectively
to reflect expected interest and mortality experience.
In addition
to paying current benefits and expenses, CIGNA Disability and Life establishes
reserves in amounts estimated to be sufficient to pay reported claims not yet paid, as well as
claims incurred but not yet reported. For liabilities with longer-term pay-out periods such as
long-term disability, reserves represent the present value of future expected payments. CIGNA
Disability and Life discounts these expected payments using assumptions for interest rates and the
length of time over which claims are expected to be paid. The annual effective interest rate
assumptions used in determining reserves for most of the long-term disability insurance business is
4.75% for claims that were incurred in 2008 and 2007. For universal life insurance, CIGNA
Disability and Life establishes reserves for deposits received and interest credited to the
policyholder, less mortality and administrative charges assessed against the policyholders fund
balance.
The profitability of this segments products depends on the adequacy of premiums charged
relative to claims, including the degree to which future experience deviates from mortality and
morbidity assumptions, expenses and investment returns. CIGNA Disability and Lifes previous claim
experience and industry data indicate a correlation between disability claim incidence levels and
economic conditions, with submitted claims rising under adverse economic conditions. The
effectiveness of return to work programs and mortality levels also impact the profitability of
disability insurance products.
In order to reduce its exposure to large individual and catastrophic losses under group life,
disability and accidental death policies, CIGNA Disability and Life purchases reinsurance from
unaffiliated reinsurers.
Markets and Distribution
CIGNA Disability and Life markets the group insurance products and services described above to
employers, employees, professional and other associations and groups. In marketing these products,
CIGNA Disability and Life employs a captive sales force to target customers with 50 or more
employees and the products and services of this segment are primarily distributed through insurance
brokers and consultants, along with some direct sales. As of December 31, 2008, the field sales
force for the products and services of this segment consisted of
approximately 200 sales
professionals in 27 field locations.
12
Competition
The principal competitive factors that affect the CIGNA Disability and Life segment are
underwriting and pricing, the quality and effectiveness of claims management, relative operating
efficiency, investment and risk management, distribution methodologies and producer relations, the
breadth and variety of products and services offered, and the quality of customer service. The
Company believes that CIGNA Disability and Lifes claims management capabilities and integration
with CIGNA HealthCares benefits provide a competitive advantage in this marketplace.
For certain products with longer-term liabilities, such as group long-term disability
insurance, the financial strength of the insurer, as indicated by ratings issued by nationally
recognized rating agencies, is also a competitive factor. For more information concerning
insurance ratings, see Ratings in Section J beginning on page 28.
The principal competitors of CIGNAs group disability, life and accident businesses are other
large and regional insurance companies that market and distribute these or similar types of
products.
As of December 31, 2008, CIGNA is one of the top providers of group disability, life and
accident insurance, based on premiums.
Industry Developments and Strategic Initiatives
The group insurance market remains highly competitive as the rising cost of providing medical
coverage to employees has forced companies to reevaluate their overall employee benefit spending.
Demographic shifts have further driven demand for products and services that are sufficiently
flexible to meet the evolving needs of employers and employees who want innovative, cost-effective
solutions to their insurance needs. A shift to greater employee participatory coverage and
voluntary purchases is also an emerging trend.
Employers are also expressing a growing interest in employee wellness, absence management and
productivity and recognizing a strong link between health, productivity and their profitability.
As a result, employers are looking to offer programs that promote a healthy lifestyle, offer
assistance in returning to work and integrate health care and disability programs. CIGNA believes
it is well positioned to deliver integrated solutions that address these broad employer and
employee needs. CIGNA also believes that its strong disability management portfolio and fully
integrated programs provide employers and employees tools to improve health status. This focus on
managing the employees total absence enables CIGNA to increase the number and likelihood of
interventions and minimize disabling events.
The disability industry is under continuing review by regulators and legislators with respect
to its offset practices regarding Social Security Disability Insurance (SSDI). There has been
specific inquiry as to the industrys role in assisting individuals with their applications for
SSDI. The Company has received one Congressional inquiry and has responded to the information
request. Also legislation prohibiting the offset of SSDI payments against private disability
insurance payments for prospectively issued policies has been introduced in the Connecticut state
legislature. The Company is also involved in related pending
litigation. If the industry is
forced to change its offset SSDI procedures, the practices and products for this segment could be
significantly impacted.
Other Risks
For more information on Disability and Life, see the Industry Developments and Other
Matters section beginning on page 67 of this Form 10-K and Note 21 to the Consolidated Financial
Statements beginning on page 130.
13
E. International
CIGNAs International segment (CIGNA International) offers life, accident and supplemental
health insurance products as well as international health care products and services. These
products and services are provided by subsidiaries of CIGNA Corporation, including foreign
operating entities.
Principal Products and Services
Life, Accident and Supplemental Health Insurance
CIGNA Internationals life, accident and supplemental health insurance products generally
provide simple, affordable coverage of risks for the health and financial security of individuals.
Supplemental health products provide a specified payment for a variety of health risks and include
personal accident, accidental death, critical illness, hospitalization, dental, cancer and other
dread disease coverages. Variable universal life insurance products are also included in the
product portfolio.
International Health Care
CIGNA Internationals health care operations primarily consist of products and services to
meet the needs of multinational companies and their expatriate employees and dependents. These
benefits include medical, dental, vision, life, accidental death and dismemberment and disability
products. The expatriate benefits products and services are offered through guaranteed cost,
experience-rated, administrative services only, and minimum premium funding arrangements. For
definitions of funding arrangements, see Funding Arrangements in Section C beginning on page 1.
In addition, CIGNA Internationals health care operations include medical products, which are
provided through group benefits programs. These products are primarily medical indemnity
insurance coverage, with some offerings having managed care or administrative service aspects.
These products generally provide an alternative or supplement to government programs.
Pricing, Reserves and Reinsurance
Premiums for CIGNA Internationals life, accident and supplemental health insurance products
are based on assumptions about mortality, morbidity, customer retention, expenses and target profit
margins, as well as interest rates. The profitability of these products is primarily driven by
mortality, morbidity, and customer retention.
Fees for variable universal life insurance products consist of mortality, administrative,
asset management and surrender charges assessed against the contractholders fund balance.
Mortality charges on variable universal life may be adjusted prospectively to reflect expected
mortality experience.
Premiums and fees for CIGNA Internationals health care products reflect assumptions about
future claims, expenses, investment returns, and profit margins. For products using networks of
contracted providers, premiums reflect assumptions about the impact of provider contracts and
utilization management on future claims. Most of the premium volume for the medical indemnity
business is on a guaranteed cost basis. Other premiums are established on an experience-rated
basis. Most contracts permit rate changes at least annually.
The profitability of health care products is dependent upon the accuracy of projections for
health care inflation (unit cost, location of delivery of care, including currency of incurral and
utilization), the adequacy of fees charged for administration and risk assumptions and effective
medical cost management.
In addition to paying current benefits and expenses, CIGNA International establishes reserves
in amounts estimated to be sufficient to settle reported claims not yet paid, claims incurred but
not yet reported as well as future amounts payable on experience rated arrangements. Additionally,
for some individual life insurance and supplemental health insurance products, CIGNA International
establishes policy reserves which reflect the present value of expected future obligations less the
present value of expected future premiums attributable to policyholder obligations. CIGNA
International defers acquisition costs, such as commissions, solicitation and policy fulfillment
costs, incurred in the sales of long-duration life, accident and supplemental health products. For
most products, these costs are amortized in proportion to premium revenue recognized, which is
impacted by customer retention. For variable universal life products, acquisition costs are
amortized in proportion to expected gross profits.
14
CIGNA International reduces its exposure to large and/or multiple losses arising out of a
single occurrence by purchasing reinsurance from unaffiliated reinsurers.
Markets and Distribution
CIGNA Internationals life, accident and supplemental health insurance products are generally
marketed through distribution partners with whom the individual insured has an affinity
relationship. These products are sold primarily through direct marketing channels, such as
outbound telemarketing, in-branch bancassurance and direct response television. Marketing
campaigns are conducted through these channels under a variety of arrangements with affinity
partners. These affinity partners primarily include banks, credit card companies, other financial
institutions, and other businesses. CIGNA Internationals life, accident and supplemental health
insurance operations are located in South Korea, Taiwan, Hong Kong, Indonesia, New Zealand, China,
Thailand, and the European Union. In the second quarter of 2008, CIGNA sold its run-off Brazilian
life insurance business.
CIGNA Internationals health care products are distributed through independent brokers and
consultants, select partners as well as CIGNA Internationals own sales personnel. The customers of
CIGNA Internationals expatriate benefits business are multinational companies and international
organizations headquartered in the United States, Canada, Europe, the Middle East, Hong Kong and
other international locations. In addition, CIGNA Internationals health care operations include
medical products, which are provided through group benefits programs in the United Kingdom and
Spain.
For CIGNA Internationals life, accident and supplemental health insurance products a
significant portion of the premiums are billed and collected through credit cards. A substantial
contraction in consumer credit could impact CIGNA Internationals ability to retain existing
policies and sell new policies. A decline in customer retention can result in both a reduction of
revenue and an acceleration of the amortization of acquisition related costs.
Competition
Competitive factors in CIGNA Internationals life, accident and supplemental health operations
and expatriate benefits business include product and distribution innovation and differentiation,
efficient management of direct marketing processes, commission levels paid to distribution
partners, and quality of claims and customer services.
The principal competitive factors that affect CIGNA Internationals health care operations are
underwriting and pricing, relative operating efficiency, relative effectiveness in medical cost
management, product innovation and differentiation, producer relations, and the quality of claims
and customer service. In most overseas markets, perception of financial strength is also an
important competitive factor.
For the life, accident and supplemental health insurance line of business, competitors are
primarily locally based insurance companies, including insurance subsidiaries of banks. However,
insurance company competitors in this segment primarily focus on traditional product distribution
through captive agents, with direct marketing being a secondary objective. CIGNA International
estimates that it has less than 2% market share of the total life insurance premiums in any given
market in which it operates.
For the expatriate benefits business, CIGNA International is the market leader in the U.S.,
whose primary competitors include U.S.-based and European health insurance companies with global
expatriate benefits operations. For the health care operations in the UK and Spain, the primary
competitors are regional and local insurers, with CIGNAs market share at less than 5% of the
premiums of the total local health care market.
CIGNA International expects that the competitive environment will intensify as U.S. and
Europe-based insurance and financial services providers pursue global expansion opportunities.
Industry Developments
Pressure on social health care systems and increased wealth and education in emerging markets
is leading to higher demand for products providing health insurance and financial security. In the
life, accident and supplemental health business, direct marketing is growing and attracting new
competitors while industry consolidation among financial institutions and other affinity partners
continues. For the international health care benefits business, trade liberalization and rapid
economic growth in emerging markets is leading to multi-national companies expanding foreign
operations.
15
F. Run-off Reinsurance
Principal Products and Services
Until 2000, CIGNA offered reinsurance coverage for part or all of the risks written by other
insurance companies (or ceding companies) under life and annuity policies (both group and
individual); accident policies (workers compensation, personal accident, and catastrophe
coverages); and health policies. The products and services related to these operations were
offered by subsidiaries of CIGNA Corporation.
In 2000, CIGNA sold its U.S. individual life, group life and accidental death reinsurance
businesses. CIGNA placed its remaining reinsurance businesses (including its accident, domestic
health, international life and health, and annuity reinsurance businesses) into run-off as of June
1, 2000 and stopped underwriting new reinsurance business.
CIGNAs exposures stem primarily from its annuity reinsurance business, including its
reinsurance of guaranteed minimum death benefits (GMDB) and guaranteed minimum income benefits
(GMIB) contracts. Additional exposures arise from its reinsurance of workers compensation and
other personal accident and catastrophic risks.
Life and Annuity Policies
Guaranteed Minimum Death Benefit Contracts
CIGNAs reinsurance segment reinsured GMDB (also known as variable annuity death benefits
(VADBe)), under certain variable annuities issued by other insurance companies. These variable
annuities are essentially investments in mutual funds combined with a death benefit. CIGNA has
equity and other market exposures as a result of this product. The Company purchased
retrocessional protection that covers a portion of the assumed risks. The Company also maintains a
dynamic hedge program (GMDB equity hedge program) to substantially reduce the equity market
exposures relating to GMDB contracts by entering into exchange-traded futures contracts.
For additional information about guaranteed minimum death benefit contracts, see
Run-off Reinsurance
beginning on page 62 and Note 7 to
CIGNAs Consolidated Financial Statements beginning on page 100
of this
Form 10-K.
Guaranteed Minimum Income Benefit Contracts
In certain circumstances where CIGNAs reinsurance operations reinsured the guaranteed minimum
death benefit, CIGNA also reinsured GMIB under certain variable annuities issued by other insurance
companies. These variable annuities are essentially investments in mutual funds combined with
minimum income and death benefits. All reinsured GMIB policies also have a GMDB benefit reinsured
by the Company. When annuitants elect to receive these minimum income benefits, CIGNA may be
required to make payments which will vary based on changes in underlying mutual fund values and
interest rates. CIGNA has retrocessional coverage for 55% of the exposures on these contracts,
provided by two external reinsurers.
For additional information about guaranteed minimum income benefit contracts, see Guaranteed
Minimum Income Benefits under Run-off Reinsurance
beginning on page 62 and Note 11 to CIGNAs
Consolidated Financial Statements beginning on page 110 of this Form
10-K.
Workers
Compensation, Personal Accident and Catastrophe
CIGNA reinsured workers compensation and other personal accident and catastrophic risks in
the London market and in the United States. CIGNA purchased retrocessional coverage in these
markets to substantially reduce the risk of loss on these contracts.
Health
The health policies have been substantially run off.
16
Markets and Distribution
These products under CIGNAs Run-off Reinsurance segment were sold principally in North
America and Europe through a small sales force and through intermediaries.
Prior to 2000, CIGNA also purchased reinsurance to reduce the risk of losses on contracts that
it had written. CIGNA determines its net exposure for run-off reinsurance contracts by estimating
the portion of its policy and claim reserves that it expects will be recovered from its reinsurers
(or retrocessionaires) and reflecting these in its financial statements as Reinsurance
Recoverables, or, with respect to guaranteed minimum income benefit contracts discussed above, as
Other Assets.
Other Risks
For more information see Run-off Reinsurance beginning on page 62, and Note 8 to CIGNAs
Consolidated Financial Statements beginning on page 103 of this Form 10-K. For more information on
the risk associated with Run-off Reinsurance, see the Risk Factors beginning on page 31 of this
Form 10-K, and the Critical Accounting Estimates section of the MD&A beginning on page 49 of this
Form 10-K.
17
G. Other Operations
Other Operations consists of:
|
|
non-leveraged and leveraged corporate-owned life insurance;
|
|
|
|
deferred gains recognized from the 1998 sale of the individual life insurance and annuity
business and the 2004 sale of the retirement benefits business; and
|
|
|
|
run-off settlement annuity business.
|
The products and services related to these operations are offered by subsidiaries of CIGNA
Corporation.
Corporate-owned Life Insurance (COLI)
Principal Products and Services
The principal products of the COLI business are permanent insurance contracts sold to
corporations to provide coverage on the lives of certain of their employees. Permanent life
insurance provides coverage that, when adequately funded, does not expire after a term of years.
The contracts are primarily non-participating universal life policies. The key distinction between
leveraged and non-leveraged COLI products is that, with leveraged COLI, the product design
anticipates borrowing by the policy owner of a portion of the surrender value, while policy loans
are not a significant feature of non-leveraged COLI.
Universal life policies typically provide flexible coverage and flexible premium payments.
Policy cash values fluctuate with the amount of the premiums paid, mortality and expense charges
assessed, and interest credited to the policy. Variable universal life policies are universal life
contracts in which the cash values vary directly with the performance of a specific pool of
investments underlying the policy.
The principal services provided by the corporate-owned life insurance business are issuance
and administration of the insurance policies (e.g., maintenance of records regarding cash values
and death benefits, claims processing, etc.) as well as oversight of the investment management for
separate account assets that support the variable universal life product.
Product Features
Cash values on universal life policies are credited interest at a declared interest rate that
reflects the anticipated investment results of the assets backing these policies and may vary with
the characteristics of each product. Universal life policies generally have a minimum guaranteed
declared interest rate which may be cumulative from the issuance date of the policy. The declared
interest rate may be changed monthly, but is generally changed less frequently. While variable
universal life products may have a guaranteed minimum crediting rate, CIGNA did not have any such
contracts at December 31, 2008.
In lieu of credited interest rates, holders of certain universal life policies may elect to
receive credited income based on changes in an equity index, such as the S&P 500
®
. No
such elections have been made since 2004.
Mortality risk is retained according to guidelines established by CIGNA. To the extent a
given policy carries mortality risk that exceeds these guidelines, reinsurance is purchased from
third parties for the balance.
Pricing, Reserves, and Reinsurance
Fees for universal life insurance products consist of mortality, administrative and surrender
charges assessed against the
policyholders fund balance. Interest credited and mortality charges for universal life and
mortality charges on variable
universal life may be adjusted prospectively to reflect expected interest and mortality
experience.
For universal life insurance, CIGNA establishes reserves for deposits received and interest
credited to the contractholder, less
mortality and administrative charges assessed against the contractholders fund balance.
18
In order to reduce its exposure to large individual and catastrophe losses, CIGNA purchases
reinsurance from unaffiliated reinsurers.
Markets and Distribution
Prior to 2008, the Company was not actively marketing and distributing COLI products. In
2008, the Company decided to re-enter the market for COLI products, and is currently actively
pursuing opportunities associated with the COLI business.
The principal markets for COLI products are regional to national account-sized corporations,
including banks. CIGNAs COLI products are offered through a select group of independent brokers
with particular expertise in the bank market and in the use of COLI for the financing of benefit
plan liabilities.
Competition
The principal competitive factors that affect CIGNAs COLI business are pricing, service,
product innovation and access to third-party distribution.
For CIGNAs COLI business, competitors are primarily national life insurance companies,
including insurance subsidiaries of banks.
CIGNA expects that the competitive environment will intensify as the economy recovers and
competitors develop new investment strategies and product designs, and aggressively price their
offerings to build distribution capacity and gain market share.
Industry Developments and Strategic Initiatives
The legislative environment surrounding COLI has evolved considerably over the past decade.
Most recently, the Pension Protection Act of 2006 included provisions related to the notice
requirements given to insured employees and limited coverage to certain more highly compensated
employees. These changes were widely viewed as clarification of existing rules or industry best
practices.
Sale of Individual Life Insurance & Annuity and Retirement Benefits Businesses
CIGNA sold its individual life insurance and annuity business in 1998 and its retirement
business in 2004. Portions of the gains from these sales were deferred because the principal
agreements to sell these businesses were structured as reinsurance arrangements. The deferred
portion relating to the remaining reinsurance is being recognized at the rate that earnings from
the sold businesses would have been expected to emerge, primarily over 15 years on a declining
basis.
Because the individual life and annuity business was sold in an indemnity reinsurance
transaction, CIGNA is not relieved of primary liability for the reinsured business and had
reinsurance recoverables totaling $4.6 billion as of December 31, 2008. Effective as of December
14, 2007, the purchaser placed a significant portion of the assets supporting the reserves for the
purchased business into a trust for the benefit of CIGNA which qualifies to support CIGNAs credit
for the reinsurance ceded under Regulation 114 of the New York Department of Insurance. Trust
assets are limited to cash, certificates of deposits in U.S. banks, and securities specified by
section 1404 (a) of the New York insurance law and consist primarily of fixed maturities. At
December 31, 2008, the value of the trust assets secured approximately 90% of the reinsurance
recoverable. The remaining balance is currently unsecured. If Lincoln National Life Insurance
Company and Lincoln Life & Annuity of New York do not maintain a specified minimum credit or claims
paying rating, these reinsurers are required to fully secure the outstanding balance. S&P has
assigned both of these reinsurers a rating of AA.
CIGNAs sale of its retirement business primarily took the form of an arrangement under which
CIGNA reinsured with the purchaser of the retirement business the general account contractholder
liabilities under an indemnity reinsurance arrangement and the separate account liabilities under
modified coinsurance and indemnity reinsurance arrangements.
Since the sale of the retirement benefits business in 2004, the purchaser of that business has
entered into agreements with certain insured party contractholders (novation agreements), which
relieved CIGNA of any remaining contractual obligations to the contractholders. As a result, CIGNA
reduced reinsurance recoverables, contractholder deposit funds, and separate account balances
19
for
these obligations. The purchaser of the retirement benefits business deposited assets associated
with the reinsurance of general account contracts into a trust (the Ceded Business Trust) to
provide security to CIGNA for the related reinsurance recoverables. The
purchaser is permitted to withdraw assets from the Ceded Business Trust equal to the reduction
in CIGNAs reserves whenever a reduction occurs. For example, reductions will occur when the
purchaser enters into additional novation agreements and directly assumes liability to the insured
party. Assets in the trust must be greater than or equal to general account statutory liabilities
of the ceded business. Trust assets are limited to those types of investments that are permitted by
the state of Connecticut for general account investing and consist primarily of fixed maturities.
As of December 31, 2008, assets totaling $2.5 billion remained in the Ceded Business Trust, and the
remaining reserves for the purchased business were $1.9 billion.
Settlement Annuity Business
CIGNAs settlement annuity business is a run-off block of contracts. These contracts are
primarily liability settlements with approximately 35% of the liabilities associated with payments
which are guaranteed and not contingent on survivorship. In the case of the contracts that involve
non-guaranteed payments, such payments are contingent on the survival of one or more parties
involved in the settlement.
The Settlement Annuities business is premium deficient, meaning initial premiums were not
sufficient to cover all claims and profit. Liabilities are estimates of the present value of
benefits to be paid less the present value of investment income generated by the assets supporting
the product including realized and unrealized capital gains. The company estimates these
liabilities based on assumptions for investment yields, mortality, and administrative expenses.
Refer to Note 2 to CIGNAs Consolidated Financial Statements
beginning on page 86 for additional information
regarding reserves for this business.
Other Risks
For
more information, see Other Operations beginning on page
65 of this Form 10-K.
20
H. Investments and Investment Income
CIGNAs investment operations provide investment management and related services primarily for
CIGNAs corporate invested assets and the insurance-related invested assets in its General Account
(Invested Assets). CIGNA acquires or originates, directly or through intermediaries, various
investments including private placements, public securities, commercial mortgage loans, real estate
and short-term investments. CIGNAs Invested Assets are managed primarily by CIGNA subsidiaries
and external managers with whom CIGNAs subsidiaries contract.
The Invested Assets comprise a majority of the combined assets of the Health Care, Disability
and Life, Run-off Reinsurance and Other Operations segments (collectively, the Domestic
Portfolios). There are, in addition, portfolios containing Invested Assets that consist of the
assets of the International segment (collectively, the International Portfolios).
Net investment income and realized investment gains (losses) are not reported separately in
the investment operations. Instead, net investment income is included as a component of earnings
for each of CIGNAs operating segments (Health Care, Disability and Life, Run-off Reinsurance,
Other Operations, International and Corporate), net of the expenses attributable to the investment
operations. Realized investment gains (losses) are reported for each of CIGNAs operating
segments.
Assets Under Management
CIGNAs Invested Assets under management at December 31, 2008 totaled $18.0 billion. See
Schedule I to CIGNAs 2008 Consolidated Financial Statements on page FS-3 of this Form 10-K for
more information as to the allocation to types of investments.
As of December 31, 2008, CIGNAs separate account funds consisted of:
|
|
$1.5 billion in separate account assets that are managed by the buyer of the retirement
benefits business pursuant to reinsurance arrangements described in Sale of Individual Life
Insurance & Annuity and Retirement Benefits Businesses in Note 3 beginning on page 96 of this
Form 10-K;
|
|
|
|
$1.5 billion in separate account assets which constitute a portion of the assets of the
CIGNA Pension Plan; and
|
|
|
|
$2.9 billion in separate account assets which primarily support certain corporate-owned
life insurance, health care and disability and life products.
|
Types of Investments
CIGNA invests in a broad range of asset classes, including domestic and international fixed
maturities and common stocks, commercial mortgage loans, real estate and short-term investments.
Fixed maturity investments include publicly traded and private placement corporate bonds,
government bonds, publicly traded and private placement asset-backed securities, and redeemable
preferred stocks. In connection with CIGNAs investment strategy to enhance investment yields by
selling senior participations of commercial mortgage loans, as of December 31, 2008, commercial
mortgage loans include $75 million of commercial mortgage loans originated with the intent to sell.
These commercial mortgage loans held for sale are carried at the lower of cost or fair value with
any resulting valuation allowance reported in realized investment gains and losses.
For the International Portfolios, CIGNA invests primarily in publicly traded fixed maturities,
short-term investments and time deposits denominated in the currency of the relevant liabilities
and surplus.
Fixed Maturities
CIGNAs fixed maturities are 92% investment grade as determined by external rating agencies
(for public investments) and by CIGNA (for private investments). These assets are well diversified
by individual holding and industry sector. For information about below investment grade holdings,
see the Investment Assets section of the MD&A beginning on page 73 of this Form 10-K.
Commercial Mortgages and Real Estate
Commercial mortgage loan investments are subject to underwriting criteria addressing
loan-to-value ratio, debt service coverage, cash flow, tenant quality, leasing, market, location
and borrowers financial strength. Such investments consist primarily of first
21
mortgage loans on commercial properties and are diversified by property type, location and
borrower. CIGNA invests primarily in commercial mortgages on fully completed and substantially
leased commercial properties. Virtually all of CIGNAs commercial mortgage loans are balloon
payment loans, under which all or a substantial portion of the loan principal is due at the end of
the loan term. CIGNA holds no direct residential mortgages. The weighted average loan to value
ratio of the Companys commercial mortgage loan portfolio, based on managements annual valuation
completed in the third quarter of 2008, was approximately 64% and the weighted average debt service
coverage was approximately 1.5 times.
CIGNA enters into joint ventures with local partners to develop, lease, manage, and sell
commercial real estate to maximize investment returns. CIGNAs portfolio of real estate
investments consists of properties under development and stabilized properties, and is diversified
relative to property type and location. CIGNA also acquires real estate through foreclosure of
commercial mortgage loans. CIGNA rehabilitates, re-leases, and sells foreclosed properties, a
process that usually takes from two to four years unless management considers a near-term sale
preferable. Additionally, CIGNA invests in third party sponsored real estate funds to maximize
investment returns and to maintain diversity with respect to its real estate related exposure.
CIGNA sold its remaining foreclosed property and did not acquire any properties through foreclosure
in 2008.
Mezzanine and Private Equity Partnerships
CIGNA invests in limited partnership interests in partnerships formed and managed by seasoned,
experienced fund managers with diverse mezzanine and private equity strategies.
Derivative Instruments
CIGNA generally uses derivative financial instruments to minimize its exposure to certain
market risks. CIGNA has also written derivative instruments to minimize certain insurance
customers market risks. In addition, to enhance investment returns, CIGNA may invest in indexed
credit default swaps or other credit derivatives from time to time. However, as of December 31,
2008, CIGNA held no indexed credit default swaps or other credit derivatives. For information
about CIGNAs use of derivative financial instruments, see Note
12 to CIGNAs 2008 Consolidated
Financial Statements beginning on page 115 of this Form 10-K.
See also the Investment Assets section of the MD&A beginning on page 73, and Notes 2, 12,
and 13 to the Consolidated Financial Statements beginning on pages 86, 115 and
121, respectively, of this Form 10-K for
additional information about CIGNAs investments.
Domestic Portfolios Investment Strategy
As of December 31, 2008 the Domestic Portfolios had $16.6 billion in Invested Assets,
allocated among fixed maturity investments (63%); commercial mortgage loan investments (22%); and
policy loans, real estate investments, short-term investments and mezzanine and private equity
partnership investments (15%).
CIGNA generally manages the characteristics of these assets to reflect the underlying
characteristics of related insurance and contractholder liabilities and related capital
requirements, as well as regulatory and tax considerations pertaining to those liabilities, and
state investment laws. CIGNAs domestic insurance and contractholder liabilities as of December
31, 2008, excluding liabilities of businesses sold through the use of reinsurance arrangements,
were associated with the following products, and the Invested Assets are allocated proportionally
as follows: other life and health, 52%; fully guaranteed annuity, 19%; and interest-sensitive life
insurance, 29%.
While the businesses and products supported are described elsewhere in this Form 10-K, the
Invested Assets supporting CIGNAs insurance and contractholder liabilities related to each of its
segments are as follows:
|
|
The Invested Assets supporting CIGNAs Health Care segment are structured to emphasize
investment income, and provide the necessary liquidity to meet cash flow requirements.
|
|
|
|
The Invested Assets supporting CIGNAs Disability and Life segment are also structured to
emphasize investment income, and provide necessary liquidity to meet cash flow requirements.
Invested Assets supporting longer-term group disability insurance benefits and group life
waiver of premium benefits are generally managed to an aggregate duration similar to that of
the related benefit cash flows.
|
22
|
|
The Invested Assets supporting the Run-off Reinsurance segment with respect to reinsurance
provided for guaranteed minimum death benefit contracts and guaranteed minimum income benefit
contracts are structured to emphasize investment income, and provide the necessary liquidity
to meet cash flow requirements. For information about CIGNAs use of derivative financial
instruments in the Run-off Reinsurance segment, see Notes 7 and 11 to CIGNAs Consolidated
Financial Statements beginning on pages 100 and 110 of this Form 10-K.
|
|
|
|
The Invested Assets supporting CIGNAs Other Operations segment are associated primarily
with fully guaranteed annuities (primarily settlement annuities) and interest-sensitive life
insurance (primarily corporate-owned life insurance products). Because settlement annuities
generally do not permit withdrawal by policyholders prior to maturity, the amount and timing
of future benefit cash flows can be reasonably estimated so funds supporting these products
are invested in fixed income investments that generally match the aggregate duration of the
investment portfolio with that of the related benefit cash flows. As of December 31, 2008,
the duration of assets that supported these liabilities was approximately 12.2 years. Invested
Assets supporting interest-sensitive life insurance products are primarily fixed income
investments and policy loans. Fixed income investments emphasize investment yield while
meeting the liquidity requirements of the related liabilities.
|
Investment strategy and results are affected by the amount and timing of cash available for
investment, competition for investments, economic conditions, interest rates and asset allocation
decisions. CIGNA routinely monitors and evaluates the status of its investments in light of
current economic conditions, trends in capital markets and other factors. Such factors include
industry sector considerations for fixed maturity investments and mezzanine and private equity
partnership investments, and geographic and property-type considerations for commercial mortgage
loan and real estate investments.
International Portfolios Investment Strategy
As of December 31, 2008 the International Portfolios had $1.4 billion in Invested Assets. The
International Portfolios are primarily managed by external managers with whom CIGNAs subsidiaries
contract.
The characteristics of these assets are generally managed to reflect the underlying
characteristics of related insurance and contractholder liabilities, as well as regulatory and tax
considerations in the countries where CIGNAs subsidiaries operate. CIGNA Internationals Invested
Assets are generally invested in the currency of related liabilities, typically the currency in
which the subsidiaries operate and with an aggregate duration generally matching the duration of
insurance liabilities and surplus. CIGNAs investment policy allows the investment of subsidiary
assets in U.S. dollars to the extent permitted by regulation. CIGNA Internationals Invested
Assets as of December 31, 2008 were held primarily in support of statutory surplus and liabilities
associated with the life, accident and supplemental health and healthcare products described in
Section E on page 14.
23
I. Regulation
CIGNA and its subsidiaries are subject to federal, state and international regulations and
CIGNA has established policies and procedures to comply with applicable requirements.
CIGNAs insurance and HMO subsidiaries must be licensed by the jurisdictions in which they
conduct business. These subsidiaries are subject to numerous state and federal regulations related
to their business operations, including, but not limited to:
|
|
the form and content of customer contracts including benefit mandates (including special
requirements for small groups, generally under 50 employees);
|
|
|
|
premium rates;
|
|
|
|
the content of agreements with participating providers of covered services;
|
|
|
|
producer appointment and compensation;
|
|
|
|
claims processing and appeals;
|
|
|
|
underwriting practices;
|
|
|
|
reinsurance arrangements;
|
|
|
|
unfair trade and claim practices;
|
|
|
|
protecting the privacy and confidentiality of the information received from members;
|
|
|
|
risk sharing arrangements with providers; and
|
|
|
|
the operation of consumer-directed plans (including health savings accounts, health
reimbursement accounts, flexible spending accounts and debit cards).
|
CIGNA and its international subsidiaries comply with regulations in international
jurisdictions where foreign insurers are, in some countries, faced with greater restrictions than
their domestic competitors. These restrictions may include discriminatory licensing procedures,
compulsory cessions of reinsurance, required localization of records and funds, higher premium and
income taxes, and requirements for local participation in an insurers ownership.
CIGNA and its subsidiaries are also subject to state and federal laws relating to business
entities.
Other types of regulatory oversight predominantly as to CIGNA and its subsidiaries products
and services are described below.
Regulation of Insurance Companies
Financial Reporting
Regulators closely monitor the financial condition of licensed insurance companies and HMOs.
States regulate the form and content of statutory financial statements and the type and
concentration of permitted investments. CIGNAs insurance and HMO subsidiaries are required to
file periodic financial reports with regulators in most of the jurisdictions in which they do
business, and their operations and accounts are subject to examination by such agencies at regular
intervals.
Guaranty Associations, Indemnity Funds, Risk Pools and Administrative Funds
Most states and certain non-U.S. jurisdictions require insurance companies to support guaranty
associations or indemnity funds, which are established to pay claims on behalf of insolvent
insurance companies. In the United States, these associations levy assessments on member insurers
licensed in a particular state to pay such claims.
24
Several states also require HMOs to participate in guaranty funds, special risk pools and
administrative funds. For additional information about guaranty fund and other assessments, see
Note 22 to CIGNAs Consolidated Financial Statements beginning on page 133 of this Form 10-K.
Some states also require health insurers and HMOs to participate in assigned risk plans, joint
underwriting authorities, pools or other residual market mechanisms to cover risks not acceptable
under normal underwriting standards.
Solvency and Capital Requirements
Many states have adopted some form of the National Association of Insurance Commissioners
(NAIC) model solvency-related laws and risk-based capital rules (RBC rules) for life and health
insurance companies. The RBC rules recommend a minimum level of capital depending on the types and
quality of investments held, the types of business written and the types of liabilities incurred.
If the ratio of the insurers adjusted surplus to its risk-based capital falls below statutory
required minimums, the insurer could be subject to regulatory actions ranging from increased
scrutiny to conservatorship.
In addition, various non-U.S. jurisdictions prescribe minimum surplus requirements that are
based upon solvency, liquidity and reserve coverage measures. During 2008, CIGNAs HMOs and life
and health insurance subsidiaries, as well as non-U.S. insurance subsidiaries, were compliant with
applicable RBC and non-U.S. surplus rules.
In
2008, the NAIC adopted Actuarial Guideline VACARVM, Commissioners
Annuity Reserve Valuation Method for Variable Annuities, which will be effective December 31,
2009. VACARVM will impact statutory and tax reserves for CIGNAs contracts covering guaranteed
minimum death benefits and guaranteed minimum income benefits. Upon implementation, it is
anticipated that statutory reserves for those products will increase and thus statutory surplus for
Connecticut General Life Insurance Company will be reduced. The magnitude of any impact depends on
equity market and interest rate levels at the time of implementation.
Holding Company Laws
CIGNAs domestic insurance companies and certain of its HMOs are subject to state laws
regulating subsidiaries of insurance holding companies. Under such laws, certain dividends,
distributions and other transactions between an insurance or HMO subsidiary and its affiliates may
require notification to, or approval by, one or more state insurance commissioners.
Oversight of Marketing, Advertising and Broker Compensation
State and/or federal regulatory scrutiny of life and health insurance company and HMO
marketing and advertising practices, including the adequacy of disclosure regarding products and
their administration, may result in increased regulation. Products offering limited benefits, such
as those issued in connection with the Star HRG business acquired in July 2006, may attract
increased regulatory scrutiny. States have responded to concerns about the marketing, advertising
and administration of insurance and HMO products and administrative practices by increasing the
number and frequency of market conduct examinations and imposing larger penalties for violations of
applicable laws and regulations.
In recent years, perceived abuses in broker compensation practices have been the focus of
greatly heightened regulatory scrutiny. This increased regulatory focus may lead to legislative or
regulatory changes that would affect the manner in which CIGNA and its competitors compensate
brokers. For more information regarding general governmental inquiries relating to CIGNA
subsidiaries, see Legal Proceedings in Item 3 beginning on page 39.
Licensing Requirements
Pharmacy Licensure Laws
Certain CIGNA subsidiaries are pharmacies, which dispense prescription drugs to participants
of benefit plans administered or insured by CIGNA subsidiary HMOs and insurance companies. These
pharmacy-subsidiaries are subject to state licensing requirements and regulation.
25
Claim Administration, Utilization Review and Related Services
Certain CIGNA subsidiaries contract for the provision of claim administration, utilization
management and other related services with respect to the administration of self-insured benefit
plans. These CIGNA subsidiaries may be subject to state third-party administration and other
licensing requirements and regulation.
Federal Regulations
Employee Retirement Income Security Act
CIGNA subsidiaries sell most of their products and services to sponsors of employee benefit
plans that are governed by the Federal Employee Retirement Income Security Act (ERISA). CIGNA
subsidiaries may be subject to requirements imposed by ERISA on plan fiduciaries and parties in
interest, including regulations affecting claim and appeals procedures for health, dental,
disability, life and accident plans.
Medicare Regulations
Several CIGNA subsidiaries engage in businesses that are subject to federal Medicare
regulations such as:
|
|
those offering individual and group Medicare Advantage (HMO) coverage in Arizona;
|
|
|
|
contractual arrangements with the federal government for the processing of certain Medicare
claims and other administrative services; and
|
|
|
|
those offering Medicare Pharmacy (Part D) and Medicare Advantage Private Fee-for-Service
products that are subject to federal Medicare regulations.
|
Federal Audits of Government Sponsored Health Care Programs
Participation in government sponsored health care programs subjects CIGNA to a variety of
federal laws and regulations and risks associated with audits conducted under the programs (which
may occur in years subsequent to provision by CIGNA of the relevant services under audit). These
risks may include reimbursement claims as well as potential fines and penalties. For example, the
federal government requires Medicare and Medicaid providers to file detailed cost reports for
health care services provided. These reports may be audited in subsequent years. CIGNA HMOs that
contract to provide community-rated coverage to participants in the federal Employees Health
Benefit Plan may be required to reimburse the federal government if, following an audit, it is
determined that a federal employee group did not receive the benefit of a discount offered by a
CIGNA HMO to one of the two groups closest in size to the federal employee group. See Health
Care in Section C beginning on page 1 for additional information about CIGNAs participation in
government health-related programs.
Privacy and Information Disclosure and Portability Regulations
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) imposes requirements
for guaranteed issuance (for groups with 50 or fewer lives), electronic data security standards,
and renewal and portability, on health care insurers and HMOs. In addition, HIPAA regulations
required the assignment of a unique national identifier for providers by May 2007. The federal
government, states and territories (as well as most non-U.S. jurisdictions) impose requirements
regarding the use and disclosure of identifiable information about individuals and, in an effort to
deal with the growing threat of identity theft, the handling of privacy and security breaches.
Antitrust Regulations
CIGNA subsidiaries are also engaged in activities that may be scrutinized under federal and
state antitrust laws and regulations. These activities include the administration of strategic
alliances with competitors, information sharing with competitors and provider contracting.
26
Anti-Money Laundering Regulations
Certain CIGNA subsidiaries are subject to United States Department of the Treasury anti-money
laundering regulations. Those subsidiaries have implemented anti-money laundering policies
designed to insure their affected products comply with the regulations.
Investment-Related Regulations
Depending upon their nature, CIGNAs investment management activities are subject to U.S.
federal securities laws, ERISA, and other federal and state laws governing investment related
activities. In many cases, the investment management activities and investments of individual
insurance companies are subject to regulation by multiple jurisdictions.
Regulatory Developments
The business of administering and insuring employee benefit programs, particularly health care
programs, is heavily regulated by federal and state laws and administrative agencies, such as state
departments of insurance and the federal Departments of Labor and Justice, as well as the courts.
In the growing area of consumer-driven plans, health savings accounts and health reimbursement
accounts are also regulated by the United States Department of the Treasury and the Internal
Revenue Service. For information on Regulatory and Industry Developments, see page 67 in the MD&A
and Note 22 to CIGNAs Consolidated Financial Statements beginning on page 133 of this Form
10-K.
Federal and state regulation and legislation may affect CIGNAs operations in a variety of
ways. In addition to proposals discussed above related to increased regulation of the health care
industry, other proposed measures that may significantly affect CIGNAs operations include calls
for universal health care coverage and for government sponsored single payor, market reforms
achieved through state and federal legislation, modifications of the Medicare program, and employee
benefit regulation including modification to the tax treatment of employee benefits.
The economic and competitive effects of the legislative and regulatory proposals discussed
above on CIGNAs business operations will depend upon the final form of any such legislation or
regulation.
27
J. Ratings
CIGNA and certain of its insurance subsidiaries are rated by nationally recognized rating
agencies. The significance of individual ratings varies from agency to agency. However, companies
that are assigned ratings at the top end of the range have, in the opinion of the rating agency,
the strongest capacity for repayment of debt or payment of claims, while companies at the bottom
end of the range have the weakest capacity.
Insurance ratings represent the opinions of the rating agencies on the financial strength of a
company and its capacity to meet the obligations of insurance policies. The principal agencies that
rate CIGNAs insurance subsidiaries characterize their insurance rating scales as follows:
|
|
A.M. Best Company, Inc. (A.M. Best), A++ to S (Superior to Suspended);
|
|
|
|
Moodys Investors Service (Moodys), Aaa to C (Exceptional to Lowest);
|
|
|
|
Standard & Poors Corp. (S&P), AAA to R (Extremely Strong to Regulatory Action);
and
|
|
|
|
Fitch, Inc. (Fitch), AAA to D (Exceptionally Strong to Order of Liquidation).
|
As of February 25, 2009, the insurance financial strength ratings for CIGNA subsidiaries,
Connecticut General Life Insurance Company (CG Life) and Life Insurance Company of North America
(LINA) were as follows:
|
|
|
|
|
|
|
CG Life
|
|
LINA
|
|
|
Insurance
|
|
Insurance
|
|
|
Ratings
(1)
|
|
Ratings
(1)
|
|
A.M. Best
|
|
A
(Excellent,
3
rd
of 16)
|
|
A
(Excellent,
3
rd
of 16)
|
Moodys
|
|
A2
(Good,
6
th
of 21)
|
|
A2
(Good,
6
th
of 21)
|
S&P
|
|
A
(Strong,
6
th
of 21)
|
|
|
Fitch
|
|
A+
(Strong,
5
th
of 24)
|
|
A+
(Strong,
5
th
of 24)
|
|
|
|
(1)
|
|
Includes the rating assigned, the agencys characterization of the rating and the position of
the rating in the agencys rating scale (e.g., CG Lifes rating by A.M. Best is the
3
rd
highest rating awarded in its scale of 16).
|
28
Debt ratings are assessments of the likelihood that a company will make timely payments of
principal and interest. The principal agencies that rate CIGNAs senior debt characterize their
rating scales as follows:
|
|
|
Moodys, Aaa to C (Exceptional to Lowest);
|
|
|
|
|
S&P, AAA to D (Extremely Strong to Default); and
|
|
|
|
|
Fitch, AAA to D (Highest to Default).
|
The commercial paper rating scales for those agencies are as follows:
|
|
|
Moodys, Prime-1 to Not Prime (Superior to Not Prime);
|
|
|
|
|
S&P, A-1+ to D (Extremely Strong to Default); and
|
|
|
|
|
Fitch, F-1+ to D (Very Strong to Distressed).
|
As of February 25, 2009, the debt ratings assigned to CIGNA Corporation by the following
agencies were as follows:
Debt Ratings
(1)
CIGNA
CORPORATION
|
|
|
|
|
|
|
|
|
Commercial
|
|
|
Senior Debt
|
|
Paper
|
Moodys
|
|
Baa2
|
|
P2
|
|
|
(Adequate,
|
|
(Strong,
|
|
|
9
th
of 21)
|
|
2
nd
of 4)
|
S&P
|
|
BBB+
|
|
A2
|
|
|
(Adequate,
|
|
(Good,
|
|
|
8
th
of 22)
|
|
3
rd
of 7)
|
Fitch
|
|
BBB+
|
|
F2
|
|
|
(Good,
8
th
of 24)
|
|
(Moderately
Strong,
3
rd
of 7)
|
|
|
|
(1)
|
|
Includes the rating assigned, the agencys characterization of the rating and the position of
the rating in the applicable agencys rating scale.
|
CIGNA is committed to maintaining appropriate levels of capital in its subsidiaries to support
financial strength ratings that meet customers expectations, and to improving the earnings of the
health care business. Lower ratings at the parent company level increase the cost to borrow funds.
Lower ratings of CG Life and LINA could adversely affect new sales and retention of current
business.
29
K. Miscellaneous
CIGNA and its principal subsidiaries are not dependent on business from one or a few
customers. No customer accounted for 10% or more of CIGNAs consolidated revenues in 2008. CIGNA
and its principal subsidiaries are not dependent on business from one or a few brokers or agents.
In addition, CIGNAs insurance businesses are generally not committed to accept a fixed portion of
the business submitted by independent brokers and agents, and generally all such business is
subject to its approval and acceptance.
CIGNA had approximately 30,300, 26,600, and 27,100 employees as of December 31, 2008,
2007 and 2006, respectively.
30
Item 1A.
RISK FACTORS
As a large company operating in a complex industry, CIGNA encounters a variety of risks and
uncertainties including those identified in this Risk Factor discussion and elsewhere in this
report. CIGNA devotes resources to developing enterprise-wide risk management processes, in
addition to the risk management processes within its businesses. These factors represent risks and
uncertainties that could have a material adverse effect on CIGNAs business, liquidity, results of
operations or financial condition. These risks and uncertainties are not the only ones CIGNA
faces. Other risks and uncertainties that CIGNA does not know about now, or that the Company does
not now think are significant and does not appropriately identify and manage, may impair its
business or the trading price of its securities. The following are significant risks identified by
CIGNA.
Future performance of CIGNAs business will depend on the Companys ability to execute its
strategic initiatives.
The future performance of CIGNAs business will depend in large part on CIGNAs ability to execute
effectively and implement its strategic initiatives. These initiatives include: executing CIGNAs
customer engagement strategy, including designing products to meet emerging market trends and
ensuring that an appropriate infrastructure is in place to meet the needs of customers; continuing
to reduce medical costs; market expansion, in particular in the individual and small business
markets, as well as growth in medical and specialty membership; and further improving the
efficiency of operations, including lowering operating costs per member and enabling higher value
services.
Successful execution of these initiatives depends on a number of factors including:
|
|
successful alignment and integration of services and operations to reduce costs and retain
and grow CIGNAs customer base;
|
|
|
|
addition and retention of customers by providing appropriate levels of support and service
for CIGNAs products, as well as avoiding service and health coaching related errors;
|
|
|
|
attraction and retention of sufficient numbers of qualified employees;
|
|
|
|
the negotiation of favorable provider contracts;
|
|
|
|
development and introduction of new products or programs, because of the inherent risks and
uncertainties associated with product development, particularly in response to government
regulation or the increased focus on consumer directed products;
|
|
|
|
the identification and introduction of the proper mix or integration of products that will
be accepted by the marketplace; and
|
|
|
|
the ability of CIGNAs products and services to differentiate CIGNA from its competitors
and for CIGNA to demonstrate that these products and services (such as disease management and
health coaching programs, provider credentialing and other quality care initiatives) result in
improved health outcomes and reduced costs.
|
If CIGNA does not adequately invest in and effectively execute improvements in its information
technology infrastructure and improve its functionality, it will not be able to deliver the service
required in the evolving marketplace at a competitive cost.
CIGNAs success in executing its consumer engagement strategy depends on the Companys continued
improvements to its information technology infrastructure and customer service offerings. The
marketplace is evolving and the level of service that is acceptable to customers today will not
necessarily be acceptable tomorrow. The Company must continue to invest in long term solutions
that will enable it to meet customer expectations. CIGNAs success is dependent, in large part, on
maintaining the effectiveness of existing technology systems and continuing to deliver and enhance
technology systems that support the Companys business processes in a cost-efficient and
resource-efficient manner. CIGNA also must develop new systems to meet the current market standard
and keep pace with continuing changes in information processing technology, evolving industry and
regulatory standards and customer needs. System development projects are long term in nature, may
be more costly than expected to complete, and may not deliver the expected benefits upon
completion.
31
CIGNAs business depends on its ability to properly maintain the integrity or security of its data
or to strategically implement new information systems.
CIGNAs business depends on effective information systems and the integrity and timeliness of the
data it uses to run its business. CIGNAs business strategy requires providing members and
providers with Internet-enabled products and information to meet their needs. CIGNAs ability to
adequately price its products and services, establish reserves, provide effective and efficient
service to its customers, and to timely and accurately report its financial results also depends
significantly on the integrity of the data in its information systems. If the information CIGNA
relies upon to run its businesses were found to be inaccurate or unreliable due to fraud or other
error, or if CIGNA were to fail to maintain effectively its information systems and data integrity,
the Company could have problems with, among other things: operational disruptions, which may
impact customers, physicians and other health care providers; determining medical cost estimates
and establishing appropriate pricing; retaining and attracting customers; and regulatory
compliance.
If CIGNA were unable to maintain the security of any sensitive data residing on the Companys
systems whether due to its own actions or those of any vendors, CIGNAs reputation would be
adversely affected and the Company could be exposed to litigation or other actions, fines or
penalties.
If CIGNA fails to manage successfully its outsourcing projects and key vendors, CIGNAs business
could be disrupted
.
CIGNA takes steps to monitor and regulate the performance of independent third parties who provide
services or to whom the Company delegates selected functions. These third parties include
information technology system providers, independent practice associations, call center and claim
service providers, specialty service providers and include those vendor relationships that the
Company acquired from Great-West HealthCare.
In addition to the software applications and human resource operations support IBM had previously
provided pursuant to several smaller contracts, in 2006, CIGNA entered into an agreement with IBM
to operate significant portions of its information technology infrastructure, including the
provision of services relating to its call center application, enterprise content management,
risk-based capital analytical infrastructure and voice and data communications network. The 2006
contract with IBM includes several service level agreements, or SLAs, related to issues such as
performance and job disruption with significant financial penalties if these SLAs are not met.
However, the Company may not be adequately indemnified against all possible losses through the
terms and conditions of the agreement. In addition, some of CIGNAs termination rights are
contingent upon payment of a fee, which may be significant. If CIGNAs relationship with IBM is
terminated, the Company may experience disruption of service to customers.
Arrangements with key vendors may make CIGNAs operations vulnerable if third parties fail to
satisfy their obligations to the Company, as a result of their performance, changes in their own
operations, financial condition, or other matters outside of CIGNAs control. Certain legislative
authorities have in recent periods discussed or proposed legislation that would restrict
outsourcing and, if enacted, could materially increase CIGNAs costs. Further, CIGNA may not fully
realize on a timely basis the anticipated economic and other benefits of the outsourcing projects
or other relationships it enters into with key vendors, which could result in substantial costs or
other operational or financial problems for the Company.
Sustained or significant deterioration in economic conditions could significantly impact the
Companys customers and vendors.
The Company is exposed to risks associated with the potential financial instability of its
customers, many of which may be adversely affected by the volatile conditions in the financial
markets. As a result of the difficult economic environment, customers may experience serious cash
flow problems and other financial difficulties. As a result, they may modify, delay or cancel
plans to purchase the Companys products, may make changes in the mix of products purchased that
are unfavorable to the Company, or may be forced to reduce their workforces. Specifically, higher
unemployment rates as a result of a prolonged economic downturn could lead to lower enrollment in
the Companys employer group plans, lower enrollment in our non-employer individual plans and a
higher number of employees opting out of CIGNAs employer group plans. The adverse economic
conditions could also cause employers to stop offering certain health care coverage as an employee
benefit or elect to offer this coverage on a voluntary, employee-funded basis as a means to reduce
their operating costs. In addition, the economic downturn could negatively impact the Companys
employer group renewal prospects and our ability to increase premiums and could result in
cancellation of products and services by customers. This could also result in increased
unemployment and an increase in the number of claims submitted. All of these developments could
lead to a decrease in CIGNAs membership levels and premium and fee revenues. Further, if
customers are not successful in generating sufficient revenue or are precluded from securing
financing, they may not be able to pay, or may delay payment of, accounts receivable that are owed
to the Company. Any inability of current and/or potential customers to pay the Company for its
products may adversely affect the Companys earnings and cash flow.
32
In addition, the Company is susceptible to risks associated with the potential financial
instability of the vendors on which it relies to provide services or to whom it delegates certain
functions. The same conditions that may affect CIGNAs customers also could adversely affect its
vendors, causing them to significantly and quickly increase their prices or reduce their output.
CIGNAs business depends on its ability to perform, in an efficient and uninterrupted fashion, its
necessary business functions.
A downgrade in the financial strength ratings of CIGNAs insurance subsidiaries could adversely
affect new sales and retention of current business, and a downgrade in CIGNAs debt ratings would
increase the cost of borrowed funds.
Financial strength, claims paying ability and debt ratings by recognized rating organizations are
an important factor in establishing the competitive position of insurance companies and health
benefits companies. Ratings information by nationally recognized ratings agencies is broadly
disseminated and generally used throughout the industry. CIGNA believes the claims paying ability
and financial strength ratings of its principal insurance subsidiaries are an important factor in
marketing its products to certain of CIGNAs customers. In addition, CIGNA Corporations debt
ratings impact both the cost and availability of future borrowings, and accordingly, its cost of
capital. Each of the rating agencies reviews CIGNAs ratings periodically and there can be no
assurance that current ratings will be maintained in the future. In addition, a downgrade of these
ratings could make it more difficult to raise capital and to support business growth at CIGNAs
insurance subsidiaries.
A description of CIGNA Corporation ratings, other subsidiary ratings, as well as more information
on these ratings, is included in Ratings in Section J beginning on page 28.
Unfavorable claims experience related to workers compensation and personal accident insurance
exposures in CIGNAs Run-off Reinsurance business could result in losses
.
Unfavorable claims experience related to workers compensation and personal accident insurance
exposures in CIGNAs run-off reinsurance business is possible and could result in future losses.
Further, CIGNA could have losses attributable to its inability to recover amounts from
retrocessionaires or ceding companies either due to disputes with the retrocessionaires or ceding
companies or their financial condition. If CIGNAs reserves for amounts recoverable from
retrocessionaires or ceding companies, as well as reserves associated with underlying reinsurance
exposures are insufficient, it could result in losses.
CIGNAs equity hedge program for its guaranteed minimum death benefits contracts could fail to
reduce the risk of stock market declines.
As part of its run-off reinsurance business, CIGNA reinsured a guaranteed minimum death benefit
under certain variable annuities issued by other insurance companies. CIGNA maintains a hedge
program to reduce equity market risks related to these contracts by selling domestic and
foreign-denominated exchange-traded futures contracts. The purpose of this program is to reduce
the adverse effects of potential future domestic and international stock market declines on CIGNAs
liabilities for these contracts. Under the program, increases in liabilities under the annuity
contracts from a declining equity market are offset by gains on the futures contracts. However the
program will not perfectly offset the change in the liability in part because the market does not
offer futures contracts that exactly match the diverse mix of equity fund investments held by
contractholders. The impact of this mismatch may be higher in periods of significant volatility and
may result in higher losses to the Company. In addition, the number of futures contracts used in
the program is adjusted only when certain tolerances are exceeded and in periods of highly volatile
equity markets when actual volatility exceeds the expected volatility assumed in the liability
calculation, losses will result. Further, CIGNA could have difficulty in entering into appropriate
futures contracts or there could be an adverse interest rate impact, (which are not covered by the
program). See Run-off Reinsurance in Section F on
page 16 for more information on the program.
Actual experience could differ significantly from CIGNAs assumptions used in estimating CIGNAs
liabilities for reinsurance contracts covering guaranteed minimum death benefits or minimum income
benefits.
CIGNA estimates reserves for guaranteed minimum death benefit and minimum income benefit exposures
based on assumptions regarding lapse, partial surrender, mortality, interest rates, volatility,
reinsurance recoverables, and, for minimum income benefit exposures, annuity income election rates.
These estimates are currently based on CIGNAs experience and future expectations. CIGNA monitors
actual experience to update these reserve estimates as necessary. CIGNA regularly evaluates the
assumptions used in establishing reserves and changes its estimates if actual experience or other
evidence suggests that earlier assumptions should be revised. Further, CIGNA could have losses
attributable to its inability to recover amounts from retrocessionaires. See Notes 7 and 11 to
CIGNAs Consolidated Financial Statements beginning on pages 100
and 110, respectively, for more information on assumptions used for the
Companys guaranteed minimum death benefit and minimum income benefit exposures.
33
Significant stock market declines could result in increased pension plan expenses, the recognition
of additional pension obligations and increased funding for those obligations as well as larger net
liabilities for guaranteed minimum death benefit contracts or for guaranteed minimum income benefit
contracts.
CIGNA has a pension plan that covers a large number of current employees and retirees. Unfavorable
investment performance due to significant stock market declines or changes in estimates of benefit
costs if significant, could significantly increase the Companys pension plan expenses and
obligations.
In addition, CIGNA currently has unfunded obligations in its pension plan. A significant decline
in the value of the plan investments or unfavorable changes in applicable laws or regulations could
materially change the timing and amount of required plan funding, which could reduce the cash
available to CIGNA, including its subsidiaries. See Note 10 to CIGNAs Consolidated Financial
Statements beginning on page 106 for more information on the Companys obligations under the pension plan.
The Company calculates a provision for expected future partial surrenders as part of the liability
for guaranteed minimum death benefit contracts. As equity markets decline, the amount of
guaranteed death benefit exposure increases and the equity hedge program is designed to offset the
corresponding change in the liability. If a contractholder withdraws substantially all of their
mutual fund investments, the liability increases reflecting the lower assumed future premiums, the
lower likelihood of lapsation, and the lower likelihood of account values recovering sufficient to
reduce death benefit exposure in future periods. These effects are not covered by the Companys
equity hedge program. Thus if equity markets decline, the provision for expected future partial
surrenders increases and there is no corresponding offset from the hedge program. As equity
markets decline, the claim amounts that the Company expects to pay out for the guaranteed minimum
income benefit business increases resulting in increased net liabilities.
Significant changes in market interest rates affect the value of CIGNAs financial instruments that
promise a fixed return or benefit.
As an insurer, CIGNA has substantial investment assets that support insurance and contractholder
deposit policy liabilities. Generally low levels of interest rates on investments, such as those
experienced in United States financial markets during recent years, have negatively impacted the
level of investment income earned by the Company in recent periods, and such lower levels of
investment income would continue if these lower interest rates were to continue. Substantially all
of the Companys investment assets are in fixed interest-yielding debt securities of varying
maturities, fixed redeemable preferred securities and commercial mortgage loans. The value of
these investment assets can fluctuate significantly with changes in market conditions. A rise in
interest rates could reduce the value of the Companys investment portfolio and increase interest
expense if CIGNA were to access its available lines of credit.
The Company is also exposed to interest rate and equity risk based upon the discount rate and
expected long-term rate of return assumptions associated with the Companys pension and other
post-retirement obligations. Sustained declines in interest rates or equity returns could have an
adverse impact on the funded status of the Companys pension plans and the Companys re-investment
yield on new investments.
As the 7-year Treasury rate (claim interest rate) declines, the claim amounts that the Company
expects to pay out for the guaranteed minimum income benefit business increases. For a subset of
the business, there is a contractually guaranteed floor of 3% for the claim interest rate.
Significant interest rate declines could significantly increase the Companys net liabilities for
guaranteed minimum income benefit contracts because of increased exposures.
New accounting pronouncements or guidance could require CIGNA to change the way in which it
accounts for operations.
The Financial Accounting Standards Board, the Securities and Exchange Commission, and other
regulatory bodies may issue new accounting standards or pronouncements, or changes in the
interpretation of existing standards or pronouncements, from time to time, which could have a
significant effect on CIGNAs reported results.
34
CIGNA faces risks related to litigation and regulatory investigations.
CIGNA is routinely involved in numerous claims, lawsuits, regulatory audits, investigations and
other legal matters arising in the ordinary course of the business of administering and insuring
employee benefit programs. Such legal matters include benefit claims, breach of contract actions,
tort claims, and disputes regarding reinsurance arrangements. In addition, CIGNA incurs and likely
will continue to incur liability for claims related to its health care business, such as failure to
pay for or provide health care, poor outcomes for care delivered or arranged, provider disputes,
including disputes over compensation, and claims related to self-funded business. Also, there are
currently, and may be in the future, attempts to bring class action lawsuits against the industry.
Court decisions and legislative activity may increase CIGNAs exposure for any of these types of
claims. In some cases, substantial non-economic or punitive damages may be sought. CIGNA currently
has insurance coverage for some of these potential liabilities. Other potential liabilities may not
be covered by insurance, insurers may dispute coverage or the amount of insurance may not be
sufficient to cover the entire damages awarded. In addition, certain types of damages, such as
punitive damages, may not be covered by insurance, and insurance coverage for all or certain forms
of liability may become unavailable or prohibitively expensive in the future.
A description of material legal actions and other legal matters in which CIGNA is currently
involved is included under Legal Proceedings in Item 3 beginning on page 39, Note 22 to
CIGNAs Consolidated Financial Statements beginning on page 133 of this Form 10-K and Regulation
in Section I beginning on page 24. The outcome of litigation and other legal matters is always
uncertain, and outcomes that are not justified by the evidence or existing law can occur. CIGNA
believes that it has valid defenses to the legal matters pending against it and is defending itself
vigorously.
CIGNAs business is subject to substantial government regulation, which, along with new regulation,
could increase its costs of doing business and could adversely affect its profitability.
CIGNAs business is regulated at the international, federal, state and local levels. The laws and
rules governing CIGNAs business and interpretations of those laws and rules are subject to
frequent change. Broad latitude is given to the agencies administering those regulations. Existing
or future laws and rules could force CIGNA to change how it does business, restrict revenue and
enrollment growth, increase health care, technology and administrative costs including pension
costs and capital requirements, take other actions such as changing its reserve levels with respect
to certain reinsurance contracts, change business practices in disability payments and increase
CIGNAs liability in federal and state courts for coverage determinations, contract interpretation
and other actions.
CIGNA must comply with the various regulations applicable to its business. In addition, CIGNA must
obtain and maintain regulatory approvals to market many of its products, to increase prices for
certain regulated products and to consummate some of its acquisitions and divestitures. Delays in
obtaining or failure to obtain or maintain these approvals could reduce the Companys revenue or
increase its costs.
For further information on regulatory matters relating to CIGNA, see Regulation in Section I
beginning on page 24 and Legal Proceedings in Item 3 beginning on page 39.
CIGNA operates a pharmacy benefit management business, which is subject to a number of risks and
uncertainties, in addition to those CIGNA faces with its health care business.
CIGNAs pharmacy benefit management business is subject to federal and state regulation, including:
the application of federal and state anti-remuneration laws; compliance requirements for pharmacy
benefit manager fiduciaries under ERISA, including compliance with fiduciary obligations under
ERISA in connection with the development and implementation of items such as formularies, preferred
drug listings and therapeutic intervention programs, contracting network practices, specialty drug
distribution and other transactions and potential liability regarding the use of
patient-identifiable medical information; and federal and state laws and regulations related to the
operation of Internet and mail-service pharmacies. Furthermore, a number of federal and state
legislative proposals are being considered that could adversely affect a variety of pharmacy
benefit industry practices, including without limitation, the receipt of rebates from
pharmaceutical manufacturers, the regulation of the development and use of formularies, and
legislation imposing additional rights to access drugs for individuals enrolled in managed care
plans.
The Companys pharmacy benefit management business would also be adversely affected by an inability
to contract on favorable terms with pharmaceutical manufacturers and could suffer claims and
reputational harm in connection with purported errors by CIGNAs mail order or retail pharmacy
businesses. Disruptions at any of the Companys pharmacy business facilities due to failure of
35
technology or any other failure or disruption to these systems or to the infrastructure due to
fire, electrical outage, natural disaster, acts of terrorism or some other catastrophic event could
reduce CIGNAs ability to process and dispense prescriptions and provide products and services to
customers.
CIGNA faces competitive pressure, particularly price competition, which could result in premiums
which are insufficient to cover the cost of the healthcare services delivered to its members and
inadequate medical claims reserves.
While health plans compete on the basis of many factors, including service quality of clinical
resources, claims administration services and medical management programs, and quality and
sufficiency of provider networks, CIGNA expects that price will continue to be a significant basis
of competition. CIGNAs customer contracts are subject to negotiation as customers seek to contain
their costs, and customers may elect to reduce benefits in order to constrain increases in their
benefit costs. Such an election may result in lower premiums for the Companys products, although
it may also reduce CIGNAs costs. Alternatively, the Companys customers may purchase different
types of products that are less profitable, or move to a competitor to obtain more favorable
premiums.
In addition, significant merger and acquisition activity has occurred in the health care industry
giving rise to speculation and uncertainty regarding the status of companies, which potentially can
affect marketing efforts and public perception. Consolidation may make it more difficult for the
Company to retain or increase customers, to improve the terms on which CIGNA does business with its
suppliers, or to maintain its position or increase profitability. Factors such as business
consolidations, strategic alliances, legislative reform and marketing practices create pressure to
contain premium price increases, despite increasing medical costs. For example, the
Gramm-Leach-Bliley Act gives banks and other financial institutions the ability to affiliate with
insurance companies, which may lead to new competitors with significant financial resources in the
insurance and health benefits fields.
If CIGNA does not compete effectively in its markets, if the Company sets rates too high in highly
competitive markets to keep or increase its market share, if membership does not increase as it
expects, or if it declines, or if CIGNA loses accounts with favorable medical cost experience while
retaining or increasing membership in accounts with unfavorable medical cost experience, CIGNAs
product margins and growth could be adversely affected.
CIGNAs profitability depends, in part, on its ability to accurately predict and control future
health care costs through underwriting criteria, provider contracting, utilization management and
product design. Premiums in the health care business are generally fixed for one-year periods.
Accordingly, future cost increases in excess of medical cost projections reflected in pricing
cannot generally be recovered in the contract year through higher premiums. Although CIGNA bases
the premiums it charges on its estimate of future health care costs over the fixed premium period,
actual costs may exceed what was estimated and reflected in premiums. Factors that may cause
actual costs to exceed premiums include: medical cost inflation; higher than expected utilization
of medical services; the introduction of new or costly treatments and technology; and membership
mix.
CIGNA records medical claims reserves for estimated future payments. The Company continually
reviews estimates of future payments relating to medical claims costs for services incurred in the
current and prior periods and makes necessary adjustments to its reserves. However, actual health
care costs may exceed what was estimated.
Public perception of CIGNAs products and practices as well as of the health benefits industry, if
negative, could reduce enrollment in CIGNAs health benefits programs.
The health care industry in general, and CIGNA specifically, are subject to negative publicity,
which can arise either from perceptions regarding the industry or CIGNAs business practices or
products. This risk may be increased as CIGNA offers new products, such as products with limited
benefits or an integrated line of products, targeted at market segments, beyond those in which
CIGNA traditionally has operated. Negative publicity may adversely affect the CIGNA brand and its
ability to market its products and services, which could reduce the number of enrollees in CIGNAs
health benefits programs.
Large-scale public health epidemics, bio-terrorist activity, natural disasters or other extreme
events could cause CIGNAs covered medical and disability expenses, pharmacy costs and mortality
experience to rise significantly, and in severe circumstances, could cause operational disruption.
If widespread public health epidemics such as an influenza pandemic, bio-terrorist or other attack,
or catastrophic natural disaster were to occur, CIGNAs covered medical and disability expenses,
pharmacy costs and mortality experience could rise significantly, depending on the governments
actions and the responsiveness of public health agencies and insurers. In addition, depending on
the severity of the situation, a widespread outbreak could curtail economic activity in general,
and CIGNAs operations in particular,
36
which could result in operational and financial disruption to CIGNA. Such disruption could, among
other things impact the timeliness of claims and revenue.
CIGNAs business depends on the uninterrupted operation of its systems and business functions,
including information technology and other business systems.
CIGNAs business is highly dependent upon its ability to perform, in an efficient and uninterrupted
fashion, its necessary business functions, such as: claims processing and payment; internet
support and customer call centers; and the processing of new and renewal business. A power outage,
pandemic, or failure of one or more of information technology, telecommunications or other systems
could cause slower system response times resulting in claims not being processed as quickly as
clients desire, decreased levels of client service and client satisfaction, and harm to CIGNAs
reputation. In addition, because CIGNAs information technology and telecommunications systems
interface with and depend on third party systems, CIGNA could experience service denials if demand
for such service exceeds capacity or a third party system fails or experiences an interruption. If
sustained or repeated, such a business interruption, systems failure or service denial could result
in a deterioration of CIGNAs ability to pay claims in a timely manner, provide customer service,
write and process new and renewal business, or perform other necessary corporate functions. This
could result in a materially adverse effect on CIGNAs business results and liquidity.
A security breach of CIGNAs computer systems could also interrupt or damage CIGNAs operations or
harm CIGNAs reputation. In addition, CIGNA could be subject to liability if sensitive customer
information is misappropriated from CIGNAs computer systems. These systems may be vulnerable to
physical break-ins, computer viruses, programming errors, attacks by third parties or similar
disruptive problems. Any publicized compromise of security could result in a loss of customers or
a reduction in the growth of customers, increased operating expenses, financial losses, additional
litigation or other claims, which could have a material adverse effect on CIGNAs business.
CIGNA is focused on further developing its business continuity program to address the continuation
of core business operations. While CIGNA continues to test and assess its business continuity
program to satisfy the needs of CIGNAs core business operations and addresses multiple business
interruption events, there is no assurance that core business operations could be performed upon
the occurrence of such an event.
CIGNAs business may be adversely impacted by global market, economic and geopolitical conditions
that may cause fluctuations in equity market prices, interest rates and credit spreads which could
reduce the Companys ability to raise or deploy capital as well as affect the Companys overall
liquidity.
The capital markets and credit market have been experiencing volatility and disruption. In recent
months, the volatility and disruption has reached unusual levels. In some cases, the markets have
produced downward pressure on stock prices and credit capacity for certain issuers without regard
to those issuers underlying financial strength. If current levels of market disruption and
volatility continue or worsen, they may adversely impact the Companys availability and cost of
credit in the future. In addition, continued unpredictable or unstable market conditions may
result in reduced opportunities to find suitable opportunities to raise capital.
CIGNA is subject to potential changes in the political environment, which could adversely affect
the markets for its products.
Policy changes on the local, state and federal level, such as the expansion of the governments
role in the health care arena, could fundamentally change the dynamics of CIGNAs industry, such as
a much larger role of the government in the health care arena. For example, a broad based public
sector alternative providing comprehensive health benefits could materially reduce the number of
private sector members and exacerbate existing competitive and economic pressures. While private
healthcare plans may be solicited to provide administrative services to an expanded national public
plan, this business opportunity may be less profitable and favor larger and lower cost competitors.
CIGNA faces risks in successfully managing the integration of Great-West Healthcare (or any other
acquisition).
CIGNA acquired Great-West Healthcare with the expectation that the acquisition will result in
various benefits, including, among others, a broader distribution and provider network in certain
geographic areas, an expanded range of health benefits and products, cost savings, increased
profitability of the acquired business by improving its total medical cost position, and
achievement of operating efficiencies. Achieving the anticipated benefits of the acquisition is
subject to a number of uncertainties, including whether CIGNA integrates Great-West Healthcare in
an efficient and effective manner, and general competitive factors in the marketplace.
37
Failure to achieve these anticipated benefits could limit CIGNAs ability to grow membership,
particularly in the small business segment, result in increased costs, decreases in the amount of
expected revenues and diversion of managements time and energy.
CIGNA faces intense competition to attract and retain key people.
CIGNA would be adversely impacted if it failed to attract additional key people and retain current
key people, as this could result in the inability to effectively execute the Companys key
initiatives and business strategy.
CIGNA would be adversely affected if its prevention, detection or control systems fail to detect
and implement required changes to maintain regulatory compliance or prevent fraud.
Failure of CIGNAs prevention, detection or control systems related to regulatory compliance and/or
compliance with its internal policies, including data systems security and/or unethical conduct by
managers and/or employees, could adversely affect its reputation and also expose us to litigation
and other proceedings, fines and/or penalties. Federal and state governments have made
investigating and prosecuting health care and other insurance fraud and abuse a priority. Fraud
and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of
members, billing for unnecessary medical services, improper marketing, and violations of patient
privacy rights. The regulations and contractual requirements applicable to us and other
participants are complex and subject to change. Although the Company believes its compliance
efforts are adequate, ongoing vigorous law enforcement and the highly technical regulatory scheme
mean that its compliance efforts in this area will continue to require significant resources.
In addition, provider or member fraud that is not prevented or detected could impact its medical
costs or those of its self-insured customers. Further during an economic downturn, CIGNAs
businesses, HealthCare, Group and Disability and International, may see increased fraudulent claims
volume which may lead to additional cost because of an increase in disputed claims and litigation.
38
Item 1B.
UNRESOLVED STAFF COMMENTS
None.
Item 2.
PROPERTIES
CIGNAs headquarters, including staff support operations, along with CIGNA Disability and Life
Insurance, the domestic office of CIGNA International, and portions of CIGNA HealthCare, are
located in approximately 450,000 square feet of leased office space at Two Liberty Place, 1601
Chestnut Street, Philadelphia. CIGNA HealthCare is located in approximately 825,000 square feet of
owned office space in the Wilde Building, located at 900 Cottage Grove Road, Bloomfield,
Connecticut. In addition, CIGNA owns or leases office buildings, or parts thereof, throughout the
United States and in other countries. CIGNA believes its properties are adequate and suitable for
its business as presently conducted. For additional information concerning leases and property,
see Notes 2 and 20 to CIGNAs Consolidated Financial Statements beginning on pages 86 and 130 of
this Form 10-K. This paragraph does not include information on investment properties.
Item 3.
LEGAL PROCEEDINGS
The information contained under Litigation and Other Legal Matters in Note 22 to CIGNAs
2008 Financial Statements which begins on page 133 of this Form 10-K, is incorporated herein by
reference.
Item 4.
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
39
Executive Officers of the Registrant
All officers are elected to serve for a one-year term or until their successors are elected.
Principal occupations and employment during the past five years are listed below.
WILLIAM L. ATWELL, 58, President of CIGNA International beginning September 2008; Managing Director
of Atwell and Associates, LLC from January 2006 until August 2008; and Executive Vice President of
The Charles Schwab Corporation from August 2000 to December 2005.
MICHAEL W. BELL, 45, Executive Vice President and Chief Financial Officer of CIGNA beginning
December 2002.
DAVID M. CORDANI, 43,
President and Chief Operating Officer of CIGNA beginning June 2008;
President, CIGNA HealthCare from July 2005 until June 2008; Senior Vice President, Customer
Segments & Marketing, CIGNA HealthCare from July 2004 until July 2005; and Senior Vice President
and Chief Financial Officer, CIGNA HealthCare, from September 2002 until July 2004.
H. EDWARD HANWAY
, 57, Chairman of CIGNA since December 2000; Chief Executive Officer of
CIGNA since January 2000; and President and a Director of CIGNA since January 1999.
JOHN M. MURABITO, 50,
Executive Vice President of CIGNA beginning August 2003, with
responsibility for Human Resources and Services.
CAROL ANN PETREN, 56, Executive Vice President and General Counsel of CIGNA beginning May 2006, and
Senior Vice President and Deputy General Counsel of MCI from August 2003 until March 2006.
KAREN S. ROHAN, 46, P
resident of CIGNA Group Insurance beginning November 2005; President
of CIGNA Dental & Vision Care beginning April 2004; President of CIGNA Specialty Companies from
November 2004 until November 2005; and Chief Underwriting Officer, CIGNA HealthCare from January
2003 until April 2004.
MICHAEL WOELLER, 56, Executive Vice President and Chief Information Officer of CIGNA beginning
October 2007; Vice Chairman and Senior Vice President and Chief Information Officer, Canadian
Imperial Bank of Commerce from April 2000 until October 2007.
40
PART II
Item 5.
MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF
EQUITY SECURITIES
The information under the caption Quarterly Financial DataStock and Dividend Data appears on
page 138 and the number of shareholders of record as of December 31, 2008 appears under the
caption Highlights on page 42 of this Form 10-K. CIGNAs common stock is listed with, and trades
on, the New York Stock Exchange under the symbol CI.
Issuer Purchases of Equity Securities
The following table provides information about CIGNAs share repurchase activity for the quarter
ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
Issuer Purchases of Equity Securities
|
Period
|
|
Total # of
|
|
Average price
|
|
Total # of shares purchased
|
|
Approximate dollar value of
|
|
|
shares
|
|
paid per share
|
|
as part of publicly
|
|
shares that may yet be purchased
|
|
|
purchased
|
|
|
|
announced program (2)
|
|
as part of publicly announced
|
|
|
(1)
|
|
|
|
|
|
program (3)
|
|
October 1-31, 2008
|
|
1,195,344
|
|
$26.37
|
|
1,194,200
|
|
$448,919,605
|
November 1-30, 2008
|
|
0
|
|
$0
|
|
0
|
|
$448,919,605
|
December 1-31, 2008
|
|
3,380
|
|
$14.23
|
|
0
|
|
$448,919,605
|
|
Total
|
|
1,198,724
|
|
$26.33
|
|
1,194,200
|
|
N/A
|
|
(1)
|
|
Includes shares tendered by employees as payment of taxes withheld on the exercise of
stock options and the vesting of restricted stock granted under the Companys equity
compensation plans. Employees tendered 1,144 shares in October and 3,380 shares in
December.
|
|
(2)
|
|
CIGNA has had a repurchase program for many years, and has had varying levels of
repurchase authority and activity under this program. The program has no expiration date.
CIGNA suspends activity under this program from time to time, generally without public
announcement. Remaining authorization under the program was approximately $449 million as
of December 31, 2008.
|
|
|
(3)
|
|
Approximate dollar value of shares is as of the last date of the applicable month.
|
41
Item 6.
SELECTED FINANCIAL DATA
Highlights
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in millions, except per share amounts)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees and other revenues
|
|
$
|
17,004
|
|
|
$
|
15,376
|
|
|
$
|
13,987
|
|
|
$
|
14,449
|
|
|
$
|
15,153
|
|
Net investment income
|
|
|
1,063
|
|
|
|
1,114
|
|
|
|
1,195
|
|
|
|
1,359
|
|
|
|
1,643
|
|
Mail order pharmacy revenues
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
|
|
883
|
|
|
|
857
|
|
Realized investment gains (losses)
|
|
|
(170
|
)
|
|
|
15
|
|
|
|
220
|
|
|
|
(7
|
)
|
|
|
523
|
|
|
Total revenues
|
|
$
|
19,101
|
|
|
$
|
17,623
|
|
|
$
|
16,547
|
|
|
$
|
16,684
|
|
|
$
|
18,176
|
|
|
Results of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care
|
|
$
|
664
|
|
|
$
|
679
|
|
|
$
|
653
|
|
|
$
|
688
|
|
|
$
|
763
|
|
Disability and Life
|
|
|
273
|
|
|
|
254
|
|
|
|
226
|
|
|
|
227
|
|
|
|
182
|
|
International
|
|
|
182
|
|
|
|
176
|
|
|
|
138
|
|
|
|
109
|
|
|
|
76
|
|
Run-off Reinsurance
|
|
|
(646
|
)
|
|
|
(11
|
)
|
|
|
(14
|
)
|
|
|
(64
|
)
|
|
|
(115
|
)
|
Other Operations
|
|
|
87
|
|
|
|
109
|
|
|
|
106
|
|
|
|
339
|
|
|
|
424
|
|
Corporate
|
|
|
(162
|
)
|
|
|
(97
|
)
|
|
|
(95
|
)
|
|
|
(12
|
)
|
|
|
(114
|
)
|
Realized investment gains (losses), net of taxes
|
|
|
(110
|
)
|
|
|
10
|
|
|
|
145
|
|
|
|
(11
|
)
|
|
|
361
|
|
|
Income from continuing operations
|
|
|
288
|
|
|
|
1,120
|
|
|
|
1,159
|
|
|
|
1,276
|
|
|
|
1,577
|
|
Income (loss) from discontinued operations, net of taxes
|
|
|
4
|
|
|
|
(5
|
)
|
|
|
(4
|
)
|
|
|
349
|
|
|
|
-
|
|
Cumulative effect of accounting change, net of taxes
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(139
|
)
|
|
Net income
|
|
$
|
292
|
|
|
$
|
1,115
|
|
|
$
|
1,155
|
|
|
$
|
1,625
|
|
|
$
|
1,438
|
|
|
Income per share from continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.05
|
|
|
$
|
3.95
|
|
|
$
|
3.50
|
|
|
$
|
3.34
|
|
|
$
|
3.85
|
|
Diluted
|
|
$
|
1.04
|
|
|
$
|
3.88
|
|
|
$
|
3.44
|
|
|
$
|
3.28
|
|
|
$
|
3.81
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.06
|
|
|
$
|
3.94
|
|
|
$
|
3.49
|
|
|
$
|
4.25
|
|
|
$
|
3.51
|
|
Diluted
|
|
$
|
1.05
|
|
|
$
|
3.87
|
|
|
$
|
3.43
|
|
|
$
|
4.17
|
|
|
$
|
3.48
|
|
Common dividends declared per share
|
|
$
|
0.04
|
|
|
$
|
0.04
|
|
|
$
|
0.03
|
|
|
$
|
0.03
|
|
|
$
|
0.14
|
|
Total assets
|
|
$
|
41,406
|
|
|
$
|
40,065
|
|
|
$
|
42,399
|
|
|
$
|
44,893
|
|
|
$
|
81,059
|
|
Long-term debt
|
|
$
|
2,090
|
|
|
$
|
1,790
|
|
|
$
|
1,294
|
|
|
$
|
1,338
|
|
|
$
|
1,438
|
|
Shareholders equity
|
|
$
|
3,592
|
|
|
$
|
4,748
|
|
|
$
|
4,330
|
|
|
$
|
5,360
|
|
|
$
|
5,203
|
|
Per share
|
|
$
|
13.25
|
|
|
$
|
16.98
|
|
|
$
|
14.63
|
|
|
$
|
14.74
|
|
|
$
|
13.14
|
|
Common shares outstanding (in thousands)
|
|
|
271,036
|
|
|
|
279,588
|
|
|
|
98,654
|
|
|
|
121,191
|
|
|
|
132,007
|
|
Shareholders of record
|
|
|
9,014
|
|
|
|
8,696
|
|
|
|
9,117
|
|
|
|
9,440
|
|
|
|
10,249
|
|
Employees
|
|
|
30,300
|
|
|
|
26,600
|
|
|
|
27,100
|
|
|
|
28,000
|
|
|
|
28,600
|
|
|
On April 1, 2008, the Company acquired the Healthcare division of Great-West Life and Annuity, Inc. For additional information, see the Health Care section of the Managements Discussion and Analysis beginning
on page 54.
In 2008, the Company recorded significant charges related to the guaranteed minimum income benefits and guaranteed minimum death benefits businesses. For additional information, see the Run-off Reinsurance
section of the Managements Discussion and Analysis beginning on page 62.
In 2008, the Company recorded an after-tax litigation charge of $52 million in Corporate related to the CIGNA pension plan. See Note 22 to the Consolidated Financial Statements for additional information.
Effective January 1, 2007, CIGNA changed its presentation to report the results of the Run-off Retirement business within Other Operations. Prior period results have been restated to conform to this
presentation.
During 2007, CIGNA completed a three-for-one stock split of CIGNAs common shares. Per share figures have been adjusted to reflect the stock split.
Pro forma common shares outstanding, calculated as if the stock split had occurred at the beginning of the prior periods, were as follows: 295,963 in 2006; 363,573 in 2005; and 396,021 in 2004.
42
Item 7.
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INDEX
|
|
|
|
|
|
|
|
|
|
Introduction
|
43
|
|
|
|
|
|
|
Consolidated Results of Operations
|
46
|
|
|
|
|
|
|
Critical Accounting Estimates
|
49
|
|
|
|
|
|
|
Segment Reporting
|
|
|
|
|
|
|
|
Health Care
|
54
|
|
|
|
|
|
|
Disability and Life
|
59
|
|
|
|
|
|
|
International
|
60
|
|
|
|
|
|
|
Run-off Reinsurance
|
62
|
|
|
|
|
|
|
Other Operations
|
65
|
|
|
|
|
|
|
Corporate
|
66
|
|
|
|
|
|
|
Discontinued Operations
|
66
|
|
|
|
|
|
|
Industry Developments and Other Matters
|
67
|
|
|
|
|
|
|
Liquidity and Capital Resources
|
67
|
|
|
|
|
|
|
Investment Assets
|
73
|
|
|
|
|
|
|
Market Risk
|
76
|
|
|
|
|
|
|
Cautionary Statement
|
78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTRODUCTION
In this filing and in other marketplace communications, CIGNA Corporation and its subsidiaries (the
Company) make certain forward-looking statements relating to the Companys financial condition and
results of operations, as well as to trends and assumptions that may affect the
Company. Generally, forward-looking statements can be identified through the use of predictive
words (e.g., Outlook for 2009). Actual results may differ from the Companys predictions. Some
factors that could cause results to differ are discussed throughout Managements Discussion and
Analysis (MD&A), including in the Cautionary Statement beginning on page 78. The forward-looking
statements contained in this filing represent managements current estimate as of the date of this
filing. Management does not assume any obligation to update these estimates.
Certain reclassifications have been made to prior period amounts to conform to the presentation of
2008 amounts.
Overview
The Company constitutes one of the largest investor-owned health service organizations in the
United States. Its subsidiaries are major providers of health care and related benefits, the
majority of which are offered through the workplace. In addition, the Company has an international
operation that offers life, accident and supplemental health insurance products as well as
international health care products and services to businesses and individuals in selected markets.
The Company also has certain inactive businesses, including a Run-off Reinsurance segment.
Ongoing Operations
The Company generates revenues, net income and cash flow from ongoing operations by:
|
|
maintaining and growing its customer base;
|
|
|
charging prices that reflect emerging experience;
|
|
|
investing available cash at attractive rates of return for appropriate durations; and
|
|
|
effectively managing other operating expenses.
|
The Companys ability to increase revenue, net income and operating cash flow is directly related
to its ability to address broad economic and industry factors and execute its strategic
initiatives, the success of which is measured by certain key factors as discussed below.
43
Key factors affecting the Companys results from ongoing operations include:
|
|
the ability to profitably price products and services at competitive levels;
|
|
|
the volume of customers served and the mix of products and services purchased by those
customers;
|
|
|
the ability to cross sell its various health and related benefit products;
|
|
|
the relationship between other operating expenses and revenue; and
|
|
|
the effectiveness of the Companys capital deployment initiatives.
|
Run-off Operations
Effectively managing the various exposures of its run-off operations is important to the Companys
ongoing profitability, operating cash flows and available capital. The results are influenced by a
range of economic factors, especially movements in equity markets and interest rates. Results are
also influenced by behavioral factors, including partial surrender election rates for GMDB
contracts and annuity election rates for GMIB contracts, as well as the collection of amounts
recoverable from retrocessionaires. In order to manage these risks, the Company operates a GMDB
equity hedge program to substantially reduce the impact of equity market movements. The Company
actively monitors the performance of the hedge program, and evaluates the cost/benefit of hedging
other risks. The Company also actively studies policyholder behavior experience and adjusts future
expectations based on the results of the studies, as warranted. We also perform regular audits of
the ceding companies to ensure treaty compliance that premiums received and claims paid
are properly reflective of the underlying risks and to maximize the probability of
subsequent collection of claims from retrocessionaires. Finally, the Company monitors the credit
standing of the retrocessionaires.
Summary
The Companys overall results are influenced by a range of economic and other factors, especially:
|
|
cost trends and inflation for medical and related services;
|
|
|
utilization patterns of medical and other services;
|
|
|
employment levels;
|
|
|
the tort liability system;
|
|
|
developments in the political environment both domestically and internationally;
|
|
|
interest rates, equity market returns, foreign currency fluctuations and credit market
volatility, including the availability and cost of credit in the future; and
|
|
|
federal and state regulation.
|
The Company regularly monitors the trends impacting operating results from the above mentioned key
factors and economic and other factors affecting its operations. The Company develops strategic and
tactical plans designed to improve performance and maximize its competitive position in the markets
it serves. The Companys ability to achieve its financial objectives is dependent upon its ability
to effectively execute these plans and to appropriately respond to emerging economic and
company-specific trends.
The Company is continuing to improve the performance of and profitably grow its ongoing businesses
and manage the risks associated with the run-off reinsurance operations.
Acquisition of Great-West Healthcare
On April 1, 2008, the Company acquired the Healthcare division of Great-West Life and Annuity, Inc.
(Great-West Healthcare or the acquired business) through 100% indemnity reinsurance agreements
and the acquisition of certain affiliates and other assets and liabilities of Great-West
Healthcare. The purchase price was approximately $1.5 billion and consisted of a payment to the
seller of approximately $1.4 billion for the net assets acquired and the assumption of net
liabilities under the reinsurance agreement of approximately $0.1 billion. Great-West Healthcare
primarily sells medical plans on a self-funded basis with stop-loss coverage to select and regional
employer groups. Great-West Healthcares offerings also include the following specialty
products: stop-loss, life, disability, medical, dental, vision, prescription drug coverage, and
accidental death and dismemberment insurance. The acquisition, which was accounted for as a
purchase, was financed through a combination of cash and the issuance of both short and long-term
debt.
See Note 3 to the Consolidated Financial Statements for additional information
.
44
Initiatives to Lower Operating Expenses
The Company has undertaken several initiatives to realign its organization and consolidate support
functions in an effort to increase efficiency and responsiveness to customers and to reduce costs.
In 2008, the Company conducted a comprehensive review of its ongoing businesses with an emphasis on
reducing operating expenses in the Health Care segment. As a result of the review, during the
fourth quarter of 2008, the Company committed to a plan to reduce operating costs in order to meet
the challenges and opportunities presented by the current economic environment. The Company
anticipates the plan will be substantially complete by the end of 2009. As a result, the Company
recognized in other operating expenses a total charge of $55 million pre-tax ($35 million
after-tax), which included $44 million pre-tax ($28 million after-tax) for severance and other
related costs resulting from reductions of approximately 1,100 positions in its workforce and $11
million pre-tax ($7 million after-tax) resulting from consolidation of facilities. The Company
expects to pay $53 million in cash related to this charge, most of which will occur in 2009. The
Health Care segment reported $44 million pre-tax ($27 million after-tax) of the total charge. The
remainder was reported as follows: Disability and Life: $3 million pre-tax ($2 million after-tax),
and International: $8 million pre-tax ($6 million after-tax). As a result of these actions, the
Company expects annualized after-tax savings of approximately $70 million, a portion of which is
expected to be realized in 2009.
45
CONSOLIDATED RESULTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premiums and fees
|
|
$
|
16,203
|
|
|
$
|
15,008
|
|
|
$
|
13,641
|
|
Net investment income
|
|
|
1,063
|
|
|
|
1,114
|
|
|
|
1,195
|
|
Mail order pharmacy revenues
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
Other revenues
|
|
|
801
|
|
|
|
368
|
|
|
|
346
|
|
Realized investment gains (losses)
|
|
|
(170
|
)
|
|
|
15
|
|
|
|
220
|
|
|
|
|
Total revenues
|
|
|
19,101
|
|
|
|
17,623
|
|
|
|
16,547
|
|
Benefits and expenses
|
|
|
18,723
|
|
|
|
15,992
|
|
|
|
14,816
|
|
|
|
|
Income from continuing operations before taxes
|
|
|
378
|
|
|
|
1,631
|
|
|
|
1,731
|
|
Income taxes
|
|
|
90
|
|
|
|
511
|
|
|
|
572
|
|
|
|
|
Income from continuing operations
|
|
|
288
|
|
|
|
1,120
|
|
|
|
1,159
|
|
Income (loss) from discontinued operations, net of taxes
|
|
|
4
|
|
|
|
(5
|
)
|
|
|
(4
|
)
|
|
Net income
|
|
$
|
292
|
|
|
$
|
1,115
|
|
|
$
|
1,155
|
|
|
Realized investment gains (losses), net of taxes
|
|
$
|
(110
|
)
|
|
$
|
10
|
|
|
$
|
145
|
|
|
Special Items
In order to facilitate an understanding and comparison of results of operations and permit analysis
of trends in underlying revenue, expenses and income from continuing operations, presented below
are special items, which management believes are not representative of the underlying results
of operations.
|
|
|
|
|
|
|
|
|
|
SPECIAL ITEMS
|
|
Pre-Tax
|
|
|
After-Tax
|
|
|
|
Benefit
|
|
|
Benefit
|
|
(In millions)
|
|
(Charge)
|
|
|
(Charge)
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
Charges related to litigation matters
|
|
$
|
(117
|
)
|
|
$
|
(76
|
)
|
Cost reduction charge
|
|
|
(55
|
)
|
|
|
(35
|
)
|
|
Total
|
|
$
|
(172
|
)
|
|
$
|
(111
|
)
|
|
2007
|
|
|
|
|
|
|
|
|
|
Completion of IRS examination
|
|
$
|
-
|
|
|
$
|
23
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
Charge associated with settlement of shareholder litigation
|
|
$
|
(38
|
)
|
|
$
|
(25
|
)
|
Cost reduction charge
|
|
|
(37
|
)
|
|
|
(23
|
)
|
|
Total
|
|
$
|
(75
|
)
|
|
$
|
(48
|
)
|
|
Special items for 2008 included a cost reduction charge (see the Introduction section of the MD&A
beginning on page 43), a litigation matter related to the CIGNA Pension Plan (see Note 22 to the
Consolidated Financial Statements for additional information) reported in Corporate and charges
related to certain other litigation matters, which are reported in the Health Care segment.
The special item for 2007 consisted of previously unrecognized tax benefits resulting from the
completion of the IRS examination for the 2003 and 2004 tax years.
Special items for 2006 consisted of:
|
|
a charge associated with the settlement of the shareholder class action lawsuit brought
against the Company. This charge included certain costs to defend and was net of expected
insurance recoveries; and
|
|
|
a charge for severance costs resulting from a review of staffing levels in the Health Care
operations and in supporting areas.
|
46
Overview of 2008 Consolidated Results of Operations
Income from continuing operations for the year ended December 31, 2008 declined significantly
compared with 2007, as a result of the following:
|
|
The Run-off Reinsurance segment reported substantial losses in 2008, primarily due to
losses in the guaranteed minimum income benefits (GMIB) and guaranteed minimum death benefits
(GMDB) businesses, reflecting the deterioration in the financial
markets and also, for GMIB, the
effect of adopting Statement of Financial Accounting Standards No. (SFAS No.) 157. See the
Run-off Reinsurance section of the MD&A beginning on page 62 for additional information.
|
|
|
The Company reported significant net realized investment losses in 2008 primarily due to
impairments caused largely by the deterioration in the financial markets. These losses were
partially offset by gains on the sale of real estate. See the Investment Assets section of
the MD&A beginning on page 73 for more information.
|
|
|
The Companys results in 2008 were also negatively affected by the special charges for
litigation and cost reduction matters discussed beginning on page 46.
|
These factors were partially offset by higher segment earnings in each of the Companys ongoing
operating segments (Health Care, Disability and Life, and International).
Overview of 2007 Consolidated Results of Operations
Excluding the special items discussed above, income from continuing operations decreased in 2007,
compared with 2006, principally reflecting lower realized investment gains primarily due to lower
gains from sales of equity interests in real estate limited liability entities of $145 million.
These factors were partially offset by higher earnings in the Health Care (see page 54), Disability
and Life (see page 59), International (see page 60) and Run-off Reinsurance (see page 62) segments.
Outlook for 2009
The Company expects 2009 income
from continuing operations, excluding realized investments results, the results of the GMIB
business, and special items, to be higher than 2008 due to overall earnings growth in the
ongoing operating segments, as well as lower
losses in the Run-off Reinsurance segment. This outlook includes an assumption that
results of the GMDB business will be
approximately break-even for full-year 2009. This assumption
reflects managements view that the long-term reserve assumptions are
appropriate and that equity market conditions and volatility will return to
more normal levels in 2009. The Companys outlook is
subject to the factors cited in the Cautionary Statement and the sensitivities
discussed in the Critical Accounting Estimates section of
the MD&A on pages 49 through 53. If the unfavorable
equity market and interest rate movements continue, the Company could
experience additional losses related to the GMDB business.
Information is not
available for management to reasonably estimate the future results of the
GMIB business, realized investment gains
(losses), or to identify or reasonably estimate special items in 2009. However,
if unfavorable equity market and interest rate
movements continue, the Company could also experience additional losses related to
the GMIB business and investment impairments.
Potential losses related to the GMDB and GMIB businesses, as well as investment
impairments, could adversely impact the
Companys consolidated results of operations and financial
condition, and could reduce the capital of the Companys insurance
subsidiaries as well as their dividend paying capabilities.
Revenues
Total revenue increased by 8% in 2008, compared with 2007; and 7% in 2007 compared with
2006. Changes in the components of total revenue are described more fully below.
Premiums and Fees
Premiums and fees increased by 8% in 2008, compared with 2007 reflecting the impact of the acquired
business, growth in the Disability and Life segment, as well as growth and rate increases in the
International segment. See segment reporting discussions for additional detail and drivers.
47
Premiums and fees increased 10% in 2007, compared with 2006, primarily attributable to higher
specialty revenues and growth in medical membership as well as strong renewal pricing on existing
business in the Health Care segment and strong business growth in the Disability and Life and
International segments.
Net Investment Income
Net investment income decreased 5% in 2008, compared with 2007 primarily due to lower yields driven
by declines in short-term interest rates, commercial mortgage pre-payment fees, and income from
security partnerships.
Net investment income decreased 7% in 2007. This decrease was primarily attributable to lower
average assets due to share repurchase activity and a decline in the Health Care segment average
invested assets resulting from:
|
|
a shift in business from guaranteed cost products to administrative services only (ASO)
products; and
|
|
|
pre-funding of Medicare Part D claims.
|
Mail Order Pharmacy Revenues
Mail order pharmacy revenues increased 8% in 2008, compared with 2007 due to increased script
volume and rate increases.
Mail order pharmacy revenues in 2007 were comparable to 2006.
Other Revenues
Excluding the impact of the futures contracts associated with the GMDB equity hedge program, Other
revenues increased 17% in 2008, compared with 2007, primarily reflecting the impact of the acquired
business. In 2008, the Company reported gains of $333 million associated with the GMDB equity
hedge program, compared with losses of $32 million in 2007. The gains in 2008 primarily reflect
the decline in stock market values.
Excluding the impact of the GMDB equity hedge program, Other revenues decreased 10% in 2007,
compared with 2006 primarily due to lower revenues from the disability and workers compensation
case management business reported in the Disability and Life segment. The Company reported losses
on futures contracts associated with the GMDB equity hedge program of $32 million in 2007, compared
with losses of $96 million in 2006. The decline in losses in 2007 primarily reflects lower stock
market appreciation compared with 2006.
Realized Investment Results
Realized investment results in 2008 were lower than 2007, primarily due to higher losses associated
with asset write-downs and increases in valuation allowances primarily due to higher interest rates
and credit losses resulting from current economic conditions. In addition, the Company had higher
losses on sales of fixed maturities and equity securities. These losses were partially offset by
higher gains on sales of real estate investments held in joint ventures. See Note 13 to the
Consolidated Financial Statements for additional information.
Realized investment gains (losses) were lower in 2007, compared with 2006, primarily due to sales
of equity interests in real estate limited liability entities in 2006.
48
CRITICAL ACCOUNTING ESTIMATES
The preparation of consolidated financial statements in accordance with accounting principles
generally accepted in the United States of America (GAAP) requires management to make estimates and
assumptions that affect reported amounts and related disclosures in the consolidated financial
statements. Management considers an accounting estimate to be critical if:
|
|
it requires assumptions to be made that were uncertain at the time the estimate was made;
and
|
|
|
changes in the estimate or different estimates that could have been selected could have a
material effect on the Companys consolidated results of operations or financial condition.
|
Management has discussed the development and selection of its critical accounting estimates with
the Audit Committee of the Companys Board of Directors and the Audit Committee has reviewed the
disclosures presented below.
In addition to the estimates presented in the following table, there are other accounting estimates
used in the preparation of the Companys consolidated financial statements, including estimates of
liabilities for future policy benefits other than those identified in the following table, as well
as estimates with respect to goodwill, unpaid claims and claim expenses, postemployment and
postretirement benefits other than pensions, certain compensation accruals, and income taxes.
Management believes the current assumptions used to estimate amounts reflected in the Companys
consolidated financial statements are appropriate. However, if actual experience differs from the
assumptions used in estimating amounts reflected in the Companys consolidated financial
statements, the resulting changes could have a material adverse effect on the Companys
consolidated results of operations, and in certain situations, could have a material adverse effect
on the Companys liquidity and financial condition.
See Note 2 to the Consolidated Financial Statements for further information on significant
accounting policies that impact the Company.
|
|
|
|
|
|
|
Balance Sheet Caption /
|
|
Assumptions / Approach Used
|
|
Effect if Different Assumptions Used
|
Nature of Critical Accounting Estimate
|
|
|
|
|
|
Future policy benefits -
Guaranteed minimum death benefits
These liabilities are estimates of
the present value of net amounts
expected to be paid, less the present
value of net future premiums expected
to be received. The amounts to be
paid represent the excess of the
guaranteed death benefit over the
values of contractholders accounts.
The death benefit coverage in force
at December 31, 2008 (representing
the amount payable if all of
approximately 650,000 contractholders
had died as of that date) was
approximately $11 billion.
Liabilities for future policy
benefits for these contracts as of
December 31 were as follows (in
millions):
2008 $1,609
2007
$ 848
|
|
The Company estimates
these liabilities based on
assumptions for lapse,
partial surrender,
mortality, interest rates
(mean investment
performance and discount
rate), and volatility.
These assumptions are
based on the Companys
experience and future
expectations over the
long-term period. The
Company monitors actual
experience to update these
estimates as necessary.
Lapse refers to the full
surrender of an annuity
prior to a
contractholders death.
Partial surrender refers
to the fact that most
contractholders have the
ability to withdraw
substantially all of their
mutual fund investments
while retaining any
available death benefit
coverage in effect at the
time of the withdrawal.
Once a partial surrender
is made, the liability
increases reflecting lower
future assumed premiums, a
lower likelihood of
lapsation, and a lower
likelihood of account
values recovering
sufficiently to reduce the
death benefit exposure in
future periods. These
effects are not covered by
the Companys GMDB equity
hedge program. Market
declines could expose the
Company to higher amounts
of death benefit exposure
that can be retained by
contractholders subsequent
to a significant partial
surrender and to higher
election rates of future
partial surrenders. Thus,
if equity markets decline,
the Companys liability
for partial surrenders
increases and there is no
corresponding offset from
the hedge program. The
election rate for expected
future partial surrenders
is updated quarterly based
on emerging experience.
Interest rates include
both (a) the mean
investment performance
assumption considering the
Companys GMDB equity
hedge program which
reflects the average
short-term interest rate
to be earned over the life
of the program, and (b)
the liability discount
rate assumption.
|
|
Current assumptions used to estimate these
liabilities are detailed in Note 7 to the
Consolidated Financial Statements. If an
unfavorable change were to occur to those
assumptions, the approximate after-tax decrease in
net income would be as follows:
10% increase in mortality rates - $85
million
10% decrease in lapse rates - $30 million
10% increase in election rates for future
partial surrenders - $10 million
50 basis point decrease in interest rates:
Mean Investment Performance - $35 million
Discount Rate - $35 million
10% increase in volatility - $15 million
As of December 31, 2008, if contractholder account
values invested in underlying equity mutual funds
declined by 10% due to equity market performance,
the after-tax decrease in net income resulting from
an increase in the provision for partial surrenders
would be approximately $25 million.
As of December 31, 2008, if contractholder account
values invested in underlying bond/money market
mutual funds declined by 10% due to bond/money
market performance, the after-tax decrease in net
income resulting from an increase in the provision
for partial surrenders and an increase in unhedged
exposure would be approximately $50 million.
The amounts would be reflected in the Run-off
Reinsurance segment.
|
|
|
|
|
|
|
49
|
|
|
|
|
|
|
Balance Sheet Caption /
|
|
Assumptions / Approach Used
|
|
Effect if Different Assumptions Used
|
Nature of Critical Accounting Estimate
|
|
|
|
|
|
|
|
Volatility refers to the
degree of variation of
future market returns of
the underlying mutual fund
investments.
|
|
|
|
|
|
|
|
|
Health Care medical claims payable
Medical claims payable for the Health
Care segment include both reported
claims and estimates for losses
incurred but not yet reported.
Liabilities for medical claims
payable as of December 31 were as
follows (in millions):
2008 gross $924;
net $713
2007
gross $975; net $717
These
liabilities are presented above both gross
and net of reinsurance and other
recoverables.
These liabilities
generally exclude amounts for
administrative services only business.
See Note 5 to the Consolidated
Financial Statements for additional
information.
|
|
The Company develops
estimates for Health Care
medical claims payable
using actuarial principles
and assumptions based on
historical and projected
claim payment patterns,
medical cost trends, which
are impacted by the
utilization of medical
services and the related
costs of the services
provided (unit costs),
benefit design,
seasonality, and other
relevant operational
factors. The Company
consistently applies these
actuarial principles and
assumptions each reporting
period, with consideration
given to the variability
of these factors, and
recognizes the actuarial
best estimate of the
ultimate liability within
a level of confidence, as
required by actuarial
standards of practice,
which require that the
liabilities be adequate
under moderately adverse
conditions.
The Companys estimate of
the liability for medical
claims incurred but not
yet reported is primarily
calculated using
historical claim payment
patterns and expected
medical cost trends. The
Company analyzes the
historical claim payment
patterns by comparing the
dates claims were
incurred, generally the
dates services were
provided, to the dates
claims were paid to
determine completion
factors, which are a
measure of the time to
process claims. A
completion factor is
calculated for each month
of incurred claims. The
Company uses historical
completion factors
combined with an analysis
of current trends and
operational factors to
develop current estimates
of completion factors.
The Company estimates the
ultimate liability for
claims incurred in each
month by applying the
current estimates of
completion factors to the
current paid claims data.
The difference between
this estimate of the
ultimate liability and the
current paid claims data
is the estimate of the
remaining claims to be
paid for each incurral
month. These monthly
estimates are aggregated
and included in the
Companys Health Care
medical claims payable at
the end of each reporting
period. Completion
factors are used to
estimate the health care
medical claims payable for
all months where claims
have not been completely
resolved and paid, except
for the most recent month
as described below.
Completion factors are
impacted by several key
items including changes in
the level of claims
processed electronically
versus manually
(auto-adjudication),
changes in provider claims
submission rates,
membership changes and the
mix of products. As
noted, the Company uses
historical completion
factors combined with an
analysis of current trends
and operational factors to
develop current estimates
of completion factors.
This approach implicitly
assumes that historical
completion rates will be a
useful indicator for the
current period. It is
possible that the actual
completion rates for the
current period will
develop differently from
historical patterns, which
could have a material
impact on the Companys
medical claims payable and
net income.
Claims incurred in the
most recent month have
limited paid claims data,
since a large portion of
health care claims are not
submitted to the Company
for payment in the month
services have been
provided. This makes the
completion factor approach
less reliable for claims
incurred in the most
recent month. As a
result, in any reporting
period, for the estimates
of the ultimate claims
incurred in the most
recent month, the Company
primarily relies on
medical cost trend
analysis, which reflects
expected claim payment
patterns and other
relevant operational
considerations. Medical
cost trend is impacted by
several key factors
including medical service
utilization and unit costs
and the Companys ability
to
|
|
For the year ended December 31, 2008, actual
experience differed from the Companys key
assumptions, resulting in $60 million of favorable
incurred claims related to prior years medical
claims payable of 0.9% of the current year incurred
claims as reported for the year ended December 31,
2007. For the year ended December 31, 2007, actual
experience differed from the Companys key
assumptions, resulting in $80 million of favorable
incurred claims related to prior years medical
claims, or 1.3% of the current year incurred claims
reported for the year ended December 31, 2006.
Specifically, the favorable impact is due to faster
than expected completion factors and lower than
expected medical cost trends, both of which
included an assumption for moderately adverse
experience.
The corresponding impact of favorable prior year
development on net income was $7 million for the
year ended December 31, 2008. The change in the
amount of the incurred claims related to prior
years in the medical claims payable liability does
not directly correspond to an increase or decrease
in the Companys net income.
|
|
50
|
|
|
|
|
|
|
Balance Sheet Caption /
|
|
Assumptions / Approach Used
|
|
Effect if Different Assumptions Used
|
Nature of Critical Accounting Estimate
|
|
|
|
|
|
|
|
manage these factors
through benefit design,
underwriting, provider
contracting and the
Companys medical
management initiatives.
These factors are affected
by changes in the level
and mix of medical
benefits offered,
including inpatient,
outpatient and pharmacy,
the impact of copays and
deductibles, changes in
provider practices and
changes in consumer
demographics and
consumption behavior.
|
|
|
|
|
|
|
|
|
|
Because historical trend
factors are often not
representative of current
claim trends, the trend
experienced for the most
recent history along with
an analysis of emerging
trends, have been taken
into consideration in
establishing the liability
for medical claims payable
at December 31, 2008 and
2007. It is possible that
the actual medical trend
for the current period
will develop differently
from the expected, which
could have a material
impact on the Companys
medical claims payable and
net income.
|
|
|
|
|
|
|
|
|
|
For each reporting period,
the Company evaluates key
assumptions by comparing
the assumptions used in
establishing the medical
claims payable to actual
experience. When actual
experience differs from
the assumptions used in
establishing the
liability, medical claims
payable are increased or
decreased through current
period net income.
Additionally, the Company
evaluates expected future
developments and emerging
trends which may impact
key assumptions. The
estimation process
involves considerable
judgment, reflecting the
variability inherent in
forecasting future claim
payments. The adequacy of
these estimates is highly
sensitive to changes in
the Companys key
assumptions, specifically
completion factors, which
are impacted by actual or
expected changes in the
submission and payment of
medical claims, and
medical cost trends, which
are impacted by actual or
expected changes in the
utilization of medical
services and unit costs.
|
|
|
|
|
|
|
|
|
Accounts payable, accrued expenses
and other liabilities, and Other
assets -
Guaranteed minimum income benefits
These liabilities are estimates of
the present value of net amounts
expected to be paid, less the present
value of net future premiums expected
to be received. The amounts to be
paid represent the excess of the
expected value of the income benefit
over the value of the annuitants
accounts at the time of
annuitization.
The assets associated with these
contracts represent receivables in
connection with reinsurance that the
Company has purchased from two
external reinsurers, which covers 55%
of the exposures on these contracts.
As discussed in Note 2(B) to the
Consolidated Financial Statements,
the Company implemented SFAS No. 157,
Fair Value Measurements, on January
1, 2008. At adoption, the Company was
required to change certain
assumptions. As a result, the
Company recorded a charge of $131
million after-tax, net of reinsurance
($202 million pre-tax).
|
|
With the adoption of SFAS
No. 157, the Company
updated assumptions to
reflect those that the
Company believes a
hypothetical market
participant would use to
determine a current exit
price. The Company
estimates a hypothetical
market participants view
of these assumptions
considering market
observable information,
the actual and expected
experience of the Company,
and other relevant and
available industry
sources. Resulting
changes in fair value are
reported in GMIB expense.
The Company considers the
various assumptions used
to estimate the fair
values of assets and
liabilities associated
with those contracts in
two categories. The first
group of assumptions used
to estimate these fair
values consist of capital
market inputs including
market returns and
discount rates, claim
interest rates and market
volatility.
Interest rates include (a)
market returns, (b) the
liability discount rate
assumption and (c) the
projected interest rates
used to calculate the
reinsured income benefit
at the time of
annuitization (claim
interest rate).
Volatility refers to the
degree of variation of
future market returns of
the underlying mutual fund
investments.
|
|
Current assumptions used to
estimate these liabilities are
detailed in Note 11 to the
Consolidated Financial Statements.
With the adoption of SFAS No. 157,
the Companys results of operations
are expected to be more volatile in
future periods because these
assumptions will be based largely
on market-observable inputs at the
close of each period including
interest rates and market implied
volatilities.
If an unfavorable change were to
occur in these assumptions, the
approximate after-tax decrease in
net income, net of estimated
amounts receivable from reinsurers,
would be as follows:
50 basis point decrease in
interest rates (which are aligned
with LIBOR) used for projecting
market returns and discounting
$25 million
50 basis point decrease in
interest rates used for projecting
claim exposure (7-year Treasury
rates)
$20 million
20% increase in implied
market volatility
$5 million
|
|
|
|
|
|
|
51
|
|
|
|
|
|
|
Balance Sheet Caption /
|
|
Assumptions / Approach Used
|
|
Effect if Different Assumptions Used
|
Nature of Critical Accounting Estimate
|
|
|
|
|
|
During 2007, the Company increased
its assumption related to annuity
election rates and decreased its
lapse assumption resulting in a
charge (net of reinsurance) of $86
million pre-tax ($56 million
after-tax).
Liabilities related to these
contracts as of December 31, were as
follows (in millions):
2008 $1,757
2007
$313
As of December 31, estimated amounts
receivable related to these contracts
from two external reinsurers, were as
follows (in millions):
2008 $953
2007
$173
|
|
The second group of assumptions consists of future annuitant
behavior including annuity election rates, lapse, and
mortality, retrocessionaire credit risk, and a risk and
profit charge.
Annuity election rates refer to the proportion of annuitants
who elect to receive their income benefit as an annuity.
Lapse refers to the full surrender of an annuity prior to
annuitization of the policy.
Credit risk refers to the ability of these reinsurers to pay.
Risk and profit charge refers to the amount that a
hypothetical market participant would include in the
valuation to cover the uncertainty of outcomes and the
desired return on capital.
|
|
10% decrease in mortality $3 million
10% increase in annuity election
rates
$5 million
10% decrease in lapse rates
$10 million
10% decrease in amounts receivable from
reinsurers (credit risk)
$60 million
10% increase to the risk and profit
charge $5 million
Market declines which reduce annuitants account
values expose the Company to higher potential
claims which results in a larger net liability.
If annuitants account values as of December 31,
2008 declined by 10% due to the performance of
the underlying mutual funds, the approximate
after-tax decrease in net income, net of
estimated amounts receivable from reinsurers,
would be approximately $25 million.
All of these estimated impacts due to
unfavorable changes in assumptions could vary
from quarter to quarter depending on actual
reserve levels, the actual market conditions or
changes in the anticipated view of a
hypothetical market participant as of any future
valuation date.
The amounts would be reflected in the
Run-off
Reinsurance segment.
|
|
Reinsurance recoverables
Reinsurance recoverables in Run-off
Reinsurance
Collectibility of reinsurance
recoverables requires an assessment
of risks that such amounts will not
be collected, including risks
associated with reinsurer default and
disputes with reinsurers regarding
applicable coverage.
Gross and net reinsurance
recoverables in the Run-off
Reinsurance segment as of December
31, were as follows (in millions):
2008 gross
$180; net $169
2007 gross
$203; net $191
|
|
The amount of reinsurance recoverables in the Run-off
Reinsurance segment, net of reserves, represents
managements best estimate of recoverability, including an
assessment of the financial strength of reinsurers.
|
|
A 10% reduction of net reinsurance recoverables
due to uncollectibility at December 31, 2008,
would reduce net income by approximately $11
million after-tax.
The amounts would be reflected in the
Run-off
Reinsurance segment.
See Note 8 to the Consolidated Financial
Statements for additional information.
|
|
Accounts payable, accrued expenses
and other liabilitiespension
liabilities
These liabilities are estimates of
the present value of the qualified
and nonqualified pension benefits to
be paid (attributed to employee
service to date) net of the fair
value of plan assets. The accrued pension benefit liability as of
December 31 was as follows (in
millions):
|
|
The Company estimates these liabilities with actuarial
models using various assumptions including discount rates
and an expected long-term return on plan assets.
Discount rates are set by applying actual annualized yields
at various durations from the Citigroup Pension Liability
curve, without adjustment, to the expected cash flows of the
pension liabilities.
The expected long-term return on plan assets for the
domestic qualified pension plan is developed considering actual historical returns, expected long-term market
conditions, plan asset mix and managements investment
strategy. In addition, to measure pension costs the Company
uses a market-related asset value method for domestic
qualified pension plan assets invested in non-fixed income
investments, which are approximately 80% of total plan
assets. This method recognizes the difference between
actual and expected returns in the non-fixed income
portfolio over 5 years, a method that reduces the short-term impact of market fluctuations on pension cost.
|
|
Using past experience, the Company expects that
it is reasonably possible that a favorable or
unfavorable change in these key assumptions of
50 basis points could occur. An unfavorable
change is a decrease in these key assumptions
with resulting impacts as discussed below.
If discount rates for the qualified and
nonqualified pension plans decreased by 50 basis
points:
|
2008
$1,853
2007
$628
See Note 10 to the Consolidated
Financial Statements for additional
information.
|
|
|
annual pension costs for 2009 would
increase by approximately $15 million,
after-tax; and
the accrued pension benefit liability
would increase by approximately $180 million as
of December 31, 2008 resulting in an after-tax
decrease to shareholders equity of
approximately $120 million as of December 31,
2008.
If the expected long-term return on domestic
qualified pension plan assets decreased by 50
basis points, annual pension costs for 2009
would
|
|
|
|
|
|
|
52
|
|
|
|
|
|
|
Balance Sheet Caption /
|
|
Assumptions / Approach Used
|
|
Effect if Different Assumptions Used
|
Nature of Critical Accounting Estimate
|
|
|
|
|
|
|
|
The significant decline in value of equity securities during
2008 has resulted in an accumulated unrecognized actuarial
loss of $1.5 billion at December 31, 2008. The actuarial
loss is adjusted for unrecognized changes in market-related
asset values and amortized over the remaining service life
of pension plan participants if the adjusted loss exceeds
10% of the market-related value of plan assets or 10% of the
projected benefit obligation, whichever is greater. As of
December 31, 2008, approximately $0.4 billion of the
adjusted actuarial loss exceeded 10% of the projected
benefit obligation. As a result, approximately $35 million
after-tax will be expensed in 2009 net income. For the year
ended December 31, 2008, $37 million after-tax was expensed
in net income.
|
|
increase by approximately $10 million, after-tax.
If the December 31, 2008 fair values of domestic
qualified plan assets decreased by 10%, the
accrued pension benefit liability would increase
by approximately $225 million as of December 31,
2008 resulting in an after-tax decrease to
shareholders equity of approximately $145
million.
A favorable change is an increase in these key
assumptions and would result in impacts to
annual pension costs, the accrued pension
liability and shareholders equity in an
opposite direction, but similar amounts.
|
|
Investments Fixed maturities
Recognition of losses from other
than temporary impairments of
public and private placement
fixed maturities
Losses for other than temporary
impairments of fixed maturities must
be recognized in net income based on
an estimate of fair value by
management.
Changes in fair value are reflected
as an increase or decrease in
shareholders equity. A decrease in
fair value is recognized in net
income when the decrease is
determined to be other than
temporary.
Determining whether a decline in
value is other than temporary
includes an evaluation of the reasons
for and the significance of the
decrease in value of the security as
well as the duration of the decrease.
|
|
Management estimates the amount of an other than temporary
impairment when a decline in value is expected to persist,
using quoted market prices for public securities with active
markets and generally the present value of future cash flows
for private placement bonds and other public securities.
Expected future cash flows are based on historical
experience of the issuer and managements expectation of
future performance. See Quality Ratings in the Investment
Assets section of the MD&A beginning on page 73 for
additional information.
The Company recognized other than temporary impairments of
investments in fixed maturities as follows (in millions,
after-tax):
2008
$138
2007 $20
2006 $18
See Note 12(A) to the Consolidated Financial Statements for
a discussion of the Companys review of declines in fair
value.
|
|
For all fixed maturities with cost in excess of
their fair value, if this excess was determined
to be other-than-temporary, the Companys net
income for the year ended December 31, 2008
would have decreased by approximately $388
million after-tax.
For private placement bonds considered impaired,
a decrease of 10% of all expected future cash
flows for the impaired bonds would reduce net
income by approximately $1 million after-tax.
|
|
|
|
|
|
|
53
SEGMENT REPORTING
Operating segments generally reflect groups of related products, but the International segment is
generally based on geography. The Company measures the financial results of its segments using
segment earnings (loss), which is defined as income (loss) from continuing operations excluding
after-tax realized investment gains and losses.
Health Care Segment
Segment Description
The Health Care segment includes medical, dental, behavioral health, prescription drug and other
products and services that may be integrated to provide consumers with comprehensive health care
solutions. This segment also includes group disability and life insurance products that were
historically sold in connection with certain experience-rated medical products. These products and
services are offered through a variety of funding arrangements such as guaranteed cost,
retrospectively experience-rated and administrative services only arrangements.
The Company measures the operating effectiveness of the Health Care segment using the following key
factors:
|
|
segment earnings;
|
|
|
|
membership growth;
|
|
|
|
sales of specialty products to core medical customers;
|
|
|
|
changes in operating expenses per member; and
|
|
|
|
medical expense as a percentage of premiums (medical cost ratio) in the guaranteed cost
business.
|
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premiums and fees
|
|
$
|
11,615
|
|
|
$
|
10,666
|
|
|
$
|
9,830
|
|
Net investment income
|
|
|
200
|
|
|
|
202
|
|
|
|
261
|
|
Mail order pharmacy revenues
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
Other revenues
|
|
|
317
|
|
|
|
250
|
|
|
|
226
|
|
|
|
|
Segment revenues
|
|
|
13,336
|
|
|
|
12,236
|
|
|
|
11,462
|
|
Mail order pharmacy cost of goods sold
|
|
|
961
|
|
|
|
904
|
|
|
|
922
|
|
Benefits and other expenses
|
|
|
11,359
|
|
|
|
10,295
|
|
|
|
9,534
|
|
|
|
|
Benefits and expenses
|
|
|
12,320
|
|
|
|
11,199
|
|
|
|
10,456
|
|
|
|
|
Income before taxes
|
|
|
1,016
|
|
|
|
1,037
|
|
|
|
1,006
|
|
Income taxes
|
|
|
352
|
|
|
|
358
|
|
|
|
353
|
|
|
Segment earnings
|
|
$
|
664
|
|
|
$
|
679
|
|
|
$
|
653
|
|
|
Realized investment gains (losses), net of taxes
|
|
$
|
(13
|
)
|
|
$
|
14
|
|
|
$
|
105
|
|
|
Special items (after-tax) included in segment earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
Charges related to litigation matters
|
|
$
|
(24
|
)
|
|
$
|
-
|
|
|
$
|
-
|
|
Cost reduction charge
|
|
$
|
(27
|
)
|
|
$
|
-
|
|
|
$
|
(15
|
)
|
|
The Health Care segments earnings in 2008, as compared with 2007, were favorably impacted by lower
management incentive compensation expense of $21 million after-tax. In addition, the segments
earnings include the after-tax impact of favorable prior year claim development of $7 million in
2008, $8 million in 2007 and $54 million in 2006. The amount of prior year claim development
recorded in 2008 and 2007, compared with 2006, is lower because actual medical cost trends and
completion factors were more in line with initial assumptions.
Excluding the special items for cost reduction and litigation charges as well as the items
mentioned above, segment earnings increased in 2008 compared with 2007 due to:
|
|
earnings from the acquired business;
|
|
|
|
higher service fees due to membership growth and rate increases;
|
54
|
|
|
favorable specialty earnings due to increased sales to core medical customers as well as
strong performance in the direct specialty
|
|
|
business; and
|
|
|
|
improved Medicare Part D results due in part to increased membership.
|
These favorable effects were partially offset by:
|
|
lower membership and higher medical cost ratio in the guaranteed cost business;
|
|
|
|
lower medical margins in the experience-rated business; and
|
|
|
|
higher operating expenses reflecting spending on operational improvement initiatives,
including segment expansion and investments in information technology, partially offset by
expense reductions in certain areas, primarily service operations.
|
Excluding prior year claim development and the special items for cost reduction, segment earnings
in 2007 increased over 2006 due to:
|
|
increased earnings from the specialty businesses;
|
|
|
|
margin improvements in the stop-loss product;
|
|
|
|
a lower medical cost ratio in the guaranteed cost business of 160 basis points due to
strong renewal pricing increases in excess of medical cost trend; and
|
|
|
|
aggregate medical membership growth of approximately 800,000 members, including growth in
the voluntary/limited benefits business.
|
These factors were partially offset by lower margins in the experience-rated business as well as
lower net investment income due to lower average assets and lower yields.
Revenues
The table below shows premiums and fees for the Health Care segment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Medical:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial HMO (1)
|
|
$
|
1,430
|
|
|
$
|
2,220
|
|
|
$
|
2,744
|
|
Open access/Other guaranteed cost (2)
|
|
|
2,025
|
|
|
|
1,657
|
|
|
|
946
|
|
Voluntary/limited benefits
|
|
|
200
|
|
|
|
160
|
|
|
|
72
|
|
|
|
|
Total guaranteed cost
|
|
|
3,655
|
|
|
|
4,037
|
|
|
|
3,762
|
|
Experience-rated medical (3)
|
|
|
1,946
|
|
|
|
1,877
|
|
|
|
1,760
|
|
Dental
|
|
|
785
|
|
|
|
773
|
|
|
|
776
|
|
Medicare
|
|
|
400
|
|
|
|
349
|
|
|
|
321
|
|
Medicare Part D
|
|
|
299
|
|
|
|
326
|
|
|
|
215
|
|
Acquired business medical
|
|
|
603
|
|
|
|
-
|
|
|
|
-
|
|
Other medical (4)
|
|
|
1,168
|
|
|
|
1,062
|
|
|
|
929
|
|
|
|
|
Total medical
|
|
|
8,856
|
|
|
|
8,424
|
|
|
|
7,763
|
|
Life and other non-medical
|
|
|
156
|
|
|
|
235
|
|
|
|
305
|
|
Acquired business non-medical
|
|
|
28
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
Total premiums
|
|
|
9,040
|
|
|
|
8,659
|
|
|
|
8,068
|
|
Fees (5)
|
|
|
2,208
|
|
|
|
2,007
|
|
|
|
1,762
|
|
Acquired business Fees
|
|
|
367
|
|
|
|
-
|
|
|
|
-
|
|
|
Total premiums and fees
|
|
$
|
11,615
|
|
|
$
|
10,666
|
|
|
$
|
9,830
|
|
|
(1) Premiums and/or fees associated with certain specialty products are also included.
(2) Includes premiums associated with other risk-related products, primarily network and PPO plans.
(3) Includes minimum premium members, who have a risk profile similar to experience-rated funding arrangements. The risk portion of minimum
premium revenue is reported in experience-rated medical premium whereas the self funding portion of minimum premium revenue is recorded in fees.
Also, includes certain non-participating cases for which special customer level reporting of experience is required.
(4) Other medical premiums include risk revenue for stop-loss and specialty products.
(5) Represents administrative service fees for medical members and related specialty product fees for non-medical members as well as fees related to
Medicare Part D of $96 million in 2008, $61 million in 2007, and $27 million in 2006.
55
Premiums and fees
increased by 9% in 2008, compared with 2007, primarily reflecting:
|
|
the impact of the acquired business;
|
|
|
|
increases in the experience-rated business due to rate increases;
|
|
|
|
higher other medical premiums due to increased sales to core medical customers and rate
increases in specialty business; and
|
|
|
|
higher service fees due to increased membership and rate increases.
|
These factors were partially offset by a decrease in the guaranteed cost business which was due to
membership declines largely in commercial HMO business partially offset by rate increases.
Premiums and fees increased 9% in 2007, compared with 2006, primarily reflecting:
|
|
strong renewal pricing on existing business, particularly in the guaranteed cost business;
|
|
|
|
higher Medicare Part D premiums of $111 million;
|
|
|
|
growth in specialty revenues; and
|
|
|
|
aggregate medical membership growth, including the voluntary/limited benefits business.
|
In addition, premiums and fees in 2007 reflect a change in the mix of products to more service-only
products from guaranteed cost products.
Net investment income
decreased by 1% in 2008 compared with 2007 reflecting lower yields partially
offset by higher average assets. Net investment income decreased by 23% in 2007 compared with 2006
reflecting primarily lower average assets and to a lesser extent lower yields.
Other revenues
for the Health Care segment consist of revenues earned on direct channel sales of
certain specialty products, including behavioral health and disease management.
Other revenues increased 27% in 2008 and 11% in 2007. In 2008, the increase primarily reflected
the impact of the acquired business, while the increase in 2007 was primarily due to business
growth.
Benefits and Expenses
Health Care segment benefits and expenses consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Medical claims expense
|
|
$
|
7,252
|
|
|
$
|
6,798
|
|
|
$
|
6,111
|
|
Other benefit expenses
|
|
|
193
|
|
|
|
225
|
|
|
|
260
|
|
Mail order pharmacy cost of goods sold
|
|
|
961
|
|
|
|
904
|
|
|
|
922
|
|
Other operating expenses
|
|
|
3,914
|
|
|
|
3,272
|
|
|
|
3,163
|
|
|
Total benefits and expenses
|
|
$
|
12,320
|
|
|
$
|
11,199
|
|
|
$
|
10,456
|
|
|
Medical claims expense
included favorable prior year claim development of approximately $11 million
in 2008, $12 million in 2007 and $83 million in 2006. Medical claims expense increased 7% in 2008
compared with 2007 largely due to the impact of the acquired business. In addition, medical trend
was largely offset by lower risk membership. Excluding the prior year claim development, medical
claims expense increased 10% in 2007 compared with 2006 primarily due to medical trend, increased
Medicare Part D membership and the impact of the Star HRG operations.
Other operating expenses
include expenses related to:
|
|
integration and operating costs associated with the acquired business;
|
|
|
|
both retail and mail order pharmacy;
|
|
|
|
disease management;
|
|
|
|
voluntary and limited benefits; and
|
|
|
|
Medicare claims administration businesses.
|
56
Excluding the items noted above, other operating expenses increased in 2008, compared with 2007,
primarily reflecting higher spending on operational improvement initiatives, including segment
expansion and investments in information technology. This
increase was partially offset by lower
management incentive compensation expenses in 2008, as well as productivity savings which were
reflected in lower operating expenses per member due to the success of various expense reduction
initiatives. Other operating expenses increased in 2007, compared with 2006, reflecting membership
growth and higher spending on information technology, including market facing capabilities.
Other Items Affecting Health Care Results
Medical Membership
The Companys medical membership includes any individual for whom the Company retains medical
underwriting risk, who uses the Companys network for services covered under their medical coverage
or for whom the Company administers medical claims. As of December 31, estimated medical
membership was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Guaranteed cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial HMO
|
|
|
326
|
|
|
|
523
|
|
|
|
764
|
|
Medicare
|
|
|
35
|
|
|
|
31
|
|
|
|
32
|
|
Open access/Other guaranteed cost
(1)
|
|
|
530
|
|
|
|
515
|
|
|
|
366
|
|
|
|
|
Total guaranteed cost, excluding voluntary/limited benefits
|
|
|
891
|
|
|
|
1,069
|
|
|
|
1,162
|
|
Voluntary/limited benefits
|
|
|
201
|
|
|
|
180
|
|
|
|
164
|
|
|
|
|
Total guaranteed cost
|
|
|
1,092
|
|
|
|
1,249
|
|
|
|
1,326
|
|
Experience-rated
(2)
|
|
|
851
|
|
|
|
907
|
|
|
|
935
|
|
Service
|
|
|
8,096
|
|
|
|
8,013
|
|
|
|
7,128
|
|
Acquired business
(3)
|
|
|
1,640
|
|
|
|
-
|
|
|
|
-
|
|
|
Total medical membership
|
|
|
11,679
|
|
|
|
10,169
|
|
|
|
9,389
|
|
|
(1) Includes membership associated with other risk-related products, primarily network and PPO plans.
(2) Includes minimum premium members, who have a risk profile similar to experience-rated funding arrangements. The risk portion of minimum
premium revenue is reported in experience-rated medical premium whereas the self funding portion of minimum premium revenue is recorded in
fees. Also, includes certain non-participating cases for which special customer level reporting of experience is required.
(3) Represents members associated with the acquisition of Great-West Healthcare effective April 1, 2008.
Operational Improvement Initiatives
The Company is focused on several initiatives including developing and enhancing a customer focused
service model. This effort is expected to require significant investments over the next 3 to 5
years. These investments are expected to enable the Company to grow its membership and to improve
operational effectiveness and profitability by developing innovative products and services that
promote customer engagement at a competitive cost. Executing on these operational improvement
initiatives is critical to attaining a leadership position in the health care marketplace.
The operational improvement initiatives currently underway are discussed below.
Reducing other operating expenses.
The Company operates in an intensely competitive marketplace
and its ability to establish a fully competitive cost advantage is key to achieving its
initiatives. Accordingly, the Company is focused on reducing operating expenses in three key areas
primarily to facilitate operating efficiency and responsiveness to customers. These three areas
include: customer acquisition, which encompasses spending on sales, the account management process,
underwriting and marketing; fulfillment, mainly claims processing and billing; and reducing
overhead in various administrative and staffing functions. In connection with these efforts, in
the fourth quarter of 2008, the Company completed a review of staffing levels and organization and
announced a plan to reorganize its business model and supporting areas to more tightly align the
ongoing operating segments. See the Introduction section to this
MD&A for further discussion beginning on page 43. The
Company expects to take additional actions during 2009 to further reduce operating expenses and
improve its competitive cost position in the marketplace.
57
Maintaining and upgrading information technology systems.
The Companys current business model and
long-term strategy require effective and reliable information technology systems. The Companys
current systems architecture will require continuing investment to meet the challenges of
increasing customer demands from both our existing and emerging customer base to support its
business growth and strategies, improve its competitive position and provide appropriate levels of
service to customers. The Company is focused on providing these enhanced strategic capabilities in
response to increasing customer expectations, while continuing to provide a consistent, high
quality customer service experience with respect to the Companys current programs. Accordingly, in
2009, the Companys efforts will be focused primarily on optimizing the technology underlying our
claims processing and call servicing capabilities with specific emphasis on reducing handling time
and improving customer service. Continued integration of the Companys multiple administrative
and customer facing platforms is also required to support the Companys growth strategies, and to
ensure reliable, efficient and effective customer service both in todays employer focused model as
well as in a customer directed model. The Companys ability to effectively deploy capital to make
these investments will influence the timing and the impact these initiatives will have on its
operations.
Profitably growing medical membership.
The Company continues to focus on growing its medical
membership by:
|
|
increasing its share of the national, regional and select segments;
|
|
|
|
providing a diverse product portfolio that meets current market needs as well as emerging consumer-directed trends;
|
|
|
|
developing and implementing the systems, information technology and infrastructure to deliver member service that keeps
pace with the emerging consumer-directed market trends;
|
|
|
|
ensuring competitive provider networks;
|
|
|
|
maintaining a strong clinical quality in medical, specialty health care and disability management; and
|
|
|
|
increasing specialty penetration.
|
The Company is also focused on segment and product expansion. In segments, our focus is
predominantly in the Select (employers with 51-250), small business (employers with 2-50) and
individual segments. We also expect to expand our voluntary capabilities and to focus on health as
well as pharmacy and dental. As part of its effort to achieve these objectives, the Company
completed the acquisition of Great-West Healthcare of Denver, Colorado on April 1, 2008. Also, our
Star HRG acquisition serves as our platform to further develop our voluntary portfolio. These
acquisitions will enable the Company to broaden its distribution reach and provider network,
particularly in the western regions of the United States, and expand the range of health benefits
and product offerings. Additionally, the Company has recently developed new product offerings for
both our guaranteed cost and experienced rated portfolios. Driving additional cross selling is
also key to our value proposition. We are expanding network access for our dental product and
improving network flexibility to ensure better alignment with our
customers needs. Also, with the
acquisition of Great-West Healthcare, we will be working in 2009 to transition this book to CIGNA
pharmacy and increase penetration across the entire book.
Offering products that meet emerging customer and market trends.
In order to meet emerging customer
and market trends, the Companys suite of products (CIGNATURE
®
, CareAllies
®
, and CIGNA Choice
Fund
®
) offers various options to customers and employers and is key to our customer engagement
strategy. Offerings include: choice of benefit, participating provider network, funding, medical
management, and health advocacy options. Through the CIGNA Choice Fund
®
, the Company offers a set
of customer-directed capabilities that includes options for health reimbursement arrangements
and/or health savings accounts and enables customers to make effective health decisions using
information tools provided by the Company.
Underwriting and pricing products effectively.
One of the Companys key priorities is to achieve
strong profitability in a competitive health care market. The Company is focused on effectively
managing pricing and underwriting decisions at both the case and overall book of business level,
particularly for the guaranteed cost and experience-rated businesses.
Effectively managing medical costs.
The Company operates under a centralized medical management
model, which helps facilitate consistent levels of care for its members and reduces infrastructure
expenses.
The Company is focused on continuing to effectively manage medical utilization and unit costs. The
Company believes that by increasing the quality of medical care and improving access to care we can
drive reductions in total medical cost. To help achieve this, the Company continues to focus on
renegotiating contracts with providers and certain facilities to limit increases in medical
reimbursement costs. In addition, the Company seeks to strengthen its network position in selected
markets. In connection with the Great-West Healthcare acquisition in April 2008, the Company is
converting and integrating these acquired members to its extensive preferred provider network which
offers access to a broad range of utilization review and case management services. By directing
members to the highest quality and most efficient network providers and leveraging their clinical
engagement protocols we are realizing benefits from the increased utilization.
58
Delivering quality member and provider service.
The Company is focused on delivering competitive
service to members, providers and customers. The Company believes that further enhancing quality
service can improve member retention and, when combined with useful health information and tools,
can help motivate members to become more engaged in their personal health, and will help promote
healthy outcomes thereby removing cost from the system. The evolution of the consumer-driven
healthcare market is driving increased product and service complexity and is raising customers
expectations with respect to service levels, which is expected to require significant investment,
management attention and heightened interaction with customers.
The Company is focused on the development and enhancement of a service model that is capable of
meeting the challenges brought on by the increasing product and service complexity and the
heightened expectations of health care customers. The Company continues to make significant
investments in the development and implementation of systems and technology to improve the member
and provider service experience, enhance its capabilities and improve its competitive position.
The Companys health advocacy capabilities support its recent membership growth efforts. The
Company must be able to deliver those capabilities efficiently and cost-effectively. The Company
continues to identify additional cost savings to further improve its competitive cost
position. Savings generated from the Companys operating efficiency initiatives provide capital to
make investments that will enhance its capabilities in the areas of customer engagement,
particularly product development, the delivery of member service and health advocacy and related
technology.
Disability and Life Segment
Segment Description
The Disability and Life segment includes group disability, life, accident and specialty insurance
and case management for disability and workers compensation.
Key factors for this segment are:
|
|
premium growth, including new business and customer retention;
|
|
|
|
net investment income;
|
|
|
|
benefits expense as a percentage of earned premium (loss ratio); and
|
|
|
|
other operating expense as a percentage of earned premiums and fees (expense ratio).
|
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premiums and fees
|
|
$
|
2,562
|
|
|
$
|
2,374
|
|
|
$
|
2,108
|
|
Net investment income
|
|
|
256
|
|
|
|
276
|
|
|
|
256
|
|
Other revenues
|
|
|
117
|
|
|
|
131
|
|
|
|
161
|
|
|
|
|
Segment revenues
|
|
|
2,935
|
|
|
|
2,781
|
|
|
|
2,525
|
|
Benefits and expenses
|
|
|
2,553
|
|
|
|
2,435
|
|
|
|
2,214
|
|
|
|
|
Income before taxes
|
|
|
382
|
|
|
|
346
|
|
|
|
311
|
|
Income taxes
|
|
|
109
|
|
|
|
92
|
|
|
|
85
|
|
|
Segment earnings
|
|
$
|
273
|
|
|
$
|
254
|
|
|
$
|
226
|
|
|
Realized investment gains (losses), net of taxes
|
|
$
|
(48
|
)
|
|
$
|
(5
|
)
|
|
$
|
6
|
|
|
Special item (after-tax) included in segment earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
Completion of IRS examination
|
|
$
|
-
|
|
|
$
|
6
|
|
|
$
|
-
|
|
Cost reduction charge
|
|
$
|
(2
|
)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
Segment earnings in 2008 include the favorable after-tax impact of reserve studies and a favorable
reinsurance settlement which aggregated to $19 million, partially offset by a special item for a
cost reduction charge of $2 million. Segment earnings in 2007 include the favorable after-tax
impact of reserve studies of $12 million and a special item of $6 million of previously
unrecognized tax benefits resulting from the completion of the IRS examination for the 2003 and
2004 tax years. Segment earnings in 2006 include the favorable after-tax impact of reserve studies
of $28 million, partially offset by severance charges of $6 million. Excluding the impact
59
of the
items noted above, segment earnings increased 8% in 2008, compared
with 2007 reflecting:
|
|
|
favorable claims experience in the specialty insurance business;
|
|
|
|
a lower expense ratio driven by effective operating expense management and lower management
incentive compensation; and
|
|
|
|
higher premiums and fees in the disability, life and accident businesses due to business
growth.
|
These factors were partially offset by less favorable claims experience in the life and accident
businesses and lower net investment income primarily due to lower average yields.
Excluding the impact of reserve studies and the items noted above, segment earnings increased 16%
in 2007, compared with 2006 reflecting:
|
|
continued strong disability claims management results;
|
|
|
|
higher net investment income due to higher average assets and yields;
|
|
|
|
favorable claims experience in the accident, group universal life and specialty businesses;
|
|
|
|
a lower expense ratio driven by effective operating expense management; and
|
|
|
|
strong earned premium growth.
|
Revenues
Premiums and fees
increased 8% in 2008 and 13% in 2007 reflecting new sales growth in the
disability, life and accident lines of business and strong customer retention.
Benefits and Expenses
Excluding the pre-tax impact of the reserve studies, reinsurance settlement and cost reduction
charge noted above, benefits and expenses increased 5% in 2008 compared with 2007, reflecting
overall business growth, partially offset by favorable claims experience in the disability and
specialty businesses tempered by less favorable claims experience in the life and accident
businesses. In addition, lower expenses were driven by continued focus on operating expense
management, lower disability and workers compensation case management expenses and lower
management incentive compensation expenses.
Excluding the pre-tax impact of the reserve studies and severance charge noted above, benefits and
expenses increased 9% in 2007 compared with 2006, reflecting overall business growth, continued
strong disability claims management and unfavorable life claims experience largely offset by
favorable accident and specialty claims experience. In addition, lower expenses were driven by
continued focus on operating expense management and lower disability and workers compensation case
management expenses.
International Segment
Segment Description
The International segment includes life, accident and supplemental health insurance products and
international health care products and services, including those offered to expatriate employees of
multinational corporations.
The key factors for this segment are:
|
|
premium growth, including new business and customer retention;
|
|
|
|
benefits expense as a percentage of earned premium (loss ratio); and
|
|
|
|
operating expense as a percentage of earned premium (expense ratio).
|
60
Results
of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premiums and fees
|
|
$
|
1,870
|
|
|
$
|
1,800
|
|
|
$
|
1,526
|
|
Net investment income
|
|
|
79
|
|
|
|
77
|
|
|
|
79
|
|
Other revenues
|
|
|
18
|
|
|
|
7
|
|
|
|
2
|
|
|
|
|
Segment revenues
|
|
|
1,967
|
|
|
|
1,884
|
|
|
|
1,607
|
|
Benefits and expenses
|
|
|
1,683
|
|
|
|
1,612
|
|
|
|
1,394
|
|
|
|
|
Income before taxes
|
|
|
284
|
|
|
|
272
|
|
|
|
213
|
|
Income taxes
|
|
|
102
|
|
|
|
96
|
|
|
|
75
|
|
|
Segment earnings
|
|
$
|
182
|
|
|
$
|
176
|
|
|
$
|
138
|
|
|
Impact of foreign currency movements included in segment earnings
|
|
|
(13
|
)
|
|
|
4
|
|
|
|
4
|
|
|
Realized investment gains (losses), net of taxes
|
|
$
|
(3
|
)
|
|
$
|
1
|
|
|
$
|
(1
|
)
|
|
Special item (after-tax) included in segment earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
Completion of IRS examination
|
|
$
|
-
|
|
|
$
|
2
|
|
|
$
|
-
|
|
Cost reduction charge
|
|
$
|
(6
|
)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
Excluding the special items noted in the table above, International segment earnings increased 8%
in 2008, compared with 2007, and 26% in 2007 compared with 2006, primarily due to continued growth
in the life, accident and supplemental health insurance business and the expatriate employee
benefits business, as well as continued competitively strong margins. Earnings growth in 2008 was
partially offset by unfavorable currency movements, primarily in South Korea. International
segment earnings, excluding the impact of foreign currency movements and the special items noted in
the table above, increased 16% in 2008, compared with 2007, and 23% in 2007 compared with 2006.
The impact of foreign currency movements is calculated by comparing the reported results to what
the results would have been had the monthly average exchange rates remained constant with the prior
years comparable period exchange rates.
Revenues
Premiums and fees.
The increase in premiums and fees of 4% in 2008, compared with 2007, and 18% in
2007 compared with 2006, was primarily attributable to new sales growth in the life, accident and
supplemental health insurance operations, particularly in Taiwan and South Korea, and membership
growth in the expatriate employee benefits business. These increases also continue to reflect rate
adjustments on the renewal of existing business. Premium growth in 2008 was partially offset by
unfavorable foreign currency movements in South Korea.
Premiums and fees, excluding the effect of foreign currency movements, were (in millions): $1,971
in 2008, $1,745 in 2007 and $1,494 in 2006.
Benefits and Expenses
Benefits and expenses increased 4% in 2008, compared with 2007 and 16% in 2007 compared with 2006,
primarily due to business growth in all lines of business, partially offset by foreign currency
movements, primarily in South Korea.
Loss ratios decreased in 2008 and 2007 in the life, accident and supplemental health business due
to favorable claims experience and a shift away from traditional life products toward accident and
health products. In the expatriate business, loss ratios decreased slightly in 2008 and increased
slightly in 2007 due to claims volatility.
Expense ratios increased slightly in 2008 in the life, accident and supplemental health business
and the expatriate benefits business as a result of higher expenses to support growth initiatives
and expansion. Expense ratios in the life, accident and health and expatriate benefits businesses
continue to be strong due to effective expense management.
Other Items Affecting International Results
For the
Companys International segment, South Korea is the single largest geographic market. South
Korea generated 29% of the segments revenues and 39% of the segments earnings in 2008. Due to
the concentration of business in South Korea, the International segment is exposed to potential
losses resulting from economic and geopolitical developments in that country, as well as
61
foreign
currency movements affecting the South Korean currency, which could have a significant impact on
the segments results and the Companys consolidated financial results.
Run-off Reinsurance Segment
Segment Description
The Companys reinsurance operations were discontinued and are now an inactive business in run-off
mode since the sale of the U.S. individual life, group life and accidental death reinsurance
business in 2000. This segment is predominantly comprised of guaranteed minimum death benefit
(GMDB, also known as VADBe), guaranteed minimum income benefit (GMIB), workers compensation and
personal accident reinsurance products.
The determination of liabilities for GMDB and GMIB requires the Company to make critical accounting
estimates. The Company has updated the assumptions for GMIB and the effects of hypothetical
changes in those assumptions in connection with the implementation of SFAS No. 157. The Company
describes the assumptions used to develop the reserves for GMDB and the assets and liabilities for
GMIB and provides the effects of hypothetical changes in those assumptions in the Critical
Accounting Estimates section of the MD&A beginning on page 49.
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premiums and fees
|
|
$
|
43
|
|
|
$
|
60
|
|
|
$
|
64
|
|
Net investment income
|
|
|
104
|
|
|
|
93
|
|
|
|
95
|
|
Other revenues
|
|
|
331
|
|
|
|
(47
|
)
|
|
|
(97
|
)
|
|
|
|
Segment revenues
|
|
|
478
|
|
|
|
106
|
|
|
|
62
|
|
Benefits and expenses
|
|
|
1,499
|
|
|
|
160
|
|
|
|
80
|
|
|
|
|
Loss before income tax benefits
|
|
|
(1,021
|
)
|
|
|
(54
|
)
|
|
|
(18
|
)
|
Income tax benefits
|
|
|
(375
|
)
|
|
|
(43
|
)
|
|
|
(4
|
)
|
|
Segment loss
|
|
$
|
(646
|
)
|
|
$
|
(11
|
)
|
|
$
|
(14
|
)
|
|
Realized investment gains (losses), net of taxes
|
|
$
|
(19
|
)
|
|
$
|
2
|
|
|
$
|
22
|
|
|
Results of GMIB business (after-tax) included in segment earnings (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
Charge on adoption of SFAS No. 157 for GMIB contracts
|
|
$
|
(131
|
)
|
|
$
|
-
|
|
|
$
|
-
|
|
Results of GMIB business excluding charge on adoption
|
|
$
|
(306
|
)
|
|
$
|
(91
|
)
|
|
$
|
(1
|
)
|
|
Segment losses for the year included losses from the GMIB business of $437 million, and losses from
the GMDB business of $267 million. Excluding the charge on adoption of SFAS No. 157 for the GMIB
business, (see Note 2(B) to the Consolidated Financial Statements) these losses were primarily
related to declines in equity markets and interest rates and increased market volatility.
Excluding the results of the GMIB and GMDB businesses, segment earnings for Run-off Reinsurance
were lower in 2008 than 2007, reflecting reduced favorable settlement activity related to personal
accident and workers compensation.
Excluding the results of the GMIB business, segment earnings improved in 2007 compared with 2006.
The improvement was predominantly due to an increase in earnings from several settlements and
commutations that were favorable to the Companys reserve position at the time, as well as higher
earnings in the workers compensation and personal accident business, resulting from more favorable
claim development.
Other Revenues
Other revenues included pre-tax gains from futures contracts used in the GMDB equity hedge program
(see Note 7 to the Consolidated Financial Statements) of $333 million in 2008, compared with
pre-tax losses of $32 million in 2007 and $96 million in 2006. Amounts reflecting corresponding
changes in liabilities for GMDB contracts were included in benefits and expenses consistent with
GAAP when a premium deficiency exists (see below Other Benefits and Expenses). The notional
amount of the futures contract positions held by the Company at December 31, 2008 related to this
program was $1.4 billion.
62
Benefits and Expenses
Benefits and expenses were comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
For the years ended December 31,
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
GMIB expense
|
|
$
|
690
|
|
|
$
|
147
|
|
|
$
|
7
|
|
Other benefits and expenses
|
|
|
809
|
|
|
|
13
|
|
|
|
73
|
|
|
Benefits and expenses
|
|
$
|
1,499
|
|
|
$
|
160
|
|
|
$
|
80
|
|
|
GMIB Expense.
GMIB expense in 2008 includes a pre-tax charge of $202 million for the adoption of
SFAS No. 157, which is discussed in Notes 2(B) and 11 to the Consolidated Financial Statements.
GMIB expense in 2007 includes a pre-tax charge of $86 million related to updated assumptions for
annuity election and lapse rates. With the adoption of SFAS No. 157 in 2008, the Companys results
of operations are expected to be more volatile in future periods both because the liabilities, net
of receivables from reinsurers, are larger and because these assumptions will be based largely on
market-observable inputs at the close of each reporting period including interest rates (LIBOR swap
curve) and market-implied volatilities.
Excluding the charge on adoption of SFAS No. 157, the GMIB business generated additional pre-tax
expense of $488 million in 2008 primarily as a result of:
|
|
decreases in interest rates since December 31, 2007: $232 million;
|
|
|
|
the impact of declines in underlying account values in the period, driven by declines in
equity markets and bond fund returns, resulting in increased exposure: $158 million;
|
|
|
|
updates to the risk and profit charge estimate: $50 million;
|
|
|
|
updates to other assumptions that are used in the fair value calculation: $25 million; and
|
|
|
|
other amounts including the compounding effects of declines in interest rates and equity
markets, as well as experience varying from assumptions: $23 million.
|
Excluding the charge to update assumptions for annuity election and lapse rates, the GMIB business
generated additional pre-tax expense of $61 million in 2007, primarily the result of unfavorable
annuitization and lapse experience.
The GMIB liabilities and related assets are calculated using a complex internal model and
assumptions that in 2008 are from the viewpoint of a hypothetical market participant. This
resulting liability (and related asset) is higher than the Company
believes will ultimately be
required to settle claims primarily because market-observable interest rates are used to project
growth in account values of the underlying mutual funds to estimate fair value from the viewpoint
of a hypothetical market participant. The Companys payments for GMIB claims are expected to occur
over the next 15 to 20 years and will be based on actual values of the underlying mutual funds and
the 7-year Treasury rate at the dates benefits are elected. The Company does not believe that
current market-observable interest rates reflect actual growth expected for the underlying mutual
funds over that timeframe, and therefore believes that the recorded liability and related asset do
not represent what management believes will ultimately be required as this business runs off.
However, the significant decline in financial markets during 2008 has had an unfavorable impact on
the GMIB business. Significant declines in mutual fund values that underlie the contracts
(increasing the exposure to the Company) together with declines in the 7-year Treasury rate (used
to determine claim payments) increased the expected amount of claims that will be paid out for
contractholders who choose to annuitize while these conditions continue. It is also possible that
these unfavorable market conditions will have an impact on the level of contractholder
annuitizations, particularly if these unfavorable market conditions persist for an extended period.
Other Benefits and Expenses.
During 2008, the Company recorded additional other benefits and
expenses of $412 million ($267 million after-tax) primarily to strengthen GMDB reserves following
an analysis of experience and reserve assumptions. These amounts were primarily due to:
|
|
adverse impacts of overall market declines of $210 million ($136 million after-tax). This
includes (a) $185 million ($120 million after-tax) related to the provision for partial
surrenders, including $40 million ($26 million after-tax) for an increase in the assumed
election rates for future partial surrenders and (b) $25 million ($16 million after-tax)
related to declines in the values of contractholders non-equity investments such as bond
funds, neither of which is included in the GMDB equity hedge program;
|
|
|
|
adverse volatility-related impacts due to turbulent equity market conditions. Volatility
risk is not covered by the GMDB equity
|
63
|
|
hedge program. Also, the equity market volatility,
particularly during the second half of the year, impacted the
effectiveness of the hedge program. In aggregate, these volatility-related impacts totaled $182 million ($118
million after-tax). The GMDB equity hedge program is designed so that changes in the value of a
portfolio of actively managed futures contracts will offset changes in the liability resulting
from equity market movements. In periods of equity market declines, the liability will
increase; the program is designed to produce gains on the futures contracts to offset the
increase in the liability. However, the program will not perfectly offset the change in the
liability, in part because the market does not offer futures contracts that exactly match the
diverse mix of equity fund investments held by contractholders, and because there is a time lag
between changes in underlying contractholder mutual funds, and corresponding changes in the
hedge position. In 2008, the impact of this mismatch was higher than most prior periods due to
the relatively large changes in market indices from day to day. In addition, the number of
futures contracts used in the program is adjusted only when certain tolerances are exceeded and
in periods of highly volatile equity markets when actual volatility exceeds the expected
volatility assumed in the liability calculation, losses will result. These conditions have had
an adverse impact on earnings, and during 2008, the increase in the liability due to equity
market movements was only partially offset by the results of the futures contracts; and
|
|
|
|
adverse interest rate impacts. Interest rate risk is not covered by the GMDB equity hedge
program, and the interest rate returns on the futures contracts were less than the Companys
long-term assumption for mean investment performance generating an additional $14 million ($9
million after-tax).
|
In addition to the reserve strengthening discussed above, other benefits and expenses were higher
in 2008 than 2007 due to the impact of changes in the equity markets on GMDB contracts. Equity
markets decreased significantly in 2008 while they increased in 2007 leading to higher benefits
expense in 2008. Equity market declines result in decreases in underlying annuity account values,
which increases the exposure under the contracts. These changes in benefits expense are partially
offset by futures gains and losses, discussed in Other Revenues above. In addition, benefits
expense related to personal accident and workers compensation was higher in 2008 than 2007, as a
result of reduced favorable settlement activity in 2008.
Other benefits and expenses were lower in 2007, compared with 2006, due to lower expense in the
workers compensation and personal accident businesses, due to the impact of favorable claim
experience and settlements and commutations that were favorable to the Companys reserved position.
This was partially offset by higher benefits expense for the guaranteed minimum death benefit
business, as improvements in equity markets for 2007 were smaller than in 2006.
See Note 7 to the Consolidated Financial Statements for additional information about assumptions
and reserve balances related to GMDB.
Segment Summary
The Companys payment obligations for underlying reinsurance exposures assumed by the Company under
these contracts are based on ceding companies claim payments. For GMDB and GMIB, claim payments
vary because of changes in equity markets and interest rates, as well as mortality and policyholder
behavior. For workers compensation and personal accident, the claim payments relate to accidents
and injuries. Any of these claim payments can extend many years into the future, and the amount of
the ceding companies ultimate claims, and therefore the amount of the Companys ultimate payment
obligations and corresponding ultimate collection from retrocessionaires may not be known with
certainty for some time.
The Companys reserves for underlying reinsurance exposures assumed by the Company, as well as for
amounts recoverable from retrocessionaires, are considered appropriate as of December 31, 2008,
based on current information. However, it is possible that future developments, which could
include but are not limited to worse than expected claim experience and higher than expected
volatility, could have a material adverse effect on the Companys consolidated results of
operations and could have a material adverse effect on the Companys financial condition. The
Company bears the risk of loss if its payment obligations to cedents increase or if its
retrocessionaires are unable to meet, or successfully challenge, their reinsurance obligations to
the Company.
64
Other Operations Segment
Segment Description
Other Operations consist of:
|
|
non-leveraged and leveraged corporateowned life insurance (COLI);
|
|
|
|
deferred gains recognized from the 1998 sale of the individual life insurance and annuity
business and the 2004 sale of the retirement benefits business; and
|
|
|
|
run-off settlement annuity business.
|
The COLI portion of this business has contributed the majority of the earnings in 2008, 2007 and
2006 for Other Operations. Federal legislation enacted in 1996 affected certain policies sold by
the COLI business by eliminating on a prospective basis the tax deduction for policy loan interest
for most leveraged COLI products. There have been no sales of this particular product since 1997.
As a result of an Internal Revenue Service initiative to settle tax disputes regarding leveraged
products, some customers have surrendered their policies and management expects earnings associated
with these products to continue to decline. Management does not expect this to have a significant
impact on the future operating results of the segment.
From April 1, 2004 through March 31, 2006, the Company had a modified coinsurance arrangement
relating to the single premium annuity business sold to the buyer of the retirement benefits
business. Under that arrangement, the Company retained the invested assets supporting the
reinsured liabilities. These invested assets were held in a business trust established by the
Company. Effective April 1, 2006, the buyer converted this modified coinsurance arrangement to an
indemnity reinsurance structure and took ownership of the trust assets.
Results
of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Premiums and fees
|
|
$
|
113
|
|
|
$
|
108
|
|
|
$
|
113
|
|
Net investment income
|
|
|
414
|
|
|
|
437
|
|
|
|
467
|
|
Other revenues
|
|
|
71
|
|
|
|
82
|
|
|
|
102
|
|
|
|
|
Segment revenues
|
|
|
598
|
|
|
|
627
|
|
|
|
682
|
|
Benefits and expenses
|
|
|
468
|
|
|
|
473
|
|
|
|
531
|
|
|
|
|
Income before taxes
|
|
|
130
|
|
|
|
154
|
|
|
|
151
|
|
Income taxes
|
|
|
43
|
|
|
|
45
|
|
|
|
45
|
|
|
Segment earnings
|
|
$
|
87
|
|
|
$
|
109
|
|
|
$
|
106
|
|
|
Realized investment gains (losses), net of taxes
|
|
$
|
(27
|
)
|
|
$
|
(2
|
)
|
|
$
|
13
|
|
|
Special items (after-tax) included in segment earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
Completion of IRS examination
|
|
$
|
-
|
|
|
$
|
5
|
|
|
$
|
-
|
|
|
Excluding the special item noted above, segment earnings for Other Operations declined in 2008
compared with 2007, reflecting lower results from the COLI business driven by less favorable
mortality and lower interest margins. Interest margins decreased due to the movement of assets
from the general account to separate accounts, and lower interest rates. In addition, the
continuing decline in deferred gain amortization associated with sold businesses contributed to
lower earnings.
Excluding the special item noted above, segment earnings decreased for Other Operations in 2007,
primarily reflecting expected lower deferred gain amortization associated with the sales of the
individual life insurance and annuity and retirement benefits businesses. This decrease was
partially offset by higher COLI earnings primarily reflecting favorable mortality experience.
65
Revenues
Net investment income
.
Net investment income decreased 5% in 2008 compared with 2007, primarily
reflecting lower average invested assets due in part to the movement of assets from the general
account to separate accounts in the COLI business as well as lower interest rates. Net investment
income decreased 6% in 2007 compared with 2006 primarily due to a reduction in assets resulting
from the conversion of the single premium annuity business to indemnity reinsurance and the
resulting transfer of trust assets to the buyer of the retirement benefits business.
Other revenues
.
Other revenues decreased 13% in 2008 compared with 2007, and 20% in 2007 compared
with 2006 primarily due to lower deferred gain amortization related to the sold retirement benefits
and individual life insurance and annuity businesses. The amount of the deferred gain amortization
recorded was $38 million in 2008, $47 million in 2007 and $62 million in 2006.
Corporate
Description
Corporate reflects amounts not allocated to segments, such as interest expense on corporate debt
and on uncertain tax positions, certain litigation matters, net investment income on investments
not supporting segment operations, intersegment eliminations, compensation cost for stock options
and certain corporate overhead expenses such as directors expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Segment loss
|
|
$
|
(162
|
)
|
|
$
|
(97
|
)
|
|
$
|
(95
|
)
|
|
Special items (after-tax) included in segment loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
Charge related to litigation matter
|
|
$
|
(52
|
)
|
|
$
|
-
|
|
|
$
|
-
|
|
Completion of IRS examination
|
|
$
|
-
|
|
|
$
|
10
|
|
|
$
|
-
|
|
Charge associated with settlement of shareholder litigation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(25
|
)
|
Cost reduction charge
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(8
|
)
|
|
Excluding the special items noted above (see Consolidated Results of Operations section of the MD&A
beginning on page 46 for more information on special items), Corporate results were lower in 2008,
compared with 2007, primarily reflecting higher net interest expense attributable to lower average
invested assets and increased debt to finance the acquired business. These factors were partially
offset by lower directors expenses due to reduced deferred compensation obligations caused by a
decline in the Companys stock price.
Excluding the special items noted in the table above, Corporate results in 2007, compared with
2006, were lower, reflecting higher net interest expense resulting from the issuance of additional
debt combined with lower average assets due to share repurchase activity. In addition, the
increase in segment loss also reflects the absence in 2007 of certain favorable expense items
recorded in 2006.
DISCONTINUED OPERATIONS
Description
Discontinued operations represent results associated with certain investments or businesses that
have been sold or are held for sale.
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Income before income (taxes) benefits
|
|
$
|
3
|
|
|
$
|
25
|
|
|
$
|
19
|
|
Income (taxes) benefits
|
|
|
1
|
|
|
|
(7
|
)
|
|
|
(6
|
)
|
|
|
|
Income from operations
|
|
|
4
|
|
|
|
18
|
|
|
|
13
|
|
Impairment loss, net of tax
|
|
|
-
|
|
|
|
(23
|
)
|
|
|
(17
|
)
|
|
Income (loss) from discontinued operations, net of taxes
|
|
$
|
4
|
|
|
$
|
(5
|
)
|
|
$
|
(4
|
)
|
|
66
Discontinued operations for 2008 primarily represents a gain of $3 million after-tax from the
settlement of certain issues related to a past divestiture.
For 2007 and 2006, discontinued operations primarily reflects:
|
|
impairment losses related to the dispositions in 2007 and 2006 of several Latin American
insurance operations as discussed in Note 3 to the Consolidated Financial Statements; and
|
|
|
|
realized gains on the disposition of certain directly-owned real estate investments in 2007
and 2006 as discussed in Note 13 to the Consolidated Financial Statements.
|
INDUSTRY DEVELOPMENTS AND OTHER MATTERS
The disability industry is under continuing review by regulators and legislators with respect to
its offset practices regarding Social Security Disability Insurance (SSDI). There has been
specific inquiry as to the industrys role in assisting individuals with their applications for
SSDI. The Company has received one Congressional inquiry and has responded to the information
request. Also, legislation prohibiting the offset of SSDI payments against private disability
insurance payments for prospectively issued policies has been introduced in the Connecticut state
legislature. The Company is also involved in related pending
litigation. If the industry is
forced to change its offset SSDI procedures, the practices and products for the Companys
Disability & Life segment could be significantly impacted.
There are certain other matters that present significant uncertainty, which could result in a
material adverse impact on the Companys consolidated results of operations. See Note 22 to the
Consolidated Financial Statements for further information.
LIQUIDITY AND CAPITAL RESOURCES
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Financial Summary
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Short-term investments
|
|
$
|
236
|
|
|
$
|
21
|
|
|
$
|
89
|
|
Cash and cash equivalents
|
|
$
|
1,342
|
|
|
$
|
1,970
|
|
|
$
|
1,392
|
|
Short-term debt
|
|
$
|
301
|
|
|
$
|
3
|
|
|
$
|
382
|
|
Long-term debt
|
|
$
|
2,090
|
|
|
$
|
1,790
|
|
|
$
|
1,294
|
|
Shareholders equity
|
|
$
|
3,592
|
|
|
$
|
4,748
|
|
|
$
|
4,330
|
|
|
Liquidity
The Company maintains liquidity at two levels: the subsidiary level and the parent company level.
Liquidity requirements at the subsidiary level generally consist of:
|
|
claim and benefit payments to policyholders; and
|
|
|
|
operating expense requirements, primarily for employee compensation and benefits.
|
The Companys subsidiaries normally meet their operating requirements by:
|
|
maintaining appropriate levels of cash, cash equivalents and short-term investments;
|
|
|
|
using cash flows from operating activities;
|
|
|
|
selling investments;
|
|
|
|
matching investment maturities to the estimated duration of the related insurance and contractholder liabilities; and
|
|
|
|
borrowing from its parent company.
|
Liquidity requirements at the parent level generally consist of:
|
|
debt service and dividend payments to shareholders; and
|
|
|
|
pension plan funding.
|
67
The parent normally meets its liquidity requirements by:
|
|
maintaining appropriate levels of cash, cash equivalents and short-term investments;
|
|
|
|
collecting dividends from its subsidiaries;
|
|
|
|
using proceeds from issuance of debt and equity securities;
|
|
|
|
collecting pension contributions from subsidiaries in the amount of the GAAP expense charged; and
|
|
|
|
borrowing from its subsidiaries.
|
Cash flows for the years ended December 31, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Operating activities
|
|
$
|
1,656
|
|
|
$
|
1,342
|
|
|
$
|
642
|
|
Investing activities
|
|
$
|
(2,572
|
)
|
|
$
|
269
|
|
|
$
|
1,548
|
|
Financing activities
|
|
$
|
314
|
|
|
$
|
(1,041
|
)
|
|
$
|
(2,513
|
)
|
|
Cash flow from operating activities consists of cash receipts and disbursements for premiums and
fees, gains (losses) recognized in connection with the Companys GMDB equity hedge program,
investment income, taxes, and benefits and expenses.
Because certain income and expense transactions do not generate cash, and because cash transactions
related to revenue and expenses may occur in periods different from when those revenues and
expenses are recognized in net income, cash flow from operating activities can be significantly
different from net income. The Company assesses cash flows from operating activities by comparing
it with adjusted income from operations, which is defined as income from continuing operations
excluding the results of GMIB and special items, and further adjusted to exclude pre-tax realized
investment results and depreciation and amortization charges.
Cash flows from investing activities generally consist of net investment purchases or sales and net
purchases of property and equipment, which includes capitalized software, as well as cash used to
acquire businesses.
Cash flows from financing activities is generally comprised of issuances and re-payment of debt at
the parent level, proceeds on the issuance of common stock resulting from stock option exercises,
and stock repurchases. In addition, the subsidiaries report net deposits/withdrawals to/from
investment contract liabilities (which include universal life insurance liabilities) because such
liabilities are considered financing activities with policyholders.
2008:
Operating activities
For the year ended December 31, 2008, cash flows from operating activities were greater than
adjusted income from operations by $406 million, including cash inflows of $333 million associated
with the GMDB equity hedge program which did not affect net income. Excluding those inflows, cash
flows from operating activities were higher than adjusted income from operations by $73 million,
primarily reflecting favorable receivable collections and increases in GMDB reserves due to the
2008 charges. These factors were partially offset by payments for certain prepaid expenses and
litigation matters.
Cash flows from operating activities increased by $314 million in 2008 compared with
2007. Excluding the results of the GMDB equity hedge program (which did not affect net income),
cash flows from operating activities decreased by $51 million. This decrease in 2008 primarily
reflects higher payments for certain prepaid expenses in 2008.
Investing activities
The Company used net cash of $1.3 billion to fund the acquisition of Great-West Healthcare,
consisting of a cash payment to Great-West Life and Annuity, Inc. of approximately $1.4 billion,
partially offset by cash acquired from Great-West Healthcare of approximately $0.1
billion. Excluding this item, cash used in investing activities was $1.3 billion. This use of
cash primarily consisted of net purchases of investments of $988 million and net purchases of
property and equipment of $257 million.
Financing activities
Cash provided from financing activities primarily consisted of proceeds from the net issuance of
short-term debt of $298 million and long-term debt of $297 million. These borrowing arrangements
were entered into for general corporate purposes, including the
68
financing of the acquisition of Great-West Healthcare. Financing activities also included net
deposits from contractholder deposit
funds of $91 million, proceeds from the issuance of common
stock under the Companys stock plans of $37 million and dividends on and repurchases of common
stock of $392 million.
2007:
Operating activities
For the year ended December 31, 2007, cash flows from operating activities were lower than adjusted
income from operations by $21 million, including cash outflows of $32 million associated with the
GMDB equity hedge program which did not affect net income. Excluding those outflows, cash flows
from operating activities were higher than adjusted income from operations by $11 million.
Investing activities
Cash provided by investing activities primarily consisted of net sales of investments of $495
million and net purchases of property and equipment of $180 million.
Financing activities
Cash used in financing activities primarily consisted of dividends on and repurchases of common
stock of $1.2 billion and repayment of debt of $378 million, partially offset by proceeds from the
issuance of debt of $498 million and proceeds from the issuance of common stock under the Companys
stock plans of $248 million.
Interest Expense
Interest expense on long-term debt, short-term debt and capital leases was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Interest expense
|
|
$
|
146
|
|
|
$
|
122
|
|
|
$
|
104
|
|
|
The increase in interest expense in 2008 was primarily due to the issuance of debt in connection
with the Great-West Healthcare acquisition. At December 31, 2008, the Company has recognized
cumulative losses of $40 million pre-tax ($26 million after-tax) related to its treasury rate lock
derivative in accumulated other comprehensive income. The loss on this derivative will continue to
fluctuate until it closes in 2009. If the Company issues debt in the first half of 2009 as
expected, the loss at the time the derivative closes would increase the effective interest rate
recognized over the life of the debt. If the Company is unable to issue debt in the first half of
2009, this loss would be recognized as a reduction to results of operations in the first half of
2009.
Capital Resources
The Companys capital resources (primarily retained earnings and the proceeds from the issuance of
debt and equity securities) provide protection for policyholders, furnish the financial strength to
underwrite insurance risks and facilitate continued business growth.
Management, guided by regulatory requirements and rating agency capital guidelines, determines the
amount of capital resources that the Company maintains. Management allocates resources to new
long-term business commitments when returns, considering the risks, look promising and when the
resources available to support existing business are adequate.
The Company prioritizes its use of capital resources to:
|
|
provide capital necessary to support growth and maintain or improve the financial strength
ratings of subsidiaries;
|
|
|
|
consider acquisitions that are strategically and economically advantageous; and
|
|
|
|
return capital to investors through share repurchase.
|
The availability of capital resources will be impacted by equity and credit market conditions.
Extreme volatility in credit or equity market conditions may reduce the Companys ability to issue
debt or equity securities. Significant volatility and deterioration of the equity markets during
2008 has resulted in reduced retained earnings and has reduced the capital available for growth,
acquisitions, and share repurchase.
69
On March 14, 2008, the Company entered into a new commercial paper program (the Program). Under
the Program, the Company
is authorized to sell from time to time short-term unsecured commercial
paper notes up to a maximum of $500 million. The proceeds are used for general corporate purposes,
including working capital, capital expenditures, acquisitions and share repurchases. The Company
uses the credit facility described below as back-up liquidity to support the outstanding commercial
paper. If at any time funds are not available on favorable terms under the Program, the Company
may use the Credit Agreement (see below) for funding. In October 2008, the Company added an
additional dealer to its Program. As of December 31, 2008, the Company had $299 million in
commercial paper outstanding, at a weighted average interest rate of 6.31%, used to finance the
Great-West Healthcare acquisition and for other corporate purposes.
On March 4, 2008, the Company issued $300 million of 6.35% Notes (with an effective interest rate
of 6.68% per year). Interest is payable on March 15 and September 15 of each year beginning
September 15, 2008. The proceeds of this debt were used for general corporate purposes, including
financing the acquisition of Great-West Healthcare. These Notes will mature on March 15, 2018.
The Company may redeem these Notes, at any time, in whole or in part, at a redemption price equal
to the greater of:
|
|
100% of the principal amount of the Notes to be redeemed; or
|
|
|
|
the present value of the remaining principal and interest payments on the Notes being
redeemed discounted at the applicable Treasury Rate plus 40 basis points.
|
In June 2007, the Company amended and restated its five-year committed revolving credit and letter
of credit agreement for $1.75 billion, which permits up to $1.25 billion to be used for letters of
credit. This agreement is diversified among 22 banks, with three banks each having 11% of the
commitment and the other 21 banks having the remaining 67% of the commitment. The credit agreement
includes options, which are subject to consent by the administrative agent and the committing
banks, to increase the commitment amount up to $2.0 billion and to extend the term of the
agreement. The Company entered into the agreement for general corporate purposes, including support
for the issuance of commercial paper and to obtain statutory reserve credit for certain reinsurance
arrangements. There was a $25 million letter of credit issued as of December 31, 2008.
Liquidity and Capital Resources Outlook
At December 31, 2008, there was approximately $90 million in cash available at the parent company
level. In 2009, the parent companys debt service consists of scheduled interest payments of
approximately $140 million on outstanding long term debt of $2.1 billion at December 31, 2008 and
approximately $300 million of commercial paper that will mature over the next three months. There
are no scheduled long-term debt repayments in 2009. The company expects to refinance the
commercial paper either by issuing long-term debt or re-issuing commercial paper.
The Companys best estimate is that contributions to the qualified pension plan will be
approximately $410 million pre-tax during 2009.
The parent company expects
to fund the $410 million pre-tax contribution with subsidiary contributions equal to GAAP expense
and parent company tax benefits.
However, this amount could change based on final valuation
amounts and the level at which the Company decides to fund the plan.
The parent company would fund the estimated remaining $130
million net after-tax contribution with ongoing parent company cash sources including, but not
limited to, subsidiary dividends. These estimates do not include funding requirements related to
the litigation matter discussed in Note 22 to the Consolidated Financial Statements, as management
does not expect this matter to be resolved in 2009. Future years contributions will ultimately be
based on a wide range of factors including but not limited to asset returns, discount rates, and
funding targets.
The availability of resources at the parent company level is partially dependent on dividends from
the Companys subsidiaries, most of which are subject to regulatory restrictions and rating agency
capital guidelines, and partially dependent on the availability of liquidity from the issuance of
debt or equity securities.
The Company expects, based on current projections for cash activity, to have sufficient liquidity
to meet its obligations.
However, the Companys cash projections may not be realized and the demand for funds could exceed
available cash if:
|
|
ongoing businesses experience unexpected shortfalls in earnings;
|
|
|
|
regulatory restrictions or rating agency capital guidelines reduce the amount of dividends available to be distributed
to the parent company from the insurance and HMO subsidiaries (including the impact of equity market deterioration and
volatility on subsidiary capital);
|
|
|
|
continued significant disruption or volatility in the capital and credit markets reduces the Companys ability to raise
capital or
|
70
|
|
creates unexpected losses related to the GMDB and GMIB businesses;
|
|
|
|
a substantial increase in funding over current projections is required for the Companys pension plan; or
|
|
|
a substantial increase in funding is required for the Companys GMDB equity hedge program.
|
|
In those cases, the Company expects to have the flexibility to satisfy liquidity needs through a
variety of measures, including intercompany borrowings and sales of liquid investments. The parent
company may borrow up to $400 million from Connecticut General Life Insurance Company without prior
state approval. In addition, the Company may use short-term borrowings, such as the commercial
paper program and the committed line of credit agreement of up to $1.75 billion subject to the
maximum debt leverage covenant in its line of credit agreement. As of December 31, 2008, the
Company had an additional $750 million of borrowing capacity within the maximum debt leverage
covenant in the line of credit agreement in addition to the $2.4 billion of debt outstanding as of
December 31, 2008.
Though the Company believes it has adequate sources of liquidity, continued significant disruption
or volatility in the capital and credit markets could affect the Companys ability to access those
markets for additional borrowings or increase costs associated with borrowing funds.
Solvency regulation
Many states have adopted some form of the National Association of Insurance
Commissioners (NAIC) model solvency-related laws and risk-based capital rules (RBC rules) for
life and health insurance companies. The RBC rules recommend a minimum level of capital depending
on the types and quality of investments held, the types of business written and the types of
liabilities incurred. If the ratio of the insurers adjusted surplus to its risk-based capital
falls below statutory required minimums, the insurer could be subject to regulatory actions ranging
from increased scrutiny to conservatorship.
In addition, various non-U.S. jurisdictions prescribe minimum surplus requirements that are based
upon solvency, liquidity and reserve coverage measures. During 2008, the Companys HMOs and life
and health insurance subsidiaries, as well as non-U.S. insurance subsidiaries, were compliant with
applicable RBC and non-U.S. surplus rules.
In 2008, the NAIC adopted Actuarial Guideline VACARVM, which will be effective December 31, 2009.
VACARVM will impact statutory and tax reserves for CIGNAs GMDB and GMIB contracts. Upon
implementation, it is anticipated that statutory reserves for these contracts will increase and
thus statutory surplus for Connecticut General Life Insurance Company will be reduced. The
magnitude of any impact depends on equity market and interest rate levels at the time of
implementation.
Guarantees and Contractual Obligations
The Company, through its subsidiaries, is contingently liable for various contractual obligations
entered into in the ordinary course of business. The maturities of the Companys primary
contractual cash obligations, as of December 31, 2008, are estimated to be as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less
|
|
|
|
|
|
|
|
|
|
|
(In millions, on an
|
|
|
|
|
|
than 1
|
|
|
1-3
|
|
|
4-5
|
|
|
After 5
|
|
undiscounted basis)
|
|
Total
|
|
|
year
|
|
|
years
|
|
|
years
|
|
|
years
|
|
|
On-Balance Sheet:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractholder deposit funds
|
|
$
|
7,591
|
|
|
$
|
646
|
|
|
$
|
797
|
|
|
$
|
733
|
|
|
$
|
5,415
|
|
Future policy benefits
|
|
|
11,670
|
|
|
|
505
|
|
|
|
1,030
|
|
|
|
847
|
|
|
|
9,288
|
|
Health Care medical claims payable
|
|
|
924
|
|
|
|
924
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Unpaid claims and claims expenses
|
|
|
4,770
|
|
|
|
1,303
|
|
|
|
876
|
|
|
|
628
|
|
|
|
1,963
|
|
Short-term debt
|
|
|
305
|
|
|
|
305
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Long-term debt
|
|
|
4,134
|
|
|
|
138
|
|
|
|
723
|
|
|
|
221
|
|
|
|
3,052
|
|
Non-recourse obligations
|
|
|
16
|
|
|
|
16
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Other long-term liabilities
|
|
|
1,933
|
|
|
|
886
|
|
|
|
404
|
|
|
|
193
|
|
|
|
450
|
|
Off-Balance Sheet:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase obligations
|
|
|
1,226
|
|
|
|
451
|
|
|
|
503
|
|
|
|
264
|
|
|
|
8
|
|
Operating leases
|
|
|
535
|
|
|
|
121
|
|
|
|
200
|
|
|
|
107
|
|
|
|
107
|
|
|
Total
|
|
$
|
33,104
|
|
|
$
|
5,295
|
|
|
$
|
4,533
|
|
|
$
|
2,993
|
|
|
$
|
20,283
|
|
|
71
On-Balance Sheet:
|
|
Insurance liabilities.
Contractual cash obligations for insurance liabilities, excluding
unearned premiums and fees, represent estimated net benefit payments for health, life and
disability insurance policies and annuity contracts. Recorded contractholder deposit funds
reflect current fund balances primarily from universal life customers. Contractual cash
obligations for these universal life contracts are estimated by projecting future payments
using assumptions for lapse, withdrawal and mortality. These projected future payments
include estimated future interest crediting on current fund balances based on current
investment yields less estimated cost of insurance charges and mortality and administrative
fees. Actual obligations in any single year will vary based on actual morbidity, mortality,
lapse, withdrawal, investment and premium experience. The sum of the obligations presented
above exceeds the corresponding insurance and contractholder liabilities of $15.7 billion
recorded on the balance sheet because the recorded insurance liabilities reflect discounting
for interest and the recorded contractholder liabilities exclude future interest crediting,
charges and fees. The Company manages its investment portfolios to generate cash flows needed
to satisfy contractual obligations. Any shortfall from expected investment yields could
result in increases to recorded reserves and adversely impact results of operations. The
amounts associated with the sold retirement benefits and individual life insurance and annuity
businesses are excluded from the table above as net cash flows associated with them are not
expected to impact the Company. The total amount of these reinsured reserves excluded is
approximately $6.5 billion.
|
|
|
|
Short-term debt
represents commercial paper and current obligations under capital leases.
|
|
|
|
Long-term debt
includes scheduled interest payments. Capital leases are included in
long-term debt and represent obligations for software licenses.
|
|
|
|
Nonrecourse obligations
represent principal and interest payments due which may be limited
to the value of specified assets, such as real estate properties held in joint ventures.
|
|
|
|
Other long-term liabilities.
These items are presented in accounts payable, accrued
expenses and other liabilities in the Companys Consolidated Balance Sheets. This table
includes estimated payments for GMIB contracts, pension and other postretirement and
postemployment benefit obligations, supplemental and deferred compensation plans, interest
rate and foreign currency swap contracts, and certain tax and reinsurance liabilities.
|
|
|
|
Estimated payments of $85 million for deferred compensation, non-qualified and International
pension plans and other postretirement and postemployment benefit plans are expected to be paid
in less than one year. The Companys best estimate is that contributions to the qualified
domestic pension plan during 2009 will be approximately $410 million. This amount could change
based on final valuation amounts and the level at which the Company decides to fund the plan.
The Company expects to make payments subsequent to 2009 for these obligations, however
subsequent payments have been excluded from the table as their timing is based on plan
assumptions which may materially differ from actual activities (see Note 10 to the Consolidated
Financial Statements for further information on pension and other postretirement benefit
obligations).
|
|
|
|
The above table also does not contain $164 million of gross liabilities for uncertain tax
positions because the Company cannot reasonably estimate the timing of their resolution with the
respective taxing authorities. See Note 18 to the Consolidated Financial Statements for the
year ended December 31, 2008 for further information.
|
Off-Balance Sheet:
|
|
Purchase obligations.
As of December 31, 2008, purchase obligations consisted of estimated
payments required under contractual arrangements for future services and investment
commitments as follows:
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Fixed maturities
|
|
$
|
-
|
|
Commercial mortgage loans
|
|
|
65
|
|
Real estate
|
|
|
9
|
|
Limited liability entities (other long-term investments)
|
|
|
470
|
|
|
|
|
Total investment commitments
|
|
|
544
|
|
Future service commitments
|
|
|
682
|
|
|
Total purchase obligations
|
|
$
|
1,226
|
|
|
72
|
|
The Company had commitments to invest in limited liability entities that hold real estate or
loans in real estate entities or securities. See Note 12(C) to the Consolidated Financial
Statements for additional information.
|
|
|
Future service commitments include an agreement with IBM for various information technology (IT)
infrastructure services. The Companys remaining commitment under this contract is
approximately $504 million over a 5-year period. The Company has the ability to terminate this
agreement with 90 days notice, subject to termination fees.
|
|
|
The Companys remaining estimated future service commitments primarily represent contracts for
certain outsourced business processes and IT maintenance and support. The Company generally has
the ability to terminate these agreements, but does not anticipate doing so at this time.
Purchase obligations exclude contracts that are cancelable without penalty or those that do not
specify minimum levels of goods or services to be purchased.
|
|
|
Operating leases.
For additional information, see Note 20 to the Consolidated Financial
Statements.
|
Guarantees
The Company, through its subsidiaries, is contingently liable for various financial guarantees
provided in the ordinary course of business. See Note 22 to the Consolidated Financial Statements
for additional information on guarantees.
Share Repurchase
The Company maintains a share repurchase program, which was authorized by its Board of Directors.
Decisions to repurchase shares depend on market conditions and alternative uses of capital. The
Company has, and may continue from time to time, to repurchase shares on the open market through a
Rule 10b5-1 plan which permits a company to repurchase its shares at times when it otherwise might
be precluded from doing so under insider trading laws or because of self-imposed trading blackout
periods.
The Company repurchased 10.0 million shares in 2008 for $378 million and 23.7 million shares in
2007 for $1.2 billion. The total remaining share repurchase authorization as of February 25, 2009,
was $449 million.
INVESTMENT ASSETS
The Companys investment assets do not include separate account assets. Additional information
regarding the Companys investment assets and related accounting policies is included in Notes 2,
11, 12, 13 and 16 to the Consolidated Financial Statements.
Fixed Maturities
Investments in fixed maturities (bonds) include publicly traded and privately placed debt
securities, mortgage and other asset-backed securities, preferred stocks redeemable by the investor
and trading securities. Fixed maturities and equity securities include hybrid securities. Fair
values are based on quoted market prices when available. When market prices are not available,
fair value is generally estimated using discounted cash flow analyses, incorporating current market
inputs for similar financial instruments with comparable terms and credit quality. In instances
where there is little or no market activity for the same or similar instruments, the Company
estimates fair value using methods, models and assumptions that the Company believes a hypothetical
market participant would use to determine a current transaction price.
The Company performs ongoing analyses on prices to conclude that they represent reasonable
estimates of fair value. This process involves quantitative and qualitative analysis and is
overseen by the Companys investment professionals. This process also includes review of pricing
methodologies, pricing statistics and trends and backtesting recent trades.
73
The Companys fixed maturity portfolio continues to be diversified by issuer and industry type,
with no single industry constituting more than 10% of total invested assets as of December 31,
2008.
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
Federal government and agency
|
|
$
|
762
|
|
|
$
|
628
|
State and local government
|
|
|
2,486
|
|
|
|
2,489
|
Foreign government
|
|
|
944
|
|
|
|
882
|
Corporate
|
|
|
6,856
|
|
|
|
7,419
|
Federal agency mortgage-backed
|
|
|
37
|
|
|
|
-
|
Other mortgage-backed
|
|
|
125
|
|
|
|
221
|
Other asset-backed
|
|
|
571
|
|
|
|
442
|
|
Total
|
|
$
|
11,781
|
|
|
$
|
12,081
|
|
Other mortgage-backed assets consist principally of commercial mortgage-backed securities and
collateralized mortgage obligations of which $41 million were residential mortgages and home equity
lines of credit, all of which were originated utilizing standard underwriting practices and are not
considered sub-prime loans.
Quality ratings
As of December 31, 2008, $10.8 billion, or 92%, of the fixed maturities in the Companys investment
portfolio were investment grade (Baa and above, or equivalent), and the remaining $1.0 billion were
below investment grade. Most of the bonds that are below investment grade are rated at the higher
end of the non-investment grade spectrum.
Private placement investments are generally less marketable than public bonds, but yields on these
investments tend to be higher than yields on publicly offered debt with comparable credit risk.
The fair value of private placement investments was $4.4 billion as of December 31, 2008 and 2007.
The Company maintains controls on its participation in private placement investments. In
particular, the Company performs a credit analysis of each issuer, diversifies investments by
industry and issuer and requires financial and other covenants that allow the Company to monitor
issuers for deteriorating financial strength so the Company can take remedial actions, if
warranted. See the Critical Accounting Estimates section of the MD&A beginning on page 49 for
additional information.
Because of the higher yields and the inherent risk associated with privately placed investments and
below investment grade securities, gains or losses from such investments could affect future
results of operations. However, since management matches the duration of assets to the duration of
liabilities, it expects to hold a significant portion of these assets for the long term and
therefore, does not expect such gains or losses to be material to the Companys liquidity or
financial condition.
Commercial Mortgage Loans
The Companys commercial mortgage loans are made exclusively to commercial borrowers; therefore
there is no exposure to either prime or sub-prime residential mortgages. These fixed rate loans
are diversified by property type, location and borrower to reduce exposure to potential losses.
Loans are secured by the related property and are generally made at less than 75% of the propertys
value. The Company routinely monitors and evaluates the status of its commercial mortgage loans by
reviewing loan and property-related information, including cash flows, expiring leases, financial
health of the borrower and major tenants, loan payment history, occupancy and room rates for hotels
and market conditions. The Company evaluates this information in light of current economic
conditions as well as geographic and property type considerations.
Problem and Potential Problem Investments
Problem bonds and commercial mortgage loans are either delinquent by 60 days or more or have been
restructured as to terms (interest rate or maturity date). Potential problem bonds and
commercial mortgage loans are considered current (no payment more
than 59 days past due), but management believes they have certain
characteristics that increase the likelihood that they may become problems. These
characteristics include, but are not limited to, the following:
|
|
request from the borrower for restructuring;
|
|
|
principal or interest payments past due by more than 30 but fewer than 60 days;
|
|
|
downgrade in credit rating;
|
|
|
deterioration in debt service ratio;
|
|
|
collateral losses on asset-backed securities; and
|
74
|
|
significant vacancy in commercial rental mortgage property, or a decline in sales for
commercial retail mortgage property.
|
The Company recognizes interest income on problem bonds and commercial mortgage loans only when
payment is actually received because of the risk profile of the underlying investment. The amount
that would have been reflected in net income if interest on non-accrual investments had been
recognized in accordance with the original terms was not significant in 2008, 2007 or 2006.
The following table shows problem and potential problem investments at amortized cost as of
December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Gross
|
|
|
|
Reserve
|
|
|
Net
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
Problem bonds
|
|
$
|
94
|
|
|
$
|
(59
|
)
|
|
$
|
35
|
Potential problem bonds
|
|
$
|
140
|
|
|
$
|
(14
|
)
|
|
$
|
126
|
Potential problem commercial mortgage loans
|
|
$
|
92
|
|
|
$
|
-
|
|
|
$
|
92
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Problem bonds
|
|
$
|
47
|
|
|
$
|
(30
|
)
|
|
$
|
17
|
Potential problem bonds
|
|
$
|
34
|
|
|
$
|
(9
|
)
|
|
$
|
25
|
Potential problem commercial mortgage loans
|
|
$
|
70
|
|
|
$
|
-
|
|
|
$
|
70
|
Foreclosed real estate
(1)
|
|
$
|
16
|
|
|
$
|
(3
|
)
|
|
$
|
13
|
|
(1) The Company sold its remaining foreclosed property and did not acquire any properties through foreclosure in 2008.
Summary
The Company recorded after-tax realized investment losses for investment asset write-downs and
changes in valuation reserves as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
Credit-Related
|
|
$
|
44
|
|
|
$
|
12
|
|
|
$
|
11
|
Other
(1)
|
|
|
97
|
|
|
|
14
|
|
|
|
18
|
|
Total
|
|
$
|
141
|
|
|
$
|
26
|
|
|
$
|
29
|
|
(1) Other primarily represents the impact of rising interest rates on investments where the Company cannot demonstrate the intent and ability to hold
until recovery.
In addition to these asset write-downs, in 2008, the Company recognized after-tax losses of $9
million on hybrid securities (classified as equity securities) of certain quasi-federal government
agencies where the Company believes that the decline in fair value is other-than-temporary.
The U.S. and global financial
markets experienced significant challenges throughout 2008. The
unprecedented downgrading of billions of dollars of previously highly rated, liquid public
securities led to a significant crisis of confidence and a dramatic tightening of credit conditions
leading to historically wide credit spreads and substantially higher market yields in spite of near
record low treasury rates. Both debt and equity markets are expected to remain volatile until
confidence is restored. As a result of this economic environment, the credit risks in the
Companys investment portfolio are elevated.
The market conditions described above resulted in a significant net increase in investment yields
across the credit spectrum. While this increase is positive for new investments, it drove a
significant decline in value for the Companys existing investment portfolio. The Companys
corporate fixed maturity and commercial mortgage loan portfolios are well diversified by borrower,
sector, and geographic region, limiting exposure. However, if broad economic conditions and/or
illiquidity in the capital markets persist or worsen, this would likely result in an increase in
the severity and duration of the decline in asset values, and may cause the Company to experience
additional investment losses.
The value of the Companys fixed maturity portfolio declined substantially throughout 2008
resulting in after-tax unrealized depreciation of $147 million. The Companys commercial mortgage
portfolio also declined substantially in 2008, resulting in after-tax unrealized depreciation of
$140 million (a decline in fair value versus carrying value). The possibility of increased market
investment yields for an extended period could cause the Company to recognize impairment losses if
it cannot demonstrate the intent and ability to hold certain
75
investments until recovery. Future
realized and unrealized investment results will be impacted largely by market conditions that exist
when a transaction occurs or at the reporting date. These future conditions are not reasonably
predictable.
Management believes that a significant portion of the Companys fixed maturity and commercial
mortgage investments will continue to perform under their contractual terms, and that the recent
declines in their fair values are temporary. Based on the Companys strategy to match the
duration of invested assets to the duration of insurance and contractholder liabilities, it has
both the intent and ability to hold these assets to recovery. Therefore, future credit related
losses are not expected to have a material adverse effect on the Companys liquidity or financial
condition.
MARKET RISK
Financial Instruments
The Companys assets and liabilities include financial instruments subject to the risk of potential
losses from adverse changes in market rates and prices. The Companys primary market risk
exposures are:
|
|
Interest-rate risk
on fixed-rate, domestic, medium-term instruments. Changes in market
interest rates affect the value of instruments that promise a fixed return and impact the
value of liabilities for reinsured GMDB and GMIB contracts.
|
|
|
Foreign currency exchange rate risk
of the U.S. dollar to the South Korean won, Taiwan
dollar, euro, Hong Kong dollar, British pound, and Thai Bhat. An unfavorable change in
exchange rates reduces the carrying value of net assets denominated in foreign currencies.
|
|
|
Equity price risk
for domestic equity securities and for GMDB and GMIB contracts resulting
from unfavorable changes in variable annuity account values based on underlying mutual fund
investments.
|
For further discussion of reinsured contracts, see Note 7 for GMDB contracts and Note 11 for GMIB
contracts in the Consolidated Financial Statements.
The Companys Management of Market Risks
The Company predominantly relies on three techniques to manage its exposure to market risk:
|
|
Investment/liability matching.
The Company generally selects investment assets with
characteristics (such as duration, yield, currency and liquidity) that correspond to the
underlying characteristics of its related insurance and contractholder liabilities so that the
Company can match the investments to its obligations. Shorter-term investments support
generally shorter-term life and health liabilities. Medium-term, fixed-rate investments
support interest-sensitive and health liabilities. Longer-term investments generally support
products with longer pay out periods such as annuities and long-term disability liabilities.
|
|
|
Use of local currencies for foreign operations
.
The Company generally conducts its
international business through foreign operating entities that maintain assets and liabilities
in local currencies. While this technique does not reduce the Companys foreign currency
exposure of its net assets, it substantially limits exchange rate risk to net assets.
|
|
|
Use of derivatives.
The Company generally uses derivative financial instruments to
minimize certain market risks and enhance investment returns.
|
See Notes 2(C) and 12(F) to the Consolidated Financial Statements for additional information about
financial instruments, including derivative financial instruments.
Effect of Market Fluctuations on the Company
The examples that follow illustrate the effect of hypothetical changes in market rates or prices on
the fair value of certain financial instruments including:
|
|
hypothetical changes in market interest rates primarily for fixed maturities and
commercial mortgage loans, partially offset by liabilities for long-term debt and GMIB
contracts;
|
|
|
hypothetical changes in market rates for foreign currencies, primarily for the net assets
of foreign subsidiaries denominated in a foreign currency; and
|
|
|
hypothetical changes in market prices for equity exposures primarily for equity securities
and GMIB contracts.
|
In addition, hypothetical effects of changes in equity indices and foreign exchange rates are
presented separately for futures contracts used in the GMDB equity hedge program.
76
Management believes that actual results could differ materially from these examples because:
|
|
these examples were developed using estimates and assumptions;
|
|
|
changes in the fair values of all insurance-related assets and liabilities have been
excluded because their primary risks are insurance rather than market risk;
|
|
|
changes in the fair values of investments recorded using the equity method of accounting
and liabilities for pension and other postretirement and postemployment benefit plans (and
related assets) have been excluded, consistent with the disclosure guidance; and
|
|
|
changes in the fair values of other significant assets and liabilities such as goodwill,
deferred acquisition costs, taxes, and various accrued liabilities have been excluded; because
they are not financial instruments, their primary risks are other than market risk.
|
The effects of hypothetical changes in market rates or prices on the fair values of certain of the
Companys financial instruments, subject to the exclusions noted above (particularly insurance
liabilities), would have been as follows as of December 31:
|
|
|
|
|
|
|
|
|
|
Market scenario for
|
|
|
certain non-insurance
|
|
|
financial instruments
|
|
Loss in fair value
|
|
|
2008
|
|
2007
|
|
100 basis point increase in interest rates
|
|
$700 million
|
|
$800 million
|
10% strengthening in U.S.
dollar to foreign currencies
|
|
$160 million
|
|
$150 million
|
10% decrease in market prices for equity exposures
|
|
$50 million
|
|
$60 million
|
|
The effect of a hypothetical increase in interest rates on the fair value of certain of the
Companys financial instruments decreased in 2008 as a result of increased net liabilities for GMIB
contracts, along with declining fair values of fixed maturities, partially offset by a decrease in
the duration of long-term debt. Net liabilities for GMIB contracts increased in 2008 primarily due
to the adoption of SFAS No. 157 and declines in the equity markets and interest rates. During
2008, the underlying equity account values from GMIB contracts decreased by 50% primarily due to
equity market declines. Therefore, the current effect of a hypothetical 10% decrease in market
prices for equity exposures at December 31, 2008 is expected to be less than at December 31, 2007.
See the Critical Accounting Estimates section of the MD&A beginning on page 49 for further
discussion of guaranteed minimum income benefits.
The effect of a hypothetical increase in interest rates was determined by estimating the present
value of future cash flows using various models, primarily duration modeling and, for GMIB
contracts, stochastic modeling. The effect of a hypothetical strengthening of the U.S. dollar
relative to the foreign currencies held by the Company was estimated to be 10% of the U.S. dollar
equivalent fair value. The effect of a hypothetical decrease in the market prices of equity
exposures was estimated based on a 10% decrease in the equity mutual fund values underlying
guaranteed minimum income benefits reinsured by the Company and a 10% decrease in the value of
equity securities held by the Company. See Note 11 to the Consolidated Financial Statements for
additional information.
The Company uses futures contracts as part of a GMDB equity hedge program to substantially reduce
the effect of equity market changes on certain reinsurance contracts that guarantee minimum death
benefits based on unfavorable changes in underlying variable annuity account values. The
hypothetical effect of a 10% increase in the S&P 500, S&P 400, Russell 2000, NASDAQ, TOPIX
(Japanese), EUROSTOXX and FTSE (British) equity indices and a 10% weakening in the U.S. dollar to
the Japanese yen, British pound and euro would have been a decrease of approximately $140 million
in the fair value of the futures contracts outstanding under this program as of December 31, 2008.
A corresponding decrease in liabilities for GMDB contracts would result from the hypothetical 10%
increase in these equity indices and 10% weakening in the U.S. dollar. See Note 7 to the
Consolidated Financial Statements for further discussion of this program and related GMDB
contracts.
As noted above, the Company manages its exposures to market risk by matching investment
characteristics to its obligations.
Stock Market Performance
The performance of equity markets can have a significant effect on the Companys businesses,
including on:
|
|
risks and exposures associated with GMDB (see Note 7 to the Consolidated Financial
Statements) and GMIB contracts (see Note 11 to the Consolidated Financial Statements); and
|
|
|
pension liabilities since equity securities comprise a significant portion of the assets of
the Companys employee pension plans.
|
77
CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
The Company and its representatives may from time to time make written and oral forward-looking
statements, including statements contained in press releases, in the Companys filings with the
Securities and Exchange Commission, in its reports to shareholders and in meetings with analysts
and investors. Forward-looking statements may contain information about financial prospects,
economic conditions, trends and other uncertainties. These forward-looking statements are based on
managements beliefs and assumptions and on information available to management at the time the
statements are or were made. Forward-looking statements include but are not limited to the
information concerning possible or assumed future business strategies, financing plans, competitive
position, potential growth opportunities, potential operating performance improvements, trends and,
in particular, the Companys productivity initiatives, litigation and other legal matters,
operational improvement in the health care operations, and the outlook for the Companys full year
2009 results. Forward-looking statements include all statements that are not historical facts and
can be identified by the use of forward-looking terminology such as the words believe, expect,
plan, intend, anticipate, estimate, predict, potential, may, should or similar
expressions.
You should not place undue reliance on these forward-looking statements. The Company cautions that
actual results could differ materially from those that management expects, depending on the outcome
of certain factors. Some factors that could cause actual results to differ materially from the
forward-looking statements include:
1.
|
|
increased medical costs that are higher than anticipated in establishing premium rates in the
Companys health care operations, including increased use and costs of medical services;
|
2.
|
|
increased medical, administrative, technology or other costs resulting from new legislative
and regulatory requirements imposed on the Companys employee benefits businesses;
|
3.
|
|
challenges and risks associated with implementing operational improvement initiatives and
strategic actions in the ongoing operations of the businesses, including those related to: (i)
offering products that meet emerging market needs, (ii) strengthening underwriting and pricing
effectiveness, (iii) strengthening medical cost and medical membership results, (iv)
delivering quality member and provider service using effective technology solutions, (v)
lowering administrative costs and (vi) transitioning to an integrated operating company model,
including operating efficiencies related to the transition;
|
4.
|
|
risks associated with pending and potential state and federal class action lawsuits, disputes
regarding reinsurance arrangements, other litigation and regulatory actions challenging the
Companys businesses, government investigations and proceedings, and tax audits;
|
5.
|
|
heightened competition, particularly price competition, which could reduce product margins
and constrain growth in the Companys businesses, primarily the health care business;
|
6.
|
|
risks associated with the Companys mail order pharmacy business which, among other things,
includes any potential operational deficiencies or service issues as well as loss or
suspension of state pharmacy licenses;
|
7.
|
|
significant changes in interest rates for a sustained period of time;
|
8.
|
|
downgrades in the financial strength ratings of the Companys insurance subsidiaries, which
could, among other things, adversely affect new sales and retention of current business;
|
9.
|
|
limitations on the ability of the Companys insurance subsidiaries to dividend capital to the
parent company as a result of downgrades in the subsidiaries financial strength ratings,
changes in statutory reserve or capital requirements or other financial constraints;
|
10.
|
|
inability of the program adopted by the Company to substantially reduce equity market risks
for reinsurance contracts that guarantee minimum death benefits under certain variable
annuities (including possible market difficulties in entering into appropriate futures
contracts and in matching such contracts to the underlying equity risk);
|
11.
|
|
adjustments to the reserve assumptions (including lapse, partial surrender, mortality,
interest rates and volatility) used in estimating the Companys liabilities for reinsurance
contracts covering guaranteed minimum death benefits under certain variable annuities;
|
12.
|
|
adjustments to the assumptions (including annuity election rates and amounts collectible
from reinsurers) used in estimating the Companys assets and liabilities for reinsurance
contracts covering guaranteed minimum income benefits under certain variable annuities;
|
13.
|
|
significant stock market declines, which could, among other things, result in increased
expenses for guaranteed minimum income benefit contracts, guaranteed minimum death benefit
contracts and the Companys pension plan in future periods as well as the recognition of
additional pension obligations;
|
14.
|
|
unfavorable claims experience related to workers compensation and personal accident
exposures of the run-off reinsurance business, including losses attributable to the inability
to recover claims from retrocessionaires;
|
15.
|
|
significant deterioration in economic conditions and significant market volatility, which
could have an adverse effect on the Companys operations, investments, liquidity and access
to capital markets;
|
16.
|
|
significant deterioration in economic conditions and significant market volatility, which
could have an adverse effect on the
|
78
|
|
businesses of our customers (including the amount and type
of healthcare services provided to their workforce and our customers
ability to pay receivables) and our vendors (including their ability to provide services);
|
17.
|
|
changes in public policy and in the political environment, which could affect state and
federal law, including legislative and regulatory proposals related to health care issues,
which could increase cost and affect the market for the Companys health care products and
services; and amendments to income tax laws, which could affect the taxation of employer
provided benefits, and pension legislation, which could increase pension cost;
|
18.
|
|
potential public health epidemics and bio-terrorist activity, which could, among other
things, cause the Companys covered medical and disability expenses, pharmacy costs and
mortality experience to rise significantly, and cause operational disruption, depending on the
severity of the event and number of individuals affected;
|
19.
|
|
risks associated with security or interruption of information systems, which could, among
other things, cause operational disruption;
|
20.
|
|
challenges and risks associated with the successful management of the Companys outsourcing
projects or key vendors, including the agreement with IBM for provision of technology
infrastructure and related services;
|
21.
|
|
the ability to successfully integrate and operate the businesses acquired from Great-West by,
among other things, renewing insurance and administrative services contracts on competitive
terms, retaining and growing membership, realizing revenue, expense and other synergies,
successfully leveraging the information technology platform of the acquired businesses, and
retaining key personnel; and
|
22.
|
|
the ability of the Company to execute its growth plans by successfully managing Great-West
Healthcares outsourcing projects and leveraging the Companys capabilities and those of the
business acquired from Great-West to further enhance the combined organizations network
access position, underwriting effectiveness, delivery of quality member and provider service,
and increased penetration of its membership base with differentiated product offerings.
|
This list of important factors is not intended to be exhaustive. Other sections of the Companys
2008 Annual Report on Form 10-K, including the Risk Factors section, and other documents filed
with the Securities and Exchange Commission include both expanded discussion of these factors and
additional risk factors and uncertainties that could preclude the Company from realizing the
forward-looking statements. The Company does not assume any obligation to update any
forward-looking statements, whether as a result of new information, future events or otherwise,
except as required by law.
79
Managements Annual Report on Internal Control over Financial Reporting
Management of CIGNA Corporation (the Company) is responsible for establishing and maintaining
adequate internal controls over financial reporting. The Companys internal controls were designed
to provide reasonable assurance to the Companys Management and Board of Directors that the
Companys consolidated published financial statements for external purposes were prepared in
accordance with generally accepted accounting principles. The Companys internal controls over
financial reporting include those policies and procedures that:
|
(i)
|
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets and liabilities of the Company;
|
|
|
(ii)
|
|
provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the Company are being made only in
accordance with authorization of management and directors of the Company; and
|
|
|
(iii)
|
|
provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisitions, use or disposition of the Companys assets that could have a material effect
on the financial statements.
|
Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements.
Management assessed the effectiveness of the Companys internal controls over financial reporting
as of December 31, 2008. In making this assessment, Management used the criteria set forth by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO) in
Internal
Control-Integrated Framework.
Based on Managements assessment and the criteria set forth by COSO,
it was determined that the Companys internal controls over financial reporting are effective as of
December 31, 2008.
The Companys independent registered public accounting firm, PricewaterhouseCoopers, has audited
the effectiveness of the Companys internal control over financial reporting, as stated in their
report located on page 137 in this Form 10-K.
80
Item 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information contained under the caption Market Risk in the MD&A section of this Form 10-K is
incorporated by reference.
81
Item 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
CIGNA Corporation
Consolidated Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31,
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees
|
|
$
|
16,203
|
|
|
$
|
15,008
|
|
|
$
|
13,641
|
|
Net investment income
|
|
|
1,063
|
|
|
|
1,114
|
|
|
|
1,195
|
|
Mail order pharmacy revenues
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
Other revenues
|
|
|
801
|
|
|
|
368
|
|
|
|
346
|
|
Realized investment gains (losses)
|
|
|
(170
|
)
|
|
|
15
|
|
|
|
220
|
|
|
|
|
Total revenues
|
|
|
19,101
|
|
|
|
17,623
|
|
|
|
16,547
|
|
|
|
|
Benefits and Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care medical claims expense
|
|
|
7,252
|
|
|
|
6,798
|
|
|
|
6,111
|
|
Other benefit expenses
|
|
|
4,285
|
|
|
|
3,401
|
|
|
|
3,153
|
|
Mail order pharmacy cost of goods sold
|
|
|
961
|
|
|
|
904
|
|
|
|
922
|
|
Guaranteed minimum income benefits expense
|
|
|
690
|
|
|
|
147
|
|
|
|
7
|
|
Other operating expenses
|
|
|
5,535
|
|
|
|
4,742
|
|
|
|
4,623
|
|
|
|
|
Total benefits and expenses
|
|
|
18,723
|
|
|
|
15,992
|
|
|
|
14,816
|
|
|
|
|
Income from Continuing Operations before Income Taxes
|
|
|
378
|
|
|
|
1,631
|
|
|
|
1,731
|
|
|
|
|
Income taxes (benefits):
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
|
|
|
311
|
|
|
|
511
|
|
|
|
595
|
|
Deferred
|
|
|
(221
|
)
|
|
|
-
|
|
|
|
(23
|
)
|
|
|
|
Total taxes
|
|
|
90
|
|
|
|
511
|
|
|
|
572
|
|
|
|
|
Income from Continuing Operations
|
|
|
288
|
|
|
|
1,120
|
|
|
|
1,159
|
|
Income (Loss) from Discontinued Operations, Net of Taxes
|
|
|
4
|
|
|
|
(5
|
)
|
|
|
(4
|
)
|
|
|
|
Net Income
|
|
$
|
292
|
|
|
$
|
1,115
|
|
|
$
|
1,155
|
|
|
Basic Earnings Per Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.05
|
|
|
$
|
3.95
|
|
|
$
|
3.50
|
|
Income (loss) from discontinued operations
|
|
|
0.01
|
|
|
|
(0.01
|
)
|
|
|
(0.01
|
)
|
|
Net income
|
|
$
|
1.06
|
|
|
$
|
3.94
|
|
|
$
|
3.49
|
|
|
Diluted Earnings Per Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.04
|
|
|
$
|
3.88
|
|
|
$
|
3.44
|
|
Income (loss) from discontinued operations
|
|
|
0.01
|
|
|
|
(0.01
|
)
|
|
|
(0.01
|
)
|
|
Net income
|
|
$
|
1.05
|
|
|
$
|
3.87
|
|
|
$
|
3.43
|
|
|
The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.
82
CIGNA Corporation
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except per share amounts)
|
|
As of December 31,
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
2007
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities, at fair value (amortized cost, $11,492; $11,409)
|
|
|
|
|
|
$
|
11,781
|
|
|
|
|
|
|
$
|
12,081
|
|
Equity securities, at fair value (cost, $140; $127)
|
|
|
|
|
|
|
112
|
|
|
|
|
|
|
|
132
|
|
Commercial mortgage loans
|
|
|
|
|
|
|
3,617
|
|
|
|
|
|
|
|
3,277
|
|
Policy loans
|
|
|
|
|
|
|
1,556
|
|
|
|
|
|
|
|
1,450
|
|
Real estate
|
|
|
|
|
|
|
53
|
|
|
|
|
|
|
|
49
|
|
Other long-term investments
|
|
|
|
|
|
|
632
|
|
|
|
|
|
|
|
520
|
|
Short-term investments
|
|
|
|
|
|
|
236
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
|
|
|
|
17,987
|
|
|
|
|
|
|
|
17,530
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
1,342
|
|
|
|
|
|
|
|
1,970
|
|
Accrued investment income
|
|
|
|
|
|
|
225
|
|
|
|
|
|
|
|
233
|
|
Premiums, accounts and notes receivable, net
|
|
|
|
|
|
|
1,407
|
|
|
|
|
|
|
|
1,405
|
|
Reinsurance recoverables
|
|
|
|
|
|
|
6,973
|
|
|
|
|
|
|
|
7,331
|
|
Deferred policy acquisition costs
|
|
|
|
|
|
|
789
|
|
|
|
|
|
|
|
816
|
|
Property and equipment
|
|
|
|
|
|
|
804
|
|
|
|
|
|
|
|
625
|
|
Deferred income taxes, net
|
|
|
|
|
|
|
1,617
|
|
|
|
|
|
|
|
794
|
|
Goodwill
|
|
|
|
|
|
|
2,878
|
|
|
|
|
|
|
|
1,783
|
|
Other assets, including other intangibles
|
|
|
|
|
|
|
1,520
|
|
|
|
|
|
|
|
536
|
|
Separate account assets
|
|
|
|
|
|
|
5,864
|
|
|
|
|
|
|
|
7,042
|
|
|
Total assets
|
|
|
|
|
|
$
|
41,406
|
|
|
|
|
|
|
$
|
40,065
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractholder deposit funds
|
|
|
|
|
|
$
|
8,539
|
|
|
|
|
|
|
$
|
8,594
|
|
Future policy benefits
|
|
|
|
|
|
|
8,754
|
|
|
|
|
|
|
|
8,147
|
|
Unpaid claims and claim expenses
|
|
|
|
|
|
|
4,037
|
|
|
|
|
|
|
|
4,127
|
|
Health Care medical claims payable
|
|
|
|
|
|
|
924
|
|
|
|
|
|
|
|
975
|
|
Unearned premiums and fees
|
|
|
|
|
|
|
414
|
|
|
|
|
|
|
|
496
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total insurance and contractholder liabilities
|
|
|
|
|
|
|
22,668
|
|
|
|
|
|
|
|
22,339
|
|
Accounts payable, accrued expenses and other liabilities
|
|
|
|
|
|
|
6,875
|
|
|
|
|
|
|
|
4,127
|
|
Short-term debt
|
|
|
|
|
|
|
301
|
|
|
|
|
|
|
|
3
|
|
Long-term debt
|
|
|
|
|
|
|
2,090
|
|
|
|
|
|
|
|
1,790
|
|
Nonrecourse obligations
|
|
|
|
|
|
|
16
|
|
|
|
|
|
|
|
16
|
|
Separate account liabilities
|
|
|
|
|
|
|
5,864
|
|
|
|
|
|
|
|
7,042
|
|
|
Total liabilities
|
|
|
|
|
|
|
37,814
|
|
|
|
|
|
|
|
35,317
|
|
|
Contingencies Note 22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock (par value per share, $0.25; shares issued, 351)
|
|
|
|
|
|
|
88
|
|
|
|
|
|
|
|
88
|
|
Additional paid-in capital
|
|
|
|
|
|
|
2,502
|
|
|
|
|
|
|
|
2,474
|
|
Net unrealized appreciation (depreciation), fixed maturities
|
|
$
|
(147
|
)
|
|
|
|
|
|
$
|
140
|
|
|
|
|
|
Net unrealized appreciation, equity securities
|
|
|
7
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
Net unrealized depreciation, derivatives
|
|
|
(13
|
)
|
|
|
|
|
|
|
(19
|
)
|
|
|
|
|
Net translation of foreign currencies
|
|
|
(60
|
)
|
|
|
|
|
|
|
61
|
|
|
|
|
|
Postretirement benefits liability adjustment
|
|
|
(861
|
)
|
|
|
|
|
|
|
(138
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
|
|
|
|
(1,074
|
)
|
|
|
|
|
|
|
51
|
|
Retained earnings
|
|
|
|
|
|
|
7,374
|
|
|
|
|
|
|
|
7,113
|
|
Less treasury stock, at cost
|
|
|
|
|
|
|
(5,298
|
)
|
|
|
|
|
|
|
(4,978
|
)
|
|
Total shareholders equity
|
|
|
|
|
|
|
3,592
|
|
|
|
|
|
|
|
4,748
|
|
|
Total liabilities and shareholders equity
|
|
|
|
|
|
$
|
41,406
|
|
|
|
|
|
|
$
|
40,065
|
|
|
Shareholders Equity Per Share
|
|
|
|
|
|
$
|
13.25
|
|
|
|
|
|
|
$
|
16.98
|
|
|
The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.
83
CIGNA Corporation
Consolidated Statements of Comprehensive Income
and Changes in Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except per share amounts)
|
For the years ended December 31,
|
|
2008
|
|
2007
|
|
2006
|
|
|
Compre-
|
|
Share-
|
|
Compre-
|
|
Share-
|
|
Compre-
|
|
Share-
|
|
|
hensive
|
|
holders
|
|
hensive
|
|
holders
|
|
hensive
|
|
holders
|
|
|
Income
|
|
Equity
|
|
Income
|
|
Equity
|
|
Income
|
|
Equity
|
|
Common Stock, beginning of year
|
|
|
|
|
|
$
|
88
|
|
|
|
|
|
|
$
|
40
|
|
|
|
|
|
|
$
|
40
|
|
Effect of issuance of stock for stock split
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
48
|
|
|
|
|
|
|
|
-
|
|
|
Common Stock, end of year
|
|
|
|
|
|
|
88
|
|
|
|
|
|
|
|
88
|
|
|
|
|
|
|
|
40
|
|
|
Additional Paid-In Capital, beginning of year
|
|
|
|
|
|
|
2,474
|
|
|
|
|
|
|
|
2,451
|
|
|
|
|
|
|
|
2,385
|
|
Effect of issuance of stock for stock split
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(48
|
)
|
|
|
|
|
|
|
-
|
|
Effect of issuance of stock for employee benefit plans
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
71
|
|
|
|
|
|
|
|
66
|
|
|
Additional Paid-In Capital, end of year
|
|
|
|
|
|
|
2,502
|
|
|
|
|
|
|
|
2,474
|
|
|
|
|
|
|
|
2,451
|
|
|
Accumulated Other Comprehensive Income (Loss), beginning
of year prior to implementation effect
|
|
|
|
|
|
|
51
|
|
|
|
|
|
|
|
(169
|
)
|
|
|
|
|
|
|
(509
|
)
|
Implementation effect of SFAS No. 155 (See Note 2)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(12
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss), beginning
of year as adjusted
|
|
|
|
|
|
|
51
|
|
|
|
|
|
|
|
(181
|
)
|
|
|
|
|
|
|
(509
|
)
|
Net unrealized depreciation, fixed maturities
|
|
$
|
(287
|
)
|
|
|
(287
|
)
|
|
$
|
(47
|
)
|
|
|
(47
|
)
|
|
$
|
(8
|
)
|
|
|
(8
|
)
|
Net unrealized depreciation, equity securities
|
|
|
-
|
|
|
|
-
|
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation on securities
|
|
|
(287
|
)
|
|
|
|
|
|
|
(50
|
)
|
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
Net unrealized appreciation (depreciation), derivatives
|
|
|
6
|
|
|
|
6
|
|
|
|
(4
|
)
|
|
|
(4
|
)
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Net translation of foreign currencies
|
|
|
(121
|
)
|
|
|
(121
|
)
|
|
|
28
|
|
|
|
28
|
|
|
|
31
|
|
|
|
31
|
|
Postretirement benefits liability adjustment
|
|
|
(723
|
)
|
|
|
(723
|
)
|
|
|
258
|
|
|
|
258
|
|
|
|
-
|
|
|
|
-
|
|
Minimum pension liability adjustment: prior to adoption
of SFAS No. 158
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
284
|
|
|
|
284
|
|
Minimum pension liability adjustment: reversal on adoption
of SFAS No. 158
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
432
|
|
Postretirement benefits liability adjustment: adoption of
SFAS No. 158
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(396
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss)
|
|
|
(1,125
|
)
|
|
|
|
|
|
|
232
|
|
|
|
|
|
|
|
304
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss), end of year
|
|
|
|
|
(1,074
|
)
|
|
|
|
|
|
|
51
|
|
|
|
|
|
|
|
(169
|
)
|
|
Retained Earnings, beginning of year prior to
implementation effects
|
|
|
|
|
|
|
7,113
|
|
|
|
|
|
|
|
6,177
|
|
|
|
|
|
|
|
5,162
|
|
Implementation effect of SFAS No. 155 (see Note 2)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
-
|
|
Implementation effect of FIN No. 48 (see Note 2)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(29
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained Earnings, beginning of year as adjusted
|
|
|
|
|
|
|
7,113
|
|
|
|
|
|
|
|
6,160
|
|
|
|
|
|
|
|
5,162
|
|
Net income
|
|
|
292
|
|
|
|
292
|
|
|
|
1,115
|
|
|
|
1,115
|
|
|
|
1,155
|
|
|
|
1,155
|
|
Effects of issuance of stock for employee benefit plans
|
|
|
|
|
|
|
(20
|
)
|
|
|
|
|
|
|
(151
|
)
|
|
|
|
|
|
|
(129
|
)
|
Common dividends declared (per share: $0.04; $0.04; $0.03)
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
(11
|
)
|
|
Retained Earnings, end of year
|
|
|
|
|
|
|
7,374
|
|
|
|
|
|
|
|
7,113
|
|
|
|
|
|
|
|
6,177
|
|
|
Treasury Stock, beginning of year
|
|
|
|
|
|
|
(4,978
|
)
|
|
|
|
|
|
|
(4,169
|
)
|
|
|
|
|
|
|
(1,718
|
)
|
Repurchase of common stock
|
|
|
|
|
|
|
(378
|
)
|
|
|
|
|
|
|
(1,158
|
)
|
|
|
|
|
|
|
(2,775
|
)
|
Other, primarily issuance of treasury stock for employee
benefit plans
|
|
|
|
|
|
|
58
|
|
|
|
|
|
|
|
349
|
|
|
|
|
|
|
|
324
|
|
|
Treasury Stock, end of year
|
|
|
|
|
|
|
(5,298
|
)
|
|
|
|
|
|
|
(4,978
|
)
|
|
|
|
|
|
|
(4,169
|
)
|
|
Total Comprehensive Income (Loss) and
Shareholders Equity
|
|
$
|
(833
|
)
|
|
$
|
3,592
|
|
|
$
|
1,347
|
|
|
$
|
4,748
|
|
|
$
|
1,459
|
|
|
$
|
4,330
|
|
|
The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.
84
CIGNA Corporation
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
For the years ended December 31,
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Cash Flows from Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
292
|
|
|
$
|
1,115
|
|
|
$
|
1,155
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
(Income) loss from discontinued operations
|
|
|
(4
|
)
|
|
|
5
|
|
|
|
4
|
|
Insurance liabilities
|
|
|
485
|
|
|
|
(24
|
)
|
|
|
(390
|
)
|
Reinsurance recoverables
|
|
|
63
|
|
|
|
159
|
|
|
|
93
|
|
Deferred policy acquisition costs
|
|
|
(74
|
)
|
|
|
(106
|
)
|
|
|
(63
|
)
|
Premiums, accounts and notes receivable
|
|
|
219
|
|
|
|
47
|
|
|
|
69
|
|
Other assets
|
|
|
(860
|
)
|
|
|
(134
|
)
|
|
|
(46
|
)
|
Accounts payable, accrued expenses and other liabilities
|
|
|
1,466
|
|
|
|
150
|
|
|
|
(106
|
)
|
Current income taxes
|
|
|
(72
|
)
|
|
|
10
|
|
|
|
245
|
|
Deferred income taxes
|
|
|
(221
|
)
|
|
|
-
|
|
|
|
(23
|
)
|
Realized investment (gains) losses
|
|
|
170
|
|
|
|
(15
|
)
|
|
|
(220
|
)
|
Depreciation and amortization
|
|
|
244
|
|
|
|
194
|
|
|
|
208
|
|
Gains on sales of businesses (excluding discontinued operations)
|
|
|
(38
|
)
|
|
|
(47
|
)
|
|
|
(61
|
)
|
Mortgage loans originated and held for sale
|
|
|
-
|
|
|
|
(80
|
)
|
|
|
(315
|
)
|
Proceeds from sales of mortgage loans held for sale
|
|
|
1
|
|
|
|
76
|
|
|
|
99
|
|
Other, net
|
|
|
(15
|
)
|
|
|
(8
|
)
|
|
|
(7
|
)
|
|
|
|
Net cash provided by operating activities
|
|
|
1,656
|
|
|
|
1,342
|
|
|
|
642
|
|
|
|
|
Cash Flows from Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from investments sold:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities
|
|
|
1,459
|
|
|
|
1,012
|
|
|
|
3,405
|
|
Equity securities
|
|
|
6
|
|
|
|
28
|
|
|
|
53
|
|
Commercial mortgage loans
|
|
|
48
|
|
|
|
1,293
|
|
|
|
495
|
|
Other (primarily short-term and other long-term investments)
|
|
|
492
|
|
|
|
260
|
|
|
|
1,185
|
|
Investment maturities and repayments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities
|
|
|
872
|
|
|
|
973
|
|
|
|
964
|
|
Commercial mortgage loans
|
|
|
98
|
|
|
|
123
|
|
|
|
432
|
|
Investments purchased:
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities
|
|
|
(2,681
|
)
|
|
|
(2,150
|
)
|
|
|
(3,069
|
)
|
Equity securities
|
|
|
(18
|
)
|
|
|
(27
|
)
|
|
|
(43
|
)
|
Commercial mortgage loans
|
|
|
(488
|
)
|
|
|
(693
|
)
|
|
|
(1,075
|
)
|
Other (primarily short-term and other long-term investments)
|
|
|
(776
|
)
|
|
|
(394
|
)
|
|
|
(612
|
)
|
Property and equipment sales
|
|
|
-
|
|
|
|
82
|
|
|
|
11
|
|
Property and equipment purchases
|
|
|
(257
|
)
|
|
|
(262
|
)
|
|
|
(147
|
)
|
Conversion of single premium annuity business
|
|
|
-
|
|
|
|
-
|
|
|
|
(45
|
)
|
Acquisition of Great-West Healthcare, net of cash acquired
|
|
|
(1,319
|
)
|
|
|
-
|
|
|
|
-
|
|
Cash provided by investing activities of discontinued operations
|
|
|
-
|
|
|
|
70
|
|
|
|
32
|
|
Other (primarily other acquisitions/dispositions)
|
|
|
(8
|
)
|
|
|
(46
|
)
|
|
|
(38
|
)
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
(2,572
|
)
|
|
|
269
|
|
|
|
1,548
|
|
|
|
|
Cash Flows from Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits and interest credited to contractholder deposit funds
|
|
|
1,305
|
|
|
|
1,175
|
|
|
|
1,230
|
|
Withdrawals and benefit payments from contractholder deposit funds
|
|
|
(1,214
|
)
|
|
|
(1,368
|
)
|
|
|
(1,354
|
)
|
Change in cash overdraft position
|
|
|
(17
|
)
|
|
|
(20
|
)
|
|
|
66
|
|
Net change in short-term debt
|
|
|
298
|
|
|
|
-
|
|
|
|
(75
|
)
|
Net proceeds on issuance of long-term debt
|
|
|
297
|
|
|
|
498
|
|
|
|
246
|
|
Repayment of long-term debt
|
|
|
-
|
|
|
|
(378
|
)
|
|
|
(100
|
)
|
Repurchase of common stock
|
|
|
(378
|
)
|
|
|
(1,185
|
)
|
|
|
(2,765
|
)
|
Issuance of common stock
|
|
|
37
|
|
|
|
248
|
|
|
|
251
|
|
Common dividends paid
|
|
|
(14
|
)
|
|
|
(11
|
)
|
|
|
(12
|
)
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
314
|
|
|
|
(1,041
|
)
|
|
|
(2,513
|
)
|
|
|
|
Effect of foreign currency rate changes on cash and cash equivalents
|
|
|
(26
|
)
|
|
|
8
|
|
|
|
6
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(628
|
)
|
|
|
578
|
|
|
|
(317
|
)
|
Cash and cash equivalents, beginning of year
|
|
|
1,970
|
|
|
|
1,392
|
|
|
|
1,709
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
1,342
|
|
|
$
|
1,970
|
|
|
$
|
1,392
|
|
|
Supplemental Disclosure of Cash Information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid, net of refunds
|
|
$
|
366
|
|
|
$
|
455
|
|
|
$
|
317
|
|
Interest paid
|
|
$
|
140
|
|
|
$
|
122
|
|
|
$
|
105
|
|
|
The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.
85
Notes to the Consolidated Financial Statements
Note 1 Description of Business
CIGNA Corporation together with its subsidiaries (referred to collectively as the Company)
constitutes one of the largest investor-owned health service organizations in the United States.
Its subsidiaries are major providers of health care and related benefits, the majority of which are
offered through the workplace, including health care products and services such as medical
coverages, pharmacy, behavioral health, dental benefits, and disease management; group disability,
life and accident insurance; and disability and workers compensation case management and related
services. In addition, the Company has an international operation that offers life, accident and
supplemental health insurance products and international health care products and services to
businesses and individuals in selected markets. The Company also has certain inactive businesses,
including a run-off reinsurance operation.
Note 2 Summary of Significant Accounting Policies
A.
Basis of Presentation
The consolidated financial statements include the accounts of CIGNA Corporation, its significant
subsidiaries, and variable interest entities of which CIGNA Corporation is the primary beneficiary.
Intercompany transactions and accounts have been eliminated in consolidation.
These consolidated financial statements were prepared in conformity with accounting principles
generally accepted in the United States of America (GAAP). Amounts recorded in the consolidated
financial statements reflect managements estimates and assumptions about medical costs, investment
valuation, interest rates and other factors. Significant estimates are discussed throughout these
Notes; however, actual results could differ from those estimates.
Certain reclassifications have been made to prior period amounts to conform to the presentation of
2008 amounts.
Discontinued operations.
Summarized financial data for discontinued operations in 2008 primarily
represents a gain of $3 million after-tax from the settlement of certain issues related to a past
divestiture.
For 2007 and 2006, discontinued operations primarily reflects:
|
|
impairment losses related to the dispositions in 2007 and 2006 of several Latin American
insurance operations as discussed in Note 3; and
|
|
|
realized gains on the disposition of certain directly-owned real estate investments in 2007
and 2006 as discussed in Note 13.
|
Unless otherwise indicated, amounts in these Notes exclude the effects of discontinued operations
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Income before income (taxes) benefits
|
|
$
|
3
|
|
|
$
|
25
|
|
|
$
|
19
|
|
Income (taxes) benefits
|
|
|
1
|
|
|
|
(7
|
)
|
|
|
(6
|
)
|
|
|
|
Income from operations
|
|
|
4
|
|
|
|
18
|
|
|
|
13
|
|
Impairment loss, net of tax
|
|
|
-
|
|
|
|
(23
|
)
|
|
|
(17
|
)
|
|
Income (loss) from discontinued operations, net of taxes
|
|
$
|
4
|
|
|
$
|
(5
|
)
|
|
$
|
(4
|
)
|
|
Variable interest entities.
As of December 31, 2008 the Company is no longer a primary beneficiary
in any variable interest entities. As of 2007, the Company consolidated $5 million in assets and
$5 million in liabilities as the primary beneficiary of one real estate joint venture.
B.
Recent Accounting Pronouncements
Fair value measurements.
Effective January 1, 2008, the Company adopted Statement of Financial
Accounting Standards No. (SFAS No.) 157, Fair Value Measurements. This standard expands
disclosures about fair value measurements and clarifies how to measure fair value by focusing on
the price that would be received when selling an asset or paid to transfer a liability (exit
price). In addition, the Financial Accounting Standards Board (FASB) amended SFAS No. 157 to
provide additional guidance for determining the fair value of a financial asset when the market for
that instrument is not active. See Note 11 for information on the Companys fair value measurements
including new required disclosures.
86
The Company carries certain financial instruments at fair value in the financial statements
including approximately $12.1 billion in invested assets at December 31, 2008. The Company also
carries derivative instruments at fair value, including assets and liabilities for reinsurance
contracts covering guaranteed minimum income benefits (GMIB assets and liabilities) under certain
variable annuity contracts issued by other insurance companies and related retrocessional
contracts. The Company also reports separate account assets at fair value; however, changes in the
fair values of these assets accrue directly to policyholders and are not included in the Companys
revenues and expenses. At the adoption of SFAS No. 157, there were no effects to the Companys
measurements of fair values for financial instruments other than for GMIB assets and liabilities
discussed below. In addition, there were no effects to the Companys measurements of financial
assets of adopting the recent amendment to SFAS No. 157.
At adoption, the Company was required to change certain assumptions used to estimate the fair
values of GMIB assets and liabilities. As a result, the Company recorded a charge of $131 million
after-tax, net of reinsurance ($202 million pre-tax), in Run-off Reinsurance. Because there is no
market for these contracts, the assumptions used to estimate their fair values at adoption were
determined using a hypothetical market participants view of an exit price. The Company considered
the following in determining the view of a hypothetical market participant:
|
|
that the most likely transfer of these assets and liabilities would be
through a reinsurance transaction with an independent insurer having a
market capitalization and credit rating similar to that of the
Company; and
|
|
|
|
that because this block of contracts is in run-off mode, an insurer
looking to acquire these contracts would have similar existing
contracts with related administrative and risk management
capabilities.
|
At adoption, the assumptions used to estimate the fair value of these contracts were determined
using a hypothetical market participants view of an exit price rather than using historical market
data and actual experience to establish the Companys future expectations. For many of these
assumptions, there is limited or no observable market data so determining an exit price requires
the Company to exercise significant judgment and make critical accounting estimates.
The Company considers the various assumptions used to estimate fair values of these contracts in
two categories: capital markets and future annuitant and retrocessionaire behavior
assumptions. Estimated components of the charge by category (net of reinsurance) are described
below, including how these updated assumptions differ from those used historically to estimate fair
values for these contracts.
Assumptions Related to Capital Markets
-
$183 million of the $202 million pre-tax charge, net of
estimated receivables for reinsurance, reflected the impact of changes in capital markets
assumptions including market return, discount rate, the projected interest rate used to calculate
the reinsured income benefits at the time of annuitization (claim interest rate), and volatility.
These assumptions were updated to reflect market-observable interest rates (LIBOR swap curve) and
volatility consistent with that implied by derivative instruments in a consistently active market,
under the assumption that a hypothetical market participant would hedge all or a portion of the net
liability. The capital markets pre-tax charge is comprised of:
|
|
$131 million related to using market-observable interest rates to
project the growth in the contractholders underlying investment
accounts rather than using an estimate of the actual returns for the
underlying equity and bond mutual funds over time. Market-observable
growth rates were lower than the market return assumptions at December
31, 2007 which ranged from 5-11% varying by fund type. The Company
believes market-observable rates would be used by a hypothetical
market participant who is expected to hedge the risk associated with
these contracts because they would earn market interest returns from
hedging instruments. However, the Companys actual payments will be
based on, among other variables, the actual returns that the
contractholders earn on their underlying investment accounts.
|
|
|
|
$23 million related to assuming implied market volatility as of
January 1, 2008 for certain indices where observable in a consistently
active market. The Company believes that a hypothetical market
participant would use these market-implied volatilities rather than
use average historical market volatilities.
|
|
|
|
$20 million related to projecting the interest rate used to calculate
the reinsured income benefits at the time of annuitization (claim
interest rate) using the market-implied forward rate curve and
volatility as of January 1, 2008. Claim payments are based on the
7-year Treasury Rate at the time the benefit is elected, and the
Company believes that a hypothetical market participant would likely
use the above market-implied approach rather than projecting the
7-year Treasury Rate grading from current levels to long-term average
levels.
|
|
|
|
$9 million related to using market-observable interest rates as of
January 1, 2008 to discount the liability. The Company believes that
a hypothetical market participant would use market-observable interest
rates for discounting rather than a rate anticipated to be earned on
the assets invested to settle the liability. The impact of using
market-observable interest rates to discount the liability is
significantly less than the impact of using these rates to project the
growth in contractholders underlying investment accounts because
market-observable interest rates as of January 1, 2008 were much
closer to the discount rate assumption of
|
87
|
|
5.75% used at December 31,
2007 prior to the adoption of SFAS No. 157.
|
Assumptions Related to Future Annuitant and Retrocessionaire Behavior
-
$19 million of the $202
million pre-tax charge, net of estimated receivables for reinsurance, reflected the impact of the
Companys view of a hypothetical market participants assumptions for future annuitant and
retrocessionaire behavior and primarily reflects an incremental risk and profit charge.
The Companys results of operations related to this business are expected to continue to be
volatile in future periods both because underlying assumptions will be based on current
market-observable inputs which will likely change each period and because the recorded
liabilities, net of receivables from reinsurers, are higher after adoption of SFAS No. 157. See
Note 11 for additional information.
The FASB deferred the effective date of SFAS No. 157 until the first quarter of 2009 for
non-financial assets and liabilities (such as intangible assets, property and equipment and
goodwill) that are required to be measured at fair value on a periodic basis (such as at
impairment). On adoption in the first quarter of 2009, the Company does not expect material
changes to their periodic fair value measurements for non-financial assets and liabilities.
Fair value option.
Effective January 1, 2008, the Company adopted SFAS No. 159, The Fair Value
Option for Financial Assets and Financial Liabilities, which permits entities to choose fair value
measurement for many financial instruments, including insurance contracts, with subsequent changes
in fair value to be reported in net income for the period. This choice is made for each individual
financial instrument, is irrevocable and, after implementation, must be determined when the entity
first commits to or recognizes the financial instrument. The adoption of SFAS No. 159 did not
impact the Companys consolidated financial statements, as no items were elected for fair value
measurement. For financial assets and liabilities acquired after adoption, the Company determines
whether to use the fair value election at the time of acquisition.
Uncertain tax positions.
Effective January 1, 2007, the Company implemented FASB Interpretation
No. (FIN No.) 48, Accounting for Uncertainty in Income Taxes. This interpretation provides
guidance for recognizing and measuring uncertain tax positions that are more likely than not to
result in a benefit if challenged by the Internal Revenue Service (IRS). The guidance clarifies
that the amount of tax benefit recognized should be measured using managements best estimate based
on the most favorable expected benefit with greater than fifty percent likelihood of being
realized. The interpretation also requires that interest expense and penalties be recognized for
any reserved portion of an uncertain tax position beginning when the effect of that position is
reported to tax authorities. The cumulative effect of implementing the interpretation for
unrecognized tax benefits decreased opening retained earnings by $29 million. See Note 18 for
additional information.
Certain financial instruments.
Effective January 1, 2007, the Company implemented SFAS No. 155,
Accounting for Certain Hybrid Financial Instruments, an amendment of FASB Statements No. 133 and
140. This standard clarifies when certain financial instruments and features of financial
instruments must be treated as derivatives and reported on the balance sheet at fair value with
changes in fair value reported in net income. At adoption, the Company elected to fair value
certain existing investments in preferred stock and debt securities with call or conversion
features (hybrid securities) and future changes in the fair value of these investments will be
reported in net income. As a result, the Company reclassified $12 million after-tax of unrealized
appreciation from the opening balance of accumulated other comprehensive loss to retained earnings
with no net change to total shareholders equity. In addition, this standard may affect future
income recognition for certain future financial instruments if the fair value election is used or
if additional derivatives are identified because any changes in their fair values will be
recognized in net income each period. See Note 12(A) for a review of instruments that the Company
has elected to fair value.
Deferred acquisition costs.
Effective January 1, 2007, the Company implemented the American
Institute of Certified Public Accountants (AICPA) Statement of Position (SOP) 05-1, Accounting by
Insurance Enterprises for Deferred Acquisition Costs in Connection With Modifications or Exchanges
of Insurance Contracts. The SOP requires that deferred acquisition costs be expensed in full when
the original contract is substantially changed by election or amendment of an existing contract
feature or by replacement with a new contract. There were no material effects to the consolidated
financial statements at implementation. Although substantial contract changes are not expected to
occur, the effect of this SOP in future periods may vary based on the nature and volume of any such
contract changes.
88
Pension and other postretirement benefit plans.
Effective December 31, 2006, the Company
implemented SFAS No. 158, Employers Accounting for Defined Benefit Pension and Other
Postretirement Benefits Plans. This standard requires that the overfunded or underfunded status of
all defined benefit postretirement plans be measured as the difference between the fair value of
plan assets and the benefit obligation and recognized in the balance sheet. Changes in actuarial
gains and losses and prior service costs are required to be recognized in accumulated other
comprehensive income, net of tax, each period. The effects on the consolidated financial
statements were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before
|
|
|
|
|
|
|
After
|
|
|
|
Application of
|
|
|
Adjust-
|
|
|
Application of
|
|
(In millions)
|
|
SFAS No. 158
|
|
|
ments
|
|
|
SFAS No. 158
|
|
|
Liability for pension benefits
|
|
$
|
744
|
|
|
$
|
99
|
|
|
$
|
843
|
|
Liability for other postretirement benefits
|
|
$
|
590
|
|
|
$
|
(155
|
)
|
|
$
|
435
|
|
Total liabilities
|
|
$
|
38,125
|
|
|
$
|
(56
|
)
|
|
$
|
38,069
|
|
Deferred income tax asset
|
|
$
|
946
|
|
|
$
|
(20
|
)
|
|
$
|
926
|
|
Accumulated other comprehensive (loss)
|
|
$
|
(205
|
)
|
|
$
|
36
|
|
|
$
|
(169
|
)
|
Total shareholders equity
|
|
$
|
4,294
|
|
|
$
|
36
|
|
|
$
|
4,330
|
|
|
Liabilities for pension benefits and other postretirement benefits are recorded in accounts
payable, accrued expenses and other liabilities on the Companys Consolidated Balance Sheets.
The implementation of SFAS No. 158 did not impact the Companys pension expense, funding
requirements or financial covenants. See Note 10 for further information on pension and other
postretirement benefit plans.
Earnings per share.
In 2008, the FASB issued FASB Staff Position EITF 03-6-1, Determining Whether
Instruments Granted in Share-Based Payment Transactions Are Participating Securities, to require
outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends to
be included in the denominator of both basic and diluted earnings per share calculations. These
new requirements must be applied through restatement of prior-period earnings per share data
beginning in the first quarter of 2009. On adoption, the Company does not expect material changes
to either basic or diluted earnings per share data.
Business combinations.
In 2007, the FASB issued SFAS No. 141 (revised 2007, referred to as SFAS
No. 141R,) Business Combinations, to require fair value measurements for all future acquisitions,
including contingent purchase price and contingent assets or liabilities of the entity to be
acquired. This standard also expands the definition of business combination to include all
transactions or events in which an entity obtains control of a business, requires acquisition
related and restructuring costs to be expensed as incurred and requires changes in deferred tax
asset valuation allowances and acquired income tax uncertainties after the acquisition date to be
reported in income tax expense. SFAS No. 141R is effective for all business combinations beginning
in 2009. The effect of these new requirements on the Companys financial condition and results of
operations will depend on the volume and terms of acquisitions in 2009 and beyond, but will likely
increase the amount and change the timing of recognizing expenses related to acquisition
activities.
Noncontrolling interests in subsidiaries.
In 2007, the FASB issued SFAS No. 160, Noncontrolling
Interests in Consolidated Financial Statements, an amendment of ARB No. 51, to require that
noncontrolling interests in subsidiaries be presented as part of equity of the consolidated group,
separate from the parent shareholders equity. In addition, net income and components of other
comprehensive income of the subsidiary must be allocated between the controlling and noncontrolling
interests and presented separately based on relative ownership interests or contractual
arrangements. These new presentation requirements must be applied through retrospective
restatement of prior financial statements beginning in 2009. On adoption, the Company does not
expect material changes to the results of operations or financial condition.
C.
Financial Instruments
In the normal course of business, the Company enters into transactions involving various types of
financial instruments. These financial instruments may include:
|
|
various investments (such as fixed maturities, commercial mortgage loans and equity
securities);
|
|
|
|
short- and long-term debt; and
|
|
|
|
off-balance-sheet instruments (such as investment and certain loan commitments and
financial guarantees).
|
89
These instruments may change in value due to interest rate and market fluctuations, and most also
have credit risk. The Company evaluates and monitors each financial instrument individually and,
when management considers it appropriate, uses a derivative instrument or obtains collateral or
another form of security to minimize risk of loss.
Most financial instruments that are subject to fair value disclosure requirements are carried in
the consolidated financial statements at amounts that approximate fair value. The following table
shows the fair values and carrying values of the Companys financial instruments not carried at
fair value that are subject to fair value disclosure requirements, at the end of 2008 and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
|
Fair
|
|
|
Carrying
|
|
|
Fair
|
|
|
Carrying
|
|
|
|
Value
|
|
|
Value
|
|
|
Value
|
|
|
Value
|
|
|
Commercial mortgage loans
|
|
$
|
3,401
|
|
|
$
|
3,617
|
|
|
$
|
3,315
|
|
|
$
|
3,277
|
|
Contractholder deposit funds, excluding universal life products
|
|
$
|
889
|
|
|
$
|
915
|
|
|
$
|
931
|
|
|
$
|
936
|
|
Long-term debt, excluding capital leases
|
|
$
|
1,684
|
|
|
$
|
2,077
|
|
|
$
|
1,790
|
|
|
$
|
1,777
|
|
|
Fair values of off-balance-sheet financial instruments were not material.
Fair values of financial instruments are based on quoted market prices when available. When market
prices are not available, management generally estimates fair value based on discounted cash flow
analyses, which use current interest rates for similar financial instruments with comparable terms
and credit quality. Management estimates the fair value of the liabilities for contractholder
deposit funds using the amount payable on demand.
D.
Investments
The Companys accounting policies for investment assets are discussed below:
Fixed maturities and equity securities.
Fixed maturities include bonds, mortgage- and other
asset-backed securities and preferred stocks redeemable by the investor. Equity securities include
common stocks and preferred stocks that are non-redeemable or redeemable only by the issuer. These
investments are primarily classified as available for sale and are carried at fair value with
changes in fair value recorded in accumulated other comprehensive income (loss) within
shareholders equity. Fixed maturities and equity securities are considered impaired, and their
cost basis is written down to fair value through earnings, when management expects a decline in
value to persist (i.e. the decline is other than temporary). Fixed maturities and equity
securities include certain trading and hybrid securities carried at fair value with changes in fair
value reported in realized investment gains and losses, beginning after the implementation of SFAS
No. 155 on January 1, 2007 for hybrid securities. The Company elected fair value accounting for
certain hybrid securities to simplify accounting and mitigate volatility in results of operations
and financial condition.
Commercial mortgage loans.
Mortgage loans held by the Company are made exclusively to commercial
borrowers, therefore there is no exposure to either prime or sub-prime residential mortgages.
Generally, commercial mortgage loans are carried at unpaid principal balances and are issued at a
fixed rate of interest. Commercial mortgage loans held for sale are carried at the lower of unpaid
principal balance or fair value with any resulting valuation allowance reported in realized
investment gains and losses. Commercial mortgage loans are considered impaired when it is probable
that the Company will not collect amounts due according to the terms of the loan agreement.
Impaired loans are carried at the lower of unpaid principal or fair value of the underlying
collateral. The Company estimates the fair value of the underlying collateral using internal
valuations generally based on discounted cash flow analyses.
Policy loans.
Policy loans are carried at unpaid principal balances.
Real estate.
Investment real estate can be held and used or held for sale. The Company
accounts for real estate as follows:
|
|
Real estate held and used is expected to be held longer than one year and includes real
estate acquired through the foreclosure of commercial mortgage loans. The Company carries
real estate held and used at depreciated cost less any write-downs to fair value due to
impairment and assesses impairment when cash flows indicate that the carrying value may not be
recoverable. Depreciation is generally calculated using the straight-line method based on the
estimated useful life of the particular real estate asset.
|
|
|
|
Real estate is held for sale when a buyers investigation is completed, a deposit has
been received and the sale is expected to be completed within the next year. Real estate held
for sale is carried at the lower of carrying value or current fair value, less estimated costs
to sell, and is not depreciated. Valuation reserves reflect any changes in fair value.
|
|
|
|
The Company uses several methods to determine the fair value of real estate, but relies
primarily on discounted cash flow
|
90
|
|
analyses and, in some cases, third party appraisals.
|
At the time of foreclosure, properties are reclassified from commercial mortgage loans to real
estate. The Company rehabilitates, re-leases and sells foreclosed properties. This process
usually takes from 2 to 4 years unless management considers a near-term sale preferable.
Other long-term investments.
Other long-term investments include investments in unconsolidated
entities. These entities include certain limited partnerships and limited liability companies
holding real estate, securities or loans. These investments are carried at
cost plus the Companys ownership percentage of reported income or loss in cases where the Company
has significant influence, otherwise the investment is carried at cost. Also included in other
long-term investments are loans to unconsolidated real estate entities secured by the equity
interests of these real estate entities, which are carried at unpaid principal balances (mezzanine
loans). Additionally, other long-term investments include interest rate and foreign currency swaps
carried at fair value. See Note 12(F) for information on the Companys accounting policies for
these derivative financial instruments.
Short-term investments.
Investments with maturities of less than one year from time of purchase are
classified as short-term, available for sale and carried at fair value, which approximates cost.
Derivative financial instruments.
Note 12(F) discusses the Companys accounting policies for
derivative financial instruments.
Net investment income.
When interest and principal payments on investments are current, the
Company recognizes interest income when it is earned. The Company stops recognizing interest
income when interest payments are delinquent or when certain terms (interest rate or maturity date)
of the investment have been restructured. Net investment income on these investments is only
recognized when interest payments are actually received. Interest and dividends earned on trading
and hybrid securities are included in net investment income.
Investment gains and losses.
Realized investment gains and losses result from sales, investment
asset write-downs, changes in the fair values of trading and hybrid securities and certain
derivatives and changes in valuation reserves, based on specifically identified assets. Realized
investment gains and losses on the disposition of certain directly owned real estate investments
are eliminated from ongoing operations and reported in discontinued operations when the operations
and cash flows of the underlying assets are clearly distinguishable and the Company has no
significant continuing involvement in their operations.
Unrealized gains and losses on fixed maturities and equity securities carried at fair value
(excluding trading and hybrid securities) and certain derivatives are included in accumulated other
comprehensive income (loss), net of:
|
|
amounts required to adjust future policy benefits for run-off settlement annuity business;
and
|
|
|
|
deferred income taxes.
|
E.
Cash and Cash Equivalents
Cash equivalents consist of short-term investments with maturities of three months or less from the
time of purchase that are classified as held to maturity and carried at amortized cost. The
Company reclassifies cash overdraft positions to accounts payable, accrued expenses and other
liabilities when the legal right of offset does not exist.
F.
Premiums, Accounts and Notes Receivable and Reinsurance Recoverables
Premiums, accounts and notes receivable are reported net of an allowance for doubtful accounts of
$50 million as of December 31, 2008 and $54 million as of December 31, 2007. Reinsurance
recoverables are estimates of amounts that the Company will receive from reinsurers and are
recorded net of an allowance for unrecoverable reinsurance of $23 million as of December 31, 2008
and $27 million as of December 31, 2007.
G.
Deferred Policy Acquisition Costs
Acquisition costs include sales compensation, commissions, premium taxes and other costs that the
Company incurs in connection with new and renewal business. Depending on the product line they
relate to, the Company records acquisition costs in different ways. Acquisition costs for:
|
|
Universal life products
are deferred and amortized in proportion to the present value of
total estimated gross profits over the expected lives of the contracts.
|
91
|
|
|
Annuity and other individual life insurance (primarily international) and group health
indemnity products
are deferred and amortized, generally in proportion to the ratio of
periodic revenue to the estimated total revenues over the contract periods.
|
|
|
|
Other products
are expensed as incurred.
|
For universal life, annuity and other individual products, management estimates the present value
of future revenues less expected payments. For group health indemnity products, management
estimates the sum of future expected claims and related costs less unearned premiums and
anticipated net investment income. If managements estimates are less than the deferred costs, the
Company reduces deferred policy acquisition costs and records an expense. Anticipated investment
income is considered in the calculation of
premium deficiency losses for short-duration contracts. The Company recorded in other operating
expenses amortization for policy acquisition costs of $314 million in 2008, $242 million in 2007
and $202 million in 2006. There are no deferred policy acquisition costs attributable to the sold
individual life insurance and annuity and retirement businesses or the run-off reinsurance
operations.
H.
Property and Equipment
Property and equipment is carried at cost less accumulated depreciation. When applicable, cost
includes interest, real estate taxes and other costs incurred during construction. Also included
in this category is internal-use software that is acquired, developed or modified solely to meet
the Companys internal needs, with no plan to market externally. Costs directly related to
acquiring, developing or modifying internal-use software are capitalized. See Note 9 for
additional information on internal-use software.
The Company calculates depreciation and amortization principally using the straight-line method
based on the estimated useful life of each asset as follows: buildings and improvements, 1 year to
40 years; equipment and software, 1 year to 10 years. Depreciation and amortization expense on
property and equipment, including internal-use software, was $219 million in 2008, $185 million in
2007 and $187 million in 2006. Accumulated depreciation and amortization on property and
equipment, including internal-use software was $1.5 billion at December 31, 2008 and $1.4 billion
at December 31, 2007.
I.
Goodwill
Goodwill represents the excess of the cost of businesses acquired over the fair value of their net
assets. Substantially all goodwill relates to the Health Care segment. The Company evaluates
goodwill for impairment annually during the third quarter at the reporting unit level, based on
discounted cash flow analyses and writes it down through results of operations if impaired.
Consistent with prior years, the Companys evaluations used the best information available at the
time, including reasonable assumptions and projections consistent with those used in its annual
planning process. The discounted cash flow analyses used a range of discount rates that correspond
with the Companys weighted average cost of capital, consistent with that used for investment
decisions considering the specific and detailed operating plans and strategies within the Health
Care segment. The resulting discounted cash flow analyses indicated an estimated fair value for the
reporting units of the Health Care segment exceeding their carrying values, including goodwill and
other intangibles. Finally, the Company determined that no events or circumstances occurred
subsequent to the annual evaluation of goodwill that would more likely than not reduce the fair
value of the reporting units of the Health Care segment below their carrying values. See Note 9 for
additional information.
J.
Other Assets, including Other Intangibles
Other assets consist of various insurance-related assets and the gain position of certain
derivatives, primarily GMIB assets. The Companys other intangible assets include purchased
customer and producer relationships, provider networks, and trademarks. The Company amortizes
other intangibles on an accelerated or straight-line basis over periods from 1 to 30 years.
Management revises amortization periods if it believes there has been a change in the length of
time that an intangible asset will continue to have value. See Note 9 for additional information.
K.
Separate Account Assets and Liabilities
Separate account assets and liabilities are contractholder funds maintained in accounts with
specific investment objectives. The assets of these accounts are legally segregated and are not
subject to claims that arise out of any of the Companys other businesses. These separate account
assets are carried at fair value with equal amounts for related separate account liabilities. The
investment income, gains and losses of these accounts generally accrue to the contractholders and
are not included in the Companys revenues and expenses. Fees earned for asset management services
are reported in premiums and fees.
92
L.
Contractholder Deposit Funds
Liabilities for contractholder deposit funds include deposits received from customers for
investment-related and universal life products and investment earnings on their fund balances.
These liabilities are adjusted to reflect administrative charges and, for universal life fund
balances, mortality charges.
M.
Future Policy Benefits
Future policy benefits are liabilities for the present value of estimated future obligations under
long-term life and supplemental health insurance policies and annuity products currently in force.
These obligations are estimated using actuarial methods and primarily
consist of reserves for annuity contracts, life insurance benefits, guaranteed minimum death
benefit contracts and certain life, accident and health insurance products in our International
operations.
Obligations for annuities represent specified periodic benefits to be paid to an individual or
groups of individuals over their remaining lives. Obligations for life insurance policies
represent benefits to be paid to policyholders, net of future premiums to be received. Management
estimates these obligations based on assumptions as to premiums, interest rates, mortality and
surrenders, allowing for adverse deviation. Mortality, morbidity, and surrender assumptions are
based on either the Companys own experience or actuarial tables. Interest rate assumptions are
based on managements judgment considering the Companys experience and future expectations, and
range from 1.5% to 10.0%. Obligations for the run-off settlement annuity business include
adjustments for investment returns consistent with requirements of GAAP when a premium deficiency
exists.
Certain reinsurance contracts guarantee a minimum death benefit (GMDB) under variable annuities
issued by other insurance companies. These obligations represent the guaranteed death benefit in
excess of the contractholders account values (based on underlying equity and bond mutual fund
investments). These obligations are estimated based on assumptions regarding lapse, partial
surrenders, mortality, interest rates (mean investment performance and discount rate), market
volatility as well as investment returns and premiums, consistent with the requirements of GAAP
when a premium deficiency exists. Lapse, partial surrenders, mortality, interest rates and
volatility are based on managements judgment considering the Companys experience and future
expectations. The results of futures contracts used in the GMDB equity hedge program are reflected
in the liability calculation as a component of investment returns. See also Note 7 for additional
information.
N.
Unpaid Claims and Claims Expenses
Liabilities for unpaid claims and claim expenses are estimates of payments to be made under
insurance coverages (primarily long-term disability, workers compensation and life and health) for
reported claims and for losses incurred but not yet reported.
The Company develops these estimates for losses incurred but not yet reported using actuarial
principles and assumptions based on historical and projected claim incidence patterns, claim size
and the length of time over which payments are expected to be made. The Company consistently
applies these actuarial principles and assumptions each reporting period, with consideration given
to the variability of these factors, and recognizes the actuarial best estimate of the ultimate
liability within a level of confidence, as required by actuarial standards of practice, which
require that the liabilities be adequate under moderately adverse conditions.
The Companys estimate of the liability for disability claims reported but not yet paid is
primarily calculated as the present value of expected benefit payments to be made over the
estimated time period that a policyholder remains disabled. The Company estimates the expected
time period that a policyholder may be disabled by analyzing the rate at which an open claim is
expected to close (claim resolution rate). Claim resolution rates may vary based upon the length
of time a policyholder is disabled, the covered benefit period, cause of disability, benefit design
and the policyholders age, gender and income level. The Company uses historical resolution rates
combined with an analysis of current trends and operational factors to develop current estimates of
resolution rates. The reserve for the gross monthly disability benefits due to a policyholder is
reduced (offset) by the income that the policyholder receives under other benefit programs, such as
Social Security Disability Income, workers compensation, statutory disability or other group
disability benefit plans. For awards of such offsets that have not been finalized, the Company
estimates the probability and amount of the offset based on the Companys experience over the past
three to five years.
Because benefit payments may be made over an extended time period, the Company discounts certain
claim liabilities related to group long-term disability and workers compensation. Discount rate
assumptions are based on projected investment returns for the asset portfolios that support these
liabilities and range from 2.1% to 6.5%. When estimates change, the Company records the adjustment
in benefits and expenses in the period in which the change in estimate is identified. Discounted
liabilities associated with the long-term disability and certain workers compensation businesses
were $3.2 billion at December 31, 2008 and $3.1 billion at December 31, 2007.
93
O.
Health Care Medical Claims Payable
Medical claims payable for the Health Care segment include both reported claims and estimates for
losses incurred but not yet reported.
The Company develops these estimates using actuarial principles and assumptions based on historical
and projected claim payment patterns, medical cost trends, which are impacted by the utilization of
medical services and the related costs of the services provided (unit costs), benefit design,
seasonality, and other relevant operational factors. The Company consistently applies these
actuarial principles and assumptions each reporting period, with consideration given to the
variability of these factors, and recognizes the
actuarial best estimate of the ultimate liability within a level of confidence, as required by
actuarial standards of practice, which require that the liabilities be adequate under moderately
adverse conditions.
The Companys estimate of the liability for medical claims incurred but not yet reported is
primarily calculated using historical claim payment patterns and expected medical cost trends. The
Company analyzes the historical claim payment patterns by comparing the dates claims were incurred,
generally the dates services were provided, to the dates claims were paid to determine completion
factors, which are a measure of the time to process claims. A completion factor is calculated for
each month of incurred claims. The Company uses historical completion factors combined with an
analysis of current trends and operational factors to develop current estimates of completion
factors. The Company estimates the ultimate liability for claims incurred in each month by
applying the current estimates of completion factors to the current paid claims data. The
difference between this estimate of the ultimate liability and the current paid claims data is the
estimate of the remaining claims to be paid for each incurral month. These monthly estimates are
aggregated and included in the Companys Health Care medical claims payable at the end of each
reporting period. Completion factors are used to estimate the Health Care medical claims payable
for all months where claims have not been completely resolved and paid, except for the most recent
month as described below.
Completion factors are impacted by several key items including changes in the level of claims
processed electronically versus manually (auto-adjudication), changes in provider claims submission
rates, membership changes and the mix of products. As noted, the Company uses historical
completion factors combined with an analysis of current trends and operational factors to develop
current estimates of completion factors. This approach implicitly assumes that historical
completion rates will be a useful indicator for the current period. It is possible that the actual
completion rates for the current period will develop differently from historical patterns, which
could have a material impact on the Companys medical claims payable and net income.
Claims incurred in the most recent month have limited paid claims data, since a large portion of
health care claims are not submitted to the Company for payment in the month services have been
provided. This makes the completion factor approach less reliable for claims incurred in the most
recent month. As a result, in any reporting period, for the estimates of the ultimate claims
incurred in the most recent month, the Company primarily relies on medical cost trend analysis,
which reflects expected claim payment patterns and other relevant operational considerations.
Medical cost trend is impacted by several key factors including medical service utilization and
unit costs and the Companys ability to manage these factors through benefit design, underwriting,
provider contracting and the Companys medical management initiatives. These factors are affected
by changes in the level and mix of medical benefits offered, including inpatient, outpatient and
pharmacy, the impact of copays and deductibles, changes in provider practices and changes in
consumer demographics and consumption behavior.
Because historical trend factors are often not representative of current claim trends, the trend
experienced for the most recent history along with an analysis of emerging trends, have been taken
into consideration in establishing the liability for Health Care medical claims payable at December
31, 2008 and 2007. It is possible that the actual medical trend for the current period will
develop differently from that expected, which could have a material impact on the Companys medical
claims payable and net income.
For each reporting period, the Company evaluates key assumptions by comparing the assumptions used
in establishing the medical claims payable to actual experience. When actual experience differs
from the assumptions used in establishing the liability, medical claims payable are increased or
decreased through current period net income. Additionally, the Company evaluates expected future
developments and emerging trends which may impact key assumptions. The estimation process involves
considerable judgment, reflecting the variability inherent in forecasting future claim payments.
The adequacy of these estimates is highly sensitive to changes in the Companys key assumptions,
specifically completion factors, which are impacted by actual or expected changes in the submission
and payment of medical claims, and medical cost trends, which are impacted by actual or expected
changes in the utilization of medical services and unit costs.
94
P.
Unearned Premiums and Fees
Premiums for life, accident and health insurance are recognized as revenue on a pro rata basis over
the contract period. Fees for mortality and contract administration of universal life products are
recognized ratably over the coverage period. The unrecognized portion of these amounts is recorded
as unearned premiums and fees.
Q.
Accounts Payable, Accrued Expenses and Other Liabilities
Accounts payable, accrued expenses and other liabilities consist principally of pension, other
postretirement and postemployment benefits and various insurance-related liabilities, including
amounts related to reinsurance contracts and insurance-related assessments that management can
reasonably estimate. Accounts payable, accrued expenses and other liabilities also include certain
overdraft positions and the loss position of certain derivatives, primarily for GMIB contracts (see
Note 12(F)). Legal costs to defend the
Companys litigation and arbitration matters are expensed when incurred in larger cases for which
the Company cannot reasonably estimate the ultimate cost to defend. In smaller cases for which the
Company can reasonably estimate the cost to defend, these costs are recognized when the claim is
reported.
R.
Translation of Foreign Currencies
The Company generally conducts its international business through foreign operating entities that
maintain assets and liabilities in local currencies, which are generally their functional
currencies. The Company uses exchange rates as of the balance sheet date to translate assets and
liabilities into U.S. dollars. Translation gains or losses on functional currencies, net of
applicable taxes, are recorded in accumulated other comprehensive income (loss). The Company uses
average monthly exchange rates during the year to translate revenues and expenses into U.S.
dollars.
S.
Premiums and Fees, Revenues and Related Expenses
Premiums for life, accident and health insurance and managed care coverages are recognized as
revenue on a pro rata basis over the contract period. Benefits and expenses are recognized when
incurred.
Premiums for individual life insurance and individual and group annuity products, excluding
universal life and investment-related products, are recognized as revenue when due. Benefits and
expenses are matched with premiums.
Revenue for investment-related products is recognized as follows:
|
|
Net investment income on assets supporting investment-related products is recognized as
earned.
|
|
|
|
Contract fees, which are based upon related administrative expenses, are recognized in
premiums and fees as they are earned ratably over the contract period.
|
Benefits and expenses for investment-related products consist primarily of income credited to
policyholders in accordance with contract provisions.
Revenue for universal life products is recognized as follows:
|
|
Net investment income on assets supporting universal life products is recognized as earned.
|
|
|
|
Fees for mortality are recognized as assessed, which is as earned.
|
|
|
|
Administration fees are recognized as services are provided.
|
|
|
|
Surrender charges are recognized as assessed, which is as earned.
|
Benefits and expenses for universal life products consist of benefit claims in excess of
policyholder account balances. Expenses are recognized when claims are submitted, and income is
credited in accordance with contract provisions.
Contract fees and expenses for administrative services only programs and pharmacy programs and
services are recognized as services are provided. Mail order pharmacy revenues and cost of goods
sold are recognized as each prescription is shipped.
95
T.
Stock Compensation
The Company records compensation expense for stock awards and options over their vesting periods
based on the estimated fair value of the stock options, which is calculated using an option-pricing
model. Compensation expense is recorded for restricted stock grants and deferred stock units over
their vesting periods based on fair value, which is equal to the market price of the Companys
common stock on the date of grant.
U.
Participating Business
The Companys participating life insurance policies entitle policyholders to earn dividends that
represent a portion of the earnings of the Companys life insurance subsidiaries. Participating
insurance accounted for approximately 2% of the Companys total life insurance in force at the end
of 2008, 2007 and 2006.
V.
Income Taxes
The Company and its domestic subsidiaries file a consolidated United States federal income tax
return. The Companys foreign subsidiaries file tax returns in accordance with foreign law. U.S.
taxation of these foreign subsidiaries may differ in timing and amount from taxation under foreign
laws. Reportable amounts, including credits for foreign tax paid by these subsidiaries, are
reflected in the U.S. tax return of the affiliates domestic parent.
The Company recognizes deferred income taxes when the financial statement and tax based carrying
values of assets and liabilities are different and recognizes deferred income tax liabilities on
the unremitted earnings of foreign subsidiaries. The Company establishes valuation allowances
against deferred tax assets if it is more likely than not that the deferred tax asset will not be
realized. The need for a valuation allowance is determined based on the evaluation of various
factors, including expectations of future earnings and managements judgment. Note 18 contains
detailed information about the Companys income taxes.
The Company recognizes interim period income taxes by estimating an annual effective tax rate and
applying it to year-to-date results. The estimated annual effective tax rate is periodically
updated throughout the year based on actual results to date and an updated projection of full year
income. Although the effective tax rate approach is generally used for interim periods, taxes on
significant, unusual and infrequent items are recognized at the statutory tax rate entirely in the
period the amounts are realized.
Note 3 Acquisitions and Dispositions
The Company may from time to time acquire or dispose of assets, subsidiaries or lines of business.
Significant transactions are described below.
A.
Great-West Healthcare Acquisition
On April 1, 2008, the Company acquired the Healthcare division of Great-West Life and Annuity, Inc.
(Great-West Healthcare or the acquired business) through 100% indemnity reinsurance agreements
and the acquisition of certain affiliates and other assets and liabilities of Great-West
Healthcare. The purchase price of approximately $1.5 billion consisted of a payment to the seller
of approximately $1.4 billion for the net assets acquired and the assumption of net liabilities
under the reinsurance agreement of approximately $0.1 billion. Great-West Healthcare primarily
sells medical plans on a self-funded basis with stop loss coverage to select and regional employer
groups. Great-West Healthcares offerings also include the following specialty products: stop
loss, life, disability, medical, dental, vision, prescription drug coverage, and accidental death
and dismemberment insurance. The acquisition, which was accounted for as a purchase, was financed
through a combination of cash and the issuance of both short and long-term debt.
In accordance with SFAS No. 141, Business Combinations, the Company has substantially completed
its allocation of the total purchase price to the tangible and intangible net assets acquired based
on managements estimates of their fair values and expects only minor adjustments in the first
quarter of 2009, the remaining allocation period. Accordingly, approximately $290 million was
allocated to intangible assets, primarily customer relationships and internal-use software. The
weighted average amortization period is 9 years for customer relationships and 6 years for
internal-use software. The remainder, net of tangible net assets acquired, is goodwill which
approximated $1.1 billion and was allocated entirely to the Health Care segment. Substantially all
of the goodwill is tax deductible and will be amortized over the next 15 years for federal income
tax purposes.
96
As part of the reinsurance and administrative service arrangements, the Company is responsible to
pay claims for the group medical and long-term disability business of Great-West Healthcare and
collect related amounts due from their third party reinsurers. Any such amounts not collected will
represent additional assumed liabilities of the Company and decrease net income if and when these
amounts are determined uncollectible. At December 31, 2008, receivables recorded for paid claims
due from third party reinsurers for this business approximated $1 million and unpaid claims related
to this business were estimated at $27 million.
The condensed balance sheet of Great-West Healthcare at the acquisition date was as follows:
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Investments
|
|
$
|
147
|
|
Cash and cash equivalents
|
|
|
55
|
|
Premiums, accounts and notes receivable
|
|
|
226
|
|
Reinsurance recoverables
|
|
|
12
|
|
Property and equipment (primarily capitalized software)
|
|
|
142
|
|
Deferred income taxes
|
|
|
7
|
|
Goodwill
|
|
|
1,095
|
|
Other assets, including other intangibles
|
|
|
151
|
|
|
|
|
|
Total assets acquired
|
|
|
1,835
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
|
78
|
|
Unpaid claims and claim expenses
|
|
|
15
|
|
Health Care medical claims payable
|
|
|
90
|
|
Accounts payable, accrued expenses and other liabilities
(1)
|
|
|
278
|
|
|
|
|
|
Total liabilities acquired
|
|
|
461
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
$
|
1,374
|
|
|
|
|
|
|
|
|
|
|
|
(1) Includes $18 million of liabilities related to integration
activities, including severance of $14 million and consolidation of
facilities of $4 million.
|
|
|
|
|
The results of Great-West Healthcare are included in the Companys Consolidated Financial
Statements from the date of acquisition.
The following table presents selected unaudited pro forma information for the Company assuming the
acquisition had occurred as of January 1, 2007. The pro forma information does not purport to
represent what the Companys actual results would have been if the acquisition had occurred as of
the date indicated or what such results would be for any future periods.
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
Year Ended December 31,
|
(In millions, except per share amounts)
|
|
2008
|
|
2007
|
|
Total revenues
|
|
$
|
19,469
|
|
|
$
|
19,173
|
|
Income from continuing operations
|
|
$
|
309
|
|
|
$
|
1,224
|
|
Net income
|
|
$
|
313
|
|
|
$
|
1,219
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.12
|
|
|
$
|
4.32
|
|
Diluted
|
|
$
|
1.12
|
|
|
$
|
4.25
|
|
Net income
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.14
|
|
|
$
|
4.30
|
|
Diluted
|
|
$
|
1.13
|
|
|
$
|
4.23
|
|
|
B.
Sale of the Chilean Insurance Operations
On August 10, 2007, the Company completed the sale of its Chilean insurance operations, which was
classified as a discontinued operation in the second quarter of 2007. The Company recognized an
impairment loss in the second quarter of 2007 for this business of $19 million after-tax primarily
relating to the write-off of unrecoverable tax assets and foreign currency translation losses. As
of
97
December 31, 2006, the assets and liabilities of the Chilean insurance operations, which were
held for sale, were reported in other
assets and accounts payable, accrued expenses and other liabilities.
C.
Sale of Retirement Benefits Business
In 2004, the Company sold its retirement benefits business, excluding the corporate life insurance
business, for cash proceeds of $2.1 billion. The sale resulted in an initial after-tax gain of $809
million, of which $267 million after-tax was recognized immediately and the remaining amount was
deferred. The Company recognized deferred gains of $3 million after-tax in 2008, $5 million
after-tax in 2007 and $14 million after-tax in 2006. As of December 31, 2008, the remaining
deferred gain of $33 million after-tax will be recognized in the Companys results of operations
through 2032.
D.
Sale of Individual Life Insurance and Annuity Business
In 1998, the Company sold its individual life insurance and annuity business for cash proceeds of
$1.4 billion. The sale generated an after-tax gain of approximately $800 million, the majority of
which was deferred and is recognized at the rate that earnings from the sold business would have
been expected to emerge (primarily over 15 years on a declining basis). The Company recognized
deferred gains of $22 million after-tax in 2008, $25 million after-tax in 2007 and $28 million
after-tax in 2006. The remaining deferred gain as of December 31, 2008, was $108 million
after-tax.
Note 4 Earnings Per Share
Basic and diluted earnings per share were computed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions,
|
|
|
|
|
|
Effect of
|
|
|
|
|
except per share amounts)
|
|
Basic
|
|
|
Dilution
|
|
|
Diluted
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
288
|
|
|
$
|
-
|
|
|
$
|
288
|
|
|
Shares
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
|
|
|
274,848
|
|
|
|
-
|
|
|
|
274,848
|
|
Options and restricted stock grants
|
|
|
-
|
|
|
|
1,954
|
|
|
|
1,954
|
|
|
Total shares
|
|
|
274,848
|
|
|
|
1,954
|
|
|
|
276,802
|
|
|
EPS
|
|
$
|
1.05
|
|
|
$
|
(0.01
|
)
|
|
$
|
1.04
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1,120
|
|
|
$
|
-
|
|
|
$
|
1,120
|
|
|
Shares
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
|
|
|
283,191
|
|
|
|
-
|
|
|
|
283,191
|
|
Options and restricted stock grants
|
|
|
|
|
|
|
5,141
|
|
|
|
5,141
|
|
|
Total shares
|
|
|
283,191
|
|
|
|
5,141
|
|
|
|
288,332
|
|
|
EPS
|
|
$
|
3.95
|
|
|
$
|
(0.07
|
)
|
|
$
|
3.88
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1,159
|
|
|
$
|
-
|
|
|
$
|
1,159
|
|
|
Shares
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
|
|
|
331,257
|
|
|
|
-
|
|
|
|
331,257
|
|
Options and restricted stock grants
|
|
|
|
|
|
|
5,728
|
|
|
|
5,728
|
|
|
Total shares
|
|
|
331,257
|
|
|
|
5,728
|
|
|
|
336,985
|
|
|
EPS
|
|
$
|
3.50
|
|
|
$
|
(0.06
|
)
|
|
$
|
3.44
|
|
|
The following outstanding employee stock options were not included in the computation of diluted
earnings per share because their effect would have increased diluted earnings per share
(antidilutive) as their exercise price was greater than the average share price of the Companys
common stock for the period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
2007
|
|
2006
|
|
Antidilutive options
|
|
|
6.3
|
|
|
|
1.2
|
|
|
|
3.9
|
|
|
98
Note 5 Health Care Medical Claims Payable
Medical claims payable for the Health Care segment reflects estimates of the ultimate cost of
claims that have been incurred but not yet reported, those which have been reported but not yet
paid (reported claims in process) and other medical expense payable, which primarily comprises
accruals for provider incentives and other amounts payable to providers. Incurred but not yet
reported comprises the majority of the reserve balance as follows:
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Incurred but not yet reported
|
|
$
|
782
|
|
|
$
|
786
|
|
Reported claims in process
|
|
|
114
|
|
|
|
145
|
|
Other medical expense payable
|
|
|
28
|
|
|
|
44
|
|
|
Medical claims payable
|
|
$
|
924
|
|
|
$
|
975
|
|
|
Activity in medical claims payable was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Balance at January 1,
|
|
$
|
975
|
|
|
$
|
960
|
|
|
$
|
1,165
|
|
Less: Reinsurance and other amounts recoverable
|
|
|
258
|
|
|
|
250
|
|
|
|
342
|
|
|
|
|
Balance at January 1, net
|
|
|
717
|
|
|
|
710
|
|
|
|
823
|
|
Acquired April 1, net
|
|
|
90
|
|
|
|
-
|
|
|
|
-
|
|
Incurred claims related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
7,312
|
|
|
|
6,878
|
|
|
|
6,284
|
|
Prior years
|
|
|
(60
|
)
|
|
|
(80
|
)
|
|
|
(173
|
)
|
|
|
|
Total incurred
|
|
|
7,252
|
|
|
|
6,798
|
|
|
|
6,111
|
|
Paid claims related to:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
|
6,716
|
|
|
|
6,197
|
|
|
|
5,615
|
|
Prior years
|
|
|
630
|
|
|
|
594
|
|
|
|
609
|
|
|
|
|
Total paid
|
|
|
7,346
|
|
|
|
6,791
|
|
|
|
6,224
|
|
Balance at December 31, net
|
|
|
713
|
|
|
|
717
|
|
|
|
710
|
|
Add: Reinsurance and other amounts recoverable
|
|
|
211
|
|
|
|
258
|
|
|
|
250
|
|
|
Balance at December 31,
|
|
$
|
924
|
|
|
$
|
975
|
|
|
$
|
960
|
|
|
Reinsurance and other amounts recoverable reflect amounts due from reinsurers and policyholders to
cover incurred but not reported and pending claims for minimum premium products and certain
administrative services only business where the right of offset does not exist. See Note 8 for
additional information on reinsurance. For the year ended December 31, 2008, actual experience
differed from the Companys key assumptions resulting in favorable incurred claims related to prior
years medical claims payable of $60 million, or 0.9% of the current year incurred claims as
reported for the year ended December 31, 2007. Actual completion factors resulted in a reduction in
medical claims payable of $29 million, or 0.4% of the current year incurred claims as reported for
the year ended December 31, 2007 for the insured book of business. Actual medical cost trend
resulted in a reduction in medical claims payable of $31 million, or 0.5% of the current year
incurred claims as reported for the year ended December 31, 2007 for the insured book of business.
For the year ended December 31, 2007, actual experience differed from the Companys key
assumptions, resulting in favorable incurred claims related to prior years medical claims payable
of $80 million, or 1.3% of the current year incurred claims as reported for the year ended December
31, 2006. Actual completion factors resulted in a reduction of the medical claims payable of $46
million, or 0.7% of the current year incurred claims as reported for the year ended December 31,
2006 for the insured book of business. Actual medical cost trend resulted in a reduction of the
medical claims payable of $34 million, or 0.6% of the current year incurred claims as reported for
the year ended December 31, 2006 for the insured book of business.
The favorable impact in 2008 and 2007 relating to completion factor and medical cost trend
variances is primarily due to the release of the provision for moderately adverse conditions, which
is a component of the assumptions for both completion factors and medical cost trend, established
for claims incurred related to prior years. This release was substantially offset by the
establishment of the provision for moderately adverse conditions established for claims incurred
related to the current year.
99
The corresponding impact of prior year development on net income was $7 million in 2008 and $8
million in 2007. The change in the
amount of the incurred claims related to prior years in the medical claims payable liability does
not directly correspond to an increase or decrease in the Companys net income recognized for the
following reasons:
First, due to the nature of the Companys retrospectively experience-rated business, only
adjustments to medical claims payable on accounts in deficit affect net income. An increase or
decrease to medical claims payable on accounts in deficit, in effect, accrues to the Company and
directly impacts net income. An account is in deficit when the accumulated medical costs and
administrative charges, including profit charges, exceed the accumulated premium received.
Adjustments to medical claims payable on accounts in surplus accrue directly to the policyholder
with no impact on the Companys net income. An account is in surplus when the accumulated premium
received exceeds the accumulated medical costs and administrative charges, including profit
charges.
Second, the Company consistently recognizes the actuarial best estimate of the ultimate liability
within a level of confidence, as required by actuarial standards of practice, which require that
the liabilities be adequate under moderately adverse conditions. As the Company establishes the
liability for each incurral year, the Company ensures that its assumptions appropriately consider
moderately adverse conditions. When a portion of the development related to the prior year incurred
claims is offset by an increase deemed appropriate to address moderately adverse conditions for the
current year incurred claims, the Company does not consider that offset amount as having any impact
on net income.
Note 6
Initiatives to Lower Operating Expenses
The Company has undertaken several initiatives to realign its organization and consolidate support
functions in an effort to increase efficiency and responsiveness to customers.
In 2008, the Company conducted a comprehensive review of its ongoing businesses with an emphasis on
reducing operating expenses in the Health Care segment. As a result of the review, during the
fourth quarter of 2008, the Company committed to a plan to reduce operating costs in order to meet
the challenges and opportunities presented by the current market environment. The Company
anticipates the plan will be substantially complete by the end of 2009. As a result, the Company
recognized in other operating expenses a total charge of $55 million pre-tax ($35 million
after-tax), which included $44 million pre-tax ($28 million after-tax) for severance and other
related costs resulting from reductions of approximately 1,100 positions in its workforce and $11
million pre-tax ($7 million after-tax) resulting from consolidation of facilities. The Company
expects to pay $53 million in cash related to this charge, most of which will occur in 2009. The
Health Care segment reported $44 million pre-tax ($27 million after-tax) of the total charge. The
remainder was reported as follows: Disability and Life: $3 million pre-tax ($2 million after-tax),
and International: $8 million pre-tax ($6 million after-tax).
In the fourth quarter of 2006, the Company completed a review of staffing levels in the health care
operations and in supporting areas. As a result, the Company recognized in other operating
expenses a charge for severance costs of $37 million pre-tax ($23 million after-tax). The Company
substantially completed this program in 2007.
Note 7 Guaranteed Minimum Death Benefit Contracts
The Companys reinsurance operations, which were discontinued in 2000 and are now an inactive
business in run-off mode, reinsured a guaranteed minimum death benefit (GMDB), also known as
variable annuity death benefits (VADBe), under certain variable annuities issued by other insurance
companies. These variable annuities are essentially investments in mutual funds combined with a
death benefit. The Company has equity and other market exposures as a result of this product. In
periods of declining equity markets and in periods of flat equity markets following a decline, the
Companys liabilities for these guaranteed minimum death benefits increase. Conversely, in periods
of rising equity markets, the Companys liabilities for these guaranteed minimum death benefits
decrease.
In order to substantially reduce the equity market exposures relating to guaranteed minimum death
benefit contracts, the Company operates a dynamic hedge program (GMDB equity hedge program), using
exchange-traded futures contracts. The hedge program is designed to offset both positive and
negative impacts of changes in equity markets on the GMDB liability. The hedge program involves
detailed, daily monitoring of equity market movements and rebalancing the futures contracts within
established parameters. While the hedge program is actively managed, it may not exactly offset
changes in the GMDB liability due to, among other things, divergence between the performance of the
underlying mutual funds and the hedge instruments, high levels of volatility in the equity markets,
and differences between actual contractholder behavior and what is assumed. The performance of the
underlying mutual funds compared to the hedge instruments is further impacted by a time lag, since
the data is not reported and incorporated into the
100
required hedge position on a real time basis.
Although this hedge program does not qualify for GAAP hedge accounting, it is an economic hedge
because it is designed to and is effective in reducing equity market exposures resulting from this
product. The results of the futures contracts are included in other revenue and amounts reflecting corresponding changes
in liabilities for these GMDB contracts are included in benefits and expenses, consistent with GAAP
when a premium deficiency exists.
The Company had future policy benefit reserves for GMDB contracts of $1.6 billion as of December
31, 2008, and $848 million as of December 31, 2007. The increase in reserves is primarily due to
declines in the equity market driving down the value of the underlying mutual fund investments.
During 2008, the Company recorded additional benefits and expenses of $412 million pre-tax ($267
million after-tax) primarily to strengthen GMDB reserves following an analysis of experience and
reserve assumptions. The amounts were primarily due to:
|
|
adverse impacts of overall market declines of $210 million pre-tax ($136 million
after-tax). This is comprised of (a) $185 million ($120 million after-tax) related to the
provision for partial surrenders, including $40 million ($26 million after-tax) for an
increase in the assumed election rates for future partial surrenders and (b) $25 million ($16
million after-tax) related to declines in the values of contractholders non-equity
investments such as bond funds, neither of which is included in the GMDB equity hedge program;
|
|
|
|
adverse volatility-related impacts due to turbulent equity market conditions. Volatility
risk is not covered by the GMDB equity hedge program. Also, the equity market volatility,
particularly during the second half of the year impacted the effectiveness of the hedge
program. In aggregate, these volatility-related impacts totaled $182 million of the pre-tax
charge ($118 million after-tax). The GMDB equity hedge program is designed so that changes in
the value of a portfolio of actively managed futures contracts will offset changes in the
liability resulting from equity market movements. In periods of equity market declines, the
liability will increase; the hedge program is designed to produce gains on the futures
contracts to offset the increase in the liability. However, the hedge program will not
perfectly offset the change in the liability, in part because the market does not offer
futures contracts that exactly match the diverse mix of equity fund investments held by
contractholders, and because there is a time lag between changes in underlying contractholder
mutual funds, and corresponding changes in the hedge position. In 2008, the impact of this
mismatch was higher than most prior periods due to the relatively large changes in market
indices from day to day. In addition, the number of futures contracts used in the hedge
program is adjusted only when certain tolerances are exceeded and in periods of highly
volatile equity markets when actual volatility exceeds the expected volatility assumed in the
liability calculation, losses will result. These conditions have had an adverse impact on
earnings, and during 2008, the increase in the liability due to equity market movements was
only partially offset by the results of the futures contracts; and
|
|
|
|
adverse interest rate impacts. Interest rate risk is not covered by the GMDB equity hedge
program, and the interest rate returns on the futures contracts were less than the Companys
long-term assumption for mean investment performance generating $14 million of the pre-tax
charge ($9 million after-tax).
|
Management estimates reserves for GMDB exposures based on assumptions regarding lapse, partial
surrender, mortality, interest rates (mean investment performance and discount rate) and
volatility. These assumptions are based on the Companys experience and future expectations over
the long-term period. The Company monitors actual experience to update these reserve estimates as
necessary.
Lapse refers to the full surrender of an annuity prior to a contractholders death. Partial
surrender refers to the fact that most contractholders have the ability to withdraw substantially
all of their mutual fund investments while retaining the death benefit coverage in effect at the
time of the withdrawal. Mean investment performance refers to market rates to be earned over the
life of the GMDB equity hedge program and market volatility refers to market fluctuations.
The determination of liabilities for GMDB requires the Company to make critical accounting
estimates. The Company regularly evaluates the assumptions used in establishing reserves and
changes its estimates if actual experience or other evidence suggests that earlier assumptions
should be revised. If actual experience differs from the assumptions (including lapse, partial
surrender, mortality, interest rates and volatility) used in estimating these reserves, the
resulting change could have a material adverse effect on the Companys consolidated results of
operations, and in certain situations, could have a material adverse effect on the Companys
financial condition.
The following provides information about the Companys reserving methodology and assumptions for
GMDB as of December 31, 2008:
|
|
The reserves represent estimates of the present value of net amounts expected to be paid,
less the present value of net future premiums. Included in net amounts expected to be paid is
the excess of the guaranteed death benefits over the values of the contractholders accounts
(based on underlying equity and bond mutual fund investments).
|
101
|
|
|
The reserves include an estimate for partial surrenders that essentially lock in the death
benefit for a particular policy based on annual election rates that vary from 0-24% depending
on the net amount at risk for each policy and whether surrender charges
apply.
|
|
|
|
The mean investment performance assumption is 5% considering the Companys GMDB equity hedge
program using futures contracts. This is reduced by fund fees ranging from 1-3% across all
funds. The results of futures contracts are reflected in the liability calculation as a
component of investment returns.
|
|
|
|
The volatility assumption is based on a review of historical monthly returns for each key
index (e.g. S&P 500) over a period of at least ten years. Volatility represents the
dispersion of historical returns compared to the average historical return (standard
deviation) for each index. The assumption is 16-30%, varying by equity fund type; 4-10%,
varying by bond fund type; and 2% for money market funds. These volatility assumptions are
used along with the mean investment performance assumption to project future return scenarios.
|
|
|
|
The discount rate is 5.75%.
|
|
|
|
The mortality assumption is 70-75% of the 1994 Group Annuity Mortality table, with 1% annual
improvement beginning January 1, 2000.
|
|
|
|
The lapse rate assumption is 0-15%, depending on contract type, policy duration and the ratio
of the net amount at risk to account value.
|
Activity in future policy benefit reserves for these GMDB contracts was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Balance at January 1
|
|
$
|
848
|
|
|
$
|
862
|
|
|
$
|
951
|
|
Add: Unpaid Claims
|
|
|
21
|
|
|
|
22
|
|
|
|
24
|
|
Less: Reinsurance and other amounts recoverable
|
|
|
19
|
|
|
|
22
|
|
|
|
27
|
|
|
|
|
|
Balance at January 1, net
|
|
|
850
|
|
|
|
862
|
|
|
|
948
|
|
Add: Incurred benefits
|
|
|
822
|
|
|
|
62
|
|
|
|
11
|
|
Less: Paid benefits
|
|
|
112
|
|
|
|
74
|
|
|
|
97
|
|
|
|
|
|
Ending balance, net
|
|
|
1,560
|
|
|
|
850
|
|
|
|
862
|
|
Less: Unpaid Claims
|
|
|
34
|
|
|
|
21
|
|
|
|
22
|
|
Add: Reinsurance and other amounts recoverable
|
|
|
83
|
|
|
|
19
|
|
|
|
22
|
|
|
Ending balance
|
|
$
|
1,609
|
|
|
$
|
848
|
|
|
$
|
862
|
|
|
Benefits paid and incurred are net of ceded amounts. Incurred benefits reflect the favorable or
unfavorable impact of a rising or falling equity market on the liability, and include the charges
discussed above. As discussed below, losses or gains have been recorded in other revenues as a
result of the GMDB equity hedge program to reduce equity market exposures.
The majority of the Companys exposure arises under annuities that guarantee that the benefit
received at death will be no less than the highest historical account value of the related mutual
fund investments on a contractholders anniversary date. Under this type of death benefit, the
Company is liable to the extent the highest historical anniversary account value exceeds the fair
value of the related mutual fund investments at the time of a contractholders death. Other
annuity designs that the Company reinsured guarantee that the benefit received at death will be:
|
|
the contractholders account value as of the last anniversary date (anniversary reset); or
|
|
|
|
no less than net deposits paid into the contract accumulated at a specified rate or net
deposits paid into the contract.
|
102
The table below presents the account value, net amount at risk and average attained age of
underlying contractholders for guarantees in the event of death, by type of benefit as of December
31. The net amount at risk is the death benefit coverage in force or the amount that the Company
would have to pay if all contractholders died as of the specified date, and represents the excess
of the guaranteed benefit amount over the fair value of the underlying mutual fund investments.
|
|
|
|
|
|
|
|
|
|
(Dollars in millions)
|
|
2008
|
|
|
2007
|
|
|
Highest anniversary annuity value
|
|
|
|
|
|
|
|
|
Account value
|
|
$
|
13,154
|
|
|
$
|
24,675
|
|
Net amount at risk
|
|
$
|
9,489
|
|
|
$
|
3,617
|
|
Average attained age of contractholders (weighted by exposure)
|
|
|
68
|
|
|
|
69
|
|
Anniversary value reset
|
|
|
|
|
|
|
|
|
Account value
|
|
$
|
1,322
|
|
|
$
|
2,279
|
|
Net amount at risk
|
|
$
|
336
|
|
|
$
|
29
|
|
Average attained age of contractholders (weighted by exposure)
|
|
|
59
|
|
|
|
62
|
|
Other
|
|
|
|
|
|
|
|
|
Account value
|
|
$
|
1,846
|
|
|
$
|
3,241
|
|
Net amount at risk
|
|
$
|
1,280
|
|
|
$
|
577
|
|
Average attained age of contractholders (weighted by exposure)
|
|
|
67
|
|
|
|
67
|
|
Total
|
|
|
|
|
|
|
|
|
Account value
|
|
$
|
16,322
|
|
|
$
|
30,195
|
|
Net amount at risk
|
|
$
|
11,105
|
|
|
$
|
4,223
|
|
Average attained age of contractholders (weighted by exposure)
|
|
|
68
|
|
|
|
68
|
|
Number of contractholders (approx.)
|
|
|
650,000
|
|
|
|
750,000
|
|
|
As discussed above, the Company operates a GMDB equity hedge program to substantially reduce the
equity market exposures of this business by selling exchange-traded futures contracts, which are
expected to rise in value as the equity market declines and decline in value as the equity market
rises. In addition, the Company uses foreign currency futures contracts to reduce the
international equity market and foreign currency risks associated with this business. The notional
amount of futures contract positions held by the Company at December 31, 2008 was $1.4 billion.
The Company recorded in other revenues pre-tax gains of $333 million in 2008, compared with pre-tax
losses of $32 million in 2007 and $96 million in 2006 from these futures contracts.
The Company has also written reinsurance contracts with issuers of variable annuity contracts that
provide annuitants with certain guarantees related to minimum income benefits. All reinsured GMIB
policies also have a GMDB benefit reinsured by the Company. See Note 11 for further information.
Note 8
Reinsurance
The Companys insurance subsidiaries enter into agreements with other insurance companies to assume
and cede reinsurance. Reinsurance is ceded primarily to limit losses from large exposures and to
permit recovery of a portion of direct losses. Reinsurance is also used in acquisition and
disposition transactions where the underwriting company is not being acquired. Reinsurance does not
relieve the originating insurer of liability. The Company regularly evaluates the financial
condition of its reinsurers and monitors its concentrations of credit risk.
Retirement benefits business
.
The Company had a reinsurance recoverable of $1.9 billion as of
December 31, 2008, and $2.1 billion as of December 31, 2007 from Prudential Retirement Insurance
and Annuity Company resulting from the sale of the retirement benefits business, which was
primarily in the form of a reinsurance arrangement. The reinsurance recoverable, which is reduced
as the Companys reinsured liabilities are paid or directly assumed by the reinsurer, is secured
primarily by fixed maturities and mortgage loans equal to or greater than 100% of the reinsured
liabilities held in a trust established for the benefit of the Company. As of December 31, 2008,
the trust was adequately funded and S&P had assigned this reinsurer a rating of AA.
Individual life and annuity reinsurance.
The Company had reinsurance recoverables totaling $4.6
billion as of December 31, 2008 and $4.7 billion as of December 31, 2007 from The Lincoln National
Life Insurance Company and Lincoln Life & Annuity of New York resulting from the 1998 sale of the
Companys individual life insurance and annuity business through indemnity reinsurance
arrangements. Effective December 31, 2007, a substantial portion of the reinsurance recoverables
are secured by investments held in a trust established for the benefit of the Company. At December
31, 2008, the trust assets secured approximately 90% of the reinsurance recoverables and S&P had
assigned both of these reinsurers a rating of AA.
103
Other Ceded and Assumed Reinsurance
Ceded Reinsurance: Ongoing operations.
The Companys insurance subsidiaries have reinsurance
recoverables of $298 million as of December 31, 2008 from various reinsurance arrangements in the
ordinary course of business for its Health Care, Disability and Life, and International segments as
well as the non-leveraged and leveraged corporate-owned life insurance business. These reinsurance
arrangements are diversified among more than 90 reinsurers. One recoverable represents 14% of the
total, and the reinsurer has been assigned an AA- insurer financial strength rating from S&P. No
other single reinsurer represents more than 11% of the total.
Approximately 40% of recoverables are due from reinsurers that have been assigned ratings of AA- or
better from S&P. An additional 30% of recoverables are due from reinsurers that have been assigned
an S&P rating of A- or better and the remaining 30% primarily represent recoverables associated
with unrated reinsurers. Approximately 50% of the recoverables from unrated reinsurers are
supported by collateral arrangements with none of the remaining reinsurers holding more than 2% of
the total recoverable balance.
The Company reviews its reinsurance arrangements and establishes reserves against the recoverables
in the event that we believe that recovery is not probable. As of December 31, 2008, the Companys
recoverables related to these segments were net of a reserve of $12 million.
Assumed and Ceded reinsurance: Run-off Reinsurance segment.
The Companys Run-off Reinsurance
operations assumed risks related to GMDB contracts, GMIB contracts, workers compensation, and
personal accident business. The Companys Run-off Reinsurance operations also purchased
retrocessional coverage to reduce the risk of loss on these contracts.
Liabilities related to GMDB, workers compensation and personal accident are included in future
policy benefits and unpaid claims. Because the GMIB contracts are treated as derivatives under
GAAP, the asset related to GMIB is recorded in the Other assets, including other intangibles
caption and the liability related to GMIB is recorded in the Accounts payable, accrued expenses,
and other liabilities caption on the Companys Consolidated Balance Sheets (see Notes 11 and 22 for
additional discussion of the GMIB assets and liabilities).
The reinsurance recoverables for GMDB, workers compensation and personal accident of $169 million
are diversified over more than 100 retrocessionaires. Approximately 20% of the recoverables are
due from reinsurers that have been assigned ratings of AA- or better from S&P. An additional 60%
of the recoverables from reinsurers have been assigned an S&P rating of A- or better and the
remaining 20% primarily represent recoverables associated with unrated reinsurers. Approximately
18% of the recoverables from unrated reinsurers are supported by collateral arrangements with none
of the remaining reinsurers holding more than 5% of the total recoverable balance. The Company
reviews its reinsurance arrangements and establishes reserves against the recoverables in the event
that we believe that recovery is not probable. As of December 31, 2008, the Companys recoverables
related to this segment were net of a reserve of $11 million.
The Companys payment obligations for underlying reinsurance exposures assumed by the Company under
these contracts are based on ceding companies claim payments. For GMDB, claim payments vary
because of changes in equity markets and interest rates, as well as mortality and policyholder
behavior. For workers compensation and personal accident, the payments relate to accidents and
injuries. Any of these claim payments can extend many years into the future, and the amount of the
ceding companies ultimate claims, and therefore the amount of the Companys ultimate payment
obligations and corresponding ultimate collection from retrocessionaires, may not be known with
certainty for some time.
Summary.
The Companys reserves for underlying reinsurance exposures assumed by the Company, as
well as for amounts recoverable from reinsurers/retrocessionaires for both ongoing operations and
the run-off reinsurance operation, are considered appropriate as of December 31, 2008, based on
current information. However, it is possible that future developments could have a material
adverse effect on the Companys consolidated results of operations and, in certain situations, such
as if actual experience differs from the assumptions used in estimating reserves for GMDB, could
have a material adverse effect on the Companys financial condition. The Company bears the risk of
loss if its retrocessionaires do not meet or are unable to meet their reinsurance obligations to
the Company.
104
In the Companys consolidated income statements, premiums and fees were net of ceded premiums, and
benefits and expenses were net of reinsurance recoveries, in the following amounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-duration contracts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
|
|
$
|
14,050
|
|
|
$
|
13,669
|
|
|
$
|
12,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
1,173
|
|
|
|
331
|
|
|
|
443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded
|
|
|
(243
|
)
|
|
|
(179
|
)
|
|
|
(181
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,980
|
|
|
|
13,821
|
|
|
|
12,595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-duration contracts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
|
|
|
1,440
|
|
|
|
1,401
|
|
|
|
1,262
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
51
|
|
|
|
68
|
|
|
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual life insurance and annuity business sold
|
|
|
(220
|
)
|
|
|
(230
|
)
|
|
|
(256
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
(48
|
)
|
|
|
(52
|
)
|
|
|
(34
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,223
|
|
|
|
1,187
|
|
|
|
1,046
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,203
|
|
|
$
|
15,008
|
|
|
$
|
13,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance recoveries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual life insurance and annuity business sold
|
|
$
|
368
|
|
|
$
|
323
|
|
|
$
|
343
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
282
|
|
|
|
106
|
|
|
|
181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
650
|
|
|
$
|
429
|
|
|
$
|
524
|
|
|
The increase in assumed premiums in 2008 primarily reflects the effect of the reinsurance assumed
in connection with the acquisition of Great-West Healthcare in 2008. The effects of reinsurance on
written premiums and fees for short-duration contracts were not materially different from the
recognized premium and fee amounts shown in the above table.
Note 9 Goodwill and Other Intangibles
Substantially all goodwill relates to the Health Care segment. As a result of the acquisition of
Great-West Healthcare in 2008, and other minor acquisition in 2007, changes in the carrying value
of goodwill were as follows:
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1,
|
|
$
|
1,783
|
|
|
$
|
1,736
|
|
|
|
|
|
|
|
|
|
|
Goodwill acquired:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Great-West Healthcare
|
|
|
1,095
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
-
|
|
|
|
47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31,
|
|
$
|
2,878
|
|
|
$
|
1,783
|
|
|
105
Other intangible assets were comprised of the following at December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
|
Accumulated
|
|
|
Net Carrying
|
|
|
Amortization
|
|
(Dollars in millions)
|
|
Cost
|
|
|
Amortization
|
|
|
value
|
|
|
Period (Years)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer relationships
(1)
|
|
$
|
381
|
|
|
$
|
230
|
|
|
$
|
151
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
(1)
|
|
|
43
|
|
|
|
6
|
|
|
|
37
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total reported in other assets, including other intangibles
|
|
|
424
|
|
|
$
|
236
|
|
|
$
|
188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Internal-use software reported in property and equipment
(1)
|
|
|
957
|
|
|
|
504
|
|
|
|
453
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other intangible assets
|
|
$
|
1,381
|
|
|
$
|
740
|
|
|
$
|
641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer relationships
|
|
$
|
251
|
|
|
$
|
208
|
|
|
$
|
43
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
24
|
|
|
|
3
|
|
|
|
21
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total reported in other assets, including other intangibles
|
|
|
275
|
|
|
|
211
|
|
|
|
64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Internal-use software reported in property and equipment
|
|
|
665
|
|
|
|
361
|
|
|
|
304
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other intangible assets
|
|
$
|
940
|
|
|
$
|
572
|
|
|
$
|
368
|
|
|
|
|
|
|
|
|
|
|
(1) As a
result of the acquisition of Great-West Healthcare in 2008, customer relationships increased by $127 million, internal-use software
increased by $142 million and other intangibles, including provider networks and producer relationships, increased by $21 million.
Amortization expense for internal-use software was $143 million in 2008, $111 million in 2007 and
$97 million in 2006. Amortization expense for other intangibles, excluding internal-use software,
was $25 million in 2008, $9 million in 2007 and $21 million in 2006.
The Company estimates annual pre-tax amortization for these intangible assets over the next five
calendar years to be as follows: $142 million in 2009, $86 million in 2010, $75 million in 2011,
$66 million in 2012, and $42 million in 2013.
Note 10 Pension and Other Postretirement Benefit Plans
A.
Pension and Other Postretirement Benefit Plans
The Company and certain of its subsidiaries provide pension, health care and life insurance defined
benefits to eligible retired employees, spouses and other eligible dependents through various
plans. Effective December 31, 2008, the Company split its domestic qualified pension plan, with no
change in benefits for any plan participant. Former employees of the Company who are only entitled
to an annuity benefit but not yet receiving benefits were placed into a new plan. All other plan
participants remain in the original plan. Both plans are reflected in the information below.
106
The Company measures the assets and obligations of its domestic pension and other postretirement
benefit plans as of December 31. The following table summarizes the projected obligations and
assets related to the Companys domestic and international pension and other postretirement benefit
plans as of, and for the years ended, December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
Pension
|
|
|
Postretirement
|
|
|
|
Benefits
|
|
|
Benefits
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in benefit obligation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation, January 1
|
|
$
|
4,045
|
|
|
$
|
4,186
|
|
|
$
|
426
|
|
|
$
|
465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
|
74
|
|
|
|
73
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest cost
|
|
|
242
|
|
|
|
231
|
|
|
|
24
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) loss from past experience
|
|
|
13
|
|
|
|
(99
|
)
|
|
|
(20
|
)
|
|
|
(31
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits paid from plan assets
|
|
|
(246
|
)
|
|
|
(251
|
)
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits
paid - other
|
|
|
(24
|
)
|
|
|
(36
|
)
|
|
|
(36
|
)
|
|
|
(31
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Translation of foreign currencies
|
|
|
(3
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendments
|
|
|
-
|
|
|
|
(59
|
)
|
|
|
(16
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation, December 31
|
|
|
4,101
|
|
|
|
4,045
|
|
|
|
376
|
|
|
|
426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets, January 1
|
|
|
3,417
|
|
|
|
3,343
|
|
|
|
28
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual return on plan assets
|
|
|
(921
|
)
|
|
|
321
|
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits paid
|
|
|
(246
|
)
|
|
|
(251
|
)
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Translation of foreign currencies
|
|
|
(4
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contributions
|
|
|
2
|
|
|
|
4
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets, December 31
|
|
|
2,248
|
|
|
|
3,417
|
|
|
|
24
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded Status
|
|
$
|
(1,853
|
)
|
|
$
|
(628
|
)
|
|
$
|
(352
|
)
|
|
$
|
(398
|
)
|
|
The postretirement benefits liability adjustment included in accumulated other comprehensive loss
consisted of the following as of December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
Other
|
|
|
|
Benefits
|
|
|
Postretirement Benefits
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized net gain (loss)
|
|
$
|
(1,548
|
)
|
|
$
|
(437
|
)
|
|
$
|
84
|
|
|
$
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized prior service cost
|
|
|
50
|
|
|
|
61
|
|
|
|
88
|
|
|
|
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Postretirement benefits liability adjustment
|
|
$
|
(1,498
|
)
|
|
$
|
(376
|
)
|
|
$
|
172
|
|
|
$
|
163
|
|
|
During 2008, the Companys postretirement benefits liability adjustment increased by $1.1 billion
pre-tax ($723 million after-tax) resulting in a decrease to shareholders equity. The increase in
the liability was primarily due to the difference between expected and actual returns on pension
plan assets. Those investments experienced significant losses in 2008 due to the decline in the
equity markets, compared with the expected long-term returns of 8% assumed in the expense
calculation. Partially offsetting these losses was the amortization of actuarial losses.
Pension benefits.
The Companys pension plans were underfunded by $1.9 billion in 2008 and $628
million in 2007 and had related accumulated benefit obligations of $4.1 billion as of December 31,
2008 and $4.0 billion as of December 31, 2007.
The Company funds its qualified pension plans at least at the minimum amount required by the
Employee Retirement Income Security Act of 1974 (ERISA) and the Pension Protection Act of 2006.
The Company did not make domestic pension plan contributions in 2008 or 2007 to its primary
qualified domestic pension plan. The Company expects contributions to the qualified pension plan to
be approximately $410 million during 2009. This amount could change based on final valuation
amounts and the level at which the Company decides to fund the plan. These estimates do not
include funding requirements related to the litigation matter discussed in Note 22 to the
Consolidated Financial Statements, as management does not expect this to be resolved in 2009.
Future years contributions will ultimately be based on a wide range of
107
factors including but not
limited to asset returns, discount rates, and funding targets.
Components of net pension cost, for the years ended December 31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
74
|
|
|
$
|
73
|
|
|
$
|
71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest cost
|
|
|
242
|
|
|
|
231
|
|
|
|
223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected long-term return on plan assets
|
|
|
(234
|
)
|
|
|
(209
|
)
|
|
|
(208
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from past experience
|
|
|
57
|
|
|
|
119
|
|
|
|
152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior service cost
|
|
|
(11
|
)
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net pension cost
|
|
$
|
128
|
|
|
$
|
213
|
|
|
$
|
237
|
|
|
The Company expects to recognize in 2009 $54 million of pre-tax loss from amortization of past
experience and $11 million of pre-tax gain from amortization of prior service cost.
Other postretirement benefits.
Unfunded retiree health benefit plans had accumulated benefit
obligations of $235 million at December 31, 2008, and $283 million at December 31, 2007. Retiree
life insurance plans had accumulated benefit obligations of $141 million as of December 31, 2008
and $143 million as of December 31, 2007.
Components of net other postretirement benefit cost for the years ended December 31 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
1
|
|
|
$
|
2
|
|
|
$
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest cost
|
|
|
24
|
|
|
|
24
|
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected long-term return on plan assets
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net gain from past experience
|
|
|
(8
|
)
|
|
|
(6
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior service cost
|
|
|
(17
|
)
|
|
|
(17
|
)
|
|
|
(17
|
)
|
|
Net other postretirement benefit cost
|
|
$
|
(1
|
)
|
|
$
|
2
|
|
|
$
|
7
|
|
|
The Company expects to recognize in 2009 $19 million of pre-tax gain related to amortization of
prior service cost and $8 million of pre-tax gain from amortization of past experience.
The estimated rate of future increases in the per capita cost of health care benefits beginning in
2009 through 2012 is 7%, decreasing to 6% in 2013 and 5% thereafter. This estimate reflects the
Companys current claim experience and managements estimate that rates of growth will decline in
the future. A 1% increase or decrease in the estimated rate would change 2008 reported amounts as
follows:
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
Increase
|
|
|
Decrease
|
|
|
|
|
|
|
|
|
|
|
|
Effect on total service and interest cost
|
|
$
|
1
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
Effect on postretirement benefit obligation
|
|
$
|
11
|
|
|
$
|
10
|
|
|
Plan assets.
The following summarizes the fair value of assets related to pension plans as of
December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of
|
|
|
Target
|
|
|
|
Total Fair
|
|
|
Allocation
|
|
Plan Asset Category
|
|
Value
|
|
|
Percentage
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
57
|
%
|
|
|
64
|
%
|
|
|
57
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed income
|
|
|
20
|
%
|
|
|
20
|
%
|
|
|
20
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate
|
|
|
9
|
%
|
|
|
8
|
%
|
|
|
8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
14
|
%
|
|
|
8
|
%
|
|
|
15
|
%
|
|
108
The target investment allocation percentages are developed by management as guidelines, although
the fair values of each asset category are expected to vary as a result of changes in market
conditions. The pension plan asset portfolio has been most heavily weighted towards equity
securities, consisting of domestic and international investments, in an effort to synchronize the
expected higher rate of return on equities over the long-term with the overall long-term nature of
the pension benefit obligations. The diversification of the pension plan assets into other
investments is intended to mitigate the volatility in returns, while also providing adequate
liquidity to fund benefit distributions.
As of December 31, 2008, pension plan assets included $1.5 billion invested in the separate
accounts of Connecticut General Life Insurance Company (CGLIC) and Life Insurance Company of North
America, which are subsidiaries of the Company. Most of these separate accounts are reinsured and
managed by the buyer of the retirement benefits business.
The assets related to other postretirement benefit plans are invested in fixed income investments
in the general account of CGLIC.
Assumptions for pension and other postretirement benefit plans.
Management determined the present
value of the projected pension benefit obligation and the accumulated other postretirement benefit
obligation and related benefit costs based on the following weighted average assumptions as of and
for the years ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension benefit obligation
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
|
|
|
|
|
|
|
Other postretirement benefit obligation
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
|
|
|
|
|
|
|
Pension benefit cost
|
|
|
6.25
|
%
|
|
|
5.75
|
%
|
|
|
|
|
|
|
|
|
|
Other postretirement benefit cost
|
|
|
6.25
|
%
|
|
|
5.75
|
%
|
|
|
|
|
|
|
|
|
|
Expected long-term return on plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension benefit cost
|
|
|
8.00
|
%
|
|
|
7.50
|
%
|
|
|
|
|
|
|
|
|
|
Other postretirement benefit cost
|
|
|
5.00
|
%
|
|
|
5.00
|
%
|
|
|
|
|
|
|
|
|
|
Expected rate of compensation increase:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected pension benefit obligation
|
|
|
3.50
|
%
|
|
|
3.50
|
%
|
|
|
|
|
|
|
|
|
|
Pension benefit cost
|
|
|
3.50
|
%
|
|
|
3.50
|
%
|
|
|
|
|
|
|
|
|
|
Other postretirement benefit obligation
|
|
|
3.00
|
%
|
|
|
3.00
|
%
|
|
|
|
|
|
|
|
|
|
Other postretirement benefit cost
|
|
|
3.00
|
%
|
|
|
3.00
|
%
|
|
Discount rates are set by applying actual annualized yields at various durations from the Citigroup
Pension Liability curve, without adjustment, to the expected cash flows of the pension liabilities.
The Company believes that the Citigroup Pension Liability curve is the most representative curve
to use because it is derived from a broad array of bonds in various industries throughout the
domestic market for high quality bonds. Further, Citigroup monitors the bond portfolio to ensure
that only high quality issues are included. Accordingly, the Company does not believe that any
adjustment is required to the Citigroup curve. Expected long-term rates of return on plan assets
were developed considering actual long-term historical returns, expected long-term market
conditions, plan asset mix and managements investment strategy. Actual and target investment
allocations are very similar at December 31, 2008.
To measure pension costs, the Company uses a market-related asset valuation for domestic pension
plan assets invested in non-fixed income investments. The market-related value of pension assets
recognizes the difference between actual and expected long-term returns in the portfolio over 5
years, a method that reduces the short-term impact of market fluctuations.
The average remaining service period of active employees associated with the Companys original
domestic pension plan is approximately 6 years. The average remaining service period of active
employees associated with the other postretirement benefit plans is approximately 9 years. These
periods are used to amortize net losses from past experience. Since the new domestic qualified
pension plan contains no active employees, net losses from past experience allocated to this new
plan will be amortized over the average expected remaining life of the plan participants, which is
approximately 29 years. Expected 2009 pre-tax amortization of net losses from past experience for
the pension plans of $54 million reflects this longer period for the new plan. Had the domestic
qualified pension plan not been split, estimated 2009 pre-tax amortization would have been $23
million higher.
109
Benefit payments.
The following benefit payments, including expected future services, are expected
to be paid in:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Postretirement
|
|
|
|
|
|
|
|
Benefits
|
|
|
|
Pension
|
|
|
|
|
|
|
Net of Medicare
|
|
(In millions)
|
|
Benefits
|
|
|
Gross
|
|
|
Part D Subsidy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
$
|
447
|
|
|
$
|
42
|
|
|
$
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
$
|
328
|
|
|
$
|
40
|
|
|
$
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2011
|
|
$
|
333
|
|
|
$
|
40
|
|
|
$
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012
|
|
$
|
339
|
|
|
$
|
39
|
|
|
$
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
$
|
338
|
|
|
$
|
38
|
|
|
$
|
36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014-2018
|
|
$
|
1,709
|
|
|
$
|
167
|
|
|
$
|
161
|
|
|
B.
4
01(k)
Plans
The Company sponsors a 401(k) plan in which the Company matches a portion of employees pre-tax
contributions. Another 401(k) plan with an employer match was frozen in 1999. Participants in the
active plan may invest in a fund that invests in the Companys common stock, several diversified
stock funds, a bond fund and a fixed-income fund.
The Company may elect to increase its matching contributions if the Companys annual performance
meets certain targets. A substantial amount of the Companys matching contributions are invested
in the Company common stock. The Companys expense for these plans was $34 million for 2008,
$35 million for 2007 and $42 million for 2006.
Note 11 Fair Value Measurements
The Company carries certain financial instruments at fair value in the financial statements
including fixed maturities, equity securities, short-term investments and derivatives. Other
financial instruments are periodically measured at fair value, such as when impaired, or, for
commercial mortgage loans, when classified as held for sale.
Fair value is defined as the price at which an asset could be exchanged in an orderly transaction
between market participants at the balance sheet date. A liabilitys fair value is defined as the
amount that would be paid to transfer the liability to a market participant, not the amount that
would be paid to settle the liability with the creditor.
Fair values are based on quoted market prices when available. When market prices are not
available, fair value is generally estimated using discounted cash flow analyses, incorporating
current market inputs for similar financial instruments with comparable terms and credit
quality. In instances where there is little or no market activity for the same or similar
instruments, the Company estimates fair value using methods, models and assumptions that the
Company believes a hypothetical market participant would use to determine a current transaction
price. These valuation techniques involve some level of estimation and judgment by the Company
which becomes significant with increasingly complex instruments or pricing models. Where
appropriate, adjustments are included to reflect the risk inherent in a particular methodology,
model or input used.
The Companys financial assets and liabilities carried at fair value have been classified based
upon a hierarchy defined by SFAS No. 157. The hierarchy gives the highest ranking to fair values
determined using unadjusted quoted prices in active markets for identical assets and liabilities
(Level 1) and the lowest ranking to fair values determined using methodologies and models with
unobservable inputs (Level 3). An assets or a liabilitys classification is based on the lowest
level input that is significant to its measurement. For example, a Level 3 fair value measurement
may include inputs that are both observable (Levels 1 and 2) and unobservable (Level 3). The
levels of the fair value hierarchy are as follows:
|
|
Level 1
Values are unadjusted quoted prices for identical assets and liabilities in
active markets accessible at the measurement date. Active markets provide pricing data for
trades occurring at least weekly and include exchanges and dealer markets.
|
|
|
|
Level 2
Inputs include quoted prices for similar assets or liabilities in active
markets, quoted prices from those willing to trade in markets that are not active, or other
inputs that are observable or can be corroborated by market data for the term of the
instrument. Such inputs include market interest rates and volatilities, spreads and yield
curves. An instrument is classified in Level 2 if the Company determines that unobservable
inputs are insignificant.
|
|
|
|
Level 3
Certain inputs are unobservable (supported by little or no market activity) and
significant to the fair value measurement. Unobservable inputs reflect the Companys best
estimate of what hypothetical market participants would use to determine a transaction price
for the asset or liability at the reporting date.
|
110
Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis
The following table provides information as of December 31, 2008 about the Companys financial
assets and liabilities measured at fair value on a recurring basis. SFAS No. 157 disclosures for
separate account assets, which are also recorded at fair value on the Companys Consolidated
Balance Sheets, are provided separately as gains and losses related to these assets generally
accrue directly to policyholders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities
(1)
|
|
$
|
38
|
|
|
$
|
10,874
|
|
|
$
|
869
|
|
|
$
|
11,781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
8
|
|
|
|
84
|
|
|
|
20
|
|
|
|
112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
46
|
|
|
|
10,958
|
|
|
|
889
|
|
|
|
11,893
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
|
-
|
|
|
|
236
|
|
|
|
-
|
|
|
|
236
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GMIB assets
(2)
|
|
|
-
|
|
|
|
-
|
|
|
|
953
|
|
|
|
953
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other derivatives
(3)
|
|
|
-
|
|
|
|
9
|
|
|
|
-
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets at fair value, excluding separate accounts
|
|
$
|
46
|
|
|
$
|
11,203
|
|
|
$
|
1,842
|
|
|
$
|
13,091
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GMIB liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,757
|
|
|
$
|
1,757
|
|
|
(1) As of December 31, 2008, fixed maturities includes $514 million of net appreciation required to adjust future policy benefits for run-off settlement annuity business
including $111 million of appreciation for securities classified in Level 3.
(2) The Guaranteed Minimum Income Benefit (GMIB) assets represent retrocessional contracts in place from two external reinsurers which cover 55% of the exposures on these
contracts. The assets are net of a liability of $17 million for the future cost of reinsurance.
(3) Derivatives other than GMIB assets and liabilities are presented net of $36 million in gross derivative liabilities.
Level
1: Financial Assets - $46 million
Assets in Level 1 include actively-traded U.S. government bonds and exchange-listed equity
securities. Given the narrow definition of Level 1 and the Companys investment asset strategy to
maximize investment returns, a relatively small portion of the Companys investment assets are
classified in this category.
Level
2: Financial Assets - $11.2 billion
Fixed maturities and equity securities.
Approximately 92% of the Companys investments in fixed
maturities and equity securities are classified in Level 2 including most public and private
corporate debt and equity securities, federal agency and municipal bonds, non-government mortgage
and asset-backed securities and preferred stocks. Because many fixed maturities and preferred
stocks do not trade daily, fair values are often derived using recent trades of securities with
similar features and characteristics. When recent trades are not available, pricing models are
used to determine these prices. These models calculate fair values by discounting future cash
flows at estimated market interest rates. Such market rates are derived by calculating the
appropriate spreads over comparable U.S. Treasury securities, based on the credit quality, industry
and structure of the asset.
Typical inputs and assumptions to pricing models include, but are not limited to, benchmark yields,
reported trades, broker-dealer quotes, issuer spreads, liquidity, benchmark securities, bids,
offers, reference data, and industry and economic events. For mortgage and asset-backed
securities, inputs and assumptions may also include characteristics of the issuer, collateral
attributes, prepayment speeds and credit rating.
Short-term investments.
Short-term investments are carried at fair value, which approximates
cost. On a regular basis the Company compares market prices for these securities to recorded
amounts to validate that current carrying amounts approximate exit prices. The short-term nature
of the investments and corroboration of the reported amounts over the holding period support their
classification in Level 2.
Other derivatives.
Amounts classified in Level 2 represent over-the-counter instruments such as
swap contracts. Fair values for these instruments are determined using market observable inputs
including forward currency and interest rate curves and widely published market observable
indices. Credit risk related to the counterparty and the Company is considered when estimating the
fair values of these derivatives. However, the Company is largely protected by collateral
arrangements with counterparties, and determined that no
111
adjustment for credit risk was required as
of December 31, 2008. The nature and use of these other derivatives are described in Note
12(F).
Level
3: Financial Assets - $1.8 billion and Financial Liabilities - $1.8 billion
The Company classifies certain newly issued, privately placed, complex or illiquid securities, as
well as assets and liabilities relating to guaranteed minimum income benefits in Level 3.
Fixed maturities and equity securities
. Approximately 7% or $889 million of fixed maturities and
equity securities are priced using significant unobservable inputs and classified in this category,
including:
|
|
$518 million of mortgage and asset-backed securities;
|
|
|
|
$270 million of primarily private corporate bonds; and
|
|
|
|
$101 million of subordinated loans and private equity investments
valued at transaction price in the absence of market data
indicating a change in the estimated fair values.
|
Fair values of mortgage and asset-backed securities and corporate bonds are determined using
pricing models that incorporate the specific characteristics of each asset and related assumptions
including the investment type and structure, credit quality, industry and maturity date in
comparison to current market indices and spreads, liquidity and economic events. For mortgage and
asset-backed securities, inputs and assumptions to pricing may also include collateral attributes
and prepayment speeds. Recent trades in the subject security or similar securities are assessed
when available, and the Company may also review published research as well as the issuers
financial statements in its evaluation.
Guaranteed minimum income benefit contracts.
Because cash flows of the GMIB liabilities and assets
are affected by equity markets and interest rates, and are settled in lump sum payments, the
Company reports these liabilities and assets as derivatives at fair value. The Company estimates
the fair value of the assets and liabilities for GMIB contracts using assumptions regarding capital
markets (including market returns, interest rates and market volatilities of the underlying equity
and bond mutual fund investments), future annuitant and retrocessionaire behavior (including
mortality, lapse, annuity election rates and retrocessional credit), as well as risk and profit
charges. At adoption of SFAS No. 157, the Company updated assumptions to reflect those that the
Company believes a hypothetical market participant would use to determine a current exit price for
these contracts and recorded a charge to net income as described in Note 2(B). As certain
assumptions used to estimate fair values for these contracts are largely unobservable, the Company
classifies assets and liabilities associated with guaranteed minimum income benefits in Level 3
(GMIB assets and liabilities).
These GMIB assets and liabilities are estimated using a complex internal model run using many
scenarios to determine the present value of net amounts expected to be paid, less the present value
of net future premiums expected to be received adjusted for risk and profit charges that the
Company estimates a hypothetical market participant would require to assume this business. Net
amounts expected to be paid include the excess of the expected value of the income benefits over
the values of the annuitants accounts at the time of annuitization. Generally, market return,
interest rate and volatility assumptions are based on market observable information. Assumptions
related to annuitant behavior reflect the Companys belief that a hypothetical market participant
would consider the actual and expected experience of the Company as well as other relevant and
available industry resources in setting policyholder behavior
assumptions. The significant assumptions used
to value the GMIB assets and liabilities as of December 31, 2008 were as follows:
|
|
The market return and discount rate assumptions are based on the market-observable LIBOR swap curve.
|
|
|
|
The projected interest rate used to calculate the reinsured income benefits is indexed to the 7-year Treasury Rate at
the time of annuitization (claim interest rate) based on contractual terms. That rate was 1.87% at December 31, 2008
and must be projected for future time periods. These projected rates vary by economic scenario and are determined by an
interest rate model using current interest rate curves and the prices of instruments available in the market including
various interest rate caps and zero-coupon bonds. For a subset of the business, there is a contractually guaranteed
floor of 3% for the claim interest rate.
|
|
|
|
The market volatility assumptions for annuitants underlying mutual fund investments that are modeled based on the S&P
500, Russell 2000 and NASDAQ Composite are based on the market-implied volatility for these indices for three to seven
years grading to historical volatility levels thereafter. For the remaining 57% of underlying mutual fund investments
modeled based on other indices (with insufficient market-observable data), volatility is based on the average
historical level for each index over the past 10 years. Using this approach, volatility ranges from 16% to 46% for
equity funds, 4% to 10% for bond funds and 1% to 2% for money market funds.
|
|
|
|
The mortality assumption is 70% of the 1994 Group Annuity Mortality table, with 1% annual improvement beginning January
1, 2000.
|
|
|
|
The lapse rate assumption varies by contract from 2% to 17% and depends on the time since contract issue, the relative
value of
|
112
|
|
the guarantee and the differing experience by issuing
company of the underlying variable annuity contracts.
|
|
|
|
The annuity election rate assumption varies by contract and depends on the annuitants age, the relative value of the
guarantee, whether a contractholder has had a previous opportunity to elect the benefit and the differing experience by
issuing company of the underlying variable annuity contracts. Immediately after the expiration of the waiting period,
the assumed probability that an individual will annuitize their variable annuity contract is up to 80%. For the second
and subsequent annual opportunities to elect the benefit, the assumed probability of election is up to 30%. With
respect to the second and subsequent election opportunities, actual data is just beginning to emerge for the Company as
well as the industry and the estimates are based on this limited data.
|
|
|
|
The risk and profit charge assumption is based on the Companys estimate of the capital and return on capital that
would be required by a hypothetical market participant.
|
In
addition, the Company has considered other assumptions related to
model, expense and nonperformance risk in calculating the GMIB
liability.
The approach for these assumptions, including market-observable reference points, is consistent
with that used to estimate the fair values of these contracts at January 1, 2008. The Company
regularly evaluates each of the assumptions used in establishing these assets and liabilities by
considering how a hypothetical market participant would set assumptions at each valuation
date. Capital markets assumptions are expected to change at each valuation date reflecting current
observable market conditions. Other assumptions may also change based on a hypothetical market
participants view of actual experience as it emerges over time or other factors that impact the
net liability. If the emergence of future experience or future assumptions differs from the
assumptions used in estimating these assets and liabilities, the resulting impact could be material
to the Companys consolidated results of operations, and in certain situations, could be material
to the Companys financial condition.
GMIB liabilities are reported in the Companys Consolidated Balance Sheets in Accounts payable,
accrued expenses and other liabilities. GMIB assets associated with these contracts represent net
receivables in connection with reinsurance that the Company has purchased from two external
reinsurers and are reported in the Companys Consolidated Balance Sheets in Other assets, including
other intangibles. As of December 31, 2008, Standard & Poors (S&P) has given a financial strength
rating of AA+ to one reinsurer and a financial strength rating of A- to the parent company that
guarantees the receivable from the other reinsurer.
Changes in Level 3 Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring
Basis
The following table summarizes the changes in financial assets and financial liabilities classified
in Level 3 for the year ended December 31, 2008. This table excludes separate account assets as
changes in fair values of these assets accrue directly to policyholders. Gains and losses reported
in this table may include changes in fair value that are attributable to both observable and
unobservable inputs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Maturities &
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
Equity Securities
|
|
|
GMIB Assets
|
|
|
GMIB Liabilities
|
|
|
GMIB Net
|
|
|
Balance at 1/1/08
|
|
$
|
732
|
|
|
$
|
173
|
|
|
$
|
(313
|
)
|
|
$
|
(140
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of adoption of SFAS No. 157
|
|
|
-
|
|
|
|
244
|
|
|
|
(446
|
)
|
|
|
(202
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Results of GMIB, excluding adoption effect
|
|
|
-
|
|
|
|
604
|
|
|
|
(1,092
|
)
|
|
|
(488
|
)
|
Other
|
|
|
(21
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gains (losses) included in income
|
|
|
(21
|
)
|
|
|
848
|
|
|
|
(1,538
|
)
|
|
|
(690
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Losses included in other comprehensive income
|
|
|
(17
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains required to adjust future policy benefits for settlement annuities
(1)
|
|
|
91
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases, issuances, settlements
|
|
|
1
|
|
|
|
(68
|
)
|
|
|
94
|
|
|
|
26
|
|
Transfers into Level 3
|
|
|
103
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 12/31/08
|
|
$
|
889
|
|
|
$
|
953
|
|
|
$
|
(1,757
|
)
|
|
$
|
(804
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total gains
(losses) included in income attributable to
instruments held at the reporting date
|
|
$
|
(18
|
)
|
|
$
|
848
|
|
|
$
|
(1,538
|
)
|
|
$
|
(690
|
)
|
|
(1) Amounts do not accrue to shareholders and are not reflected in the Companys revenues.
113
As noted in the table above, total gains and losses included in net income are reflected in the
following captions in the Consolidated Statements of Income:
|
|
Realized investment gains (losses) and net investment income for amounts related to fixed
maturities and equity securities; and
|
|
|
Guaranteed minimum income benefits expense for
amounts related to GMIB assets and
liabilities.
|
Reclassifications impacting Level 3 financial instruments are reported as transfers in or out of
the Level 3 category as of the beginning of the quarter in which the transfer occurs. Therefore
gains and losses in income only reflect activity for the period the instrument was classified in
Level 3. Typically, investments that transfer out of Level 3 are classified in Level 2 as market
data on the securities becomes more readily available.
The Company provided reinsurance for other insurance companies that offer a guaranteed minimum
income benefit, and then retroceded a portion of the risk to other insurance companies. These
arrangements with third party insurers are the instruments still held at the reporting date for
GMIB assets and liabilities in the table above. Because these reinsurance arrangements remain in
effect at the reporting date, the Company has reflected the total gain or loss for the period as
the total gain or loss included in income attributable to instruments still held at the reporting
date. However, the Company reduces the GMIB assets and liabilities resulting from these
reinsurance arrangements when annuitants lapse, die, elect their benefit, or reach the age after
which the right to elect their benefit expires.
For the year ended December 31, 2008, the GMIB assets and liabilities include a charge of $202
million for the adoption of SFAS No. 157, which is discussed in Note 2(B). After the adoption of
SFAS No. 157 in 2008, the Companys GMIB assets and liabilities are expected to be more volatile in
future periods both because the liabilities, net of receivables from reinsurers, are larger and
because these assumptions will be based largely on market-observable inputs at the close of each
reporting period including interest rates and market-implied volatilities.
Excluding the charge discussed above, the increase in the net GMIB liability of $488 million for
the year ended December 31, 2008 was primarily driven by:
|
|
decreases in interest rates since December 31, 2007: $232 million;
|
|
|
|
the impact of declines in underlying account values in the period, driven by declines in
equity markets and bond fund returns, resulting in increased exposure: $158 million;
|
|
|
|
updates to the risk and profit charge estimate: $50 million;
|
|
|
|
updates to other assumptions that are used in the fair value calculation: $25 million; and
|
|
|
|
other amounts including the compounding effects of declines in interest rates and equity
markets, as well as experience varying from assumptions: $23 million.
|
Separate account assets
Fair values and changes in the fair values of separate account assets generally accrue directly to
the policyholders and are not included in the Companys revenues and expenses. As of December 31,
2008 separate account assets were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guaranteed separate accounts (See Note 22)
|
|
$
|
233
|
|
|
$
|
1,557
|
|
|
$
|
|
|
|
$
|
1,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-guaranteed separate accounts
(1)
|
|
|
1,093
|
|
|
|
2,506
|
|
|
|
475
|
|
|
|
4,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total separate account assets
|
|
$
|
1,326
|
|
|
$
|
4,063
|
|
|
$
|
475
|
|
|
$
|
5,864
|
|
|
(1) Non-guaranteed separate accounts include $1.5 billion in assets supporting the Companys pension plan, including $435 million classified in Level 3.
Separate account assets in Level 1 include exchange-listed equity securities. Level 2 assets
primarily include:
|
|
equity securities and corporate and structured bonds valued using recent trades of similar
securities or pricing models that discount future cash flows at estimated market interest
rates as described above; and
|
|
|
|
actively-traded institutional and retail mutual fund investments and separate accounts
priced using the daily net asset value which is the exit price.
|
114
Separate account assets classified in Level 3 include investments primarily in securities
partnerships and real estate generally valued at transaction price in the absence of market data
indicating a change in the estimated fair value. Values may be adjusted when evidence is available
to support such adjustments. Evidence may include market data as well as changes in the financial
results and condition of the investment.
The following table summarizes the change in separate account assets reported in Level 3 for the
year ended December 31, 2008.
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Balance at 1/1/08
|
|
$
|
403
|
|
Policyholder gains
(1)
|
|
|
11
|
|
Purchases, issuances, settlements
|
|
|
78
|
|
Transfers out of Level 3
|
|
|
(17)
|
|
|
Balance at 12/31/08
|
|
$
|
475
|
|
|
(1)
|
|
Included in this amount are losses of $4 million attributable to instruments still held at the reporting date.
|
Assets and Liabilities Measured at Fair Value on a Non-recurring Basis
Certain financial assets and liabilities are measured at fair value on a non-recurring basis, such
as commercial mortgage loans held for sale. As of December 31, 2008, the amount required to adjust
these assets and liabilities to their fair value was not significant.
Note 12 Investments
A.
Fixed Maturities and Equity Securities
Securities in the following table are included in fixed maturities and equity securities on the
Companys Consolidated Balance Sheets. These securities are carried at fair value with changes in
fair value reported in realized investment gains (losses).
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Included in fixed maturities:
|
|
|
|
|
|
|
|
|
Trading securities (amortized cost: $13; $22)
|
|
$
|
13
|
|
|
$
|
22
|
|
Hybrid securities (amortized cost: $10; $11)
|
|
|
10
|
|
|
|
11
|
|
|
|
|
Total
|
|
$
|
23
|
|
|
$
|
33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included in equity securities:
|
|
|
|
|
|
|
|
|
Hybrid securities (amortized cost: $123; $114)
|
|
$
|
84
|
|
|
$
|
110
|
|
|
Fixed maturities and equity securities included $211 million at December 31, 2008 and $89 million
at December 31, 2007, which were pledged as collateral to brokers as required under certain futures
contracts. These fixed maturities and equities securities were primarily corporate securities.
The following information about fixed maturities excludes trading and hybrid securities. The
amortized cost and fair value by contractual maturity periods for fixed maturities were as follows
at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
Amortized
|
|
|
Fair
|
|
(In millions)
|
|
Cost
|
|
|
Value
|
|
|
Due in one year or less
|
|
$
|
730
|
|
|
$
|
734
|
|
Due after one year through five years
|
|
|
3,017
|
|
|
|
3,009
|
|
Due after five years through ten years
|
|
|
4,465
|
|
|
|
4,306
|
|
Due after ten years
|
|
|
2,617
|
|
|
|
2,978
|
|
Mortgage and other asset-backed securities
|
|
|
640
|
|
|
|
731
|
|
|
Total
|
|
$
|
11,469
|
|
|
$
|
11,758
|
|
|
115
Actual maturities could differ from contractual maturities because issuers may have the right to
call or prepay obligations, with or without penalties. Also, in some cases the Company may extend
maturity dates.
Mortgage-backed assets consist principally of commercial mortgage-backed securities and
collateralized mortgage obligations of which $41 million were residential mortgages and home equity
lines of credit, all of which were originated utilizing standard underwriting practices and are not
considered sub-prime loans.
Gross unrealized appreciation (depreciation) on fixed maturities (excluding trading securities and
hybrid securities) by type of issuer is shown below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
|
|
|
|
|
|
Unrealized
|
|
|
Unrealized
|
|
|
|
|
|
|
Amortized
|
|
|
Appre-
|
|
|
Depre-
|
|
|
Fair
|
|
(In millions)
|
|
Cost
|
|
|
ciation
|
|
|
ciation
|
|
|
Value
|
|
|
Federal government and agency
|
|
$
|
359
|
|
|
$
|
403
|
|
|
$
|
-
|
|
|
$
|
762
|
|
State and local government
|
|
|
2,391
|
|
|
|
117
|
|
|
|
(22)
|
|
|
|
2,486
|
|
Foreign government
|
|
|
882
|
|
|
|
70
|
|
|
|
(8)
|
|
|
|
944
|
|
Corporate
|
|
|
7,197
|
|
|
|
167
|
|
|
|
(529)
|
|
|
|
6,835
|
|
Federal agency mortgage-backed
(1)
|
|
|
36
|
|
|
|
1
|
|
|
|
-
|
|
|
|
37
|
|
Other mortgage-backed
|
|
|
149
|
|
|
|
-
|
|
|
|
(25)
|
|
|
|
124
|
|
Other asset-backed
|
|
|
455
|
|
|
|
128
|
|
|
|
(13)
|
|
|
|
570
|
|
|
Total
|
|
$
|
11,469
|
|
|
$
|
886
|
|
|
$
|
(597)
|
|
|
$
|
11,758
|
|
|
(In millions)
|
|
December 31, 2007
|
|
Federal government and agency
|
|
$
|
346
|
|
|
$
|
282
|
|
|
$
|
-
|
|
|
$
|
628
|
|
State and local government
|
|
|
2,362
|
|
|
|
130
|
|
|
|
(3)
|
|
|
|
2,489
|
|
Foreign government
|
|
|
868
|
|
|
|
32
|
|
|
|
(18)
|
|
|
|
882
|
|
Corporate
|
|
|
7,157
|
|
|
|
318
|
|
|
|
(85)
|
|
|
|
7,390
|
|
Other mortgage-backed
|
|
|
216
|
|
|
|
6
|
|
|
|
(2)
|
|
|
|
220
|
|
Other asset-backed
|
|
|
427
|
|
|
|
29
|
|
|
|
(17)
|
|
|
|
439
|
|
|
Total
|
|
$
|
11,376
|
|
|
$
|
797
|
|
|
$
|
(125)
|
|
|
$
|
12,048
|
|
|
(1)
|
|
Federal agency mortgage-backed securities were first purchased in 2008 as part of the acquired business.
|
The above table includes investments with a fair value of $2.5 billion supporting the Companys
run-off settlement annuity business, with gross unrealized appreciation of $624 million and gross
unrealized depreciation of $110 million at December 31, 2008. Such unrealized amounts are required
to support future policy benefit liabilities of this business and, accordingly, are not included in
accumulated other comprehensive income. At December 31, 2007, investments supporting this business
had a fair value of $2.6 billion, gross unrealized appreciation of $476 million and gross unrealized
depreciation of $20 million.
As of December 31, 2008, the Company had no outstanding commitments to purchase fixed maturities.
Review of declines in fair value
.
Management reviews fixed maturities and equity securities for
impairment based on criteria that include:
|
|
length of time and severity of decline;
|
|
|
|
financial health and specific near term prospects of the issuer;
|
|
|
|
changes in the regulatory, economic or general market environment of the issuers industry
or geographic region; and
|
|
|
|
the Companys ability and intent to hold until recovery.
|
116
As of December 31, 2008, fixed maturities (excluding trading and hybrid securities) which were
primarily investment grade corporate bonds with a decline in fair value from cost were as follows,
including the length of time of such decline:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
|
|
|
Amortized
|
|
|
Unrealized
|
|
|
Number
|
|
(In millions)
|
|
Value
|
|
|
Cost
|
|
|
Depreciation
|
|
|
of Issues
|
|
|
Fixed maturities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
One year or less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment grade
|
|
$
|
2,930
|
|
|
$
|
3,255
|
|
|
$
|
(325)
|
|
|
|
622
|
|
Below investment grade
|
|
$
|
372
|
|
|
$
|
425
|
|
|
$
|
(53)
|
|
|
|
113
|
|
More than one year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment grade
|
|
$
|
920
|
|
|
$
|
1,130
|
|
|
$
|
(210)
|
|
|
|
214
|
|
Below investment grade
|
|
$
|
49
|
|
|
$
|
58
|
|
|
$
|
(9)
|
|
|
|
13
|
|
|
The unrealized depreciation of investment grade fixed maturities is primarily due to increases in
market yields since purchase. Approximately $325 million of the unrealized depreciation is due to
securities with a decline in value of greater than 20%. Approximately 95% of these securities had
been in that position for less than six months. The remaining $272 million of the unrealized
depreciation is due to securities with declines in value of less than 20%. There were no equity
securities with a material decline in fair value from cost as of December 31, 2008. See Note 13(B)
for discussion of impairments included in realized investment gains and losses.
B.
Commercial Mortgage Loans and Real Estate
Mortgage loans held by the Company are made exclusively to commercial borrowers; therefore there is
no exposure to either prime or sub-prime residential mortgages. The Companys commercial mortgage
loans and real estate investments are diversified by property type, location and, for commercial
mortgage loans, borrower. Generally, commercial mortgage loans are carried at unpaid principal
balances and are issued at a fixed rate of interest.
In connection with the Companys investment strategy to enhance investment yields by selling senior
participations, commercial mortgage loans include loans that were originated with the intent to
sell of $75 million as of December 31, 2008 and $77 million as of December 31, 2007.
At December 31, commercial mortgage loans and real estate investments were distributed among the
following property types and geographic regions:
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Property type
|
|
|
|
|
|
|
|
|
Office buildings
|
|
$
|
1,118
|
|
|
$
|
1,048
|
|
Apartment buildings
|
|
|
988
|
|
|
|
1,008
|
|
Industrial
|
|
|
546
|
|
|
|
470
|
|
Hotels
|
|
|
512
|
|
|
|
336
|
|
Retail facilities
|
|
|
441
|
|
|
|
398
|
|
Other
|
|
|
65
|
|
|
|
66
|
|
|
Total
|
|
$
|
3,670
|
|
|
$
|
3,326
|
|
|
Geographic region
|
|
|
|
|
|
|
|
|
Pacific
|
|
$
|
1,102
|
|
|
$
|
1,117
|
|
South Atlantic
|
|
|
779
|
|
|
|
616
|
|
New England
|
|
|
546
|
|
|
|
539
|
|
Central
|
|
|
512
|
|
|
|
476
|
|
Middle Atlantic
|
|
|
394
|
|
|
|
251
|
|
Mountain
|
|
|
337
|
|
|
|
327
|
|
|
Total
|
|
$
|
3,670
|
|
|
$
|
3,326
|
|
|
117
At December 31, 2008, scheduled commercial mortgage loan maturities were as follows (in millions):
$266 in 2009, $255 in 2010, $397 in 2011, $654 in 2012 and $2,045 thereafter.
Actual maturities could differ from contractual maturities for several reasons: borrowers may have
the right to prepay obligations, with or without prepayment penalties; the maturity date may be
extended; and loans may be refinanced.
As of December 31, 2008, the Company had commitments to extend credit under commercial mortgage
loan agreements of $65 million, all of which were at a fixed rate of interest. These loan
commitments are diversified by property type and geographic region. As of December 31, 2008, the
Company had commitments to contribute additional equity of $9 million to real estate investments.
The Company expects to disburse most of the committed amounts in 2009.
C.
Other Long-term Investments
As of December 31, other long-term investments consisted of the following:
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Real estate entities
|
|
$
|
321
|
|
|
$
|
313
|
|
Securities partnerships
|
|
|
242
|
|
|
|
171
|
|
Interest rate and foreign currency swaps
|
|
|
45
|
|
|
|
3
|
|
Mezzanine loans
|
|
|
21
|
|
|
|
30
|
|
Other
|
|
|
3
|
|
|
|
3
|
|
|
Total
|
|
$
|
632
|
|
|
$
|
520
|
|
|
Investments in real estate entities with a carrying value of $96 million at December 31, 2008 and
$40 million at December 31, 2007 were non-income producing during the preceding twelve months.
As of December 31, 2008, the Company had commitments to contribute:
|
|
$229 million to limited liability entities that hold either real estate or loans to real
estate entities that are diversified by property type and geographic region; and
|
|
|
$241 million to entities that hold securities diversified by issuer and maturity date.
|
The Company expects to disburse approximately 35% of the committed amounts in 2009 and the
remaining amounts by 2014.
D.
Short-Term Investments and Cash Equivalents
Short-term investments and cash equivalents included corporate securities of $1.1 billion, federal
government securities of $126 million and money market funds of $147 million at December 31, 2008.
The Companys short-term investments and cash equivalents at December 31, 2007 included corporate
securities of $1.5 billion, federal government securities of $192 million and money market funds of
$66 million.
E.
Concentration of Risk
As of December 31, 2008 and 2007, the Company did not have a concentration of investments in a
single issuer or borrower exceeding 10% of shareholders equity.
F.
Derivative Financial Instruments
The Companys investment strategy is to manage the characteristics of investment assets (such as
duration, yield, currency and liquidity) to meet the varying demands of the related insurance and
contractholder liabilities (such as paying claims, investment returns and withdrawals). As part of
this investment strategy, the Company typically uses derivatives to minimize interest rate, foreign
currency and equity price risks. The Company routinely monitors exposure to credit risk associated
with derivatives and diversifies the portfolio among approved dealers of high credit quality to
minimize credit risk. In addition, the Company has written or sold contracts to guarantee minimum
income benefits and to enhance investment returns.
118
The Company uses hedge accounting when derivatives are designated, qualify and are highly effective
as hedges. Effectiveness is formally assessed and documented at inception and each period
throughout the life of a hedge using various quantitative methods appropriate for each hedge,
including regression analysis and dollar offset. Under hedge accounting, the changes in fair value
of the derivative and the hedged risk are generally recognized together and offset each other when
reported in net income.
The Company accounts for derivative instruments as follows:
|
|
Derivatives are reported on the balance sheet at fair value with changes in fair values
reported in net income or accumulated other comprehensive income.
|
|
|
Changes in the fair value of derivatives that hedge market risk related to future cash
flows and that qualify for hedge accounting are reported in a separate caption in
accumulated other comprehensive income. These hedges are referred to as cash flow hedges.
|
|
|
A change in the fair value of a derivative instrument may not always equal the change in
the fair value of the hedged item; this difference is referred to as hedge ineffectiveness.
Where hedge accounting is used, the Company reflects hedge ineffectiveness in net income
(generally as part of realized investment gains and losses).
|
|
|
Features of certain investments and obligations, called embedded derivatives, are accounted
for as derivatives. As permitted under SFAS No. 133, derivative accounting has not been
applied to these features of such investments or obligations existing before January 1, 1999.
|
The Company recorded pre-tax realized investment losses of $11 million in 2006 from terminating
swaps hedging interest rate and foreign currency risk of fixed maturities. The Company recorded
pre-tax realized investment gains from swaps on commercial loan pools of $7 million in 2006.
See Note 7 for a discussion of derivatives associated with GMDB contracts and Note 11 for a
discussion of derivatives arising from GMIB contracts. The other effects of derivatives were not
material to the Companys consolidated results of operations, liquidity or financial condition for
2008, 2007 or 2006.
The table below presents information about the nature and accounting treatment of the Companys
primary derivative financial instruments. Derivatives in the Companys separate accounts are not
included because associated gains and losses generally accrue directly to policyholders.
119
|
|
|
|
|
|
|
|
|
|
Instrument
|
|
Risk
|
|
Purpose
|
|
Cash Flows
|
|
Accounting Policy
|
|
|
Futures
|
|
Primarily equity
and foreign
currency risks
|
|
To reduce domestic
and international
equity market
exposures for
certain reinsurance
contracts that
guarantee death
benefits resulting
from changes in
variable annuity
account values
based on underlying
mutual funds.
Currency futures
are primarily
euros, Japanese yen
and British pounds.
|
|
The Company
receives (pays)
cash daily in the
amount of the
change in fair
value of the
futures contracts.
|
|
Fair value changes
are reported in
other revenues and
cash flows are
included in
operating
activities.
|
|
|
|
|
Interest rate risk
|
|
To hedge fair value
changes of fixed
maturity and
commercial mortgage
loan investments to
be purchased.
|
|
The Company
receives (pays)
cash daily in the
amount of the
change in fair
value of the
futures contracts.
|
|
Using cash flow
hedge accounting,
fair value changes
are reported in
accumulated other
comprehensive
income and
amortized into net
investment income
over the life of
the investments
purchased. Cash
flows are included
in operating
activities.
|
|
Swaps
|
|
Interest rate and
foreign currency
risks
|
|
To hedge the
interest or foreign
currency cash flows
of fixed maturities
and commercial
mortgage loans to
match associated
liabilities.
Currency swaps are
primarily Canadian
dollars, euros,
Australian dollars
and British pounds
for periods of up
to 13 years.
|
|
The Company
periodically
exchanges cash
flows between
variable and fixed
interest rates or
between two
currencies for both
principal and
interest.
|
|
Using cash flow
hedge accounting,
fair values are
reported in other
long-term
investments or
other liabilities
and accumulated
other comprehensive
income. Net
interest cash flows
are reported in net
investment income
and included in
operating
activities. When
hedge accounting
does not apply,
fair value changes
and net interest
cash flows are
reported in
realized investment
gains and losses.
|
|
|
|
|
Credit and interest
rate risks
|
|
To enhance
investment returns,
the Company sells
Dow Jones indexed
credit default
swaps on a basket
of primarily
investment grade
corporate bonds.
|
|
The Company
receives quarterly
fees and will make
future payments if
an issuer of an
underlying
corporate bond
defaults on
scheduled payments
or files for
bankruptcy. These
payments will equal
the par value of
the underlying
corporate bond and
the Company may
subsequently sell
or hold that bond
as an invested
asset. If the most
current indexed
swaps are
determined
desirable for
liquidity, credit
risk or other
reasons, the
Company also pays
or receives cash to
settle purchases
and sales.
|
|
Fair values of the
swaps are reported
in other long-term
investments or
other liabilities,
with changes
in fair value reported in
realized investment
gains and losses.
Quarterly fees and
gains and losses on
purchases and sales
are also reported
in realized
investment gains
and losses. These
cash flows are
reported in
investing
activities.
|
|
Treasury lock
|
|
Interest rate risk
|
|
To hedge the
variability of and
fix at inception
date, the benchmark
Treasury rate
component of future
interest payments
on debt to be
issued in 2009.
|
|
The Company will
receive (pay) the
fair value of the
contract at the
earliest of
expiration or debt
issuance.
|
|
Using cash flow
hedge accounting,
fair values are
reported in
short-term
investments or
other liabilities,
with changes in
fair value reported
in accumulated
other comprehensive
income and
amortized to
interest expense
over the life of
the debt issued.
These cash flows
are reported in
operating
activities.
|
|
Swaps on commercial
loan pools
|
|
Interest rate and
credit risks
|
|
To obtain returns
based on the
performance of
underlying
commercial loan
pools.
|
|
The Company
receives cash based
on the performance
of underlying
commercial loan
pools.
|
|
Fair values of the
swaps are reported
in other long-term
investments or
other liabilities,
with changes
in fair value reported in
realized investment
gains and losses.
These cash flows
are reported in
investing
activities.
|
|
Written and
Purchased Options
|
|
Primarily equity
and interest rate
risks
|
|
The Company has
written certain
reinsurance
contracts to
guarantee minimum
income benefits
resulting from the
level of variable
annuity account
values compared
with a
contractually
guaranteed amount.
The actual payment
by the Company
depends on the
actual account
value in the
underlying mutual
funds and the level
of interest rates
when account
holders elect to
receive minimum
income payments.
The Company
purchased
reinsurance
contracts to hedge
the market risks
assumed. These
contracts are
accounted for as
written and
purchased options.
|
|
The Company
periodically
receives (pays)
fees based on
account values.
The Company will
also pay (receive)
cash depending on
changes in account
values and interest
rates when account
holders first elect
to receive minimum
income payments.
|
|
Fair values are
reported in other
liabilities and
other assets.
Changes in fair
value are reported
in guaranteed
minimum income
benefits expense.
These cash flows
are reported in
operating
activities.
|
|
Purchased Options
|
|
Interest rate risk
|
|
To hedge the
possibility of
early policyholder
cash surrender when
the amortized cost
of underlying
invested assets is
greater than their
fair values.
|
|
The Company pays a
fee and may receive
or pay cash, based
on the difference
between the
amortized cost and
fair values of
underlying invested
assets at the time
of policyholder
surrender.
|
|
Using cash flow
hedge accounting,
fair values are
reported in other
assets or other
liabilities, with
changes in fair
value reported in
accumulated other
comprehensive
income and
amortized to
benefits expense
over the life of
the underlying
invested assets.
These cash flows
will be reported in
financing
activities.
|
|
120
Note 13 Investment Income and Gains and Losses
A.
Net Investment Income
The components of net investment income, for the years ended December 31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Fixed maturities
|
|
$
|
729
|
|
|
$
|
722
|
|
|
$
|
768
|
|
|
Equity securities
|
|
|
8
|
|
|
|
8
|
|
|
|
11
|
|
|
Commercial mortgage loans
|
|
|
219
|
|
|
|
240
|
|
|
|
266
|
|
|
Policy loans
|
|
|
86
|
|
|
|
81
|
|
|
|
78
|
|
|
Real estate
|
|
|
1
|
|
|
|
5
|
|
|
|
12
|
|
|
Other long-term investments
|
|
|
6
|
|
|
|
24
|
|
|
|
26
|
|
|
Short-term investments and cash
|
|
|
43
|
|
|
|
78
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
1,092
|
|
|
|
1,158
|
|
|
|
1,238
|
|
|
Less investment expenses
|
|
|
29
|
|
|
|
44
|
|
|
|
43
|
|
|
|
|
Net investment income
|
|
$
|
1,063
|
|
|
$
|
1,114
|
|
|
$
|
1,195
|
|
|
Net investment income for separate accounts (which is not reflected in the Companys revenues) was
$148 million for 2008, $215 million for 2007, and $140 million for 2006.
B.
Realized Investment Gains and Losses
The following realized gains and losses on investments for the years ended December 31 exclude
amounts required to adjust future policy benefits for run-off settlement annuity business.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Fixed maturities
|
|
$
|
(237
|
)
|
|
$
|
(26
|
)
|
|
$
|
(25
|
)
|
|
Equity securities
|
|
|
(31
|
)
|
|
|
13
|
|
|
|
8
|
|
|
Commercial mortgage loans
|
|
|
(2
|
)
|
|
|
8
|
|
|
|
(7
|
)
|
|
Real estate
|
|
|
-
|
|
|
|
-
|
|
|
|
(5
|
)
|
|
Other investments, including derivatives
|
|
|
100
|
|
|
|
20
|
|
|
|
249
|
|
|
|
|
|
|
Realized investment gains (losses) from continuing operations, before income taxes
|
|
|
(170
|
)
|
|
|
15
|
|
|
|
220
|
|
|
Less income taxes (benefits)
|
|
|
(60
|
)
|
|
|
5
|
|
|
|
75
|
|
|
|
|
|
|
Realized investment gains (losses) from continuing operations
|
|
|
(110
|
)
|
|
|
10
|
|
|
|
145
|
|
|
|
|
|
|
Realized investment gains from discontinued operations, before income taxes
|
|
|
-
|
|
|
|
25
|
|
|
|
19
|
|
|
Less income taxes
|
|
|
-
|
|
|
|
9
|
|
|
|
6
|
|
|
|
|
|
|
Realized investment gains from discontinued operations
|
|
|
-
|
|
|
|
16
|
|
|
|
13
|
|
|
|
|
Net realized investment gains (losses)
|
|
$
|
(110
|
)
|
|
$
|
26
|
|
|
$
|
158
|
|
|
|
Included in pre-tax realized investment gains (losses) above were asset write-downs and changes in
valuation reserves as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Credit related
|
|
$
|
67
|
|
|
$
|
18
|
|
|
$
|
17
|
|
Other
(1)
|
|
|
150
|
|
|
|
22
|
|
|
|
27
|
|
|
Total
|
|
$
|
217
|
|
|
$
|
40
|
|
|
$
|
44
|
|
|
(1)
|
|
Other primarily represents the impact of rising interest rates where the Company cannot demonstrate its intent or ability to hold until recovery.
|
In addition to these asset write-downs, in 2008, the Company recognized pre-tax losses of $14
million on hybrid securities (classified as equity securities) of certain quasi-federal government
agencies where the Company believes that the decline in fair value is other-than-temporary.
121
Realized investment gains in other investments, including derivatives primarily represent gains on
the sales of real estate properties
held in joint ventures.
Realized investment gains and (losses) that are not reflected in the Companys revenues for the
years ended December 31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Separate accounts
|
|
$
|
(146
|
)
|
|
$
|
652
|
|
|
$
|
207
|
|
|
Investment gains required to adjust future policy benefits for run-off settlement annuity business
|
|
$
|
8
|
|
|
$
|
18
|
|
|
$
|
11
|
|
|
|
Sales information for available-for-sale fixed maturities and equity securities, for the years
ended December 31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Proceeds from sales
|
|
$
|
1,465
|
|
|
$
|
1,040
|
|
|
$
|
3,458
|
|
|
Gross gains on sales
|
|
$
|
13
|
|
|
$
|
26
|
|
|
$
|
49
|
|
|
Gross losses on sales
|
|
$
|
(53
|
)
|
|
$
|
(12
|
)
|
|
$
|
(55
|
)
|
|
|
Note 14 Debt
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Short-term:
|
|
|
|
|
|
|
|
|
Commercial paper
|
|
$
|
299
|
|
|
$
|
-
|
|
Current maturities of long-term debt
|
|
|
2
|
|
|
|
3
|
|
|
Total short-term debt
|
|
$
|
301
|
|
|
$
|
3
|
|
|
Long-term:
|
|
|
|
|
|
|
|
|
Uncollateralized debt:
|
|
|
|
|
|
|
|
|
7% Notes due 2011
|
|
$
|
222
|
|
|
$
|
222
|
|
6.375% Notes due 2011
|
|
|
226
|
|
|
|
226
|
|
5.375% Notes due 2017
|
|
|
250
|
|
|
|
250
|
|
6.35% Note due 2018
|
|
|
300
|
|
|
|
-
|
|
6.37% Note due 2021
|
|
|
78
|
|
|
|
78
|
|
7.65% Notes due 2023
|
|
|
100
|
|
|
|
100
|
|
8.3% Notes due 2023
|
|
|
17
|
|
|
|
17
|
|
7.875% Debentures due 2027
|
|
|
300
|
|
|
|
300
|
|
8.3% Step Down Notes due 2033
|
|
|
83
|
|
|
|
83
|
|
6.15% Notes due 2036
|
|
|
500
|
|
|
|
500
|
|
Other
|
|
|
14
|
|
|
|
14
|
|
|
Total long-term debt
|
|
$
|
2,090
|
|
|
$
|
1,790
|
|
|
Under a universal shelf registration statement filed with the Securities and Exchange Commission
(SEC), the Company issued $300 million of 6.35% Notes on March 4, 2008 (with an effective interest
rate of 6.68% per year). Interest is payable on March 15 and September 15 of each year beginning
September 15, 2008. These Notes will mature on March 15, 2018.
The Company may redeem these Notes, at any time, in whole or in part, at a redemption price equal
to the greater of:
|
|
100% of the principal amount of the Notes to be redeemed; or
|
|
|
the present value of the remaining principal and interest payments
on the Notes being redeemed discounted at the applicable Treasury
Rate plus 40 basis points.
|
Maturities of debt and capital leases are as follows (in millions): $2 in 2009, $3 in 2010, $452
in 2011, $3 in 2012, $2 in 2013 and the remainder in years after 2013. Interest expense on
long-term debt, short-term debt and capital leases was $146 million in 2008, $122 million in 2007,
and $104 million in 2006.
122
On March 14, 2008, the Company entered into a new commercial paper program (the Program). Under
the Program, the Company is authorized to sell from time to time short-term unsecured commercial
paper notes up to a maximum of $500 million. The proceeds are used for general corporate purposes,
including working capital, capital expenditures, acquisitions and share repurchases. The Company
uses the credit facility entered into in June 2007, as back-up liquidity to support the outstanding
commercial paper. If at any time funds are not available on favorable terms under the Program, the
Company may use its credit agreement for funding. In October 2008, the Company added an additional
dealer to its Program. As of December 31, 2008, the Company had $299 million in commercial paper
outstanding, at a weighted average interest rate of 6.31%, used to finance the Great-West
Healthcare acquisition and for other corporate purposes.
In June 2007, the Company amended and restated its five-year revolving credit and letter of credit
agreement for $1.75 billion, which permits up to $1.25 billion to be used for letters of credit.
The credit agreement includes options, which are subject to consent by the administrative agent and
the committing bank, to increase the commitment amount up to $2.0 billion and to extend the term of
the agreement. The Company entered into the agreement for general corporate purposes, including
support for the issuance of commercial paper and to obtain statutory reserve credit for certain
reinsurance arrangements. There was a $25 million letter of credit issued as of December 31, 2008.
As of December 31, 2008, the Company had an additional $750 million of borrowing capacity within
the maximum debt leverage covenant in the line of credit agreement in addition to the $2.4 billion
of debt outstanding.
Note 15 Common and Preferred Stock
As of December 31, the Company had issued the following shares:
|
|
|
|
|
|
|
|
|
|
(Shares in thousands)
|
|
2008
|
|
|
2007
|
|
|
Common: Par value $0.25
|
|
|
|
|
|
|
|
|
|
600,000 shares authorized
|
|
|
|
|
|
|
|
|
|
Outstanding - January 1
|
|
|
279,588
|
|
|
|
98,654
|
|
|
Issuance of shares in split
|
|
|
-
|
|
|
|
190,917
|
|
|
Issued for stock option and other benefit
plans
|
|
|
1,458
|
|
|
|
3,244
|
|
|
Repurchase of common stock
|
|
|
(10,010)
|
|
|
|
(13,227)
|
|
|
|
|
|
Outstanding - December 31
|
|
|
271,036
|
|
|
|
279,588
|
|
|
Treasury stock
|
|
|
79,910
|
|
|
|
71,358
|
|
|
|
Issued - December 31
|
|
|
350,946
|
|
|
|
350,946
|
|
|
The Company maintains a share repurchase program, which was authorized by its Board of Directors.
Decisions to repurchase shares depend on market conditions and alternative uses of capital. The
Company has, and may continue from time to time, to repurchase shares on the open market through a
Rule 10b5-1 plan which permits a company to repurchase its shares at times when it otherwise might
be precluded from doing so under insider trading laws or because of self-imposed trading blackout
periods.
The Company has authorized a total of 25 million shares of $1 par value preferred stock. No shares
of preferred stock were outstanding at December 31, 2008 or 2007.
123
Note 16 Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss) excludes amounts required to adjust future policy
benefits for run-off settlement annuity business.
Changes in accumulated other comprehensive income (loss) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax
|
|
|
|
|
|
|
|
|
|
|
(Expense)
|
|
|
After-
|
|
(In millions)
|
|
Pre-Tax
|
|
|
Benefit
|
|
|
Tax
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation, securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation on securities arising during the year
|
|
$
|
(706
|
)
|
|
$
|
245
|
|
|
$
|
(461
|
)
|
|
Plus: reclassification adjustment for losses included in net income
|
|
|
268
|
|
|
|
(94
|
)
|
|
|
174
|
|
|
|
|
Net unrealized depreciation, securities
|
|
$
|
(438
|
)
|
|
$
|
151
|
|
|
$
|
(287
|
)
|
|
|
|
Net unrealized appreciation, derivatives
|
|
$
|
9
|
|
|
$
|
(3
|
)
|
|
$
|
6
|
|
|
|
|
Net translation of foreign currencies
|
|
$
|
(183
|
)
|
|
$
|
62
|
|
|
$
|
(121
|
)
|
|
|
|
Postretirement benefits liability adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification adjustment for amortization of net losses from past
experience and prior service costs
|
|
$
|
21
|
|
|
$
|
(7
|
)
|
|
$
|
14
|
|
|
Net change arising from assumption/plan changes and experience
|
|
|
(1,134
|
)
|
|
|
397
|
|
|
|
(737
|
)
|
|
|
|
Net postretirement benefits liability adjustment
|
|
$
|
(1,113
|
)
|
|
$
|
390
|
|
|
$
|
(723
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax
|
|
|
|
|
|
|
|
|
|
|
(Expense)
|
|
|
After-
|
|
(In millions)
|
|
Pre-Tax
|
|
|
Benefit
|
|
|
Tax
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation, securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implementation effect of SFAS No. 155
|
|
$
|
(18
|
)
|
|
$
|
6
|
|
|
$
|
(12
|
)
|
|
Net unrealized depreciation on securities arising during the year
|
|
|
(68
|
)
|
|
|
24
|
|
|
|
(44
|
)
|
|
Reclassification due to sale of discontinued operations
|
|
|
(23
|
)
|
|
|
8
|
|
|
|
(15
|
)
|
|
Plus: reclassification adjustment for losses included in net income
|
|
|
13
|
|
|
|
(4
|
)
|
|
|
9
|
|
|
|
|
Net unrealized depreciation, securities
|
|
$
|
(96
|
)
|
|
$
|
34
|
|
|
$
|
(62
|
)
|
|
|
|
Net unrealized depreciation, derivatives
|
|
$
|
(6
|
)
|
|
$
|
2
|
|
|
$
|
(4
|
)
|
|
|
|
Net translation of foreign currencies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net translation of foreign currencies arising during the year
|
|
$
|
33
|
|
|
$
|
(10
|
)
|
|
$
|
23
|
|
|
Reclassification due to sale of discontinued operations
|
|
|
8
|
|
|
|
(3
|
)
|
|
|
5
|
|
|
|
|
Net translation of foreign currencies
|
|
$
|
41
|
|
|
$
|
(13
|
)
|
|
$
|
28
|
|
|
|
|
Postretirement benefits liability adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification adjustment for amortization of net losses from past
experience and prior service costs
|
|
$
|
95
|
|
|
$
|
(33
|
)
|
|
$
|
62
|
|
|
Net change arising from assumption/plan changes and experience
|
|
|
301
|
|
|
|
(105
|
)
|
|
|
196
|
|
|
|
|
Net postretirement benefits liability adjustment
|
|
$
|
396
|
|
|
$
|
(138
|
)
|
|
$
|
258
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax
|
|
|
|
|
|
|
|
|
|
|
(Expense)
|
|
|
After-
|
|
(In millions)
|
|
Pre-Tax
|
|
|
Benefit
|
|
|
Tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation, securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation on securities arising during the year
|
|
$
|
(33
|
)
|
|
$
|
12
|
|
|
$
|
(21
|
)
|
|
Plus: reclassification adjustment for losses included in net income
|
|
|
17
|
|
|
|
(6
|
)
|
|
|
11
|
|
|
|
|
Net unrealized depreciation, securities
|
|
$
|
(16
|
)
|
|
$
|
6
|
|
|
$
|
(10
|
)
|
|
|
|
Net unrealized depreciation, derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized depreciation on derivatives arising during the year
|
|
$
|
(13
|
)
|
|
$
|
5
|
|
|
$
|
(8
|
)
|
|
Plus: reclassification adjustment for losses included in net income
|
|
|
11
|
|
|
|
(4
|
)
|
|
|
7
|
|
|
|
|
Net unrealized depreciation, derivatives
|
|
$
|
(2
|
)
|
|
$
|
1
|
|
|
$
|
(1
|
)
|
|
|
|
Net translation of foreign currencies
|
|
$
|
48
|
|
|
$
|
(17
|
)
|
|
$
|
31
|
|
|
|
|
Minimum pension liability adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Activity prior to adoption of SFAS No. 158
|
|
$
|
437
|
|
|
$
|
(153
|
)
|
|
$
|
284
|
|
|
Adoption of SFAS No. 158
|
|
|
665
|
|
|
|
(233
|
)
|
|
|
432
|
|
|
|
|
Minimum pension liability adjustment
|
|
$
|
1,102
|
|
|
$
|
(386
|
)
|
|
$
|
716
|
|
|
|
|
Postretirement benefits liability adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adoption of SFAS No. 158
|
|
$
|
(609
|
)
|
|
$
|
213
|
|
|
$
|
(396
|
)
|
|
|
Note 17 Shareholders Equity and Dividend Restrictions
State insurance departments and foreign jurisdictions that regulate certain of the Companys
subsidiaries prescribe accounting practices (which differ in some respects from GAAP) to determine
statutory net income and surplus. The Companys life insurance and HMO company subsidiaries are
regulated by such statutory requirements. The statutory net income for the years ended, and
surplus as of, December 31 of the Companys life insurance and HMO subsidiaries were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net income
|
|
$
|
420
|
|
|
$
|
1,130
|
|
|
$
|
1,416
|
|
|
Surplus
|
|
$
|
3,638
|
|
|
$
|
3,346
|
|
|
$
|
3,260
|
|
|
As of December 31, 2008, surplus for each of the Companys life insurance and HMO subsidiaries is
sufficient to meet the minimum required by regulators. As of December 31, 2008, the Companys life
insurance and HMO subsidiaries had $395 million of investments on deposit with state departments
of insurance. The Companys life insurance and HMO subsidiaries are also subject to regulatory
restrictions that limit the amount of annual dividends or other distributions (such as loans or
cash advances) insurance companies may extend to the parent company without prior approval of
regulatory authorities. The maximum dividend distribution that the Companys life insurance and
HMO subsidiaries may make during 2009 without prior approval is
approximately $530 million. The
amount of net assets of the Company that could not be distributed without prior approval as of
December 31, 2008, was approximately $2.9 billion. In addition, one of the Companys life
insurance subsidiaries is permitted to loan up to $400 million to the parent company without prior
approval.
Note 18 Income Taxes
As discussed in Note 2(B), the Company implemented FIN No. 48 as of January 1, 2007. As a result,
total unrecognized tax benefits at January 1, 2007 were $245 million, including $108 million that
would impact net income if recognized. Total unrecognized tax benefits were $164 million at
December 31, 2008 and $260 million at December 31, 2007, including $144 million at December 31,
2008 and $124 million at December 31, 2007 that would impact net income if recognized.
125
A reconciliation of the beginning to ending amount of unrecognized tax benefits is as follows:
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Balance at January 1,
|
|
$
|
260
|
|
|
$
|
245
|
|
|
Decrease due to prior year positions
|
|
|
(119
|
)
|
|
|
(31
|
)
|
|
Increase due to current year positions
|
|
|
34
|
|
|
|
51
|
|
|
Reduction related to settlements with taxing authorities
|
|
|
(5
|
)
|
|
|
-
|
|
|
Reduction related to lapse of applicable statute
of limitations
|
|
|
(6
|
)
|
|
|
(5
|
)
|
|
|
|
Balance at December 31,
|
|
$
|
164
|
|
|
$
|
260
|
|
|
|
Over the next 12 months, the Internal Revenue Service (IRS) is expected to complete its examination
of the Companys 2005 and 2006 consolidated federal income tax returns. The Company has
determined, subject to the resolution of certain disputed matters, it is reasonably possible that
the level of unrecognized tax benefits could decline significantly as a result of this IRS review.
This decline is not expected to exceed $38 million, of which $28 million would impact net income.
The IRS completed its examination of the Companys 2003 and 2004 consolidated federal income tax
returns in 2007, for which there were two unresolved issues. These contested matters moved through
the administrative appeals process during 2008. The first issue has been tentatively resolved
subject to pending IRS Commissioner approval; the second issue remains in dispute and will likely
be litigated. Due to the nature of the litigation process, the timing of the resolution of this
matter is uncertain. In addition, the IRS is scheduled to complete its examination of the
Companys 2005 and 2006 consolidated federal income tax returns early in 2009, although it is
anticipated there will be at least one unresolved issue that will proceed to the administrative
appeals level and move through that process during 2009.
The Company classifies net interest expense on uncertain tax positions and any applicable penalties
as a component of income tax expense, but excludes these amounts from the liability for uncertain
tax positions. At January 1, 2008, the Company had $17 million of accrued interest and accrued an
additional $2 million of interest and penalties through 2008.
The IRS is expected to examine the Companys 2007 consolidated federal income tax return though the
timing of this review is uncertain. The Company conducts business in numerous states and foreign
jurisdictions, and may be engaged in multiple audit proceedings at any given time. Generally, no
further state or foreign audit activity for years prior to 2001 is expected.
Deferred income tax assets and liabilities as of December 31 are shown below.
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Deferred tax assets
|
|
|
|
|
|
|
|
|
|
Employee and retiree benefit plans
|
|
$
|
921
|
|
|
$
|
546
|
|
|
Investments, net
|
|
|
130
|
|
|
|
26
|
|
|
Other insurance and contractholder liabilities
|
|
|
454
|
|
|
|
267
|
|
|
Deferred gain on sale of business
|
|
|
78
|
|
|
|
89
|
|
|
Policy acquisition expenses
|
|
|
147
|
|
|
|
170
|
|
|
Loss carryforwards
|
|
|
111
|
|
|
|
125
|
|
|
Other accrued liabilities
|
|
|
110
|
|
|
|
88
|
|
|
Bad debt expense
|
|
|
22
|
|
|
|
21
|
|
|
Other
|
|
|
39
|
|
|
|
39
|
|
|
|
|
Deferred tax assets before valuation allowance
|
|
|
2,012
|
|
|
|
1,371
|
|
|
Valuation allowance for deferred tax assets
|
|
|
(126
|
)
|
|
|
(150
|
)
|
|
|
|
Deferred tax assets, net of valuation allowance
|
|
|
1,886
|
|
|
|
1,221
|
|
|
|
|
Deferred tax liabilities
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
238
|
|
|
|
202
|
|
|
Unrepatriated foreign income, net
|
|
|
135
|
|
|
|
116
|
|
|
Unrealized appreciation (depreciation) on investments and foreign currency translation
|
|
|
(104
|
)
|
|
|
109
|
|
|
|
|
Total deferred tax liabilities
|
|
|
269
|
|
|
|
427
|
|
|
|
|
Net deferred income tax assets
|
|
$
|
1,617
|
|
|
$
|
794
|
|
|
|
126
Management believes consolidated taxable income to be generated in the future will be sufficient in
amount and character to support realization of the Companys net deferred tax assets of $1.6
billion as of December 31, 2008 and $794 million as of December 31, 2007. This determination is
based upon the Companys consistent overall earnings history and future earnings expectations.
Other than deferred tax benefits attributable to operating loss carry forwards, there are no
constraints on the period of time within which the Companys deferred tax assets must be realized.
The Companys deferred tax asset is net of a federal and state valuation allowance (see table
above). The valuation allowance reflects managements assessment that certain deferred tax assets
may not be realizable. As was the case at December 31, 2007, the valuation allowance at December
31, 2008 relates primarily to operating losses, and other deferred tax benefits, of the run-off
reinsurance operations. It is reasonably possible there could be a significant decline in the
level of valuation allowance recorded against deferred tax benefits of the reinsurance operations
within the next 12 months. The $24 million decrease in the valuation allowance during 2008 relates
primarily to the run-off reinsurance operations, but also includes amounts related to the
international operations and certain state tax benefits. The international and state related
reductions in the valuation allowance had no impact on net income.
Weakness in debt and equity markets during 2008 has resulted in a deferred tax asset of $238
million on accumulated other comprehensive loss and other than temporary impairment losses as of
December 31, 2008. Management has concluded that no valuation allowance is required because the
Company has sufficient unrealized gains, including $514 million of adjustments to future policy
benefits excluded from other comprehensive loss, and prior taxable gains sufficient to realize the
tax benefit.
Federal operating loss carryforwards in the amount of $283 million were available at December 31,
2008. These operating losses are available only to offset future taxable income of the generating
company, and begin to expire in 2022.
Current income taxes payable included in accounts payable, accrued expenses and other liabilities
in the consolidated balance sheet were $152 million as of December 31, 2008 and $236 million as of
December 31, 2007.
The components of income taxes for the years ended December 31 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Current taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. income
|
|
$
|
253
|
|
|
$
|
462
|
|
|
$
|
553
|
|
|
Foreign income
|
|
|
57
|
|
|
|
36
|
|
|
|
25
|
|
|
State income
|
|
|
1
|
|
|
|
13
|
|
|
|
17
|
|
|
|
|
|
|
|
311
|
|
|
|
511
|
|
|
|
595
|
|
|
|
|
Deferred taxes (benefits)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. income
|
|
|
(224
|
)
|
|
|
1
|
|
|
|
(22
|
)
|
|
Foreign income
|
|
|
2
|
|
|
|
(2
|
)
|
|
|
(1
|
)
|
|
State income
|
|
|
1
|
|
|
|
1
|
|
|
|
-
|
|
|
|
|
|
|
|
(221
|
)
|
|
|
-
|
|
|
|
(23
|
)
|
|
|
|
Total income taxes
|
|
$
|
90
|
|
|
$
|
511
|
|
|
$
|
572
|
|
|
|
Total income taxes for the years ended December 31 were different from the amount computed using
the nominal federal income tax rate of 35% for the following reasons:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Tax expense at nominal rate
|
|
$
|
133
|
|
|
$
|
571
|
|
|
$
|
606
|
|
|
Tax-exempt interest income
|
|
|
(32
|
)
|
|
|
(32
|
)
|
|
|
(34
|
)
|
|
Dividends received deduction
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
|
(6
|
)
|
|
Resolution of federal tax matters
|
|
|
(1
|
)
|
|
|
(26
|
)
|
|
|
-
|
|
|
State income tax (net of federal income
tax benefit)
|
|
|
1
|
|
|
|
10
|
|
|
|
9
|
|
|
Change in valuation allowance
|
|
|
(15
|
)
|
|
|
(24
|
)
|
|
|
7
|
|
|
Other
|
|
|
7
|
|
|
|
15
|
|
|
|
(10
|
)
|
|
|
|
Total income taxes
|
|
$
|
90
|
|
|
$
|
511
|
|
|
$
|
572
|
|
|
127
During 2007, the IRS completed its examination of the Companys 2003 and 2004 tax years. As a
result, the Company recorded net income of $25 million, primarily attributable to the recognition
of previously unrecognized tax benefits, of which:
|
|
$23 million is reflected in continuing operations; and
|
|
|
|
$2 million is associated with the disposition of Lovelace Health Systems, Inc. in 2003, and
is reflected in discontinued operations.
|
Note 19 Employee Incentive Plans
The People Resources Committee of the Board of Directors awards stock options, restricted stock and
deferred stock to certain employees. To a very limited extent, the Committee has issued common
stock instead of cash compensation and dividend equivalent rights as part of restricted and
deferred stock units. Stock appreciation rights issued with stock options are authorized but have
not been issued for several years. The Company issues shares from Treasury stock for option
exercises, awards of restricted stock and payment of deferred and restricted stock units.
Compensation cost and related tax benefits
for these awards were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Compensation cost
|
|
$
|
41
|
|
|
$
|
37
|
|
|
$
|
41
|
|
|
Tax benefits
|
|
$
|
14
|
|
|
$
|
13
|
|
|
$
|
14
|
|
|
|
The Company had the following number of shares of common stock available for award at December 31:
28.5 million in 2008, 31.1 million in 2007 and 33.0 million in 2006.
Stock options.
The Company awards options to purchase the Companys common stock at the market
price of the stock on the grant date. Options vest over periods ranging from one to five years and
expire no later than 10 years after the grant date.
The table below shows the status of, and changes in, common stock options during the last three
years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Options in thousands)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Average
|
|
|
|
Options
|
|
|
Exercise Price
|
|
|
Options
|
|
|
Exercise Price
|
|
|
Options
|
|
|
Exercise Price
|
|
|
Outstanding - January 1
|
|
|
11,430
|
|
|
$
|
32.69
|
|
|
|
17,955
|
|
|
$
|
29.24
|
|
|
|
26,616
|
|
|
$
|
27.50
|
|
|
Granted
|
|
|
2,311
|
|
|
$
|
46.53
|
|
|
|
1,662
|
|
|
$
|
46.97
|
|
|
|
1,656
|
|
|
$
|
40.30
|
|
|
Exercised
|
|
|
(1,058
|
)
|
|
$
|
27.40
|
|
|
|
(7,757
|
)
|
|
$
|
27.67
|
|
|
|
(9,249
|
)
|
|
$
|
25.90
|
|
|
Expired or canceled
|
|
|
(425
|
)
|
|
$
|
40.67
|
|
|
|
(430
|
)
|
|
$
|
34.73
|
|
|
|
(1,068
|
)
|
|
$
|
31.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding - December 31
|
|
|
12,258
|
|
|
$
|
35.48
|
|
|
|
11,430
|
|
|
$
|
32.69
|
|
|
|
17,955
|
|
|
$
|
29.24
|
|
|
|
|
Options exercisable at year-end
|
|
|
8,687
|
|
|
$
|
31.19
|
|
|
|
8,383
|
|
|
$
|
29.37
|
|
|
|
13,839
|
|
|
$
|
28.94
|
|
|
|
|
Compensation expense of $25 million related to unvested stock options at December 31, 2008 will be
recognized over the next 2 years (weighted average period).
The table below summarizes information for stock options exercised during the last three years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Intrinsic value of options exercised
|
|
$
|
23
|
|
|
$
|
169
|
|
|
$
|
136
|
|
|
Cash received for options exercised
|
|
$
|
26
|
|
|
$
|
203
|
|
|
$
|
212
|
|
|
Excess tax benefits realized from options exercised
|
|
$
|
6
|
|
|
$
|
39
|
|
|
$
|
28
|
|
|
128
The following table summarizes information for outstanding common stock options at December 31,
2008:
|
|
|
|
|
|
|
|
|
|
(In millions, except options in
|
|
Options
|
|
Options
|
thousands)
|
|
Outstanding
|
|
Exercisable
|
|
Number
|
|
|
12,258
|
|
|
|
8,687
|
|
Total intrinsic value
|
|
|
$
1
|
|
|
|
$
1
|
|
Weighted average exercise price
|
|
|
$
35.48
|
|
|
|
$31.19
|
|
Weighted
average remaining
contractual life (years)
|
|
5.3 years
|
|
3.9 years
|
|
The weighted average fair value of options granted under employee incentive plans was $14.33 for
2008, $16.05 for 2007 and $14.57 for 2006, using the Black-Scholes option-pricing model and the
following assumptions:
|
|
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
2006
|
|
Dividend yield
|
|
0.1%
|
|
0.1%
|
|
0.1%
|
Expected volatility
|
|
35.0%
|
|
35.0%
|
|
35.0%
|
Risk-free interest rate
|
|
2.2%
|
|
4.7%
|
|
4.6%
|
Expected option life
|
|
4 years
|
|
4 years
|
|
4.5 years
|
|
The expected volatility reflects the Companys past daily stock price volatility. The Company does
not consider volatility implied in the market prices of traded options to be a good indicator of
future volatility because remaining maturities of traded options are less than one year. In 2008
and 2007, the expected option life reflects the Companys historical experience excluding activity
related to options granted under a replacement option feature. Prior to 2007, the Company
developed the expected option life by considering certain factors, including assumptions used by
other companies with comparable stock option plan features and the Companys cancellation of a
replacement option feature in June 2004.
Restricted stock.
The Company makes restricted stock grants to its employees or directors with
vesting periods ranging from 1 to 5 years. Recipients are entitled to receive dividends and to
vote during the vesting period, but forfeit their awards if their employment terminates before the
vesting date.
The table below shows the status of, and changes in, restricted stock grants during the last three
years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Grants in thousands)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
Average Fair Value
|
|
|
|
|
|
|
Average Fair Value
|
|
|
|
|
|
|
Average Fair Value
|
|
|
|
Grants
|
|
|
at Grant Date
|
|
|
Grants
|
|
|
at Grant Date
|
|
|
Grants
|
|
|
at Grant Date
|
|
|
Outstanding - January 1
|
|
|
2,482
|
|
|
$
|
34.28
|
|
|
|
2,802
|
|
|
$
|
26.72
|
|
|
|
3,759
|
|
|
$
|
21.01
|
|
|
Granted
|
|
|
820
|
|
|
$
|
43.90
|
|
|
|
698
|
|
|
$
|
47.20
|
|
|
|
645
|
|
|
$
|
40.41
|
|
|
Vested
|
|
|
(760
|
)
|
|
$
|
23.81
|
|
|
|
(750
|
)
|
|
$
|
19.06
|
|
|
|
(1,233
|
)
|
|
$
|
17.24
|
|
|
Forfeited
|
|
|
(195
|
)
|
|
$
|
40.47
|
|
|
|
(268
|
)
|
|
$
|
31.45
|
|
|
|
(369
|
)
|
|
$
|
24.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
- December 31
|
|
|
2,347
|
|
|
$
|
40.53
|
|
|
|
2,482
|
|
|
$
|
34.28
|
|
|
|
2,802
|
|
|
$
|
26.72
|
|
|
The fair value of vested restricted stock was: $35 million in 2008, $36 million in 2007 and $49
million in 2006.
At the end of 2008, approximately 2,500 employees held 2.3 million restricted shares with $49
million of related compensation expense to be recognized over the next 3 years (weighted average
period).
Deferred Stock.
In 2003, the Company made deferred stock unit grants with 100% vesting in three to
six years, dependent on the Companys consolidated earnings per share during this vesting period.
Upon meeting the stated performance objectives in 2005, the Board of Directors determined that the
vesting period for the deferred stock units would be three years. On vesting in 2006, stock
issuance was deferred until January of the year following an employees termination from the
Company.
129
Note 20 Leases, Rentals and Outsourced Service Arrangements
Rental expenses for operating leases, principally for office space, amounted to $131 million in
2008, $114 million in 2007 and $104 million in 2006. As of December 31, 2008, future net minimum
rental payments under non-cancelable operating leases were approximately $535 million, payable as
follows (in millions): $121 in 2009, $111 in 2010, $89 in 2011, $63 in 2012, $44 in 2013 and $107
thereafter.
The Company also has several outsourced service arrangements with third parties, primarily for
human resource and information technology support services. The initial service periods under
these arrangements range from 2 to 7 years and their related costs are reported consistent with
operating leases over the service period based on the pattern of use. The Company recorded in
other operating expense $113 million in 2008, $87 million in 2007 and $24 million in 2006 for these
arrangements.
Note 21 Segment Information
The Companys operating segments generally reflect groups of related products, except for the
International segment which is generally based on geography. In accordance with GAAP, operating
segments that do not require separate disclosure may be combined. The Company measures the
financial results of its segments using segment earnings (loss), which is defined as income
(loss) from continuing operations excluding after-tax realized investment gains and losses.
Consolidated pre-tax income from continuing operations is primarily attributable to domestic
operations. Consolidated pre-tax income from continuing operations generated by the Companys
foreign operations was approximately 36% in 2008, and 11% in 2007 and 8% in 2006.
The Company determines segment earnings (loss) consistent with the accounting policies for the
consolidated financial statements, except that amounts included in Corporate are not allocated to
segments. The Company allocates certain other operating expenses, such as systems and other key
corporate overhead expenses, on systematic bases. Income taxes are generally computed as if each
segment were filing a separate income tax return. The Company does not report total assets by
segment since this is not a metric used to allocate resources or evaluate segment performance.
The Company presents segment information as follows:
Health Care
includes medical, dental, behavioral health, prescription drug and other products and
services that may be integrated to support consumer-focused health care programs. This segment
also includes group disability and life insurance products that were historically sold in
connection with certain experience-rated medical products.
Disability and Life
includes group:
|
|
disability insurance;
|
|
|
|
disability and workers compensation case management;
|
|
|
|
life insurance;
|
|
|
|
accident; and
|
|
|
|
specialty insurance.
|
International
includes:
|
|
life, accident and supplemental health insurance products; and
|
|
|
|
international health care products and services including those offered to expatriate
employees of multinational corporations.
|
Run-off Reinsurance
includes accident, workers compensation, international life and health,
guaranteed minimum death benefit and guaranteed minimum income benefit reinsurance businesses. The
Company stopped underwriting new reinsurance business in 2000.
The Company also reports results in two other categories.
Other Operations
consist of:
|
|
non-leveraged and leveraged corporate-owned life insurance (COLI);
|
|
|
|
deferred gains recognized from the 1998 sale of the individual life insurance and annuity
business and the 2004 sale of the retirement benefits business; and
|
130
|
|
run-off settlement annuity business.
|
Corporate
reflects amounts not allocated to segments, such as interest expense on corporate debt
and on uncertain tax positions, net investment income on investments not supporting segment
operations, intersegment eliminations, compensation cost for stock options and certain corporate
overhead expenses.
Summarized segment financial information for the years ended December 31 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Health Care
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical:
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial HMO
(1)
|
|
$
|
1,430
|
|
|
$
|
2,220
|
|
|
$
|
2,744
|
|
Open access/Other guaranteed cost
(2)
|
|
|
2,025
|
|
|
|
1,657
|
|
|
|
946
|
|
Voluntary/limited benefits
|
|
|
200
|
|
|
|
160
|
|
|
|
72
|
|
|
|
|
Total guaranteed cost
(1)
|
|
|
3,655
|
|
|
|
4,037
|
|
|
|
3,762
|
|
Experience-rated medical
(3)
|
|
|
1,946
|
|
|
|
1,877
|
|
|
|
1,760
|
|
Dental
|
|
|
785
|
|
|
|
773
|
|
|
|
776
|
|
Medicare
|
|
|
400
|
|
|
|
349
|
|
|
|
321
|
|
Medicare Part D
|
|
|
299
|
|
|
|
326
|
|
|
|
215
|
|
Acquired
business - medical
|
|
|
603
|
|
|
|
-
|
|
|
|
-
|
|
Other medical
(4)
|
|
|
1,168
|
|
|
|
1,062
|
|
|
|
929
|
|
|
|
|
Total medical
|
|
|
8,856
|
|
|
|
8,424
|
|
|
|
7,763
|
|
Life and other non-medical
|
|
|
156
|
|
|
|
235
|
|
|
|
305
|
|
Acquired
business - non-medical
|
|
|
28
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
Total premiums
|
|
|
9,040
|
|
|
|
8,659
|
|
|
|
8,068
|
|
Fees
(5)
|
|
|
2,208
|
|
|
|
2,007
|
|
|
|
1,762
|
|
Acquired
business - Fees
|
|
|
367
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
Total premiums and fees
|
|
|
11,615
|
|
|
|
10,666
|
|
|
|
9,830
|
|
Mail order pharmacy revenues
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
Other revenues
|
|
|
317
|
|
|
|
250
|
|
|
|
226
|
|
Net investment income
|
|
|
200
|
|
|
|
202
|
|
|
|
261
|
|
|
|
|
Segment revenues
|
|
$
|
13,336
|
|
|
$
|
12,236
|
|
|
$
|
11,462
|
|
Income taxes
|
|
$
|
352
|
|
|
$
|
358
|
|
|
$
|
353
|
|
Segment earnings
|
|
$
|
664
|
|
|
$
|
679
|
|
|
$
|
653
|
|
|
(1) Premiums and/or fees associated with certain specialty products are also included.
(2) Includes premiums associated with other risk-related products, primarily indemnity network and PPO plans.
(3) Includes minimum premium members who have a risk profile similar to experience-rated funding arrangements. The risk portion of minimum premium
revenue is reported in experience-rated medical premium whereas the self funding portion of minimum premium revenue is recorded in fees. Also includes
certain non-participating cases for which special customer level reporting of experience is required.
(4) Other medical premiums include risk revenue for stop-loss and specialty products.
(5) Represents administrative service fees for medical members and related specialty product fees for non-medical members as well as fees related to
Medicare Part D of $96 million in 2008, $61 million in 2007 and $27 million in 2006.
131
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
Disability and Life
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life
|
|
$
|
1,261
|
|
|
$
|
1,148
|
|
|
$
|
1,050
|
|
|
Disability
|
|
|
1,004
|
|
|
|
942
|
|
|
|
798
|
|
|
Other
|
|
|
297
|
|
|
|
284
|
|
|
|
260
|
|
|
|
|
|
Total
|
|
|
2,562
|
|
|
|
2,374
|
|
|
|
2,108
|
|
|
Other revenues
|
|
|
117
|
|
|
|
131
|
|
|
|
161
|
|
|
Net investment income
|
|
|
256
|
|
|
|
276
|
|
|
|
256
|
|
|
|
|
|
Segment revenues
|
|
$
|
2,935
|
|
|
$
|
2,781
|
|
|
$
|
2,525
|
|
|
Income taxes
|
|
$
|
109
|
|
|
$
|
92
|
|
|
$
|
85
|
|
|
Segment earnings
|
|
$
|
273
|
|
|
$
|
254
|
|
|
$
|
226
|
|
|
International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care
|
|
$
|
856
|
|
|
$
|
845
|
|
|
$
|
702
|
|
|
Life, Accident and Health
|
|
|
1,014
|
|
|
|
955
|
|
|
|
824
|
|
|
|
|
|
Total
|
|
|
1,870
|
|
|
|
1,800
|
|
|
|
1,526
|
|
|
Other revenues
|
|
|
18
|
|
|
|
7
|
|
|
|
2
|
|
|
Net investment income
|
|
|
79
|
|
|
|
77
|
|
|
|
79
|
|
|
|
|
|
Segment revenues
|
|
$
|
1,967
|
|
|
$
|
1,884
|
|
|
$
|
1,607
|
|
|
Income taxes
|
|
$
|
102
|
|
|
$
|
96
|
|
|
$
|
75
|
|
|
Equity in income of investees
|
|
$
|
8
|
|
|
$
|
3
|
|
|
$
|
-
|
|
|
Segment earnings
|
|
$
|
182
|
|
|
$
|
176
|
|
|
$
|
138
|
|
|
Run-off Reinsurance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees and other revenues
|
|
$
|
374
|
|
|
$
|
13
|
|
|
$
|
(33
|
)
|
|
Net investment income
|
|
|
104
|
|
|
|
93
|
|
|
|
95
|
|
|
|
|
|
Segment revenues
|
|
$
|
478
|
|
|
$
|
106
|
|
|
$
|
62
|
|
|
Income tax benefits
|
|
$
|
(375
|
)
|
|
$
|
(43
|
)
|
|
$
|
(4
|
)
|
|
Segment loss
|
|
$
|
(646
|
)
|
|
$
|
(11
|
)
|
|
$
|
(14
|
)
|
|
Other Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees and other revenues
|
|
$
|
184
|
|
|
$
|
190
|
|
|
$
|
215
|
|
|
Net investment income
|
|
|
414
|
|
|
|
437
|
|
|
|
467
|
|
|
|
|
|
Segment revenues
|
|
$
|
598
|
|
|
$
|
627
|
|
|
$
|
682
|
|
|
Income taxes
|
|
$
|
43
|
|
|
$
|
45
|
|
|
$
|
45
|
|
|
Segment earnings
|
|
$
|
87
|
|
|
$
|
109
|
|
|
$
|
106
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other revenues and eliminations
|
|
$
|
(53
|
)
|
|
$
|
(55
|
)
|
|
$
|
(48
|
)
|
|
Net investment income
|
|
|
10
|
|
|
|
29
|
|
|
|
37
|
|
|
|
|
|
Segment revenues
|
|
$
|
(43
|
)
|
|
$
|
(26
|
)
|
|
$
|
(11
|
)
|
|
Income tax benefits
|
|
$
|
(81
|
)
|
|
$
|
(42
|
)
|
|
$
|
(57
|
)
|
|
Segment loss
|
|
$
|
(162
|
)
|
|
$
|
(97
|
)
|
|
$
|
(95
|
)
|
|
Realized investment gains (losses) from continuing operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized investment gains (losses) from continuing operations
|
|
$
|
(170
|
)
|
|
$
|
15
|
|
|
$
|
220
|
|
|
Income taxes (benefits)
|
|
|
(60
|
)
|
|
|
5
|
|
|
|
75
|
|
|
|
|
|
Realized investment gains (losses) from continuing operations, net of taxes
|
|
$
|
(110
|
)
|
|
$
|
10
|
|
|
$
|
145
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees and other revenues
|
|
$
|
17,004
|
|
|
$
|
15,376
|
|
|
$
|
13,987
|
|
|
Mail order pharmacy revenues
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
|
Net investment income
|
|
|
1,063
|
|
|
|
1,114
|
|
|
|
1,195
|
|
|
Realized investment gains (losses) from continuing operations
|
|
|
(170
|
)
|
|
|
15
|
|
|
|
220
|
|
|
|
|
|
Total revenues
|
|
$
|
19,101
|
|
|
$
|
17,623
|
|
|
$
|
16,547
|
|
|
Income taxes
|
|
$
|
90
|
|
|
$
|
511
|
|
|
$
|
572
|
|
|
Segment earnings
|
|
$
|
398
|
|
|
$
|
1,110
|
|
|
$
|
1,014
|
|
|
Realized investment gains (losses) from continuing operations, net of taxes
|
|
|
(110
|
)
|
|
|
10
|
|
|
|
145
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
288
|
|
|
$
|
1,120
|
|
|
$
|
1,159
|
|
|
132
Premiums and fees, mail order pharmacy revenues and other revenues by product type were as follows
for the years ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Medical
|
|
$
|
12,287
|
|
|
$
|
11,276
|
|
|
$
|
10,227
|
|
Disability
|
|
|
994
|
|
|
|
945
|
|
|
|
798
|
|
Life, Accident and Health
|
|
|
2,766
|
|
|
|
2,619
|
|
|
|
2,439
|
|
Mail order pharmacy
|
|
|
1,204
|
|
|
|
1,118
|
|
|
|
1,145
|
|
Other
|
|
|
957
|
|
|
|
536
|
|
|
|
523
|
|
|
Total
|
|
$
|
18,208
|
|
|
$
|
16,494
|
|
|
$
|
15,132
|
|
|
Note 22 Contingencies and Other Matters
The Company, through its subsidiaries, is contingently liable for various financial guarantees
provided in the ordinary course of business.
A.
Financial Guarantees Primarily Associated with the Sold Retirement Benefits Business
Separate account assets are contractholder funds maintained in accounts with specific investment
objectives. The Company records separate account liabilities equal to separate account assets. In
certain cases, primarily associated with the sold retirement benefits business (which was sold in
April 2004), the Company guarantees a minimum level of benefits for retirement and insurance
contracts, written in separate accounts. The Company establishes an additional liability if
management believes that the Company will be required to make a payment under these guarantees.
The Company guarantees that separate account assets will be sufficient to pay certain retiree or
life benefits. The sponsoring employers are primarily responsible for ensuring that assets are
sufficient to pay these benefits and are required to maintain assets that exceed a certain
percentage of benefit obligations. This percentage varies depending on the asset class within a
sponsoring employers portfolio (for example, a bond fund would require a lower percentage than a
riskier equity fund) and thus will vary as the composition of the portfolio changes. If employers
do not maintain the required levels of separate account assets, the Company or an affiliate of the
buyer has the right to redirect the management of the related assets to provide for benefit
payments. As of December 31, 2008, employers maintained assets that exceeded the benefit
obligations. Benefit obligations under these arrangements were $1.8 billion as of December 31,
2008. As of December 31, 2008, approximately 76% of these guarantees are reinsured by an affiliate
of the buyer of the retirement benefits business. The remaining guarantees are provided by the
Company with minimal reinsurance from third parties. There were no additional liabilities required
for these guarantees as of December 31, 2008. Separate account assets supporting these guarantees
are classified in Levels 1 and 2 of the SFAS No. 157 fair value hierarchy. See Note 11 for further
information on the fair value hierarchy.
B.
Guaranteed Minimum Income Benefit Contracts
The Companys reinsurance operations, which were discontinued in 2000 and are now an inactive
business in run-off mode, reinsured minimum income benefits under certain variable annuity
contracts issued by other insurance companies. A contractholder can elect the guaranteed minimum
income benefit (GMIB) within 30 days of any eligible policy anniversary after a specified
contractual waiting period. The Companys exposure arises when the guaranteed annuitization benefit
exceeds the annuitization benefit based on the policys current account value. At the time of
annuitization, the Company pays the excess (if any) of the guaranteed benefit over the benefit
based on the current account value in a lump sum to the direct writing insurance company.
In periods of declining equity markets or declining interest rates, the Companys GMIB liabilities
increase. Conversely, in periods of rising equity markets and rising interest rates, the Companys
liabilities for these benefits decrease.
The Company estimates the fair value of the GMIB assets and liabilities using assumptions for
market returns and interest rates, volatility of the underlying equity and bond mutual fund
investments, mortality, lapse, annuity election rates, non-performance risk, and risk and profit
charges. Assumptions were updated effective January 1, 2008 to reflect the requirements of SFAS
No. 157. See Note 11 for additional information on how fair values for these liabilities and
related receivables for retrocessional coverage are determined.
The Company is required to disclose the maximum potential undiscounted future payments for
guarantees related to minimum income benefits. Under these guarantees, the future payment amounts
are dependent on equity and bond fund market and interest rate levels
133
prior to and at the date of
annuitization election, which must occur within 30 days of a policy anniversary, after the
appropriate
waiting period. Therefore, the future payments are not fixed and determinable under the terms of
the contract. Accordingly, the Company has estimated the maximum potential undiscounted future
payments using hypothetical adverse assumptions, defined as follows:
|
|
No annuitants surrendered their accounts;
|
|
|
|
All annuitants lived to elect their benefit;
|
|
|
|
All annuitants elected to receive their benefit on the next available date (2009 through
2014); and
|
|
|
|
All underlying mutual fund investment values remained at the December 31, 2008 value of
$1.3 billion with no future returns.
|
The maximum potential undiscounted payments that the Company would make under those assumptions
would aggregate $1.8 billion before reinsurance recoveries. The Company expects the amount of
actual payments to be significantly less than this hypothetical undiscounted aggregate amount. The
Company has retrocessional coverage in place from two external reinsurers which covers 55% of the
exposures on these contracts. The Company bears the risk of loss if its retrocessionaires do not
meet or are unable to meet their reinsurance obligations to the Company.
C.
Certain Other Guarantees
The Company had indemnification obligations to lenders of up to $185 million as of December 31,
2008 related to borrowings by certain real estate joint ventures which the Company either records
as an investment or consolidates. These borrowings, which are nonrecourse to the Company, are
secured by the joint ventures real estate properties with fair values in excess of the loan
amounts and mature at various dates beginning from 2009 through 2014. The Companys
indemnification obligations would require payment to lenders for any actual damages resulting from
certain acts such as unauthorized ownership transfers, misappropriation of rental payments by
others or environmental damages. Based on initial and ongoing reviews of property management and
operations, the Company does not expect that payments will be required under these indemnification
obligations. Any payments that might be required could be recovered through a refinancing or sale
of the assets. In some cases, the Company also has recourse to partners for their proportionate
share of amounts paid. There were no liabilities required for these indemnification obligations as
of December 31, 2008.
As of December 31, 2008, the Company guaranteed that it would compensate the lessors for a
shortfall of up to $44 million in the market value of certain leased equipment at the end of the
lease. Guarantees of $28 million expire in 2012 and $16 million expire in 2016. The Company had
additional liabilities for these guarantees of $4 million as of December 31, 2008.
The Company had indemnification obligations as of December 31, 2008 in connection with acquisition
and disposition transactions. These indemnification obligations are triggered by the breach of
representations or covenants provided by the Company, such as representations for the presentation
of financial statements, the filing of tax returns, compliance with law or the identification of
outstanding litigation. These obligations are typically subject to various time limitations,
defined by the contract or by operation of law, such as statutes of limitation. In some cases, the
maximum potential amount due is subject to contractual limitations based on a percentage of the
transaction purchase price, while in other cases limitations are not specified or applicable. The
Company does not believe that it is possible to determine the maximum potential amount due under
these obligations, since not all amounts due under these indemnification obligations are subject to
limitation. There were no liabilities required for these indemnification obligations as of
December 31, 2008.
The Company does not expect that these guarantees will have a material adverse effect on the
Companys consolidated results of operations, liquidity or financial condition.
D.
Regulatory and Industry Developments
Employee benefits regulation.
The business of administering and insuring employee benefit
programs, particularly health care programs, is heavily regulated by federal and state laws and
administrative agencies, such as state departments of insurance and the Federal Departments of
Labor and Justice, as well as the courts. Regulation and judicial decisions have resulted in
changes to industry and the Companys business practices and will continue to do so in the
future. In addition, the Companys subsidiaries are routinely involved with various claims,
lawsuits and regulatory and IRS audits and investigations that could result in financial liability,
changes in business practices, or both. Health care regulation in its various forms could have an
adverse effect on the Companys health care operations if it inhibits the Companys ability to
respond to market demands or results in increased medical or administrative costs without improving
the quality of care or services.
134
Other possible regulatory and legislative changes or judicial decisions that could have an adverse
effect on the Companys employee benefits businesses include:
|
|
|
additional mandated benefits or services that increase costs;
|
|
|
|
|
legislation that would grant plan participants broader rights to sue their health plans;
|
|
|
|
|
changes in public policy and in the political environment, which could affect state and
federal law, including legislative and regulatory proposals related to health care issues,
which could increase cost and affect the market for the Companys health care products and
services; and pension legislation, which could increase pension cost;
|
|
|
|
|
changes in Employee Retirement Income Security Act (ERISA) regulations resulting in
increased administrative burdens and costs;
|
|
|
|
|
additional restrictions on the use of prescription drug formularies and rulings from
pending purported class action litigation, which could result in adjustments to or the
elimination of the average wholesale price or AWP of pharmaceutical products as a
benchmark in establishing certain rates, charges, discounts, guarantees and fees for
various prescription drugs;
|
|
|
|
|
additional privacy legislation and regulations that interfere with the proper use of
medical information for research, coordination of medical care and disease and disability
management;
|
|
|
|
|
additional variations among state laws mandating the time periods and administrative
processes for payment of health care provider claims;
|
|
|
|
|
legislation that would exempt independent physicians from antitrust laws; and
|
|
|
|
|
changes in federal tax laws, such as amendments that could affect the taxation of
employer provided benefits.
|
The employee benefits industry remains under scrutiny by various state and federal government
agencies and could be subject to government efforts to bring criminal actions in circumstances that
could previously have given rise only to civil or administrative proceedings.
Concentration of risk.
For the Companys International segment, South Korea is the single largest
geographic market. South Korea generated 29% of the segments revenues for year ended December 31,
2008. South Korea generated 39% of the segments earnings for the year ended December 31,
2008. Due to the concentration of business in South Korea, the International segment is exposed to
potential losses resulting from economic and geopolitical developments in that country, as well as
foreign currency movements affecting the South Korean currency, which could have a significant
impact on the segments results and the Companys consolidated financial results.
E.
Litigation and Other Legal Matters
The Company is routinely involved in numerous claims, lawsuits, regulatory and IRS audits,
investigations and other legal matters arising, for the most part, in the ordinary course of the
business of administering and insuring employee benefit programs. An increasing number of claims
are being made for substantial non-economic, extra-contractual or punitive damages. The outcome of
litigation and other legal matters is always uncertain, and outcomes that are not justified by the
evidence can occur. The Company believes that it has valid defenses to the legal matters pending
against it and is defending itself vigorously. Nevertheless, it is possible that resolution of one
or more of the legal matters currently pending or threatened could result in losses material to the
Companys consolidated results of operations, liquidity or financial condition.
Managed care litigation.
On April 7, 2000, several pending actions were consolidated in the United
States District Court for the Southern District of Florida in a multi-district litigation
proceeding captioned
In re Managed Care Litigation
challenging, in general terms, the mechanisms
used by managed care companies in connection with the delivery of or payment for health care
services. The consolidated cases include
Shane v. Humana, Inc., et al.
,
Mangieri v. CIGNA
Corporation
,
Kaiser and Corrigan v. CIGNA Corporation, et al.
and
Amer. Dental Assn v. CIGNA Corp.
et. al.
In 2004, the court approved a settlement agreement between the physician class and CIGNA. However,
a dispute over disallowed claims under the settlement submitted by a representative of certain
class member physicians is in arbitration. Separately, in 2005, the court approved a settlement
between CIGNA and a class of non-physician health care providers. Only the Amer. Dental Assn case
remains unresolved. On February 11, 2009, the Court dismissed five of the six counts of the
complaint without prejudice. The Company will continue to vigorously defend itself in this case.
CIGNA has received insurance
recoveries related to this litigation. In 2008, the Court ruled that the Company is not entitled
to insurance recoveries from one of the two insurers from which the Company is pursuing further
recoveries. CIGNA has appealed that decision.
135
Broker compensation.
Beginning in 2004, the Company, other insurance companies and certain
insurance brokers received subpoenas and inquiries from various regulators, including the New York
and Connecticut Attorneys General, the Florida Office of Insurance Regulation, the U.S. Attorneys
Office for the Southern District of California and the U.S. Department of Labor relating to their
investigations of insurance broker compensation. CIGNA is cooperating with the inquiries and
investigations.
On August 1, 2005, two CIGNA subsidiaries, Connecticut General Life Insurance Company and Life
Insurance Company of North America, were named as defendants in a multi-district litigation
proceeding,
In re Insurance Brokerage Antitrust Litigation
, consolidated in the United States
District Court for the District of New Jersey. The complaint alleges that brokers and insurers
conspired to hide commissions, increasing the cost of employee benefit plans, and seeks treble
damages and injunctive relief. Numerous insurance brokers and other insurance companies are named
as defendants. In 2008, the court ordered the clerk to enter judgment against plaintiffs and in
favor of the defendants. Plaintiffs have filed an appeal. CIGNA denies the allegations and will
continue to vigorously defend itself.
Amara cash balance pension plan litigation.
On December 18, 2001, Janice Amara filed a class
action lawsuit, now captioned
Janice C. Amara, Gisela R. Broderick, Annette S. Glanz, individually
and on behalf of all others similarly situated v. CIGNA Corporation and CIGNA Pension Plan,
in the
United States District Court for the District of Connecticut against CIGNA Corporation and the
CIGNA Pension Plan on behalf of herself and other similarly situated participants in the CIGNA
Pension Plan affected by the 1998 conversion to a cash balance formula. The plaintiffs allege
various ERISA violations including, among other things, that the Plans cash balance formula
discriminates against older employees; the conversion resulted in a wear away period (during which
the pre-conversion accrued benefit exceeded the post-conversion benefit); and these conditions are
not adequately disclosed in the Plan.
In 2008, the court issued a decision finding in favor of CIGNA Corporation and the CIGNA Pension
Plan on the age discrimination and wear away claims. However, the court found in favor of the
plaintiffs on many aspects of the disclosure claims and ordered an enhanced level of benefits from
the existing cash balance formula for the majority of the class, requiring class members to receive
their frozen benefits under the pre-conversion CIGNA Pension Plan and their accrued benefits under
the post-conversion CIGNA Pension Plan. The court also ordered, among other things, pre-judgment
and post-judgment interest. The court has stayed implementation of the decision until the parties
appeals have been exhausted. Both parties have appealed the courts decisions. In the second
quarter of 2008, the Company recorded a charge of $80 million pre-tax ($52 million after-tax),
which principally reflects the Companys current best estimate of the liabilities related to the
court order. The Company will continue to vigorously defend itself in this case.
Ingenix.
On February 13, 2008, State of New York Attorney General Andrew M. Cuomo announced an
industry-wide investigation into the use of data provided by Ingenix, Inc., a subsidiary of
UnitedHealthcare, used to calculate payments for services provided by out-of-network
providers. The Company received four subpoenas from the New York Attorney Generals office in
connection with this investigation and responded appropriately. On February 17, 2009, the Company
entered into an Assurance of Discontinuance resolving the investigation. In connection with the
industry-wide resolution, the Company will contribute $10 million to the establishment of a new
non-profit company that will compile and provide the data currently provided by Ingenix. In
addition, on March 28, 2008, the Company received a voluntary request for production of documents
from the Connecticut Attorney Generals office seeking certain out-of-network claim payment
information. The Company is responding appropriately.
The Company is also a defendant in two putative class actions (
Franco et al. v. Connecticut General
Life Insurance Co., CIGNA Corporation and CIGNA Health Corporation
and
Chazen et al.
v. Connecticut General Life Insurance Co., CIGNA Corporation and CIGNA Health Corporation
) brought
on behalf of members and one putative class action brought on behalf of providers (
AMA et al. v.
Connecticut General Life Insurance Co.
) asserting that due to the use of Ingenix data, the Company
improperly underpaid claims, an industry-wide issue. The
Franco
putative class action filed on
March 22, 2004 in federal district court in New Jersey asserts claims under ERISA and the RICO
statute on behalf of members of CIGNA plans. Plaintiff seeks to recover alleged underpayments in
relation to out-of-network claims for the period from 1998 to present. In 2008, the court denied
the Companys motion to dismiss for lack of standing while indicating that the named plaintiffs
unique situation might undermine her adequacy as a class representative. The parties are
conducting significant discovery, and we expect the class certification hearing to occur in the
second quarter of 2009. On August 15, 2008, the same counsel that filed the
Franco
case, filed a
second putative class action in the same court as the
Franco
case on behalf of a different class
representative, David Chazen, in order to address potential issues regarding Francos adequacy as a
class representative. The alleged damages period in the
Chazen
case encompasses 2002 to present.
On February 9, 2009, the same counsel that filed the
Franco
case, filed a third putative class
action in the same court as the
Franco
case on behalf of providers. The alleged damages period in
the
AMA
case encompasses 2005 to present. The Company denies the allegations asserted in the
investigations and litigation and will vigorously defend itself in these matters.
136
Report of Independent Registered Public Accounting Firm
To the Board of Directors
and Shareholders of CIGNA Corporation
In our opinion, the accompanying consolidated balance sheets and the related consolidated
statements of income, comprehensive income and changes in shareholders equity and cash flows
present fairly, in all material respects, the financial position of CIGNA Corporation and its
subsidiaries (the Company) at December 31, 2008 and December 31, 2007, and the results of their
operations and their cash flows for each of the three years in the period ended December 31, 2008
in conformity with accounting principles generally accepted in the United States of America. Also
in our opinion, the Company maintained, in all material respects, effective internal control over
financial reporting as of December 31, 2008, based on criteria established in Internal Control -
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission
(COSO). The Companys management is responsible for these financial statements, for maintaining
effective internal control over financial reporting and for its assessment of the effectiveness of
internal control over financial reporting, included in Managements Annual Report on Internal
Control over Financial Reporting. Our responsibility is to express opinions on these financial
statements and on the Companys internal control over financial reporting based on our integrated
audits. We conducted our audits in accordance with the standards of the Public Company Accounting
Oversight Board (United States). Those standards require that we plan and perform the audits to
obtain reasonable assurance about whether the financial statements are free of material
misstatement and whether effective internal control over financial reporting was maintained in all
material respects. Our audits of the financial statements included examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall
financial statement presentation. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a
material weakness exists, and testing and evaluating the design and operating effectiveness of
internal control based on the assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audits provide a
reasonable basis for our opinions.
As discussed in Note 2(B) to the Consolidated Financial Statements, the Company adopted Statement
of Financial Accounting Standards No. 157, Fair Value Measurements effective January 1, 2008.
A companys internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A
companys internal control over financial reporting includes those policies and procedures that (i)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of management and directors of the company;
and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 26, 2009
137
Quarterly Financial Data
(unaudited)
The following unaudited quarterly financial data is presented on a consolidated basis for each
of the years ended December 31, 2008 and 2007. Quarterly financial results necessarily rely
heavily on estimates. This and certain other factors, such as the seasonal nature of portions of
the insurance business, suggest the need to exercise caution in drawing specific conclusions from
quarterly consolidated results.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except per share amounts)
|
|
Three Months Ended
|
|
|
|
March 31
|
|
|
June 30
|
|
|
Sept. 30
|
|
|
Dec. 31
|
|
|
Consolidated Results
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
4,569
|
|
|
$
|
4,863
|
|
|
$
|
4,852
|
|
|
$
|
4,817
|
|
|
Income (loss) from continuing operations before income taxes
|
|
|
73
|
|
|
|
413
|
|
|
|
232
|
|
|
|
(340
|
)
|
|
Net income (loss)
|
|
|
58
|
(1)
|
|
|
272
|
(2)
|
|
|
171
|
(3)
|
|
|
(209)
|
(4)
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
0.21
|
|
|
|
0.98
|
|
|
|
0.63
|
|
|
|
(0.77
|
)
|
|
Diluted
|
|
|
0.21
|
|
|
|
0.97
|
|
|
|
0.62
|
|
|
|
(0.77
|
)
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
4,374
|
|
|
$
|
4,381
|
|
|
$
|
4,413
|
|
|
$
|
4,455
|
|
|
Income from continuing operations before income taxes
|
|
|
413
|
|
|
|
328
|
|
|
|
502
|
|
|
|
388
|
|
|
Net income
|
|
|
289
|
(5)
|
|
|
198
|
(6)
|
|
|
365
|
(7)
|
|
|
263
|
(8)
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
1.00
|
|
|
|
0.70
|
|
|
|
1.30
|
|
|
|
0.95
|
|
|
Diluted
|
|
|
0.98
|
|
|
|
0.68
|
|
|
|
1.28
|
|
|
|
0.93
|
|
|
Stock and Dividend Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price range of common stock high
|
|
$
|
56.98
|
|
|
$
|
44.43
|
|
|
$
|
44.13
|
|
|
$
|
34.47
|
|
|
low
|
|
$
|
36.75
|
|
|
$
|
35.07
|
|
|
$
|
31.76
|
|
|
$
|
8.00
|
|
|
Dividends declared per common share
|
|
$
|
0.040
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price range of common stock high
|
|
$
|
49.11
|
|
|
$
|
56.87
|
|
|
$
|
54.70
|
|
|
$
|
56.89
|
|
|
low
|
|
$
|
42.33
|
|
|
$
|
47.63
|
|
|
$
|
43.65
|
|
|
$
|
48.21
|
|
|
Dividends declared per common share
|
|
$
|
0.008
|
|
|
$
|
0.010
|
|
|
$
|
0.010
|
|
|
$
|
0.010
|
|
|
|
|
(1)
|
|
The first quarter of 2008 includes an after-tax loss of $195 million for the GMIB business
and an after-tax charge of $24 million associated with litigation matters.
|
|
|
(2)
|
|
The second quarter of 2008 includes an after-tax benefit of $34 million for the GMIB business
and an after-tax charge of $52 million associated with litigation matters.
|
|
|
(3)
|
|
The third quarter of 2008 includes an after-tax loss of $61 million for the GMIB business.
|
|
|
(4)
|
|
The fourth quarter of 2008 includes an after-tax loss of $215 million for the GMIB business,
an after-tax loss of $192 million for the GMDB business and an
after-tax charge of $35 million
for the cost reduction program partially offset by an after-tax benefit of $47 million for a
reduction in management incentive compensation accruals.
|
|
|
(5)
(6)
|
|
The first quarter of 2007 includes an after-tax loss of $15 million for the GMIB business.
The second quarter of 2007 includes an after-tax loss of $61 million for the GMIB business.
|
|
|
(7)
|
|
The third quarter of 2007 includes an after-tax benefit of $23 million related to an IRS
settlement.
|
|
|
(8)
|
|
The fourth quarter of 2007 includes an after-tax loss of $17 million for the GMIB business.
|
138
Item 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Item 9A.
CONTROLS AND PROCEDURES
A. Disclosure Controls and Procedures
Based on an evaluation of the effectiveness of CIGNAs disclosure controls and procedures
conducted under the supervision and with the participation of CIGNAs management, CIGNAs Chief
Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered
by this report, CIGNAs disclosure controls and procedures are effective to ensure that information
required to be disclosed by CIGNA in the reports that it files or submits under the Exchange Act is
recorded, processed, summarized and reported, within the time periods specified in the SECs rules
and forms.
B. Internal Control Over Financial Reporting
Managements Annual Report on Internal Control over Financial Reporting
The Companys management report on internal control over financial reporting under the caption
Managements Annual Report on Internal Control over Financial Reporting on page 80 in this Form
10-K.
139
Attestation Report of the Registered Public Accounting Firm
The attestation report of CIGNAs independent registered public accounting firm, on the
effectiveness of CIGNAs internal control over financial reporting appears under the caption
Report of Independent Registered Public Accounting Firm on page 137 of this Form 10-K.
Changes in Internal Control Over Financial Reporting
There have been no changes in CIGNAs internal control over financial reporting identified in
connection with the evaluation described in the above paragraph that have materially affected, or
are reasonably likely to materially affect, CIGNAs internal control over financial reporting.
Item 9B.
OTHER INFORMATION
None.
PART III
Item 10.
DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
A
.
Directors of the Registrant
The information under the captions The Board of Directors Nominees for Terms to Expire in
April 2012, Directors Who Will Continue in Office, Board of Directors and Committee Meetings,
Membership, Attendance and Independence (as it relates to Audit Committee disclosure), and
Section 16(a) Beneficial Ownership Reporting Compliance in CIGNAs proxy statement to be dated on
or about March 19, 2009 is incorporated by reference.
B. Executive Officers of the Registrant
See
PART I Executive Officers of the Registrant on page 40 in this Form 10-K.
C. Code of Ethics and Other Corporate Governance Disclosures
CIGNAs Code of Ethics is the Companys code of business conduct and ethics,
and applies to CIGNAs directors, officers (including the chief executive officer, chief financial
officer and chief accounting officer) and employees. The Code of
Ethics is posted on the Corporate Governance section found on the About Us page of the Companys
website, www.cigna.com. In the event the Company substantively amends its Code of Ethics or waives a provision of the Code, CIGNA intends to disclose the amendment or waiver on
the Corporate Governance section of the Companys website.
In addition, the Companys corporate governance guidelines (Board Practices) and the charters
of its board committees (audit, corporate governance, executive, finance and people resources) are
available on the Corporate Governance section of the Companys website. These corporate governance
documents, as well as the Code of Ethics, are available in print to any
shareholder who requests them.
Item 11.
EXECUTIVE COMPENSATION
The information under the captions Director Compensation, Report of the People Resources
Committee, Compensation Discussion and Analysis and Executive Compensation in CIGNAs proxy
statement to be dated on or about March 19, 2009 is incorporated by reference.
140
Item 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS
The following table presents information regarding CIGNAs equity compensation plans as of December
31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
|
|
|
|
|
|
|
|
|
Securities Remaining
|
|
|
|
|
|
|
|
|
|
|
Available For Future
|
|
|
Securities To Be Issued
|
|
Weighted Average
|
|
Issuance Under Equity
|
|
|
Upon Exercise Of
|
|
Exercise Price Of
|
|
Compensation Plans
|
|
|
Outstanding Options,
|
|
Outstanding Options,
|
|
(Excluding Securities
|
Plan Category
|
|
Warrants And Rights
|
|
Warrants And Rights
|
|
Reflected In Column (a))
|
Equity Compensation
Plans Approved by
Security Holders
|
|
|
12,237,289
|
|
|
$
|
35.49
|
|
|
|
28,488,871
|
|
Equity Compensation
Plans Not Approved by
Security
Holders
(1)
|
|
|
21,185
|
|
|
$
|
27.06
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
12,258,474
|
|
|
$
|
35.48
|
|
|
|
28,488,871
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Consists of the CIGNA-Healthsource Stock Plan of 1997 discussed below under
Description of the Equity Compensation Plan Not Approved by Security Holders.
|
Description of the Equity Compensation Plan Not Approved by Security Holders
. The
CIGNA-Healthsource Stock Plan of 1997 was adopted by CIGNAs Board of Directors in 1997 in
connection with the acquisition of Healthsource, Inc. The plan provided for CIGNA stock option
grants to replace prior Healthsource stock option grants as well as new incentive compensation
grants to Healthsource employees after the acquisition. The plan had terms similar to those
included in other CIGNA equity compensation plans existing at the time but provided only for the
grant of stock options and restricted stock. No grants were made under the plan after 1999.
The information under the captions Stock held by Directors, Nominees and Executive Officers and
Largest Security Holders in CIGNAs proxy statement to be dated on or about March 19, 2009 is
incorporated by reference.
Item 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The information under the caption Certain Transactions in CIGNAs proxy statement to be
dated on or about March 19, 2009 is incorporated by reference.
Item 14
. PRINCIPAL ACCOUNTING FEES AND SERVICES
The information under the captions Policy for the Pre-Approval of Audit and Non-Audit
Services and Fees to Independent Registered Public Accounting Firm in CIGNAs proxy statement to
be dated on or about March 19, 2009 is incorporated by reference.
PART IV
Item 15.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
|
|
(a)
|
|
(1) The following Financial Statements appear on pages 82 through 137:
|
|
|
|
Consolidated Statements of Income for the years ended December 31, 2008, 2007 and 2006.
|
|
|
|
Consolidated Balance Sheets as of December 31, 2008 and 2007.
|
|
|
|
Consolidated Statements of Comprehensive Income and Changes in Shareholders Equity for the
years ended December 31, 2008, 2007 and 2006.
|
|
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2008, 2007 and 2006.
|
|
|
|
Notes to the Consolidated Financial Statements.
|
|
|
|
Report of
Independent Registered Public Accounting Firm.
|
|
|
|
(2) The financial statement schedules are listed in the Index to Financial Statement
Schedules on page FS-1.
|
|
141
|
|
|
|
|
(3) The exhibits are listed in the Index to Exhibits beginning on page E-1.
|
142
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
Date: February 26, 2009
|
|
|
|
|
|
CIGNA CORPORATION
|
|
|
By:
|
/s/ Michael
W. Bell
|
|
|
|
Michael W. Bell
|
|
|
|
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer)
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
Principal Executive Officer
:
|
|
Directors
:*
|
|
|
|
H. Edward Hanway*
|
|
Robert H. Campbell
|
Chairman, Chief Executive Officer
|
|
Isaiah Harris, Jr.
|
and a Director
|
|
Jane E. Henney, M.D.
|
|
|
Peter N. Larson
|
|
|
Roman Martinez IV
|
|
|
John M. Partridge
|
|
|
James E. Rogers
|
|
|
Carol Cox Wait
|
|
|
Eric C. Wiseman
|
|
|
Donna F. Zarcone
|
|
|
William D. Zollars
|
Principal Accounting Officer:
|
|
|
|
|
|
/s/
Annmarie T. Hagan
Annmarie T. Hagan
|
|
|
Vice President
|
|
|
Chief Accounting Officer and Controller
|
Date: February 26, 2009
|
|
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Nicole S. Jones
|
|
|
|
|
|
|
Nicole S. Jones
|
|
|
|
|
|
|
Attorney-in-Fact
|
|
|
|
|
|
|
Date: February 26, 2009
|
|
|
143
CIGNA CORPORATION AND SUBSIDIARIES
INDEX
TO FINANCIAL STATEMENT SCHEDULES
Schedules other than those listed above are omitted because they are not required or are not
applicable, or the required information is shown in the financial statements or notes thereto.
FS-1
Report of Independent Registered Public Accounting Firm on
Financial Statement Schedules
To the Board of Directors
of CIGNA Corporation:
Our audits of the consolidated financial statements and of the effectiveness of internal control
over financial reporting referred to in our report dated February 26, 2009 (which report and
consolidated financial statements are included under Item 8 in this Annual Report on Form 10-K)
also included an audit of the financial statement schedules listed in Item 15(a)(2) of this Form
10-K. In our opinion, these financial statement schedules present fairly, in all material
respects, the information set forth therein when read in conjunction with the related consolidated
financial statements.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 26, 2009
FS-2
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE I
SUMMARY OF INVESTMENTS-OTHER THAN INVESTMENTS IN RELATED PARTIES
December 31, 2008
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount at
|
|
|
|
|
|
|
|
|
|
|
|
which shown in
|
|
|
|
|
|
|
|
Fair
|
|
|
the Consolidated
|
|
Type of Investment
|
|
Cost
|
|
|
Value
|
|
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bonds:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States government and government
agencies and authorities
|
|
$
|
359
|
|
|
$
|
762
|
|
|
$
|
762
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
States, municipalities and political subdivisions
|
|
|
2,391
|
|
|
|
2,486
|
|
|
|
2,486
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign governments
|
|
|
882
|
|
|
|
944
|
|
|
|
944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public utilities
|
|
|
740
|
|
|
|
738
|
|
|
|
738
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All other corporate bonds
|
|
|
6,453
|
|
|
|
6,095
|
|
|
|
6,095
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States government agencies mortgage-backed
|
|
|
36
|
|
|
|
37
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other mortgage-backed
|
|
|
150
|
|
|
|
125
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other asset-backed
|
|
|
456
|
|
|
|
571
|
|
|
|
571
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable preferred stocks
|
|
|
25
|
|
|
|
23
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturities
|
|
|
11,492
|
|
|
|
11,781
|
|
|
|
11,781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stocks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial, miscellaneous and all other
|
|
|
13
|
|
|
|
24
|
|
|
|
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non redeemable preferred stocks
|
|
|
127
|
|
|
|
88
|
|
|
|
88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity securities
|
|
|
140
|
|
|
|
112
|
|
|
|
112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans on real estate
|
|
|
3,617
|
|
|
|
|
|
|
|
3,617
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policy loans
|
|
|
1,556
|
|
|
|
|
|
|
|
1,556
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate investments
|
|
|
53
|
|
|
|
|
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term investments
|
|
|
578
|
|
|
|
|
|
|
|
632
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term investments
|
|
|
236
|
|
|
|
|
|
|
|
236
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
$
|
17,672
|
|
|
|
|
|
|
$
|
17,987
|
|
|
|
|
|
|
|
|
|
|
|
|
FS-3
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF CIGNA CORPORATION
(REGISTRANT)
STATEMENTS OF INCOME
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other revenues
|
|
$
|
-
|
|
|
$
|
1
|
|
|
$
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
-
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
|
140
|
|
|
|
116
|
|
|
|
101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany interest
|
|
|
220
|
|
|
|
325
|
|
|
|
277
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
108
|
|
|
|
49
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
468
|
|
|
|
490
|
|
|
|
468
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(468
|
)
|
|
|
(489
|
)
|
|
|
(466
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefit
|
|
|
(161
|
)
|
|
|
(164
|
)
|
|
|
(166
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss of parent company
|
|
|
(307
|
)
|
|
|
(325
|
)
|
|
|
(300
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in income of subsidiaries from continuing operations
|
|
|
595
|
|
|
|
1,445
|
|
|
|
1,459
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
288
|
|
|
|
1,120
|
|
|
|
1,159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of taxes
|
|
|
4
|
|
|
|
(5
|
)
|
|
|
(4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
292
|
|
|
$
|
1,115
|
|
|
$
|
1,155
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Financial Statements on pages FS-7 and FS-8.
FS-4
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF CIGNA CORPORATION
(REGISTRANT)
BALANCE SHEETS
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
$
|
1
|
|
|
|
|
|
|
$
|
-
|
|
|
Investments in subsidiaries
|
|
|
|
|
|
|
12,275
|
|
|
|
|
|
|
|
12,581
|
|
|
Other assets
|
|
|
|
|
|
|
723
|
|
|
|
|
|
|
|
293
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
$
|
12,999
|
|
|
|
|
|
|
$
|
12,874
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany
|
|
|
|
|
|
$
|
5,088
|
|
|
|
|
|
|
$
|
5,514
|
|
|
Short-term debt
|
|
|
|
|
|
|
299
|
|
|
|
|
|
|
|
-
|
|
|
Long-term debt
|
|
|
|
|
|
|
1,998
|
|
|
|
|
|
|
|
1,698
|
|
|
Other liabilities
|
|
|
|
|
|
|
2,022
|
|
|
|
|
|
|
|
914
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
9,407
|
|
|
|
|
|
|
|
8,126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock (shares issued, 351)
|
|
|
|
|
|
|
88
|
|
|
|
|
|
|
|
88
|
|
|
Additional paid in capital
|
|
|
|
|
|
|
2,502
|
|
|
|
|
|
|
|
2,474
|
|
|
Net unrealized appreciation (depreciation) fixed maturities
|
|
$
|
(147
|
)
|
|
|
|
|
|
$
|
140
|
|
|
|
|
|
|
Net unrealized appreciation equity securities
|
|
|
7
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
|
Net unrealized depreciation derivatives
|
|
|
(13
|
)
|
|
|
|
|
|
|
(19)
|
|
|
|
|
|
|
Net translation of foreign currencies
|
|
|
(60
|
)
|
|
|
|
|
|
|
61
|
|
|
|
|
|
|
Postretirement benefits liability adjustment
|
|
|
(861
|
)
|
|
|
|
|
|
|
(138)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
|
|
|
|
(1,074)
|
|
|
|
|
|
|
|
51
|
|
|
Retained earnings
|
|
|
|
|
|
|
7,374
|
|
|
|
|
|
|
|
7,113
|
|
|
Less treasury stock, at cost
|
|
|
|
|
|
|
(5,298)
|
|
|
|
|
|
|
|
(4,978
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
|
|
|
|
3,592
|
|
|
|
|
|
|
|
4,748
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
|
|
|
|
$
|
12,999
|
|
|
|
|
|
|
$
|
12,874
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Financial Statements on pages FS-7 and FS-8.
FS-5
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF CIGNA CORPORATION
(REGISTRANT)
STATEMENTS OF CASH FLOWS
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Cash Flows from Operating Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
$
|
292
|
|
|
$
|
1,115
|
|
|
$
|
1,155
|
|
Adjustments to reconcile net income
to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in income of subsidiaries
|
|
|
(595
|
)
|
|
|
(1,445
|
)
|
|
|
(1,459
|
)
|
(Income) loss from discontinued operations
|
|
|
(4
|
)
|
|
|
5
|
|
|
|
4
|
|
Dividends received from subsidiaries
|
|
|
535
|
|
|
|
1,026
|
|
|
|
1,745
|
|
Other liabilities
|
|
|
74
|
|
|
|
87
|
|
|
|
347
|
|
Other, net
|
|
|
(116
|
)
|
|
|
275
|
|
|
|
(172
|
)
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
186
|
|
|
|
1,063
|
|
|
|
1,620
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Other, net
|
|
|
|
|
|
|
21
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
|
|
|
|
21
|
|
|
|
(15
|
)
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in intercompany debt
|
|
|
(426
|
)
|
|
|
(271
|
)
|
|
|
787
|
|
Net change in short-term debt
|
|
|
299
|
|
|
|
|
|
|
|
|
|
Net proceeds on issuance of long-term debt
|
|
|
297
|
|
|
|
498
|
|
|
|
246
|
|
Repayment of long-term debt
|
|
|
|
|
|
|
(376
|
)
|
|
|
(100
|
)
|
Issuance of common stock
|
|
|
37
|
|
|
|
248
|
|
|
|
251
|
|
Common dividends paid
|
|
|
(14
|
)
|
|
|
(11
|
)
|
|
|
(12
|
)
|
Repurchase of common stock
|
|
|
(378
|
)
|
|
|
(1,185
|
)
|
|
|
(2,765
|
)
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
(185
|
)
|
|
|
(1,097
|
)
|
|
|
(1,593
|
)
|
Net increase (decrease) in cash and cash equivalents
|
|
|
1
|
|
|
|
(13
|
)
|
|
|
12
|
|
Cash and cash equivalents, beginning of year
|
|
|
|
|
|
|
13
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
1
|
|
|
$
|
|
|
|
$
|
13
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Financial Statements on pages FS-7 and FS-8.
FS-6
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF CIGNA CORPORATION
(REGISTRANT)
NOTES TO CONDENSED FINANCIAL STATEMENTS
The accompanying condensed financial statements should be read in conjunction with the
Consolidated Financial Statements and the accompanying notes thereto in the Annual Report.
Note 1 For purposes of these condensed financial statements, CIGNA Corporations (the Company)
wholly owned subsidiaries are recorded using the equity basis of accounting. Certain
reclassifications have been made to prior years amounts to conform to the 2008 presentation.
Note 2 On April 25, 2007, the Companys Board of Directors approved a three-for-one stock split
(in the form of a stock dividend) of the Companys common shares. The stock split was
effective on June 4, 2007 for shareholders of record as of the close of business on May 21,
2007.
Note 3 Short-term and long-term debt consisted of the following at December 31:
|
|
|
|
|
|
|
|
|
(In millions)
|
|
2008
|
|
|
2007
|
|
|
Short-term:
|
|
|
|
|
|
|
|
|
Commercial Paper
|
|
$
|
299
|
|
|
$
|
-
|
|
|
Total short-term debt
|
|
$
|
299
|
|
|
$
|
-
|
|
|
Long-term:
|
|
|
|
|
|
|
|
|
Uncollateralized debt:
|
|
|
|
|
|
|
|
|
7% Notes due 2011
|
|
$
|
222
|
|
|
$
|
222
|
|
6.375% Notes due 2011
|
|
|
226
|
|
|
|
226
|
|
5.375% Notes due 2017
|
|
|
250
|
|
|
|
250
|
|
6.35% Notes due 2018
|
|
|
300
|
|
|
|
-
|
|
7.65% Notes due 2023
|
|
|
100
|
|
|
|
100
|
|
8.3% Notes due 2023
|
|
|
17
|
|
|
|
17
|
|
7.875 % Debentures due 2027
|
|
|
300
|
|
|
|
300
|
|
8.3% Step Down Notes due 2033
|
|
|
83
|
|
|
|
83
|
|
6.15% Notes due 2036
|
|
|
500
|
|
|
|
500
|
|
|
Total long-term debt
|
|
$
|
1,998
|
|
|
$
|
1,698
|
|
|
Under a universal shelf registration statement filed with the Securities and Exchange
Commission (SEC), the Company issued $300 million of 6.35% Notes on March 4, 2008 (with an
effective interest rate of 6.68% per year). Interest is payable on March 15 and September 15
of each year beginning September 15, 2008. These Notes will mature on March 15, 2018.
The Company may redeem these Notes, at any time, in whole or in part, at a redemption price
equal to the greater of:
|
|
|
100% of the principal amount of the Notes to be redeemed; or
|
|
|
|
|
the present value of the remaining principal and interest payments on the Notes being
redeemed discounted at the applicable Treasury Rate plus 40 basis points.
|
On March 14, 2008, the Company entered into a new commercial paper program (the Program).
Under the Program, the Company is authorized to sell from time to time short-term unsecured
commercial paper notes up to a maximum of $500 million. The proceeds are used for general
corporate purposes, including working capital, capital expenditures, acquisitions and share
repurchases. The Company uses the credit facility entered into in June 2007, as back-up
liquidity to support the outstanding commercial paper. If at any time funds are not
available on favorable terms under the Program, the Company may use its credit agreement for
funding. In October 2008, the Company added an additional dealer to its Program. As of
December 31, 2008, the Company had $299 million in commercial paper outstanding, at a
weighted average interest rate of 6.31%, used to finance the Great-West Healthcare
acquisition and for other corporate purposes.
FS-7
In June 2007, the Company amended and restated its five year revolving credit and letter of
credit agreement for $1.75 billion, which permits up to $1.25 billion to be used for letters
of credit. The credit agreement includes options, which are subject to consent by the
administrative agent and the committing bank, to increase the commitment amount up to $2.0
billion and to extend the term of the agreement. The Company entered into the agreement for
general corporate purposes, including support for the issuance of commercial paper and to
obtain statutory reserve credit for certain reinsurance arrangements. There was a $25
million of letter of credit issued as of December 31, 2008.
Maturities of long-term debt are as follows (in millions): none in 2009 and 2010, $448 in
2011, none in 2012 and the remainder in years after 2012.
Interest paid on short- and long-term debt amounted to $135 million, $116 million and $101
million for 2008, 2007 and 2006, respectively.
Note 4Intercompany liabilities consist primarily of loans payable to CIGNA Holdings, Inc. of $5.1
billion as of December 31, 2008 and $5.6 billion as of December 31, 2007. Interest was
accrued at an average monthly rate of 4.23% and 5.62% for 2008 and 2007, respectively.
Note 5As of December 31, 2008, the Company had guarantees and similar agreements in place to
secure payment obligations or solvency requirements of certain wholly owned subsidiaries as
follows:
|
|
|
The Company has arranged for bank letters of credit in support of CIGNA Global
Reinsurance Company, an indirect wholly owned subsidiary domiciled in Bermuda, in the
amount of $57 million. These letters of credit primarily secure the payment of
insureds claims from run-off reinsurance operations. The Company has agreed to
indemnify the banks providing the letters of credit in the event of any draw. As of
December 31, 2008 approximately $40 million of the letters of credit are issued.
|
|
|
|
|
The Company has provided a capital commitment deed in an amount up to $185 million
in favor of CIGNA Global Reinsurance Company. This deed is equal to the letters of
credit securing the payment of insureds claims from run-off reinsurance operations.
This deed is required by Bermuda regulators to have these letters of credit for the
London run-off reinsurance operations included as admitted assets.
|
|
|
|
|
Various indirect, wholly owned subsidiaries have obtained surety bonds in the normal
course of business. If there is a claim on a surety bond and the subsidiary is unable
to pay, the Company guarantees payment to the company issuing the surety bond. The
aggregate amount of such surety bonds as of December 31, 2008 was $61 million.
|
|
|
|
|
The Company is obligated under a $25 million letter of credit required by the
insurer of its high-deductible self-insurance programs to indemnify the insurer for
claim liabilities that fall within deductible amounts for policy years dating back to
1994.
|
|
|
|
|
The Company also provides solvency guarantees aggregating $34 million under state
and federal regulations in support of its indirect wholly owned medical HMOs in several
states.
|
|
|
|
|
The Company has arranged a $100 million letter of credit in support of CIGNA Europe
Insurance Company, an indirect wholly owned subsidiary. The Company has agreed to
indemnify the banks providing the letters of credit in the event of any draw. CIGNA
Europe Insurance Company is the holder of the letters of credit.
|
|
|
|
|
In addition, the Company has agreed to indemnify payment of losses included in CIGNA
Europe Insurance Companys reserves on the assumed reinsurance business transferred
from ACE. As of December 31, 2008, the reserve was $152 million.
|
In 2008, no payments have been made on these guarantees and none are pending. The Company
provided other guarantees to subsidiaries that, in the aggregate, do not represent a material
risk to the Companys results of operations, liquidity or financial condition.
FS-8
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE III
SUPPLEMENTARY INSURANCE INFORMATION
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
|
|
|
Future policy
|
|
|
Medical claims
|
|
|
|
|
|
|
policy
|
|
|
benefits and
|
|
|
payable and
|
|
|
Unearned
|
|
|
|
acquisition
|
|
|
contractholder
|
|
|
unpaid
|
|
|
premiums
|
|
Segment
|
|
costs
|
|
|
deposit funds
|
|
|
claims
|
|
|
and fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care
|
|
$
|
60
|
|
|
$
|
551
|
|
|
$
|
1,138
|
|
|
$
|
70
|
|
Disability and Life
|
|
|
7
|
|
|
|
956
|
|
|
|
3,104
|
|
|
|
36
|
|
International
|
|
|
650
|
|
|
|
843
|
|
|
|
205
|
|
|
|
265
|
|
Run-off Reinsurance
|
|
|
-
|
|
|
|
1,611
|
|
|
|
356
|
|
|
|
-
|
|
Other Operations
|
|
|
72
|
|
|
|
13,332
|
|
|
|
158
|
|
|
|
43
|
|
Corporate
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
789
|
|
|
$
|
17,293
|
|
|
$
|
4,961
|
|
|
$
|
414
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care
|
|
$
|
51
|
|
|
$
|
533
|
|
|
$
|
1,198
|
|
|
$
|
75
|
|
Disability and Life
|
|
|
9
|
|
|
|
879
|
|
|
|
3,080
|
|
|
|
39
|
|
International
|
|
|
682
|
|
|
|
912
|
|
|
|
230
|
|
|
|
331
|
|
Run-off Reinsurance
|
|
|
-
|
|
|
|
875
|
|
|
|
452
|
|
|
|
1
|
|
Other Operations
|
|
|
74
|
|
|
|
13,542
|
|
|
|
142
|
|
|
|
50
|
|
Corporate
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
816
|
|
|
$
|
16,741
|
|
|
$
|
5,102
|
|
|
$
|
496
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care
|
|
$
|
37
|
|
|
$
|
617
|
|
|
$
|
1,221
|
|
|
$
|
79
|
|
Disability and Life
|
|
|
10
|
|
|
|
867
|
|
|
|
2,915
|
|
|
|
44
|
|
International
|
|
|
579
|
|
|
|
809
|
|
|
|
204
|
|
|
|
334
|
|
Run-off Reinsurance
|
|
|
-
|
|
|
|
890
|
|
|
|
746
|
|
|
|
1
|
|
Other Operations
|
|
|
81
|
|
|
|
14,226
|
|
|
|
145
|
|
|
|
41
|
|
Corporate
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
707
|
|
|
$
|
17,409
|
|
|
$
|
5,231
|
|
|
$
|
499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FS- 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of deferred
|
|
|
|
|
|
|
|
|
|
|
Net
|
|
|
|
|
|
|
policy
|
|
|
Other
|
|
|
|
Premiums
|
|
|
investment
|
|
|
Benefit
|
|
|
acquisition
|
|
|
operating
|
|
|
|
and fees (1)
|
|
|
income
(2)
|
|
|
expenses
(1)(3)
|
|
|
expenses
|
|
|
expenses
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
11,615
|
|
|
$
|
200
|
|
|
$
|
7,445
|
|
|
$
|
138
|
|
|
$
|
4,737
|
|
|
|
|
2,562
|
|
|
|
256
|
|
|
|
1,914
|
|
|
|
6
|
|
|
|
633
|
|
|
|
|
1,870
|
|
|
|
79
|
|
|
|
1,003
|
|
|
|
164
|
|
|
|
516
|
|
|
|
|
43
|
|
|
|
104
|
|
|
|
782
|
|
|
|
-
|
|
|
|
717
|
|
|
|
|
113
|
|
|
|
414
|
|
|
|
408
|
|
|
|
6
|
|
|
|
54
|
|
|
|
|
-
|
|
|
|
10
|
|
|
|
(15)
|
|
|
|
-
|
|
|
|
215
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
16,203
|
|
|
$
|
1,063
|
|
|
$
|
11,537
|
|
|
$
|
314
|
|
|
$
|
6,872
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
10,666
|
|
|
$
|
202
|
|
|
$
|
7,023
|
|
|
$
|
100
|
|
|
$
|
4,076
|
|
|
|
|
2,374
|
|
|
|
276
|
|
|
|
1,819
|
|
|
|
6
|
|
|
|
610
|
|
|
|
|
1,800
|
|
|
|
77
|
|
|
|
997
|
|
|
|
124
|
|
|
|
491
|
|
|
|
|
60
|
|
|
|
93
|
|
|
|
(24)
|
|
|
|
-
|
|
|
|
184
|
|
|
|
|
108
|
|
|
|
437
|
|
|
|
400
|
|
|
|
12
|
|
|
|
61
|
|
|
|
|
-
|
|
|
|
29
|
|
|
|
(16)
|
|
|
|
-
|
|
|
|
129
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
15,008
|
|
|
$
|
1,114
|
|
|
$
|
10,199
|
|
|
$
|
242
|
|
|
$
|
5,551
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
9,830
|
|
|
$
|
261
|
|
|
$
|
6,371
|
|
|
$
|
71
|
|
|
$
|
4,014
|
|
|
|
|
2,108
|
|
|
|
256
|
|
|
|
1,578
|
|
|
|
6
|
|
|
|
630
|
|
|
|
|
1,526
|
|
|
|
79
|
|
|
|
861
|
|
|
|
113
|
|
|
|
420
|
|
|
|
|
64
|
|
|
|
95
|
|
|
|
26
|
|
|
|
-
|
|
|
|
54
|
|
|
|
|
113
|
|
|
|
467
|
|
|
|
441
|
|
|
|
12
|
|
|
|
78
|
|
|
|
|
-
|
|
|
|
37
|
|
|
|
(13)
|
|
|
|
-
|
|
|
|
154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
13,641
|
|
|
$
|
1,195
|
|
|
$
|
9,264
|
|
|
$
|
202
|
|
|
$
|
5,350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Amounts presented are shown net of the effects of reinsurance. See Note 8 to the
Consolidated Financial Statements included in CIGNAs 2008 Annual Report.
|
|
(2)
|
|
The allocation of net investment income is based upon the investment year method, the
identification of certain portfolios with specific segments, or a combination of both.
|
|
(3)
|
|
Benefit expenses include Health Care medical claims expense and other benefit expenses.
|
|
(4)
|
|
Other operating expenses include mail order pharmacy cost of goods sold, GMIB expense and
other operating expenses, and excludes amortization of deferred policy acquisition expenses.
|
FS-10
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE IV
REINSURANCE
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Ceded to
|
|
|
Assumed
|
|
|
|
|
|
|
of amount
|
|
|
|
Gross
|
|
|
other
|
|
|
from other
|
|
|
Net
|
|
|
assumed
|
|
|
|
amount
|
|
|
companies
|
|
|
companies
|
|
|
amount
|
|
|
to net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force
|
|
$
|
392,803
|
|
|
$
|
44,116
|
|
|
$
|
108,106
|
|
|
$
|
456,793
|
|
|
|
23.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance and annuities
|
|
$
|
2,429
|
|
|
$
|
281
|
|
|
$
|
333
|
|
|
$
|
2,481
|
|
|
|
13.4
|
%
|
Accident and health insurance
|
|
|
13,061
|
|
|
|
230
|
|
|
|
891
|
|
|
|
13,722
|
|
|
|
6.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
15,490
|
|
|
$
|
511
|
|
|
$
|
1,224
|
|
|
$
|
16,203
|
|
|
|
7.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force
|
|
$
|
376,065
|
|
|
$
|
42,886
|
|
|
$
|
99,281
|
|
|
$
|
432,460
|
|
|
|
23.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance and annuities
|
|
$
|
2,288
|
|
|
$
|
280
|
|
|
$
|
355
|
|
|
$
|
2,363
|
|
|
|
15.0
|
%
|
Accident and health insurance
|
|
|
12,782
|
|
|
|
181
|
|
|
|
44
|
|
|
|
12,645
|
|
|
|
0.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
15,070
|
|
|
$
|
461
|
|
|
$
|
399
|
|
|
$
|
15,008
|
|
|
|
2.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance in force
|
|
$
|
360,802
|
|
|
$
|
39,375
|
|
|
$
|
128,514
|
|
|
$
|
449,941
|
|
|
|
28.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums and fees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life insurance and annuities
|
|
|
2,081
|
|
|
|
290
|
|
|
|
403
|
|
|
|
2,194
|
|
|
|
18.4
|
%
|
Accident and health insurance
|
|
|
11,514
|
|
|
|
181
|
|
|
|
114
|
|
|
|
11,447
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
13,595
|
|
|
$
|
471
|
|
|
$
|
517
|
|
|
$
|
13,641
|
|
|
|
3.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FS-11
CIGNA CORPORATION AND SUBSIDIARIES
SCHEDULE V
VALUATION AND QUALFTYING ACCOUNTS AND RESERVES
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charged
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Credited)
|
|
|
Charged
|
|
|
|
|
|
|
|
|
|
Balance at
|
|
|
to
|
|
|
(Credited)
|
|
|
Other
|
|
|
Balance
|
|
|
|
beginning
|
|
|
costs and
|
|
|
to other
|
|
|
deductions
|
|
|
at end
|
|
Description
|
|
of period
|
|
|
expenses
|
|
|
accounts
|
|
|
-describe
(1)
|
|
|
of period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment asset valuation reserves:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
1
|
|
|
$
|
2
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3
|
|
|
Allowance for doubtful accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, accounts and notes
receivable
|
|
$
|
54
|
|
|
$
|
12
|
|
|
$
|
1
|
|
|
$
|
(17
|
)
|
|
$
|
50
|
|
|
Deferred tax asset valuation allowance
|
|
$
|
150
|
|
|
$
|
(15
|
)
|
|
$
|
-
|
|
|
$
|
(9
|
)
|
|
$
|
126
|
|
|
Reinsurance recoverables
|
|
$
|
27
|
|
|
$
|
(3
|
)
|
|
$
|
-
|
|
|
$
|
(1
|
)
|
|
$
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment asset valuation reserves:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
-
|
|
|
$
|
1
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1
|
|
|
Allowance for doubtful accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, accounts and notes
receivable
|
|
$
|
46
|
|
|
$
|
15
|
|
|
$
|
-
|
|
|
$
|
(7
|
)
|
|
$
|
54
|
|
|
Deferred tax asset valuation allowance
|
|
$
|
174
|
|
|
$
|
(19
|
)
|
|
$
|
-
|
|
|
$
|
(5
|
)
|
|
$
|
150
|
|
|
Reinsurance recoverables
|
|
$
|
161
|
|
|
$
|
(23
|
)
|
|
$
|
-
|
|
|
$
|
(111
|
)
|
|
$
|
27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment asset valuation reserves:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgage loans
|
|
$
|
2
|
|
|
$
|
3
|
|
|
$
|
-
|
|
|
$
|
(5
|
)
|
|
$
|
-
|
|
|
Allowance for doubtful accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, accounts and notes
receivable
|
|
$
|
62
|
|
|
$
|
5
|
|
|
$
|
1
|
|
|
$
|
(22
|
)
|
|
$
|
46
|
|
|
Deferred tax asset valuation allowance
|
|
$
|
161
|
|
|
$
|
7
|
|
|
$
|
-
|
|
|
$
|
6
|
|
|
$
|
174
|
|
|
Reinsurance recoverables
|
|
$
|
158
|
|
|
$
|
12
|
|
|
$
|
-
|
|
|
$
|
(9
|
)
|
|
$
|
161
|
|
|
|
|
(1)
|
|
Reflects charge-offs upon write-off of underlying receivable balances. The change in the deferred tax valuation allowance in 2008 and 2007
reflects a reserve release upon the write-off of a portion of the underlying deferred tax asset, resulting in no earnings impact. The change in
reinsurance recoverables reflects settlement of underlying reinsurance recoverables, resulting in no earnings impact.
|
FS-12
INDEX
TO EXHIBITS
|
|
|
|
|
|
|
Number
|
|
|
|
Description
|
|
Method of Filing
|
|
|
|
|
|
|
|
3.1
|
|
|
|
Restated Certificate of
Incorporation of the
registrant as last amended
April 23, 2008
|
|
Filed as Exhibit 3.1 to the
registrants Form 10-Q for the
period ended March 31, 2008
and incorporated herein by
reference.
|
|
3.2
|
|
|
|
By-Laws of the registrant as
last amended and restated
April 23, 2008
|
|
Filed herewith.
|
Exhibits 10.1 through 10.22 are identified as management contracts or compensatory plans or
arrangements pursuant to Item 15 of Form 10-K.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1
|
|
|
|
Deferred Compensation Plan
for Directors of CIGNA
Corporation, as amended and
restated January 1, 1997
|
|
Filed as Exhibit 10.1 to
the registrants Form 10-K
for the year ended December
31, 2006 and incorporated
herein by reference.
|
|
|
|
|
|
|
|
10.2
|
|
|
|
Deferred Compensation Plan
of 2005 for Directors of
CIGNA Corporation,
effective January 1, 2005
|
|
Filed as Exhibit 10.2 to
the registrants Form 10-K
for the year ended December
31, 2007 and incorporated herein by reference.
|
|
|
|
|
|
|
|
10.3
|
|
|
|
CIGNA Restricted Share
Equivalent Plan for
Non-Employee Directors
amended and restated
effective January 1, 2008
|
|
Filed as Exhibit 10.3 to
the registrants Form 10-K
for the year ended December
31, 2007 and incorporated
herein by reference.
|
|
|
|
|
|
|
|
10.4
|
|
|
|
CIGNA Corporation
Non-Employee Director
Compensation Program
amended and restated
effective January 1, 2008
|
|
Filed as Exhibit 10.2 to
the registrants Form 10-K
for the year ended December
31, 2007 and incorporated
herein by reference.
|
|
|
|
|
|
|
|
10.5
|
(a)
|
|
|
CIGNA Corporation Stock
Plan, as amended and
restated through July 2000
|
|
Filed as Exhibit 10.4 to
the registrants Form 10-K
for the year ended December
31, 2003 and incorporated herein by reference.
|
|
|
|
|
|
|
|
10.6
|
|
|
|
CIGNA Stock Unit Plan, as
amended and restated
effective July 22, 2008
|
|
Filed as Exhibit 10.1 to
the registrants Form 10-Q
for the period ended
September 30, 2008 and
incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.7
|
(a)
|
|
|
CIGNA Executive Severance
Benefits Plan amended and
restated effective July
22, 2008
|
|
Filed as Exhibit 10.2 to
the registrants Form 10-Q
for the period ended
September 30, 2008 and
incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.8
|
|
|
|
Description of Severance
Benefits for Executives in
Non-Change of Control
Circumstances
|
|
Filed as Exhibit 10.6 to
the registrants Form 10-K
for the year ended
December 31, 2004 and
incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.9
|
|
|
|
CIGNA Executive Incentive Plan
amended and restated January 1,
2008
|
|
Filed as Exhibit 10.8 to the
registrants Form 10-K for the
year ended December 31, 2007
and incorporated herein by
reference.
|
E-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.10
|
|
|
|
CIGNA Long-Term Incentive
Plan amended and restated
effective as of January 1,
2008
|
|
Filed as Exhibit 10.9 to the
registrants Form 10-K for
the year ended December 31,
2007 and incorporated herein
by reference.
|
|
|
|
|
|
|
|
10.11
|
|
|
|
CIGNA Deferred Compensation
Plan, as amended and restated
October 24, 2001
|
|
Filed as Exhibit 10.10 to the
registrants Form 10-K for
the year ended December 31,
2006 and incorporated herein
by reference.
|
|
|
|
|
|
|
|
10.12
|
|
|
|
CIGNA Deferred Compensation
Plan of 2005 effective as of
January 1, 2005
|
|
Filed as Exhibit 10.12 to the
registrants Form 10-K for
the year ended December 31,
2007 and incorporated herein
by reference.
|
|
|
|
|
|
|
|
10.13
|
|
|
|
Description of Amendments to
Executive Management
Compensation Arrangements
|
|
Filed as Exhibit 10.1 to the
registrants Form 10-Q for
the quarter ended March 31,
2005 and incorporated herein
by reference.
|
|
|
|
|
|
|
|
10.14
|
(a)
|
|
|
CIGNA Supplemental Pension
Plan as amended and
restated August 1, 1998
|
|
Filed as Exhibit 10.9(a)
to the registrants Form
10-K
for the year ended
December 31, 2003 and
incorporated herein by
reference.
|
|
|
|
|
|
|
|
|
(b)
|
|
|
Amendment No. 1 to the CIGNA
Supplemental Pension Plan,
effective as of September 1,
1999
|
|
Filed as Exhibit 10.10(b) to
the registrants Form 10-K for
the year ended December 31,
2004 and incorporated herein by
reference.
|
|
|
|
|
|
|
|
|
(c)
|
|
|
Amendment No. 2 dated December
6, 2000 to the CIGNA
Supplemental Pension
|
|
Filed as Exhibit 10.12(c) to
the registrants Form 10-K for
the year ended December 31,
2006 and incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.15
|
|
|
|
CIGNA Supplemental Pension
Plan of 2005 effective as of
January 1, 2005
|
|
Filed as Exhibit 10.15 to the
registrants Form 10-K for the
year ended December 31, 2007
and incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.16
|
|
|
|
Description of CIGNA
Corporation Financial Services
Program
|
|
Filed as Exhibit 10.10 to the
registrants Form 10-K for the
year ended December 31, 2003
and incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.17
|
|
|
|
Description of Mandatory
Deferral of Non-Deductible
Executive Compensation
Arrangement
|
|
Filed as Exhibit 10.14 to the
registrants Form 10-K for the
year ended December 31, 2006
and incorporated herein by
reference.
|
|
|
|
|
|
|
|
10.18
|
|
|
|
Form of Non-Compete Agreement
dated December 8, 1997 with
Mr. Hanway
|
|
Filed as Exhibit 10.15 to the
registrants Form 10-K for the
year ended December 31, 2002
and incorporated by reference.
|
|
|
|
|
|
|
|
10.19
|
|
|
|
Special Incentive Agreement
with Mr. Hanway dated March
17, 1998
|
|
Filed as Exhibit 10.19 to the
registrants Form 10-K for the
period ended December 31, 2002
and incorporated herein by
reference
|
E-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.20
|
|
|
|
Schedule regarding Amended Deferred
Stock Unit Agreements effective December
31, 2008 with Messrs. Hanway, Bell and
Murabito and Form of Amended Deferred
Stock Unit Agreement
|
|
Filed herewith.
|
|
|
|
|
|
|
|
10.21
|
|
|
|
Agreement and Release dated June 6, 2008 with
Mr. Hartley
|
|
Filed herewith.
|
|
|
|
|
|
|
|
10.22
|
|
|
|
Form of CIGNA Long-Term Incentive Plan:
Nonqualified Stock Option and Grant
Letter
|
|
Filed as Exhibit
10.22 to the
registrants Form 10-K for the period ended December 31, 2007 and incorporated herein by reference.
|
|
|
|
|
|
|
|
10.23
|
|
|
|
Asset and Stock Purchase Agreement between
Great-West Life & Annuity Insurance
Company, et al and Connecticut General
Life Insurance Company
|
|
Filed as Exhibit 10.23 to the registrants Form 10-K for the period
ended December 31,
2007 and
incorporated herein by reference.
|
|
|
|
|
|
|
|
12
|
|
|
|
Computation of Ratios of Earnings to
Fixed Charges
|
|
Filed herewith.
|
|
|
|
|
|
|
|
21
|
|
|
|
Subsidiaries of the Registrant
|
|
Filed herewith.
|
|
|
|
|
|
|
|
23
|
|
|
|
Consent of Independent Registered Public
Accounting Firm
|
|
Filed herewith.
|
|
|
|
|
|
|
|
24.1
|
(a)
|
|
|
Powers of Attorney
|
|
Filed as Exhibit
24.1 to the
registrants
Post-Effective
Amendment No. 1 to
Form S-8
Registration
Statement Under the
Securities Act of
1933 dated August
3, 2007 and
incorporated herein
by reference.
|
|
|
|
|
|
|
|
|
(b)
|
|
|
John M. Partridge Power of Attorney
|
|
Filed herewith.
|
|
|
|
|
|
|
|
31.1
|
|
|
|
Certification of Chief Executive
Officer of CIGNA Corporation
pursuant to Rule 13a-14(a) or Rule
15d-14(a) of the Securities
Exchange Act of 1934
|
|
Filed herewith.
|
|
|
|
|
|
|
|
31.2
|
|
|
|
Certification of Chief Financial
Officer of CIGNA Corporation
pursuant to Rule 13a-14(a) or Rule
15d-14(a) of the Securities
Exchange Act of 1934
|
|
Filed herewith.
|
|
|
|
|
|
|
|
32.1
|
|
|
|
Certification of Chief Executive
Officer of CIGNA Corporation
pursuant to Rule 13a-14(b) or Rule
15d-14(b) and 18 U.S.C. Section
1350
|
|
Furnished herewith.
|
|
|
|
|
|
|
|
32.2
|
|
|
|
Certification of Chief Financial
Officer of CIGNA Corporation
pursuant to Rule 13a-14(b) or Rule
15d-14(b) and 18 U.S.C. Section
1350
|
|
Furnished herewith.
|
The registrant will furnish to the Commission upon request a copy of any of the registrants
agreements with respect to its long-term debt.
Shareholders may obtain copies of exhibits by writing to CIGNA Corporation, Shareholder Services
Department, 1601 Chestnut Street, TL18, Philadelphia, PA 19192.
E-3